Session » 2016 ACR/ARHP Annual Meeting
- 9:00AM-11:00AM
-
Abstract Number: 89
2015 ACR/ARHP Workforce Study (WFS): Adult Rheumatology Specialists in the United States: Effect of Gender and Generation
- 9:00AM-11:00AM
-
Abstract Number: 93
2015 ACR/ARHP Workforce Study in the United States: Adult Rheumatologist Supply and Demand Projections for 2015-2030
- 9:00AM-11:00AM
-
Abstract Number: 768
7-Year Safety and Efficacy of Belimumab in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 164
99mtc-Hdp Digital Blood Flow Scintigraphy for Assessment of Raynaud Phenomenon Associated with Hand-Arm Vibration Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 909
A “Yellow Card” Reporting System for Sight Loss in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 332
A Comparison of Electronic and Manual Fracture Risk Assessment Tools in Screening US Veterans at Risk for Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 354
A Longitudinal Cohort Study of Denosmab and Bisphosphonate for Prevention of Vertebral Fracture in Glucocorticoid-Induced Osteoporosis in Japanese
- 9:00AM-11:00AM
-
Abstract Number: 570
A Molecular Timeline for Preclinical RA Pathogenesis Defined By Dysregulated PTPN22, Hypercitrullination, and Aberrant Cytokine/Metabolic Profiles in PBMC of at-Risk Individuals
- 9:00AM-11:00AM
-
Abstract Number: 736
A Multi-Center, Open Label, Randomized Clinical Tries of Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 446
A Multi-Group Confirmatory Factor Analyses of the Lupuspro Between Southern California and Filipino Samples of Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 850
A Multicentre Reliability Study of Laser Speckle Contrast Imaging and Thermography in Patients with Raynaud’s Phenomenon Secondary to Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 835
A Normal Pulmonary Diffusion Capacity Is Rare in Pulmonary Artery Hypertension in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 79
A NOVEL Missense Mvk mutation in a Family with Familial Mediterranean Fever-like Disease
- 9:00AM-11:00AM
-
Abstract Number: 807
A Novel Multi-Network Approach Reveals Tissue-Specific Cellular Modulators of Fibrosis in Systemic Sclerosis, Pulmonary Fibrosis and Pulmonary Arterial Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 310
A Novel One Stage Technique Applicable during Arthroscopy for the Mobilization of Synovial Mesenchymal Stromal Cells Towards Joint Regeneration
- 9:00AM-11:00AM
-
Abstract Number: 123
A Panel of Urinary Biomarkers to Assess Renal Involvement in Latin American Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 823
A Phase 2 Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness in Subjects with Systemic Sclerosis with Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 198
A Phase 2 Study to Evaluate the Efficacy and Safety of Febuxostat Extended- Versus Immediate-Release Formulations in Patients with Gout and Moderate Renal Impairment
- 9:00AM-11:00AM
-
Abstract Number: 199
A Phase 3 Study to Evaluate the Efficacy and Safety of Febuxostat Extended- Versus Immediate-Release Formulations in Patients with Gout
- 9:00AM-11:00AM
-
Abstract Number: 748
A Phase 4, Multicenter, Randomized, Open-Label Study to Evaluate the Effect of Belimumab on Vaccine Responses in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 742
A Pivotal Phase III, Randomized, Placebo-Controlled Study of Belimumab in Patients with Systemic Lupus Erythematosus Located in China, Japan, and South Korea
- 9:00AM-11:00AM
-
Abstract Number: 324
A Placebo Controlled Trial of Vertebral Fill Technique Vertebroplasty for Acute Painful Osteoporotic Fracture (VAPOUR Trial)
- 9:00AM-11:00AM
-
Abstract Number: 430
A Process to Obtain Hepatitis B Serology Screening on Immunocompromised Pediatric Rheumatology Patients
- 9:00AM-11:00AM
-
Abstract Number: 83
A Qualitative Study Exploring Participants’ Perception of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Maintain Employment
- 9:00AM-11:00AM
-
Abstract Number: 606
A Randomized, Double Blind, Single Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of ONS-3010 (Adalimumab, Oncobiologics, Inc.) Compared to Two Reference Products of Humira® (AbbVie) in Healthy Adult Subjects
- 9:00AM-11:00AM
-
Abstract Number: 638
A Randomized, Open-Label, Single-Dose, Parallel-Group Trial to Determine the Pharmacokinetics, Safety and Immunogenicity of GP2017, a Proposed Adalimumab Biosimilar, Following a Single Subcutaneous Injection By an Autoinjector or Prefilled Syringe in Healthy Male Subjects
- 9:00AM-11:00AM
-
Abstract Number: 71
A Rare Coding Allele in IFIH1 is Protective for Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 27
A Rheumatologist’s Assessment of Therapy Responses (Rxresp) and Rheumatoid Factor Status (neg/pos) in 1995 Predicted Mortality through 2015 in a Community-Based Cohort of Incident Rheumatoid Arthritis Cases and Matched Control Subjects
- 9:00AM-11:00AM
-
Abstract Number: 524
A Self-Determination Theory Based Intervention to Increase Levels of Cardiorespiratory Fitness, Self-Determined Motivation, Physical Activity and Improve Health Outcomes Among Patients Living with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 391
A Single Centre Experience from India on the Safety and Efficacy of Cipla Etanercept and Intas Etanercept and Its Comparison with Reference Etanercept(Enbrel) in Children with JIA
- 9:00AM-11:00AM
-
Abstract Number: 60
A Single Nucleotide Polymorphism of IL6-Receptor Is Associated with Response to Tocilizumab in Rheumatoid Arthritis: Results from Toci and ROC Studies
- 9:00AM-11:00AM
-
Abstract Number: 777
a Singlecenter Experience of Rituximab Treatment in 86 Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 122
A Small Number of Patients with SLE Account for Most of the Direct and Indirect Hospitalization Costs
- 9:00AM-11:00AM
-
Abstract Number: 833
A Small Proportion of Patients with Systemic Sclerosis with Suspected Pulmonary Hypertension Meet the Published Inclusion/Exclusion Criteria for Two Systemic Sclerosis Associated Pulmonary Arterial Hypertension Screening Algorithms– Results from a Single Center Cohort
- 9:00AM-11:00AM
-
Abstract Number: 328
A Study of Serum Electrolyte Levels after Denosumab Administration
- 9:00AM-11:00AM
-
Abstract Number: 230
A Survey of Knowledge of Optimal Gout Management in an Academic Primary Care Setting
- 9:00AM-11:00AM
-
Abstract Number: 610
A Systematic Review and Meta-Analysis of Comparative Efficacy of Biologics in Treating Patients with Rheumatoid Arthritis: Assessment of Long-Term Radiographic Progression from Published Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 293
A Systematic Review and Network Meta-Analysis of Long-Term Trials of Pharmacological Treatments in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 368
A Systematic Review of Chronic Pain Assessments with Children and Young People: Exploring Administrative, Scoring and Classification Issues
- 9:00AM-11:00AM
-
Abstract Number: 91
A Systematic Review of Smartphone Applications for Measuring and Recording Rheumatoid Arthritis Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 56
A Systems Biology Approach to Investigating Beneficial Effects of Endurance Exercise in Myositis Patients
- 9:00AM-11:00AM
-
Abstract Number: 338
Abaloparatide-SC Significantly Reduces Vertebral and Nonvertebral Fractures and Increases Bone Mineral Density (BMD) Regardless of Age, BMD T-Score, or Prior Fracture at Baseline
- 9:00AM-11:00AM
-
Abstract Number: 277
Abnormal Composition of Circulating T and B Cells in Patients with Polymyositis and Dermatomyositis Is More Biased in Those with Interstitial Lung Diseases
- 9:00AM-11:00AM
-
Abstract Number: 616
ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
- 9:00AM-11:00AM
-
Abstract Number: 650
ABT-122, a Tnf– and IL-17–Targeted Dual Variable Domain (DVD)–Ig™ in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results from a Phase 2 Trial
- 9:00AM-11:00AM
-
Abstract Number: 648
ABT-122, an Anti-TNF/Anti-IL-17 Dual Variable Domain Antibody, Alters T Cell Responses in Human Subjects
- 9:00AM-11:00AM
-
Abstract Number: 99
Academic and Non-Academic Rheumatology: Practice Trends and Common Barriers to Practice from the 2015 ACR/ARHP Workforce Study Survey
- 9:00AM-11:00AM
-
Abstract Number: 218
Accuracy of Humasens-Plus Point-of-Care Uric Acid Meter Using Capillary Blood Obtained By Fingertip Puncture
- 9:00AM-11:00AM
-
Abstract Number: 582
ACPA Induce Pathogenic Cytokines Expression in PBMC of ACPA+-RA Patients and Inhibition of Its Effect By Cit-ME a Synthetic Citrullinated Peptide
- 9:00AM-11:00AM
-
Abstract Number: 593
Adalimumab (HUMIRA) Halts Radiographic Progression and Reduces Disease Activity in Patients with a Poor Initial Response to Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 453
Adaptation and Validation the Systemic Sclerosis Quality of Life Questionnaire into Spanish Using Rasch Analysis
- 9:00AM-11:00AM
-
Abstract Number: 603
Additional Efficacy Results of SB4 (Etanercept Biosimilar) up to Week 100: Comparison Between Continuing SB4 and Switching from Reference Etanercept (Enbrel®) to SB4
- 9:00AM-11:00AM
-
Abstract Number: 678
Additional Information from CT or MRI Imaging Can Increase Rheumatologists’ Consensus on Grading Sacroiliitis By Radiography: Results of the Trimage Project
- 9:00AM-11:00AM
-
Abstract Number: 424
Adherence to American College of Rheumatology Immunization Recommendations for Rheumatoid Arthritis Patients in a Tertiary Care Health System and Opportunities to Close the Gap
- 9:00AM-11:00AM
-
Abstract Number: 406
Adults with Juvenile Idiopathic Arthritis Are Not Adults with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 15
Adverse Events and Persistency of Biologics in Rheumatoid Arthritis Patients with Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 133
Agreement Between DAS28-ESR, DAS28-CRP, SDAI, CDAI (Simplified/Clinical Disease Activity Index), ACR/EULAR Remission Criteria and Ultrasound Scoring (Naredo-12) in Patients with Rheumatoid Arthritis in Routine Care
- 9:00AM-11:00AM
-
Abstract Number: 203
Allopurinol Dose Escalation and Mortality Among Patients with Gout: A National Propensity-Matched Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 201
Allopurinol Reduces the Risk of Myocardial Infarction (MI) in the Elderly: A Study of Medicare Claims
- 9:00AM-11:00AM
-
Abstract Number: 202
Allopurinol Use and the Risk of Ventricular Tachycardia in the US Elderly: A Study of Medicare Claims Data
- 9:00AM-11:00AM
-
Abstract Number: 178
Alpha-Enolase Promotes Pro-Inflammatory Phenotype of Monocytes-Derived Macrophages
- 9:00AM-11:00AM
-
Abstract Number: 44
Ambroxol for Fibromyalgia. One-Group Pretest-Posttest Open Label Clinical Observation
- 9:00AM-11:00AM
-
Abstract Number: 842
Aminaphtone Treatment Increases Skin Blood Perfusion and Related Clinical Symptoms in Patients Affected By Raynaud’s Phenomenon: A Pilot Study Based on Laser Speckle Contrast Analysis
- 9:00AM-11:00AM
-
Abstract Number: 800
An Altered Cardiovascular System Development Gene Expression Signature in Skin is a Hallmark of Limited Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 95
An Analysis of Malpractice Litigation in Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 464
an Anti-Fima Antibody Attenuates Porphyromonas Gingivalis-Associated Experimental Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 333
An Assessment of Bone Health and Fracture Risk in a Bariatric Surgery Population at an Urban Medical Center
- 9:00AM-11:00AM
-
Abstract Number: 598
An Assessment of the Correlation Between Gender and Anticipated Drug Retention to TNF Inhibitors: A Meta-Regression Analysis
- 9:00AM-11:00AM
-
Abstract Number: 363
An Examination of Patient Knowledge and Education in Patients with Osteoporosis, Osteopenia and Normal Bone Mineral Density
- 9:00AM-11:00AM
-
Abstract Number: 214
Anakinra Compared to Prednisone on the Treatment of Acute CPPD Crystal Arthritis, a Randomized, Controlled, Double-Blind Study
- 9:00AM-11:00AM
-
Abstract Number: 215
Anakinra Is Effective and Well Tolerated in Medically Complex Patients Including Transplant Recipients with Gout
- 9:00AM-11:00AM
-
Abstract Number: 241
Analysis of 84 Patients with IgG4-Related Disease and Malignancy
- 9:00AM-11:00AM
-
Abstract Number: 611
Analysis of a German Subpopulation with Active Rheumatoid Arthritis Treated with Golimumab As Add-on Therapy to Disease-Modifying Antirheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 628
Analysis of Baseline Characteristics of Rheumatoid Arthritis Patients Treated with Abatacept Compared to Those Treated with Tumor Necrosis Factor Inhibitors in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 131
Analysis of Correlation and Causes for Discrepancy Between Quantitative and Semi Quantitative Doppler Scores in Synovitis in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 468
Angiotensin II Exacerbates Bone Destruction in TNF-Transgenic Arthritis Mice
- 9:00AM-11:00AM
-
Abstract Number: 130
Anti-CCP Status Determines the Power Doppler Oscillation Pattern in Rheumatoid Arthritis – a Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 503
Anti-CCP Titer and Prevalence Is Influenced By Age at Rheumatoid Arthritis Onset- Analysis Based on a Nationwide Database in Japan
- 9:00AM-11:00AM
-
Abstract Number: 574
Anti-CCP3.1 and Anti-CCP3-IgA Antibodies Are Associated with Increasing Age in Subjects without Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 576
Anti-CCP3.1 and Anti-CCP3-IgA Are Elevated in RA-Free Subjects with Idiopathic Pulmonary Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 491
Anti-Citrullinated Peptide Antibodies Testing Rate over Time in Newly Diagnosed RA Patients – Data from Three Administrative Claims Databases (2007–2014)
- 9:00AM-11:00AM
-
Abstract Number: 512
Anti-Cyclic Citrullinated Protein Antibody (ACPA) Positivity in General Population and Follow-up Results for ACPA Positive Persons
- 9:00AM-11:00AM
-
Abstract Number: 247
ANTI-Interleukin 1 Therapy in FMF Amyloidosis: A Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 126
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in African-American Patients: Disease Associations and Clinical Outcomes in an Urban Cohort
- 9:00AM-11:00AM
-
Abstract Number: 572
Anti-Periodontal Bacteria Antibody Titers Are Inversely Correlated with ACPA in RA-Free Individuals with Periodontal Disease Compared to Community Controls
- 9:00AM-11:00AM
-
Abstract Number: 752
Anti-Ro Positivity Is a Predictor of Responsiveness to Topical Steroids or Hydroxychloroquine in Patients with Discoid but Not Subacute Cutaneous Lupus
- 9:00AM-11:00AM
-
Abstract Number: 707
Anti-TNF Drugs Are Not Associated with Increasead Risk of Hzv Infections in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry
- 9:00AM-11:00AM
-
Abstract Number: 285
Antibodies to Small Ubiquitin-like Modifier Activating Enzyme: Frequency and Characteristics of Antibody-Positive Patients in an Unselected Cohort
- 9:00AM-11:00AM
-
Abstract Number: 374
Anxiolytic Effects of the Novel α2δ Ligand Mirogabalin (DS-5565) in Sluka Model, an Experimental Animal Model of Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 250
Application of the 2016 European Leage Against Rheumatism (EULAR) /American College of Rheumatology (ACR)/Paediatric Rheumatology International Trials Organisation (PRINTO) Classification Criteria of Macrophage Activation Syndrome in Patients with Adult Onset Still’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 715
Are Patients with Ankylosing Spondylitis Willing to Pay for Treatment with Infliximab?
- 9:00AM-11:00AM
-
Abstract Number: 436
Are Providers Recommending Appropriate Screening for Hydroxychloroquine-Induced Retinal Toxicity to Their Patients?
- 9:00AM-11:00AM
-
Abstract Number: 161
Are Ultrasound Definitions in Gout Reliable?: Preliminary Results from a Latin American Reliability Exercise
- 9:00AM-11:00AM
-
Abstract Number: 863
Arterial Lesions in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 74
Arthritis-Associated DNA Hypermethylation Provokes Increased Antibody Expression in Mouse Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 691
ASAS Health Index for Patients with Spondyloarthritis: Translation into Spanish, Validation, Reliability and Construct Validity
- 9:00AM-11:00AM
-
Abstract Number: 159
Assessing Agreement Among Measures of Inflammation Detected on Magnetic Resonance Imaging, Ultrasound and Clinical Findings in the Feet of Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 605
Assessment of Comparative Immunogenicity in Biosimilar Development: Immunogenicity and Pharmacokinetics Following a Single Dose of M923, a Proposed Biosimilar for Reference Adalimumab (HUMIRA®), Compared with US- and EU-Sourced Reference Adalimumab in Healthy Subjects
- 9:00AM-11:00AM
-
Abstract Number: 339
Assessment of High-Resolution Peripheral Quantitative Computed Tomography Parameters and Markers of Bone Metabolism in Community-Dwelling Elderly with and without Vertebral Fractures – the Sao Paulo Ageing & Health Study
- 9:00AM-11:00AM
-
Abstract Number: 528
Assessment of Metacarpal Head Bone Microarchitecture According to Presence or Not of Inflammation in Rheumatoid Arthritis Patients with Low Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 143
Assessment of Patient Satisfaction, Functionality and Quality of Life after Ultrasound Guided Knee Intervention: A Prospective Study Tejas Sheth, MD. Beverly Johnson, MD, MS. Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY
- 9:00AM-11:00AM
-
Abstract Number: 790
Assessment of the Construct Validity of the Lupus Low Disease Activity State (LLDAS) – an Expert Opinion Case Study
- 9:00AM-11:00AM
-
Abstract Number: 860
Assessment of the Frequency of Cardiovascular Risk Factors in Patients with Takayasu’s Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 879
Associated Inflammatory Diseases in Takayasu’s Arteritis: The Many Faces of a Disease
- 9:00AM-11:00AM
-
Abstract Number: 586
Association Between ACPA Fine Specificity and High Resolution Computed Tomography Lung Changes in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 37
Association Between Fibromyalgia and Bone Mineral Density: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 312
Association Between Grip Strength and Hand and Knee Radiographic Osteoarthritis in Older Adults: Data from the Dong-Gu Study
- 9:00AM-11:00AM
-
Abstract Number: 624
Association Between Methotrexate Use and Effects of Treatment with a Second Biologic Agent in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 596
Association Between Plasma Certolizumab Pegol Concentration and Improvement in Disease Activity in Rheumatoid Arthritis and Crohn’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 675
Association Between Structural Lesions in the Sacroiliac Joints and Spinal Inflammatory Lesions in Patients with Non-Radiographic Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 509
Association of Anti-Citrullinated Protein Antibody Positivity and Titer Levels to Low Hand BMD, and the Consequence of Low Hand BMD on DAS28 (CRP) Remission in Established RA: Findings from a US Observational Cohort
- 9:00AM-11:00AM
-
Abstract Number: 517
Association of Rheumatoid Arthritis Disease Activity and Clinical Profile with Chronic Periodontitis
- 9:00AM-11:00AM
-
Abstract Number: 393
Association of Sex, Race and Ethnicity on Disease Outcomes in Juvenile Idiopathic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 583
Associations of Serum Anti-Citrullinated Proteins and Cytokines with Radiographic Scores in African-American Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 764
Atacicept: Integrated Safety Profile from Phase II Randomized Placebo-Controlled Studies in Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 162
Automated Segmentation of Cartilage Provides Comparable Accuracy and Better Responsiveness Than Manual Segmentation: Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 844
Bardoxolone Methyl Produces Durable Benefits in Participants with Pulmonary Arterial Hypertension: Data from an Open-Label Extension Study
- 9:00AM-11:00AM
-
Abstract Number: 28
Baseline Serum Inflammatory Biomarkers at Cohort Entry in 1974 Predicted Cardiovascular Disease (CVD) Mortality from 1995 through 2015 in a Prospective, Community-Based Study of Incident Rheumatoid Arthritis (RA) Patients and Matched Non-RA (CN) Subjects
- 9:00AM-11:00AM
-
Abstract Number: 811
Basophils Are Activated and Stimulate Both B Cells and Fibroblasts in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 508
Before Clinically Detectable Arthritis Develops, ACPA-Positive and ACPA-Negative Arthralgia Patients Have Different Symptoms
- 9:00AM-11:00AM
-
Abstract Number: 780
Belimumab Use in African-American Patients in an U.S. Academic Medical Center
- 9:00AM-11:00AM
-
Abstract Number: 12
Benefit of Early Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid Arthritis and Undifferentiated Early Arthritis (CONAART)
- 9:00AM-11:00AM
-
Abstract Number: 774
BIIB059, an Anti-BDCA2 Monoclonal Antibody, Demonstrates Acceptable Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamic (PD) Effects in a Phase 1 Study with Single Ascending Doses (SAD) in Healthy Volunteers
- 9:00AM-11:00AM
-
Abstract Number: 331
Biologic Disease-Modifying Anti-Rheumatic Drug Use and the Risk of Non-Vertebral Osteoporotic Fractures in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 631
Biologic Free Remission Rate with Etanercept in Rheumatoid Arthritis: A Potential Role of Gender
- 9:00AM-11:00AM
-
Abstract Number: 637
Biologic Initiation Patterns Among Rheumatoid Arthritis Patients in Moderate or High Disease Activity While Using Conventional Disease Modifying Anti-Rheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 799
Biomarker Identification & Molecular Sub-Classification in Systemic Sclerosis for Precision Medicine Using RNA-Seq
- 9:00AM-11:00AM
-
Abstract Number: 348
Bisphosphonates-Related Atypical Femur Fractures: 8 Years’ Experience in a Single Center
- 9:00AM-11:00AM
-
Abstract Number: 548
Body Mass Index Is Positively Correlated with Diverse Disease Activity Measures in Longstanding Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 167
Bone Mineral Density Loss in Clinically Suspect Arthralgia Is Associated with Subclinical Inflammation and Progression to Clinical Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 546
Boolean-Based Remission in Rheumatoid Arthritis Using Physician Versus Patient Global Assessment: Differences in Ultrasonographic Disease Activities, Sustainabilities, and Relapse Rates
- 9:00AM-11:00AM
-
Abstract Number: 510
C-Reactive Protein and Disease Activity in Rheumatoid Arthritis: Impact of Obesity and Adiposity
- 9:00AM-11:00AM
-
Abstract Number: 128
Call to Action: Cardiovascular Comorbidities in Medicare Rheumatology Beneficiaries
- 9:00AM-11:00AM
-
Abstract Number: 381
Calprotectin As a Multipotent Biomarker in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 492
Calprotectin Levels Correlate with Inflammation in Early Rheumatoid Arthritis before Disease-Modifying Antirheumatic Drug Treatment and after 12 Months of Treatment
- 9:00AM-11:00AM
-
Abstract Number: 651
Calprotectin Serum Levels Strongly Predict Disease Flare in RA and Psa Patients with Low Disease Activity Treated with TNF Inhibitors. a One-Year Prospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 681
Can Bridging Syndesmophytes Independantly Affect Spinal Mobility?
- 9:00AM-11:00AM
-
Abstract Number: 352
Can Lumbar Spine Bone Mineral Density Predict Readmission in Denosumab-Treated Chronic Kidney Disease Patients?
- 9:00AM-11:00AM
-
Abstract Number: 500
Can Thiol/Disulphide Is a Novel Marker in Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 782
Can We Identify Who Benefits from Mycophenolate Mofetil in Systemic Lupus Erythematosus? a Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 614
Canadian Study of Outcomes in Adalimumab (HUMIRA®) Patients with Support for Adherence – Results from the Companion Study
- 9:00AM-11:00AM
-
Abstract Number: 830
Cardiopulmonary Disease Development in Anti-RNA Polymerase III Positive Systemic Sclerosis; Comparative Analyses from an Unselected, Prospective Patient Cohort
- 9:00AM-11:00AM
-
Abstract Number: 881
Cardiopulmonary Involvement in Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 423
Cardiovascular Risk and Lipid Screening in Rheumatoid Arthritis Patients in a University Rheumatology Practice: Quality Improvement Project
- 9:00AM-11:00AM
-
Abstract Number: 472
CCR6 Expression Regulates Arthritis in a T Cell Dependent Manner
- 9:00AM-11:00AM
-
Abstract Number: 179
CD11b+Gr1dimcells, Which Are Induced By GM-CSF Produced By Th17 and Group3 Innate Lymphoid Cell, May Facilitate the Progression of Pneumonitis in SKG Mice
- 9:00AM-11:00AM
-
Abstract Number: 581
Cell-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 350
Change in Bone Mineral Density with High-Dose Prednisone in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 551
Changes in Diverse Disease Activity Measures Are Highly Correlated Following the Initiation of Most Treatment Modalities in the Management of Longstanding Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 353
Changes in Femoral Neck Bone Mineral Density Inverse Correlate with Egfr in Denosumab Treated Osteoporosis Patients? a Hospital-Based Analysis
- 9:00AM-11:00AM
-
Abstract Number: 526
Changes in the Functional Status of the Rheumatoid Arthritis (RA) Population over the Biologic Era
- 9:00AM-11:00AM
-
Abstract Number: 542
Changes on Body Composition in Women with Long-Standing Established Rheumatoid Arthritis: Differences By Level of Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 554
Characteristics of Functional Impairment in Patients with Long-Standing Rheumatoid Arthritis Based on Range of Motion of Joints: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
- 9:00AM-11:00AM
-
Abstract Number: 281
Characterization of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 265
Characterization of Eye Sarcoidosis with or without Systemic Involvement: Application of Iwos Criteria in an Uveitis Unit
- 9:00AM-11:00AM
-
Abstract Number: 237
Characterization of Peripheral Lymphocyte Phenotype in Patients with IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 76
Chromatin Interactions Reveal Novel Gene Targets for Drug Repositioning in Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 371
Chronic Pain in Children Seen at a Rheumatology Clinic: Healthcare Utilization Patterns
- 9:00AM-11:00AM
-
Abstract Number: 595
Cinical Responses and Improvements in Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
- 9:00AM-11:00AM
-
Abstract Number: 891
Clinal Characterisitics and Diagnosis of Patients with Negative Temporal Artery Biopsy and without a Final Diagnosis of Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 620
Clinical Activity, Ultrasound Assessment and Drug Monitoring in Rheumatoid Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration
- 9:00AM-11:00AM
-
Abstract Number: 347
Clinical Analysis of Tumor-Induced Osteomalacia Misdiagnosed As Spondyloarthritis: A Report of 18 Cases
- 9:00AM-11:00AM
-
Abstract Number: 627
Clinical and Immunogenicity Outcomes after Switching Treatment from Innovator Infliximab to Biosimilar Infliximab in Rheumatic Diseases in Daily Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 745
Clinical and Laboratory Correlates of Response in a Phase 3 Clinical Trial of Belimumab or Placebo Administered Subcutaneously Plus Standard Care to Patients with Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 242
Clinical and Laboratory Features of IgG4-Related Retroperitoneal Fibrosis/Periarteritis in Japan: Retrospective Multicenter Study of 99 Cases
- 9:00AM-11:00AM
-
Abstract Number: 730
Clinical and Quality of Life Improvements Observed with Golimumab and Infliximab in a Large Real-Life Ankylosing Spondylitis Population
- 9:00AM-11:00AM
-
Abstract Number: 853
Clinical Associations of Anti-Eukaryotic Initiation Factor 2B (anti-eIF2B) Antibodies in a Large Cohort of Patients with Anti-Nuclear Antibody Negative Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 649
Clinical Evaluation Usefulness of Standardized Protocol Strategies of Dose Reduction in Patients with Rheumatoid Arthritis in Clinical Remission Treated with Biologic Therapies. the Optibio Study
- 9:00AM-11:00AM
-
Abstract Number: 904
Clinical Features and Mortality of 411 Chinese Takayasu’s Arteritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 901
Clinical Features of Takayasu’s Arteritis from an Inception Cohort: Early Disease Is Characterized By ‘systemic Inflammation’
- 9:00AM-11:00AM
-
Abstract Number: 223
Clinical Predictors of Acute Gout Flares within Hospitalized Patients at a Tertiary Care Center in New York
- 9:00AM-11:00AM
-
Abstract Number: 209
Clinical Response of Tophus and Flares to Extended Use of Lesinurad in Combination with a Xanthine Oxidase Inhibitor in Patients with Gout
- 9:00AM-11:00AM
-
Abstract Number: 816
Clinical Response to Treatment with Belimumab and Mycophenolate Mofetil Is Associated with Decrease in B Cell, TGF-β and PDGF Signaling in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 640
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 286
Clinical Significance and Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients with Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 504
Clinical Significance of Multiple Autoantibody Specificities in Rheumatoid Arthritis: The Role of Anti-Citrullinated Alpha-Enolase and Anti-Interferon Inducible Protein 16 Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 558
Clinical, Sonographic and Immunological Biomarkers of Ramris Progression in RA Patients in Clinical Remission: A Prospective Study with 12 Months of Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 257
CNS Manifestations of Patients with Muckle-Wells Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 234
Coexistent Gout and Rheumatoid Arthritis: Comparison of Comorbidity, Autoantibodies, Disease Measures, and All-Cause Mortality
- 9:00AM-11:00AM
-
Abstract Number: 216
Colchicine Prescribing As a Parameter for QA/QI Process in Gout Care
- 9:00AM-11:00AM
-
Abstract Number: 849
Collagen Formation/Degradation Neoepitopes Are Promising Biomarkers for Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 804
Combined-Phenotype Meta-GWAS in Systemic Sclerosis and Rheumatoid Arthritis Identifies IRF4 As a New Common Susceptibility Locus
- 9:00AM-11:00AM
-
Abstract Number: 450
Coming Full Circle with the Omeract RA Flare Questionnaire (RA-FQ): Further Evaluation of the Properties, Meaningfulness, and Utility through Rasch Analysis and Feedback from RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 187
Commensal Microbiota Tune Systemic Toll-like Receptor-Mediated Inflammatory Responses
- 9:00AM-11:00AM
-
Abstract Number: 43
Comorbid Development of Fibromyalgia and Posttraumatic Stress Disorder after Exposure to a Combat Environment
- 9:00AM-11:00AM
-
Abstract Number: 397
Comorbidities Associated with Pediatric Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 407
Comparability of Proxy, Adolescent and Adult Measures of Functional Ability in Adolescents with JIA
- 9:00AM-11:00AM
-
Abstract Number: 149
Comparation of Ultrasonic Imaging of Enthesopathy in the Lower Extremity in Patients with Psoriatic Arthritis, Psoriasis and Other Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 311
Comparative Effectiveness of Ayurveda and Conventional Care in Knee Osteoarthritis – a Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 597
Comparative Effectiveness of Different Anti-TNF Drugs As First Biological DMARD in RA: Results from the Nationwide Swedish Register 2010-2015
- 9:00AM-11:00AM
-
Abstract Number: 632
Comparative Improvement in Health-Related Quality of Life for RA Patients Between TNF-α Inhibitors, Other Biologics, and Tofacitinib: Results from a US-Wide Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 226
Comparing the Burden of Illness of Patients with Tophaceous and Non-Tophaceous Gout in France, Germany, Italy, Spain, UK, and USA
- 9:00AM-11:00AM
-
Abstract Number: 442
Comparison of Adherence and Dosing Interval of Subcutaneous Anti-TNF Biologics in Inflammatory Arthritis from a Canadian Administrative Database.
- 9:00AM-11:00AM
-
Abstract Number: 507
Comparison of Body Mass Index, Anti-Citrullinated Peptides Antibodies Status and Periodontal Condition in First Degree Relatives Individuals to Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 32
Comparison of Effects of Leukocyte-RICH and Leukocyte-Poor Platelet-RICH Plasma on PAIN and Functionality in Patients with Lateral Epicondylitis
- 9:00AM-11:00AM
-
Abstract Number: 726
Comparison of Infliximab Immunogenicity in Inflammatory Arthritis Versus Inflammatory Bowel Disease Patients in Routine Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 559
Comparison of Multi-Dimensional Health Assessment Questionnaire (MD-HAQ)-Based and Patient-Reported Outcomes Measurement Information System (PROMIS) 29-Based Routine Assessment of Patient Index 3 (RAPID3) for Assessing Rheumatoid Arthritis Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 482
Comparison of Nonclinical Pharmacology, Pharmacodynamics and Efficacy Response of the Proposed Adalimumab Biosimilar GP2017 to Originator Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 511
Complement C3 and C4 Levels and Its Correlation with Disease Activity in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 751
Complement C4d Split Products on Erythrocytes Are Associated with Composite Measure of Disease Activity in Systemic Lupus Erythematosus Subjects Receiving Methotrexate and Hydroxychloroquine
- 9:00AM-11:00AM
-
Abstract Number: 786
Complement Split Product iC3b and C3 Blood Levels Best Associate with Active and Clinically Meaningful Changes in SLE Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 836
Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 655
Comprehensive Immuno-Phenotyping of Follicular Helper T Cells and B Cell Subpopulations in Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 619
Concomitant Treatment Use during Treatment with Golimumab in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 547
Concordance Between Ultrasound Joint Synovitis and Clinical Joint Assessments By Patients or Physicians in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 235
Concurrence of Rheumatoid Arthritis and Calcium Pyrophosphate Deposition Disease: Description of a Cohort
- 9:00AM-11:00AM
-
Abstract Number: 870
Contemporary Prevalence Estimates for Giant Cell Arteritis and Polymyalgia Rheumatica, 2015
- 9:00AM-11:00AM
-
Abstract Number: 518
Contribution of Patient Global Assessment on Loss and Gain of Disease Remission in Patients with Established Rheumatoid Arthritis in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 477
Conventional Non-Steroidal Anti-Inflammatory Drugs, but Not COX2 Selective Inhibitors, Are Beneficial on Vascular Function in Arthritis: A Study in Adjuvant Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 343
Correlation Between Metacarpal Cortical Bone Mineral Density Measured By Dual X-Ray Densitometry and Radiogrammetry on Early Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 728
Correlation Between the Spinal MRI Findings and the Serum Level of DKK-1 in Patients with Spondyloarthritis Treated with TNF Antagonist
- 9:00AM-11:00AM
-
Abstract Number: 326
Cortical Bone Changes in Pre- and Postmenopausal Healthy Women Measured with HR-pQCT
- 9:00AM-11:00AM
-
Abstract Number: 253
Corticosteroid-Free Tocilizumab Monotherapy for Adult Onset Still’s Disease: Results in Six Month
- 9:00AM-11:00AM
-
Abstract Number: 308
Crepitus As a Risk Factor for Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 448
Cross-Cultural and Construct Validity of the Animated Activity Questionnaire to Assess Activity Limitations in Patients with Hip and Knee Osteoarthritis in Different Languages
- 9:00AM-11:00AM
-
Abstract Number: 451
Cross-Sectional and Longitudinal Construct Validity for the Improved Health Assessment Questionnaire Among Adults with Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 470
Crucial Involvement of Citrullinated Proteins and ACPA in the Development of Peptide-Glucose-6-Phosphate Isomerase Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 845
Current Use of Off-Label Therapies in Systemic Sclerosis-Associated Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 667
Cytokine and Chemokine Levels in Serum and Saliva As Disease Activity Biomarkers in Patients with Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 663
Cytokine and Chemokine Levels in Serum and Tears As Disease Activity Biomarkers in Patients with Primary Sjögren´s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 252
Cytokine Profiles of Korean Patients with Adult Onset Still’s Disease Treated with Biologic Agents
- 9:00AM-11:00AM
-
Abstract Number: 98
Daily Symptom Reports in a Smartphone-Based Study ‘Cloudy with a Chance of Pain’: Patterns of Attrition over the First Six Months
- 9:00AM-11:00AM
-
Abstract Number: 658
Decreased Expression of Ten Micro-RNAs in Plasmacytoid Dendritic Cells of Patients with Primary SS Indicates Dysregulation on Multiple Levels
- 9:00AM-11:00AM
-
Abstract Number: 463
Deficiency of Transmembrane Protein VISTA (V-domain Immunoglobulin Suppressor of T-cell Activation) Ameliorates Murine Collagen-II Antibody-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 832
Defining Skin Ulcers in Systemic Sclerosis: A Systematic Literature Review of Skin Ulcer Definitions and a Preliminary Consensus-Based New SSc Skin Ulcer Definition
- 9:00AM-11:00AM
-
Abstract Number: 337
Denosumab Treatment for 10 Years in Postmenopausal Women with Osteoporosis Was Associated with Substantially Lower Fracture Incidence Relative to Their Baseline FRAX-Predicted Probability
- 9:00AM-11:00AM
-
Abstract Number: 550
Despite Early Improvement and Limited Self-Reported Disability, Patients with Rheumatoid Arthritis Still Have Impaired Grip Strength 5 Years after Diagnosis
- 9:00AM-11:00AM
-
Abstract Number: 58
Detecting Novel Candidate Risk Genes in Rheumatoid Arthritis with Gene-Based Association Testing
- 9:00AM-11:00AM
-
Abstract Number: 156
Detection of Finger Joint Osteophytes and Bone Erosions By Ultrasound; A Comparison to Computed Tomography and Histology
- 9:00AM-11:00AM
-
Abstract Number: 422
Developing a Staff-Driven Electronic Smoking Cessation Referral Program in Rheumatology Clinics
- 9:00AM-11:00AM
-
Abstract Number: 686
Development and Evaluation of the Combined Ankylosing Spondylitis Spine Score (CASSS) for the Assessment of Spinal Radiographic Outcome
- 9:00AM-11:00AM
-
Abstract Number: 794
Development and Initial Validation of a Novel Lupus Disease Activity Index to Account for Glucocorticoids: Sledai-2K Glucocorticoids Index (SGI)
- 9:00AM-11:00AM
-
Abstract Number: 408
Development and Initial Validation of the Parent and Child Versions of the Juvenile Arthritis Disease Activity Score
- 9:00AM-11:00AM
-
Abstract Number: 680
Development and Preliminary Validation of the Computed Tomography Sacroiliac Structural Score for Assessment of Structural Lesions in Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 709
Development of a Novel Medication Adherence Prediction Model for Patients with Ankylosing Spondylitis Based on Results from a Global Clinical Study
- 9:00AM-11:00AM
-
Abstract Number: 837
Development of a Skin-Specific Scleroderma Patient Reported Outcome Instrument
- 9:00AM-11:00AM
-
Abstract Number: 516
Development of RA Patient Preference Phenotypes
- 9:00AM-11:00AM
-
Abstract Number: 708
Development of Spondyloarthritis-Features in Patients with Chronic Back Pain over a One-Year Course: Data from the Spondyloarthritis Caught Early (SPACE)-Cohort
- 9:00AM-11:00AM
-
Abstract Number: 20
Diabetes and Other Comorbidities in Rheumatoid Arthritis Patients Starting a Biologic DMARD: A Multi-Database Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 694
Diagnostic Delay Leads to Worse Response to Treatment
- 9:00AM-11:00AM
-
Abstract Number: 679
Diagnostic Value of MR Enterography As a Complementary Intervention to Colonoscopy in Axial Spondylarthritis Patients with Chronic Non-Bloody Diarrhea
- 9:00AM-11:00AM
-
Abstract Number: 537
Differences and Associated Factors in General Disability and Hand Disability Between Patients with Rheumatoid Arthritis and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 16
Differences Between Patient and Physician Global Assessment on Rheumatoid Arthritis Disease Activity Status in High and Lower Income Countries Contribute to Inequity
- 9:00AM-11:00AM
-
Abstract Number: 557
Differences in Clinical Outcomes in Different Socio-Economic and Racial Groups with Rheumatoid Arthritis: Data from National Inpatient Sample
- 9:00AM-11:00AM
-
Abstract Number: 575
Differences in Histological Scores and Histoclinical Correlations in ACPA- Versus ACPA+ Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 34
Differential Analgesic Pharmacological Effects on Brain Connectivity in Fibromyalgia (FM)
- 9:00AM-11:00AM
-
Abstract Number: 601
Differing Contribution of Methotrexate Polyglutamation to Infliximab and Adalimumab Exposure As Compared to Etanercept
- 9:00AM-11:00AM
-
Abstract Number: 266
Diffuse Idiopathic Skeletal Hyperostosis and Obesity- Is There a Causal Relationship?
- 9:00AM-11:00AM
-
Abstract Number: 267
Diffuse Idiopathic Skeletal Hyperostosis: Can We Identify Different Clinicoradiological Patterns?
- 9:00AM-11:00AM
-
Abstract Number: 724
Diminished Spinal Radiographic Progression during Long-Term Treatment with TNF-α Inhibitors in Ankylosing Spondylitis Patients at Risk of Poor Radiographic Outcome
- 9:00AM-11:00AM
-
Abstract Number: 552
Disability in Early Rheumatoid Arthritis, Course and Predictors
- 9:00AM-11:00AM
-
Abstract Number: 534
Discordance Between Physician-Stated Remission and 28-Joint Disease Activity Score (DAS28)-Defined Remission in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 409
Discordance Between Physician, Patient, and Parent Disease Assessment Scores in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 897
Discordance Rates of Bilateral Temporal Artery Biopsies: A Retrospective Analysis
- 9:00AM-11:00AM
-
Abstract Number: 418
Discrepancy in Reported and Actual Rates of Counseling on Teratogenicity and the Need for Contraception When Initiating Mycophenolate in Women of Childbearing Age
- 9:00AM-11:00AM
-
Abstract Number: 746
Discrepancy in Rituximab-Induced B-Cell Depletion in Peripheral Blood and the Kidney and Relationship with Clinical Response in Patients with Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 404
Disease Activity and Damage in Juvenile Idiopathic Arthritis: Comparison Between “Methotrexate” and “Biologic” Era
- 9:00AM-11:00AM
-
Abstract Number: 531
Disease Activity and Physical Fatigue As Related to Adherence and Health Literacy in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 600
Disease Activity Trends after Dose Escalation of Infliximab (Remicade) – Results from United States Consortium of Rheumatology Researchers of North America Registry
- 9:00AM-11:00AM
-
Abstract Number: 585
Disease Associated Anti-Citrullinated Protein Memory B Cells in Rheumatoid Arthritis Persist in DAS Remission
- 9:00AM-11:00AM
-
Abstract Number: 127
Disease Characteristics and Outcomes in African-American Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: a High Risk Group for Poor Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 298
Disease Progression in Osteoarthritis Is Driven By Multiple Disease Parameters Leading to Comparable Levels of Joint Destruction
- 9:00AM-11:00AM
-
Abstract Number: 248
Disease Severity and High Attack Frequency Under Colchicine Treatment Is Associated with Increased Carotid Intima Media Thickness in FMF
- 9:00AM-11:00AM
-
Abstract Number: 899
Disparities in Disease Characteristics, Treatment Pattern and Comorbidities in 1,858 Patients with Polymyalgia Rheumatica, Giant Cell Arteritis or Both Diseases
- 9:00AM-11:00AM
-
Abstract Number: 151
Distinct Phenotypes in Palindromic Rheumatism: Ultrasound and MRI during Palindromic Flares
- 9:00AM-11:00AM
-
Abstract Number: 834
Distinctive Clinical Phenotype of Anti-Centromere Antibody Positive Diffuse Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 618
Do Canadian Rheumatologists Actually Treat to Target Once a Biologic Has Been Initiated? an Analysis from a Prospective, Observational Registry
- 9:00AM-11:00AM
-
Abstract Number: 578
Do Specific Anti-Citrullinated Antibodies Predict Different Phenotype of Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 697
Does Axial Spondyloarthritis Phenotype Correlate with Imaging Morphotype?
- 9:00AM-11:00AM
-
Abstract Number: 704
Does Change in Disease Activity over One Year Result in Change in Health-Related Quality of Life in Early Axial Spondyloarthritis Patients?
- 9:00AM-11:00AM
-
Abstract Number: 108
Does Receiving Physical Therapy for Knee Osteoarthritis Impact Downstream Healthcare Utilization?
- 9:00AM-11:00AM
-
Abstract Number: 562
Does Surgical Intervention to the Upper Extremity Make the Patients with Rheumatoid Arthritis Happy?
- 9:00AM-11:00AM
-
Abstract Number: 729
Does the Presence of Multiple Spondyloarthritis-Features in Patients with Chronic Back Pain Always Lead to Diagnosis of Axial Spondyloarthritis?
- 9:00AM-11:00AM
-
Abstract Number: 808
Down-Regulation of microRNA-126 in Scleroderma Microvascular Endothelial Cells (MVECs) Is Associated with Impaired Responses to Vascular Endothelial Growth Factor (VEGF) and Defective Angiogenesis
- 9:00AM-11:00AM
-
Abstract Number: 784
Drivers of the SLE Responder Index (SRI) Endpoint in Clinical Trials of SLE
- 9:00AM-11:00AM
-
Abstract Number: 11
Drug Prescribing Trends in Adults with Rheumatoid Arthritis: A Population-Based Comparative Study from 2005-2014
- 9:00AM-11:00AM
-
Abstract Number: 327
Drug Retention Rate of Oral Bisphosphonate in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 481
Dual Effect of 3-Bromopyruvate on Both Th17 and Treg Cell Differentiation and Dendritic Cell Activation Ameliorates Autoimmune Arthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 36
Dysautonomia and Osteoporosis in 2300 Ehlers-Danlos Hypermobile Patients, As Defined By the Brighton Criteria
- 9:00AM-11:00AM
-
Abstract Number: 73
Dysregulation of Hypomethylated Age-Related CpG Sites Characterize T-Cells and Monocytes from Treatment Naive Rheumatoid Arthritis Subjects
- 9:00AM-11:00AM
-
Abstract Number: 489
Early Detection of Inflammatory Arthritis: The Role of Musculoskeletal Symptoms, Infections and Rheumatoid Arthritis-Related Comorbidities in Primary Care
- 9:00AM-11:00AM
-
Abstract Number: 115
Early Inflammatory Arthritis Presentation, Management and Outcomes in Canadian Aboriginal Patients
- 9:00AM-11:00AM
-
Abstract Number: 325
Ebselen Is a Potential Anti-Osteoporosis Agent By Suppressing RANK Ligand-Induced Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In Vivo
- 9:00AM-11:00AM
-
Abstract Number: 609
Economic Impact of Adalimumab Treatment in Japanese Patients with Rheumatoid Arthritis from the Anouveau Study (Clinicaltrial.gov: NCT01346488)
- 9:00AM-11:00AM
-
Abstract Number: 421
Educating Patients on the Cardiovascular Risks of Rheumatoid Arthritis: Usual Care Versus a Structured Approach
- 9:00AM-11:00AM
-
Abstract Number: 323
Effect of 10 Years of Denosumab Treatment on Bone Histology and Histomorphometry in the Freedom Extension Study
- 9:00AM-11:00AM
-
Abstract Number: 268
Effect of Abatacept Treatment on T Cells in Muscle Tissue and Peripheral Blood in Polymyositis and Dermatomyositis Patients
- 9:00AM-11:00AM
-
Abstract Number: 394
Effect of BMI on Symptoms and Outcomes in Juvenile Idiopathic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 372
Effect of Chronicity on Pain Behaviors in Collagenase Induced Non-Inflammatory Monoarthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 772
Effect of HMG-CoA Reductase Inhibitor Drugs (Statins) on Systemic Lupus Erythematosus Disease Activity: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 621
Effectiveness and Safety of CT- P13 (Biosimilar Reference Infliximab) in a Real-Life Setting in 151 Patients with Rheumatoid Arthritis and Ankylosing Spondylitis: A Mid-Term Interim Analysis
- 9:00AM-11:00AM
-
Abstract Number: 378
Effects of a Natural Product Containing Specialized Pro-Resolving Mediators in Subjects with OA, RA, or Other Chronic Inflammatory Conditions in a Multi-Clinic Case Series
- 9:00AM-11:00AM
-
Abstract Number: 9
Effects of Alcohol Consumption on the Severity of Inflammation in Hand and Foot Joints Detected with MR Imaging
- 9:00AM-11:00AM
-
Abstract Number: 97
Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled Retro- Study
- 9:00AM-11:00AM
-
Abstract Number: 727
Effects of Nsaids on Disease Activity in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 349
Effects of Osteoporosis Treatments for Bone Loss and Pain-Related Behavior in the Hind Limb-Unloaded Mouse Model of Disuse Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 39
Effects of Pregabalin (Lyrica®) on Cerebrospinal Fluid Substance P in Human Subjects with Fibromyalgia Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 760
Effects of Type I Interferon Inhibition on Blood Leukocyte Subsets in Patients Treated in a Phase IIb Clinical Study of Anifrolumab in SLE
- 9:00AM-11:00AM
-
Abstract Number: 622
Efficacy after Transition to SB5 from Reference Adalimumab (Humira®) Vs. Continuation of SB5 or Reference Adalimumab By Antibodies Developed after Transition from a SB5 Phase III Study
- 9:00AM-11:00AM
-
Abstract Number: 692
Efficacy and Safety of Biological Therapy and Target Synthetic Dmards: A Systematic Literature Review Informing the 2016 Update of the ASAS/EULAR Recommendations for the Management of Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 295
Efficacy and Safety of Fasinumab for Osteoarthritic Pain in Patients with Moderate to Severe Osteoarthritis of the Knees or Hips
- 9:00AM-11:00AM
-
Abstract Number: 625
Efficacy and Safety of Intravenous Golimumab Plus Methotrexate in Patients 65 Years and Younger and Those Greater Than 65 Years of Age-a Post-Hoc Analysis
- 9:00AM-11:00AM
-
Abstract Number: 733
Efficacy and Safety of Non-Biological Therapy (Non-Biological Drugs and Non-Pharmacological Interventions): A Systematic Literature Review for the 2016 Update of the ASAS/EULAR Recommendations for the Management of Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 602
Efficacy and Safety of Switching Between Certolizumab Pegol and Adalimumab after Primary Anti-TNF Treatment Failure: 2-Year Results from a Randomized, Investigator-Blind, Superiority Head-to-Head Study
- 9:00AM-11:00AM
-
Abstract Number: 53
Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 246
Efficacy of Colchicine and IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever: A Retrospective Analysis
- 9:00AM-11:00AM
-
Abstract Number: 245
Efficacy of Cyclophosphamide Therapy in Idiopathic Retroperitoneal Fibrosis in a Retrospective Monocentric Analysis
- 9:00AM-11:00AM
-
Abstract Number: 712
Efficacy of Golimumab for Nonradiographic Axial Spondyloarthritis (nr-axSpA): Subgroup Analysis By Baseline MRI and C-Reactive Protein Status
- 9:00AM-11:00AM
-
Abstract Number: 861
Efficacy of Methotrexate in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 49
Efficacy of Mirogabalin on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase 2 Proof-of-Concept Study
- 9:00AM-11:00AM
-
Abstract Number: 848
Efficacy of Prucalopride in the Treatment of Systemic Sclerosis-Related Intestinal Involvement: Results from an Open Label Cross-over Study
- 9:00AM-11:00AM
-
Abstract Number: 176
Endoplasmic Reticulum Stress Induces Lupus Kidney Disease By Facilitating Antigen Cross-Presentation Via the Increase of Endosomal Sec61
- 9:00AM-11:00AM
-
Abstract Number: 64
Enrichment of Immune Pathways in Genes Under Geographically Restricted Adaptation in the Gullah African American Population of South Carolina
- 9:00AM-11:00AM
-
Abstract Number: 399
Enthesitis in Juvenile Idiopathic Arthritis (JIA)
- 9:00AM-11:00AM
-
Abstract Number: 243
Eosinophilic Angiocentric Fibrosis : A Mimic of Vasculitis in IgG4 Related Disease Spectrum
- 9:00AM-11:00AM
-
Abstract Number: 68
Epigenetic and Expression Analysis of Ankylosing Spondylitis Association Loci Point to Key Cell Types Driving Disease
- 9:00AM-11:00AM
-
Abstract Number: 661
Epitope Specificity and End-Organ Susceptibility Dictates Anti-Ro52 Mediated Salivary Gland Dysfunction
- 9:00AM-11:00AM
-
Abstract Number: 471
Epstein-Barr Virus-Induced Expression of Receptor Activator Nuclear Factor-κb Ligand on B Cells Is Possibly Responsible for Erosive Arthritis in Epstein-Barr Virus-Infected Humanized Nonobese Diabetic/Shi-Scid/γcnull Mice
- 9:00AM-11:00AM
-
Abstract Number: 656
ERdj5 Function Is Involved in Inflammatory Manifestations of Sjögren’s Syndrome in the Salivary Glands
- 9:00AM-11:00AM
-
Abstract Number: 838
Esophageal Dysmotility and Interstitial Lung Disease in Patients with Scleroderma: A Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 796
Establishment of an International Autoantibody Standard for Anti-DFS70/LEDGF Antibodies: Proof-of-Concept Study for a Novel Strategy for the Setting up of International Autoantibody Standards
- 9:00AM-11:00AM
-
Abstract Number: 264
Ethnicity-Related Differences in the Clinical Presentation of Sarcoidosis in Spain (SARCOGEAS-SEMI Registry)
- 9:00AM-11:00AM
-
Abstract Number: 776
Eurolupus and Low Steroid Regimen in Proliferative Lupus Nephritis: Retrospective Evaluation of 38 Patients in the Black Population of Martinique
- 9:00AM-11:00AM
-
Abstract Number: 411
Evaluating Levels of Activity and Health-Related Quality of Life in a Cohort of Youth Athletes with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 341
Evaluation of 25-Hydroxyvitamin D Levels in Rheumatologic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 362
Evaluation of Osteoporosis Risk Factors in Lung Transplant Patients
- 9:00AM-11:00AM
-
Abstract Number: 85
Evaluation of Patient Satisfaction with the on-Tracc Program; Benefits of a Joint Approach
- 9:00AM-11:00AM
-
Abstract Number: 749
Evaluation of the Efficacy, Safety, and Tolerability of BIIB023 As an Adjunct to Standard of Care in Subjects with Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 478
Evaluation of the Relationship Between Methotrexate Polyglutamation and Efficacy in the Collagen-Induced Arthritis Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 155
Evaluation of Ultrasonography As Modality for Identification of Calcium Crystal Deposits in Patients of Primary Osteoarthritis of Knee Joint
- 9:00AM-11:00AM
-
Abstract Number: 775
Evaluation of Use of Belimumab in Clinical Practice Settings: Results in Argentina
- 9:00AM-11:00AM
-
Abstract Number: 373
Evidence for TMJ Pain As a Component of a Generalized Pain Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 535
Examination of Diurnal and Daily Variation of the Multi-Biomarker Disease Activity (MBDA) Score in RA to Establish the Minimally Important Difference
- 9:00AM-11:00AM
-
Abstract Number: 208
Examination of Serum Uric Acid (sUA) Lowering and Safety with Extended Lesinurad + Allopurinol Treatment in Subjects with Gout
- 9:00AM-11:00AM
-
Abstract Number: 826
Exercise Echocardiography Predicts Future Development of Pulmonary Hypertension in a High-Risk Cohort of Scleroderma Patients
- 9:00AM-11:00AM
-
Abstract Number: 329
Explore the Possible Mechanisms of 1,25(OH)2D3 on the Formation of Osteoclasts in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 488
Exploring the Association Between Air Pollutant Exposure and Seropositivity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 643
Exposure-Response Analyses of Efficacy of ABT-122, a Dual-Variable Domain Immunoglobulin (DVD-Ig™) Targeting TNF-α and IL-17A, Compared with Adalimumab in Subjects with Rheumatoid Arthritis and Background MTX
- 9:00AM-11:00AM
-
Abstract Number: 761
Exposure-Response Analysis for Selection of Optimal Dosage Regimen of Anifrolumab in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 874
Expression and Function of IL-12/23 Related Cytokine Subunits (p35, p40 and p19) in Giant-Cell Arteritis Lesions. Potential Role of p40 in Promoting Th1 -Mediated Pathways
- 9:00AM-11:00AM
-
Abstract Number: 278
Expression of Anti-Microbial Peptide LL-37 Correlates to the Activation of Type I Interferon Pathway in Patients with Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 660
Expression of the Chemokine Receptor CXCR5 Is Decreased in the Periphery of Patients with Primary Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 657
Expression of Type-III Interferons (IFNλs) and Their Receptor in Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 283
Extracellular Histidyl-tRNA Synthetase in Myositis
- 9:00AM-11:00AM
-
Abstract Number: 820
EZH2 Modulates Angiogenesis and Fibrosis in Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 635
Factors Associated to Lack of Adherence to Subcutaneous Biological Medications in Patients with Rheumatoid Arthritis from Spain. Arco Study
- 9:00AM-11:00AM
-
Abstract Number: 563
Factors Associated with Cognitive Impairment in Korean Adults with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 565
Factors Associated with Gastrointestinal Tolerance in Patients with Rheumatoid Arthritis and Methotrexate Daily Doses
- 9:00AM-11:00AM
-
Abstract Number: 779
Factors Determining Hydroxychloroquine Serum Levels in a Cohort of Chinese Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1
Factors Predicting Likelihood of Remaining Positive for Rheumatoid Arthritis-Related Autoantibodies Following Autoantibody Screening
- 9:00AM-11:00AM
-
Abstract Number: 744
Factors Related to Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 14
Failure Predictors to Anti-Tumor Necrosis Antagonists in Patients with Chronic Arthritis: Results of a National Registry Biobadasar
- 9:00AM-11:00AM
-
Abstract Number: 87
Familiarity Vital for Telemedicine Uptake Among Parents of Pediatric Rheumatology Patients
- 9:00AM-11:00AM
-
Abstract Number: 887
Fatigue and Physical Functioning in Patients with Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 892
FDG-PET CT Evaluation By Visual Grading Is Not Sufficiently Discriminative to Assess Disease Activity in Takayasu’s Arteritis Patients with ‘Persistent’ Disease
- 9:00AM-11:00AM
-
Abstract Number: 420
Feasibility of a Rheumatology Staff Protocol for Tobacco Cessation Counselling and Quit Line Electronic Referral
- 9:00AM-11:00AM
-
Abstract Number: 48
Fibromyalgia Impact Is a Potential Mediator for the Associations of Self-Efficacy and Pain Catastrophizing with Physical Functioning in Persons with Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 490
First Report of Symptoms Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire
- 9:00AM-11:00AM
-
Abstract Number: 163
Fluorescence Optical Imaging Reveals Distinct Patterns of Hand Joint Inflammation in Seropositive and Seronegative Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 883
Folate Receptor Beta and Endothelin Receptor Beta Macrophage Subtypes Are Differentially Expressed in the Vascular Compartments of the Intima and Media/Adventitia in Giant Cell Arteritis: A Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 400
Foot Involvement in Enthesitis-Related Arthritis Subtype of Juvenile Idiopathic Arthritis: Clinical, Radiological and Functional Assessment
- 9:00AM-11:00AM
-
Abstract Number: 847
Forced Vital Capacity Predicts Lung Fibrosis Progression and Mortality in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 843
Forced Vital Capacity Predicts Outcome in Scleroderma Associated Interstitial Lung Disease with Concomitant Pulmonary Hypertension: Data from the Pharos Registry
- 9:00AM-11:00AM
-
Abstract Number: 355
Fracture Incidence Rates in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 282
From ‘immune Mediated Necrotizing Myopathy’ to ‘antibody-Mediated Necrotizing Myositis: Towards the Pathogenic Role of Anti-SRP and Anti-Hmgcr Antibodies’
- 9:00AM-11:00AM
-
Abstract Number: 171
From 3D Printed Bones to Arthritis Patients – Arthro-Haptic Experience Supporting Disease Awareness
- 9:00AM-11:00AM
-
Abstract Number: 181
Functional and Quantitative Changes of CCR6+ type3 Innate Lymphoid Cells in Murine Collagen-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 714
Functional Relevance of Structural Damage in the Sacroiliac Joints in Patients with Axial Spondyloarthritis – Results from the German Spondyloarthritis Inception Cohort
- 9:00AM-11:00AM
-
Abstract Number: 304
Gait Abnormalities Due to Hip Osteoarthritis Are Different in Men and Women
- 9:00AM-11:00AM
-
Abstract Number: 514
Gender Difference Is Apparent in the Risk of Forefoot Deformity in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 759
Gene Signature for Glucocorticoid, from in Vitro to In Vivo
- 9:00AM-11:00AM
-
Abstract Number: 284
Gene-Environmental Interaction of HLA-DRB1*03:01 and Smoking for the Development of Anti-Jo-1 Autoantibodies in Idiopathic Inflammatory Myopathies: A UK Study
- 9:00AM-11:00AM
-
Abstract Number: 75
Genetic Analysis of Urate Transporters ABCG2, SLC17A3, SLC22A11 and SLC17A1 in Primary Hyperuricemia and Gout
- 9:00AM-11:00AM
-
Abstract Number: 297
Genetic and Environmental Correlation of Osteoarthritis at the Hands, Knees, and Spine
- 9:00AM-11:00AM
-
Abstract Number: 465
Genetic and Metabolic Signatures of Purified Synovial Macrophage Subsets during an Acute Murine Model of Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 65
Genetic Heterogeneity in the Risk of Lupus Nephritis According to Ancestry
- 9:00AM-11:00AM
-
Abstract Number: 57
Genetic Polymorphism of IL-1RN Encoding the IL-1 Receptor Antagonist Predicts Radiographic Severity of Symptomatic Knee OA
- 9:00AM-11:00AM
-
Abstract Number: 13
Genetic Variants of the Vasoactive Intestinal Peptide (VIP) Gen in Association with Rheumatoid Arthritis Treatment Requirements
- 9:00AM-11:00AM
-
Abstract Number: 647
Genomic and Epigenetic Bioinformatics Demonstrate Dual TNF-α and IL17A Target Engagement By ABT-122, and Suggest Mainly TNF-α–Mediated Relative Target Contribution to Drug Response in MTX-IR Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 885
Giant Cell Arteritis and Malignancy – More Than Just a Coincidence?
- 9:00AM-11:00AM
-
Abstract Number: 878
Giant-Cell Arteritis Related Stroke: A Retrospective Multicentre Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 438
Glucocorticoid Adverse Effects – the Patient Perspective
- 9:00AM-11:00AM
-
Abstract Number: 288
Glucose Homeostasis Influences the Risk of Incident Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 584
Glycoprotein VI: A Potential Target for ACPA-Mediated Platelet Activation?
- 9:00AM-11:00AM
-
Abstract Number: 629
Golimumab Improves Patient-Reported Outcomes and Socio- and Health-Economic Parameters in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS): Results from a Non-Interventional Clinical Evaluation in Germany
- 9:00AM-11:00AM
-
Abstract Number: 413
Golimumab in Refractory Uveitis Associated to Juvenile Idiopathic Arthritis. Multicenter Study of 7 Cases and Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 519
Greater Fatigue at Baseline and Female Gender Predict Worse Disability in Early RA Despite Treatment to Target: A Comparison of Two Observational Cohort Studies from the United Kingdom
- 9:00AM-11:00AM
-
Abstract Number: 555
HAQ Score Is an Independent Predictor of Sustained Remission in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 25
Have Outcomes of Patients with Inflammatory Arthritis Improved in the New Millennium? a Comparison of the 10 Year Outcome in Cohorts Recruited in 1990-4 and 2000-4
- 9:00AM-11:00AM
-
Abstract Number: 890
Health-Related Domains of Importance to Patients with Takayasu’s Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 884
Health-Related Quality of Life in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 426
Herpes Zoster Vaccine: A Quality Improvement Study in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 765
High Baseline B Lymphocyte Stimulator (BLyS) Levels Predict Response While Smoking and Organ Damage at Baseline Predict Failure to Belimumab in Three Swedish Clinical Practice Settings
- 9:00AM-11:00AM
-
Abstract Number: 902
High Disease Activity Scores and Leptin Levels in Takayasu Patients with Overweight and Obesity
- 9:00AM-11:00AM
-
Abstract Number: 829
High Level of Chemokine CCL2 Is Associated with Lung Fibrosis Progression and Reduced Survival in Two Independent Systemic Sclerosis Cohorts
- 9:00AM-11:00AM
-
Abstract Number: 499
High Levels of Mir-451a Differentiate Patients at Risk of Developing RA from Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 731
High Prevalence of Hip Arthritis in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 403
High Rate of Serious Infection in Juvenile Idiopathic Arthritis Under Biologic Therapy in a Real Life Setting
- 9:00AM-11:00AM
-
Abstract Number: 335
High Risk of Osteoporosis and Long Term Joint Damage in Adults with a History of Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 633
High Similarity Between Ex-Vivo Inhibited Cytokine Profiling By Golimumab and Adalimumab As a Putative Explanation for Inferior Treatment Response to Golimumab after Adalimumab Failure in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 571
High Titer Rheumatoid Arthritis Antibodies Distinguish Between PAD2 and PAD4 Citrullinated Fibrinogen
- 9:00AM-11:00AM
-
Abstract Number: 556
Higher Multi Biomarker Disease Activity Scores Foreshadow Greater Longitudinal Improvement in RA Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 498
Higher Serum Heavy Metals Concentrations Are Associated with Rheumatoid Arthritis : A Study of the Korean National Health and Nutrition Examination Survey (KNHANES)
- 9:00AM-11:00AM
-
Abstract Number: 723
Hip Disease Treatment and Progression in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 315
Hip Inflammation MRI Scoring System (HIMRISS) to Predict Response to Hyaluronic Acid (HAnox-M-XL) Injection in Hip Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 276
Histological Study on the Expression of Transcriptional Intermediary Factor 1 (TIF1) in the Patients with Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 182
Histone Methylation in γδ T Cells As a Biomarker of Behcet’s Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 805
HLA Class II Functional Motifs Associated with Severe Systemic Sclerosis (SSc) and Sclerotic Graft Versus Host Disease (sclGVHD): The Shared Epitopes of Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 263
How Does Sarcoidosis Present in Spain? Characteristics at Diagnosis of 979 Patients from the Sarcogeas-SEMI Registry
- 9:00AM-11:00AM
-
Abstract Number: 38
How Does Thiol/Disulphide Homeostasis Change in Fibromyalgia Patients?
- 9:00AM-11:00AM
-
Abstract Number: 41
Human Papilloma Virus Vaccination, Fibromyalgia and Dysautonomia
- 9:00AM-11:00AM
-
Abstract Number: 401
Humoral Immune Response after a Booster Dose with Tdap in Children and Adolescents with Juvenile Idiopathic Arthritis on Anti-TNF and in Healthy Controls
- 9:00AM-11:00AM
-
Abstract Number: 755
Hydroxychloroquine Blood Level Monitoring in a Predominantly Hispanic Systemic Lupus Erythematosus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 767
Hydroxychloroquine Induced Retinopathy in SLE
- 9:00AM-11:00AM
-
Abstract Number: 741
Hydroxychloroquine Is Not Associated with Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients
- 9:00AM-11:00AM
-
Abstract Number: 737
Hydroxychloroquine Whole Blood Levels Do Not Associate with Hydroxychloroquine Retinopathy
- 9:00AM-11:00AM
-
Abstract Number: 340
Hydroxychloroquine: A Potential Treatment for Osteoporosis By Osteoclast Inhibition!
- 9:00AM-11:00AM
-
Abstract Number: 670
Identification and Characterization of Sjogren’s Syndrome-Associated Genetic Variants in the IL12A and DDX6-CXCR5 Loci
- 9:00AM-11:00AM
-
Abstract Number: 55
Identification of Endogenous Autoantigens Bound to Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis: A Key Role for Citrulline Residues in Histone 4
- 9:00AM-11:00AM
-
Abstract Number: 63
Identification of Immune Gene Modules in Good Responders to Adalimumab in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 813
Identifying and Assessing Subgroups in Systemic Sclerosis Patients Based on Comprehensive Autoantibody Profiling
- 9:00AM-11:00AM
-
Abstract Number: 427
Identifying Barriers to Zoster Vaccination Rates Among RA Patients in an Academic Rheumatology Practice
- 9:00AM-11:00AM
-
Abstract Number: 70
Identifying Distal Interactions Between RUNX1 and JIA Associated Single Nucleotide Polymorphisms By Chromosome Conformation Capture
- 9:00AM-11:00AM
-
Abstract Number: 238
Identifying Immunoglobulin G4-Related Disease in Archived Pathological Specimens
- 9:00AM-11:00AM
-
Abstract Number: 821
IL-31 Is an Inflammatory Pro-Fibrotic Factor Elevated in a Subset of Scleroderma Patients with Severe Pruritus
- 9:00AM-11:00AM
-
Abstract Number: 69
IL-32 Promoter SNP rs4786370 Predisposed to Modified Lipoprotein Profiles in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 137
Imaging Remission By Musculoskeletal Ultrasound Leads to a Better Functional Outcome – Results of the US Impera Study – US 7-Score Implementation Study in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 613
Immunogenicity of Anti-TNF Therapies in Patients with Inflammatory Rheumatic Diseases and Secondary Failure: A Multicentre Study of 570 Patients
- 9:00AM-11:00AM
-
Abstract Number: 666
Immunoglobulin N-Glycosylation Acquired By Somatic Hypermutation As a Potential Mechanism for Non-Specific B Cell Activation in Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 839
Immunosuppression Does Not Prevent Severe Gastrointestinal Disease in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 831
Immunosuppression May Prevent Interstitial Lung Disease in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 80
Impact of a Patient Support Program on Abandonment of Adalimumab Treatment Initiation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 592
Impact of Adherence to Tumor Necrosis Factor Inhibitors on Radiographic Outcomes in US Veterans with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 722
Impact of Aerobic Fitness on Axial Spondyloarthritis Activity: Systematic Review and Meta-Analysis of Controlled Studies
- 9:00AM-11:00AM
-
Abstract Number: 231
Impact of an Educational Program for the Management of Gout Directed to Primary Care Physicians
- 9:00AM-11:00AM
-
Abstract Number: 496
Impact of Anti-Citrullinated Protein Antibody and/or Rheumatoid Factor on Rheumatoid Arthritis Manifestations and Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 232
Impact of Gout Flare Prophylaxis and Urate-Lowering Therapy on Endothelial Function, Smooth Muscle Responsiveness and Markers of Inflammation: Results of a Prospective Observational Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 720
Impact of HLA-B27 on Patient Profile and Treatment Response in As Patients Treated with Anti-TNF in Canadian Real-World
- 9:00AM-11:00AM
-
Abstract Number: 30
Impact of Interstitial Lung Disease on Mortality of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 119
Impact of Socioeconomic Status on Disease Outcomes in Japanese Patients with Rheumatoid Arthritis Under the Japanese National Insurance System
- 9:00AM-11:00AM
-
Abstract Number: 735
Impact of Time Since Diagnosis, Age, and Number of Prior Non-Steroidal Anti-Inflammatory Drugs on Response to Adalimumab (HUMIRA) in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 186
Impact of TLR Stimulation on Cytokine Production in Macrophage Subsets: TLR2 Stimulation Impairs Anti-Inflammatory Activity of M2 Macrophages
- 9:00AM-11:00AM
-
Abstract Number: 90
Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 819
Impaired Adiponectin Signaling in SSc Contributes to Myofibroblast Differentiation and Organ Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 474
Impaired Cognition Is Linked to Brain Depletion in Brain-Derived Neurotrophic Factor Levels in a Rat Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 271
Impaired Satellite Cell Activation and Myofiber Transition during Skeletal Muscle Regeneration in Patients with Polymyositis and Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 530
Importance of Functional and Utility Evaluation on Disease Activity Level in Rheumatoid Arthritis: Interrelations and Predictive Value
- 9:00AM-11:00AM
-
Abstract Number: 444
Improvement in Knee Arthrocentesis Via Constant Compression
- 9:00AM-11:00AM
-
Abstract Number: 107
Improvement of Quality and Cost-Effectiveness of Rheumatology Care By Creating Long-Term Alliances with Pharmaceutical Companies
- 9:00AM-11:00AM
-
Abstract Number: 441
Improving Care and Avoiding Errors. Can Our Patients Recall Their Medications and Create an Accurate Medication List?
- 9:00AM-11:00AM
-
Abstract Number: 425
Improving Pneumococcal Vaccination Rates for Immunosuppressed Patients in an Academic Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 699
In Contrast to Men, Women with Nonradiographic Axial Spondyloarthritis Have Lower Response Rates to TNF Inhibitors Than Women with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 701
In Patients with Ankylosing Spondylitis Treated with Adalimumab, Combination Therapy with DMARD, Increase the Serum Level of Adalimumab and Decrease Immunogenicity
- 9:00AM-11:00AM
-
Abstract Number: 275
In Vitro Activation of Type I Interferon Pathway Reproduces the Characteristics Damages Observed in Dermatomyositis Patients
- 9:00AM-11:00AM
-
Abstract Number: 227
Inadequately Treated Chronic Gout As the Main Reason for Primary Gout Admission in an Urban Adult Population: Results of a Retrospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 22
Incidence and Factors Associated with the Development of Non Alcoholic Fatty Liver Disease(NAFLD) Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 437
Incidence of Gastrointestinal Events and Physician Compliance of Co-Prescribing Proton Pump Inhibitors in Chronic NSAID Users with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 700
Incidence of Inflammatory Bowel Disease Events in Adalimumab (HUMIRA) Clinical Trials Across Indications
- 9:00AM-11:00AM
-
Abstract Number: 23
Incidence of Non Alcoholic Fatty Liver Disease By Key Risk Factors Among Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 895
Incidence of Osteoporotic Mayor Fractures in a Cohort of Patients with Polymyalgia Rheumatica
- 9:00AM-11:00AM
-
Abstract Number: 319
Incident Participation Restriction in Adults with Knee Osteoarthritis: Do Positive and Negative Affect Matter? the Multicenter Osteoarthritis Study
- 9:00AM-11:00AM
-
Abstract Number: 690
Increase in Serum Leptin Levels Is Associated with Radiographic Progression of Male Patients with Ankylosing Spondylitis: A 2-Year Longitudinal Study
- 9:00AM-11:00AM
-
Abstract Number: 280
Increased Expression of TIF-1 Gamma in Duodenal Adenocarcinoma from a Patient with p155/140 Dermatomyositis: A Causal Relationship?
- 9:00AM-11:00AM
-
Abstract Number: 62
Increased Frequency of Anti-Drug Antibodies in Patients Carrying Compatible IgG1 Allotypes and Treated with Anti-TNF Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 279
Increased Heat Shock Protein 90 in Muscle Tissue and Plasma in Idiopathic Inflammatory Myopathies Correlates with Disease Activity and Skeletal Muscle Involvement
- 9:00AM-11:00AM
-
Abstract Number: 125
Increased Hypertension and Renal Disease in African Americans Compared to Caucasians with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 358
Increased Infection Risk with Concomitant Use of RANK Ligand-Inhibitor, Denosumab and TNF-Inhibitors or Other Biologics: Reality or Illusion? Long Term Experience at the University of Southern California
- 9:00AM-11:00AM
-
Abstract Number: 104
Incremental Direct Expenditures Due to Osteoarthritis: A Nationally Representative Study Using Medical Expenditure Panel Survey Data
- 9:00AM-11:00AM
-
Abstract Number: 868
Infections and the Risk of Incident Giant Cell Arteritis: A Population-Based, Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 111
Influences of Osteoarthritis Pain, Comorbid Insomnia, and Depression on Health Care Use in Older Adults with Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 608
Initial Intensive Therapy of Adalimumab and Methotrexate Is Associated with Long-Term Structural Remission and Low Disease Activity after Adalimumab Discontinuation Is Maintained up to 3 Years in Japanese Patients: Hopeful-3 Study
- 9:00AM-11:00AM
-
Abstract Number: 376
Initial Validation of the Patient Reported Outcomes Measurement Information System Pediatric Pain Intensity Scale in Juvenile Idiopathic Arthritis, Juvenile Fibromyalgia and Sickle Cell Disease
- 9:00AM-11:00AM
-
Abstract Number: 77
Integrated Analysis of Microrna and mRNA Expression Profiles Related to Cardiovascular Disease in Monocytes from Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome Patients
- 9:00AM-11:00AM
-
Abstract Number: 207
Integrated Safety of Lesinurad, a Novel Uric Acid Reabsorption Inhibitor for the Treatment of Gout
- 9:00AM-11:00AM
-
Abstract Number: 109
Inter-Professional Satisfaction and Perceptions of Collaborative Practice of an Innovative Model of Care for the Early Detection of Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 346
Interest of Bone Texture Assessment By Trabecular Bone Score (TBS) in Kidney Transplants Recipients
- 9:00AM-11:00AM
-
Abstract Number: 272
Interferon Chemokine Score and Other Cytokine Measures Predict Changes in Disease Activity in Patients with Juvenile and Adult Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 871
Interleukin 33 Critically Regulates Angiogenesis and Inflammation in Large Vessels Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 467
Interleukin-21-Signaling in B Cells, but Not in T Cells, Is Indispensable for Development of Collagen-Induced Arthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 873
Interleukin-23 Stimulates Inflammatory and Proliferative Pathways in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 236
Intrathoracic Manifestations of IgG4-Related Disease: Findings in a Cohort Study from North America
- 9:00AM-11:00AM
-
Abstract Number: 770
Introducing a Novel SLE-Specific IFN-I Inhibitor CNTO 6358: Laying the Groundwork for Precision Medicine in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 461
Involvement of CD163-Positive Macrophages in the Pathogenesis of Arthritis Via Modulation of Inflammatory Cytokine and Chemokine Expression in the Synovium of a Murine Model
- 9:00AM-11:00AM
-
Abstract Number: 486
IRF5 Promotes Arthritis but Restricts Virus Replication and Spread during Chikungunya Virus Infection
- 9:00AM-11:00AM
-
Abstract Number: 705
Is a Positive Family History of Spondyloarthritis of Value in Patients with Chronic Back Pain? Results from Two Large Early Back Pain Cohorts
- 9:00AM-11:00AM
-
Abstract Number: 92
Is Patient Support Program (PSP) Participation Associated with Longer Persistence and Greater Adherence Among New Users of Adalimumab?
- 9:00AM-11:00AM
-
Abstract Number: 344
Is Rheumatoid Arthritis a Risk Factor for Fractures: A Systematic Review of Observational Studies
- 9:00AM-11:00AM
-
Abstract Number: 858
Is There a Place for Repetitive 18f-Fluorodeoxyglucose Positron Emission Tomography in Giant-Cell Arteritis with Large-Vessel Involvement?
- 9:00AM-11:00AM
-
Abstract Number: 435
It Takes Two, an Interdisciplinary Approach to Increasing Hydroxychloroquine Screening Adherence
- 9:00AM-11:00AM
-
Abstract Number: 273
Juvenile Dermatomyositis Patient-Derived Induced Pluripotent Stem Cells Do Not Retain Disease Expression Signatures
- 9:00AM-11:00AM
-
Abstract Number: 61
Killer Immunoglobulin-like Receptors Are Associated with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 825
KL-6 and Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis Related Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 292
Knee Osteoarthritis and the Risk of Fall Injuries Among Older Adults: The Health ABC Study
- 9:00AM-11:00AM
-
Abstract Number: 296
Knee Osteoarthritis As Risk for Hip Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 303
Knee Physical Exam Findings and Self-Reported Symptoms Are Associated with MRI-Detected Effusion-Synovitis Among Participants with or at Risk for Knee Osteoarthritis: Data from the Osteoarthritis Initiative (OAI)
- 9:00AM-11:00AM
-
Abstract Number: 894
Laboratory Tests in Giant Cell Arteritis – Do They Make the Cut?
- 9:00AM-11:00AM
-
Abstract Number: 40
Lateral Epicondylitis Treatment: Comparison of Bandage, Laser Therapy and Extra-Corporeal Shock Wave Therapy
- 9:00AM-11:00AM
-
Abstract Number: 734
Lateral Spine BMD Measurement and Trabecular Bone Score Can Represent a Bone Loss in Patients with Advanced Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 244
Leflunomide and Glucocorticoids Combination Therapy for the Induction and Maintenance of Remission in Patients with IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 317
Leg Muscle Imbalance Is Associated with Radiographic Grade or Pain in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 112
Leveraging a Learning Network to Implement and Standardize Self-Management Support into Care Delivery: Experience of Pediatric Rheumatology Care and Outcomes Improvement Network
- 9:00AM-11:00AM
-
Abstract Number: 487
Limited Utility of Cytokine Profiles in Rheumatoid Arthritis Patients with Clinically Active Disease and Normal Inflammatory Indices
- 9:00AM-11:00AM
-
Abstract Number: 380
Linear Discriminant Analysis of Cultured Fibroblast-like Synoviocytes Identifies 6 Candidate Genes Which Predict Extended Course in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 480
Local Cryotherapy Down-Regulates Local and Systemic IL-6/IL-17 Pathway with No Effect on TNF-α in Adjuvant-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 876
Long Term Efficacy of Ustekinumab for the Treatment of Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 302
Long-Lasting Local Knee Structural Pathology Is Associated with Persistent Multi-Site Pain
- 9:00AM-11:00AM
-
Abstract Number: 725
Long-Term Anti-TNF Treatment Is Associated with Reduction of Progression of Radiographic Changes in the Sacroiliac Joints in Patients with Non-Radiographic Axial Spa: Six-Year Results of the Esther Trial
- 9:00AM-11:00AM
-
Abstract Number: 7
Long-Term Dietary Changes after Rheumatoid Arthritis Diagnosis in Swedish Women: Data from a Population Based Cohort
- 9:00AM-11:00AM
-
Abstract Number: 732
Long-Term Effect of TNF Inhibitors on Radiographic Progression in Ankylosing Spondylitis Is Associated with Syndesmophytes at Baseline and Time-Averaged CRP Levels
- 9:00AM-11:00AM
-
Abstract Number: 389
Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry
- 9:00AM-11:00AM
-
Abstract Number: 386
Long-Term Efficacy and Safety of Adalimumab in Pediatric Patients with Enthesitis Related Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 743
Long-Term Hydroxychloroquine Therapy and Low-Dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 859
Long-Term Outcomes of Renal Artery Involvement in Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 612
Long-Term Sustainability of TNF-Blocker Injection Spacing in Rheumatoid Arthritis: Results of a 3-Year Long-Term Observational Follow-up of a Tapering randomised Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 72
Longitudinal Expression of CXCL10 in Psoriasis Patients That Develop Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 170
Low Baseline Temperature and Low Basal Flow Can be Related to the Paradoxical Raynaud’s Phenomenon in Hand Perfusion Scintigraphy
- 9:00AM-11:00AM
-
Abstract Number: 795
Low Disease Activity in Systemic Lupus Erythematosus: An Achievable Goal?
- 9:00AM-11:00AM
-
Abstract Number: 659
Low Dose IL-2 Therapy Can Restore the Balance of Th17 and Treg Cells in Refractory Patients with Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 677
Low Functional Relevance of Radiographic Spinal Progression in Patients with Early Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 841
Low Nucleoside Triphosphate Pyrophosphohydrolase Activity Contributes to Pathologic Mineralization in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 869
Low Numbers of CD16+ Monocytes Predict Shorter Time to Relapse in Polymyalgia Rheumatica
- 9:00AM-11:00AM
-
Abstract Number: 513
Low Serum 25-Hydroxyvitamin D Level Is Not Associated with Decreased Bone Mass or Bone Quality in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 6
Lower Omega-3 Fatty Acid Biomarkers Are Associated with Inflammatory Arthritis in a Population Positive for Anti-Citrullinated Protein Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 594
Maintenance of Improvements in Patients’ Physical Function, Workplace and Household Productivity, and Reduction in Caregiver Burden with 2 Years of Certolizumab Pegol Treatment in DMARD-Naive, Early RA Patients with Severe Progressive Disease
- 9:00AM-11:00AM
-
Abstract Number: 239
Malignancies in Korean Patients with Immunoglobulin G4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 757
Measures of Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus (SLE): Results from a Two-Part 52 Week Pilot Study of Repository Corticotropin Injection (H.P. Acthar® Gel)
- 9:00AM-11:00AM
-
Abstract Number: 138
Measuring Agreement in the Ultrasonographic Evaluation of Disease Activity in Rheumatoid Arthritis Patients. a Latin-American Multicenter Exercise Assessing the Influence of Sonographer Experience and Expertise
- 9:00AM-11:00AM
-
Abstract Number: 152
Median Nerve Stiffness Measured By Elastosonography in Patients with Rheumatoid Arthritis Is Higher Than Controls
- 9:00AM-11:00AM
-
Abstract Number: 289
Metabolic and Inflammatory Links to Development of Rotator Cuff Tear in Hand Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 367
Microarray Analyses of Dorsal Root Ganglia for the Study of Pathways Contributing to Pain in Experimental Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 810
Microrna-125b As a Potential Anti-Fibrotic and Anti-Apoptotic Regulator in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 809
Micrornas Targeting the Wnt Signalling Pathway in Black African Patients with Diffuse Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 590
Microvesicles in the Lungs of Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 473
Migration, Colonization and Distribution of Bone Marrow Mesenchymal Stem Cells Transplanted in CIA Rats Were Traced By Green Fluorescent Protein
- 9:00AM-11:00AM
-
Abstract Number: 300
Mindfulness Predicts Treatment Response from Non-Pharmacological Therapy in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 299
Minimally Important Differences for Four Patient-Reported Outcomes Measurement Information System (PROMIS) Short Forms: Physical Function, Pain Interference, Depression, and Anxiety Among Adults with Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 249
MiR-204-3p Associates with an Increased Level of IL-6 in Familial Mediterranean Fever By Targeting the PIK3 Signaling Pathway
- 9:00AM-11:00AM
-
Abstract Number: 24
Modifiable Rheumatoid Arthritis Factors and Impact on Cardiovascular Risk
- 9:00AM-11:00AM
-
Abstract Number: 432
Monitoring Hepatitis B Screening Compliance in Patients with Rheumatoid Arthritis (RA) Receiving Anti-TNF Therapy
- 9:00AM-11:00AM
-
Abstract Number: 812
Monocytes/Neurotrophins/Myofibroblasts As a Novel Axis in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 523
Mortality Profile of Patients with Rheumatoid Arthritis in France and Its Change in 10 Years
- 9:00AM-11:00AM
-
Abstract Number: 306
MRI-Detected Cartilage Damage, Meniscal Damage, and Meniscal Extrusion Prior to Incident Radiographic Osteoarthritis and the Subsequent Trajectory of Joint Space Loss
- 9:00AM-11:00AM
-
Abstract Number: 579
MRI-Detected Osteitis Is Not Associated with the Presence or Level of ACPA Alone, but with the Combined Presence of ACPA and RF
- 9:00AM-11:00AM
-
Abstract Number: 256
Muckle-Wells Syndrome in Chinese Adult Patients
- 9:00AM-11:00AM
-
Abstract Number: 803
Multi-Organ RNA-Sequencing of Systemic Sclerosis (SSc) Patients Shows Reproducible Gene Expression Profiles Across Organ Systems
- 9:00AM-11:00AM
-
Abstract Number: 793
Multi-Parametric Model Development for Assessing Lupus Nephritis and Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 801
Multi-Tissue Gene Expression Pathway Analysis of Emerging Therapeutics in a TGFβ Dependent Mouse Model of Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 158
Musculoskeletal Ultrasound Is a Sensitive Imaging Tool for the Assessment of Dynamic Changes of Bone Erosions in Inflammatory Arthritis: A Comparative Analysis with High-Resolution Peripheral Quantitatve Computed Tomography
- 9:00AM-11:00AM
-
Abstract Number: 824
Mycophenolate Versus Placebo for the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 475
N-3 Polyunsaturated Fatty Acids in Fat-1 Mice Attenuate Collagen Antibody-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 589
Netosis-Derived Products Might Have Diagnostic Potential for Disease Activity, Atherosclerosis and Analysis of Therapeutic Effectiveness in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 233
New Cardiovascular Risk Factors Screening in Patients with Gout
- 9:00AM-11:00AM
-
Abstract Number: 872
New Insights into the Pathogenesis of Giant Cell Arteritis through a Genome-Wide Association Study
- 9:00AM-11:00AM
-
Abstract Number: 254
NLRP12 Autoinflammatory Disease: A Chinese Case Series and Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 483
Non-Steroidal Anti-Inflammatory Drugs Are More Beneficial Than Anti-Tnfα Drugs on the Radiographic Damage in Arthritis: A Study in Adjuvant Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 59
Novel Agents for Blocking the Interaction of Immune Complexes with the Activatory FcγRIIIa Receptor
- 9:00AM-11:00AM
-
Abstract Number: 46
Novel Composite Responder Endpoints for Fibromyalgia Therapy Assessment
- 9:00AM-11:00AM
-
Abstract Number: 457
Novel Mechanism Mediated By the IL-23/Th17 Axis Contributing to Auto-Immune Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 717
NSAID Use and Functional Impairment in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 434
Nurse Scheduled Telephone Visit: The Right Rheumatology Care for the Right Patient at the Right Time
- 9:00AM-11:00AM
-
Abstract Number: 189
Nutraceutical Therapy with Polyphenol-Rich Pomegranate Fruit Extract (POMx) Inhibits Systemic NFκB-Mediated Inflammation in a Murine Model of Endotoxemia
- 9:00AM-11:00AM
-
Abstract Number: 318
Observer Variability of Joint Space with Measurements Is Subject Related in Medial Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 113
Online Consultation for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tools: A Study of Medical Economics
- 9:00AM-11:00AM
-
Abstract Number: 369
Opioid Prescriptions and Adverse Reactions in Children and Adolescents without Serious Diseases
- 9:00AM-11:00AM
-
Abstract Number: 86
Optimizing the Efficiency of Patient Data Capture Using Smartphone Technology: Evaluation of the Correlation Between Promis Instruments for PRO Data Capture
- 9:00AM-11:00AM
-
Abstract Number: 412
Oral Glucocorticoids and Rates of Incident Diabetes Mellitus and Hypertension in Children with Juvenile Idiopathic Arthritis and Attention-Deficit/Hyperactivity Disorder
- 9:00AM-11:00AM
-
Abstract Number: 365
Osteonecrosis of the Femoral Head Is Associated with Low Bone Mass.
- 9:00AM-11:00AM
-
Abstract Number: 357
Osteoporosis and Breast Cancer: Outcomes at a Specialized Osteoporosis Clinic Following a Structured Assessment
- 9:00AM-11:00AM
-
Abstract Number: 360
Osteoporosis Prevalence in Lung Transplant Patients
- 9:00AM-11:00AM
-
Abstract Number: 356
Osteoporotic Fracture As the Main Risk Factor in the Detection of Osteoporosis in Men Under 70 Years
- 9:00AM-11:00AM
-
Abstract Number: 21
Outcomes of Rheumatoid Arthritis Patients with Hip Fracture
- 9:00AM-11:00AM
-
Abstract Number: 798
Oxidized Phospholipids,Lipoprotein(a) and Glycosphingolipid Associated B-1,4 Galactosyltransferase in a Johns Hopkins Cohort of Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 377
Pain and Quality of Life Profiles in Colombian Patients with Rheumatoid Arthritis: A Mixed Cluster Analysis
- 9:00AM-11:00AM
-
Abstract Number: 379
Pain Catastrophizing Decreases in RA Patients Starting, Adding or Switching a DMARD
- 9:00AM-11:00AM
-
Abstract Number: 685
Paradoxical Psoriasis Secondary to Anti-Tnfa Agents in Patients with Ankylosing Spondylitis: A Nationwide Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 740
Patient Adherence with Mycophenolate Mofetil Therapy in a Systemic Lupus Erythematosus Cohort: A Multi-Factorial Assessment
- 9:00AM-11:00AM
-
Abstract Number: 110
Patient Decisions Related to Hip and Knee Arthroplasty and the Factors Influencing Them
- 9:00AM-11:00AM
-
Abstract Number: 456
Patient Engagement in Research: Understanding Patient Interest and Needs
- 9:00AM-11:00AM
-
Abstract Number: 541
Patient Goals in Rheumatoid Arthritis Care: A Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 224
Patient Perception of Gout Flares As a Measure of Outcome: Results from an International Study
- 9:00AM-11:00AM
-
Abstract Number: 106
Patient Satisfaction Survey of a Newly Set up Physiotherapist Lead Axial Spondyloarthritis Clinic
- 9:00AM-11:00AM
-
Abstract Number: 100
Patient Support Program for Adalimumab-Treated Patients in Brazil: Impact on Patients’ Adherence and Persistence
- 9:00AM-11:00AM
-
Abstract Number: 88
Patient-Clinician Co-Participation in Design of an App for RA Management Via Telehealth Yields an App with High Usability and Acceptance
- 9:00AM-11:00AM
-
Abstract Number: 522
Patient-Provider Discordance in Global Assessments of Disease Activity in Patients with Rheumatoid Arthritis: Persistence, Predictors and Impact
- 9:00AM-11:00AM
-
Abstract Number: 591
Patient-Reported Outcomes for Etanercept Therapy in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment
- 9:00AM-11:00AM
-
Abstract Number: 710
Patient-Reported Quality of Life in Patients with Baseline Objective Signs of Inflammation and Active Nonradiographic Axial Spondyloarthritis Treated with Golimumab: Results of the Open-Label Extension of a Randomized, Double-Blind Study
- 9:00AM-11:00AM
-
Abstract Number: 31
Patients with Either Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA) Self-Reported Flares in 24% of Assessments: An Observational Study of 86 Patients Assessed Weekly over 3 Months (ie, 1,100 assessments)
- 9:00AM-11:00AM
-
Abstract Number: 54
Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research
- 9:00AM-11:00AM
-
Abstract Number: 82
Patients with Rheumatoid Arthritis in Germany: Are They Ready for Ehealth Via Mobile Medical Applications?
- 9:00AM-11:00AM
-
Abstract Number: 225
Patterns of Joint Involvement in Gout Flares
- 9:00AM-11:00AM
-
Abstract Number: 405
Patterns of Medication Use in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry
- 9:00AM-11:00AM
-
Abstract Number: 212
Pegloticase Provides Clinical Benefit in Patients with Chronic Refractory Gout Who Did Not Meet the Clinical Trial Biochemical Definition of Response
- 9:00AM-11:00AM
-
Abstract Number: 103
People with Rheumatoid Arthritis Recruited from an Online Patient Community May Differ from Clinical Populations in Symptoms and Impacts
- 9:00AM-11:00AM
-
Abstract Number: 703
Performance of a New Spinal Mobility Index for Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 396
Performance of Disease Activity Measures in Juvenile Spondyloarthritis in a Placebo Controlled Trial with Infliximab
- 9:00AM-11:00AM
-
Abstract Number: 419
Performance of Framingham Risk Factor Score in Predicting Cardiovascular Events in Patients with Polymyalgia Rheumatica
- 9:00AM-11:00AM
-
Abstract Number: 698
Performance of Modified Minimal Disease Activity (MDA) in Patients with Peripheral Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 445
Performance of Promis Measures in a Multi-Ethnic Population-Based Systemic Lupus Erythematosus (SLE) Cohort
- 9:00AM-11:00AM
-
Abstract Number: 706
Performance of the ASAS Classification Criteria for Axial and Peripheral Spondyloarthritis – a Systematic Literature Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 94
Performance of the Patient Reported Outcomes Measurement Information System (PROMIS) Measure for Physical Function in Early RA
- 9:00AM-11:00AM
-
Abstract Number: 309
Periarticular Tibial Knee Bone Mineral Density Is Associated with Knee Symptoms
- 9:00AM-11:00AM
-
Abstract Number: 875
Pericardial Involvement in Biopsy-Proven Giant-Cell Arteritis (GCA) Patients Detected By CT Angiography (CTA): Prevalence at Diagnosis and Outcome with Glucocorticoid (GC) Treatment
- 9:00AM-11:00AM
-
Abstract Number: 851
Perioral Autologous FAT Transplantation Is More Effective THAN Hyaluronic Acid Filler on Scleroderma Skin Fibrosis: Results from a LONG TERM Controlled Study
- 9:00AM-11:00AM
-
Abstract Number: 366
Peripheral Osteoclastogensis Is Coming Back Along with Inflammation Twelve Months after Rituximab Therapy
- 9:00AM-11:00AM
-
Abstract Number: 866
Perivascular Inflammation in Temporal Artery Biopsies That Are Negative for Arteritis: Incidental or Harbinger?
- 9:00AM-11:00AM
-
Abstract Number: 251
Persistent Pruritic Skin Lesions with Dyskeratotic Cells in Upper Layer of Epidermis Are Specific and Associated with High Levels of Serum IL-18 in Adult-Onset Still’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 375
Persistent Tactile Allodynia in Male Arthritic Mice Is Accompanied By Sprouting of Sensory and Sympathetic Nerve Fibers
- 9:00AM-11:00AM
-
Abstract Number: 192
Pharmacodynamic and Pharmacokinetic Study of Verinurad in Adult Male Subjects with Mild, Moderate, and Severe Renal Impairment: A Phase 1, Open-Label Study
- 9:00AM-11:00AM
-
Abstract Number: 196
Pharmacodynamic Effects and Safety of Verinurad in Combination with Allopurinol Versus Allopurinol Alone in Adults with Gout: A Phase 2a, Open-Label Study
- 9:00AM-11:00AM
-
Abstract Number: 197
Pharmacodynamic Effects and Safety of Verinurad in Combination with Febuxostat Versus Febuxostat Alone in Adults with Gout: A Phase 2a, Open-Label Study
- 9:00AM-11:00AM
-
Abstract Number: 195
Pharmacodynamics, Pharmacokinetics, and Safety of Verinurad in Combination with Febuxostat Versus Febuxostat Alone and Verinurad Alone in Japanese Adults with Gout or Asymptomatic Hyperuricemia: A Phase 2a, Open-Label Study
- 9:00AM-11:00AM
-
Abstract Number: 615
Pharmacokinetic Similarity of ABP 710 Relative to Infliximab: Results from a Randomized, Single-Blind, Single-Dose, Parallel Group Study in Healthy Subjects
- 9:00AM-11:00AM
-
Abstract Number: 756
Pharmacokinetics and Exposure-Response Relationship of Belimumab Administered Subcutaneously to SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 194
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects with Gout
- 9:00AM-11:00AM
-
Abstract Number: 191
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Febuxostat in Healthy Adult Male Subjects
- 9:00AM-11:00AM
-
Abstract Number: 190
Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Adult Male Subjects
- 9:00AM-11:00AM
-
Abstract Number: 193
Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese Male Subjects
- 9:00AM-11:00AM
-
Abstract Number: 388
Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Pediatric Patients from Two to Less Than Eighteen Years of Age with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 880
Pilot Study of Microbubble Contrast-Enhanced Vascular Ultrasonography: A Novel Method of Detecting Large Vessel Vasculitis?
- 9:00AM-11:00AM
-
Abstract Number: 905
Platelet Activation, As Measured By Plasma Soluble Glycoprotein VI, Is Not Associated with Disease Activity or Ischaemic Events in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 67
Polymorphisms of ERAP1, IL23R and TRAILR1 Are Associated with MRI-Sacroiliitis in Early Axial Spondyloarthritis: Data from the French DESIR Cohort
- 9:00AM-11:00AM
-
Abstract Number: 882
Polymyalgia Rheumatica Activity Score without C-Reactive Protein
- 9:00AM-11:00AM
-
Abstract Number: 865
Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 646
Population Pharmacokinetics of ABT-122, an Immunoglobulin Targeting Both TNF-α and IL-17A: Analyses Across Phase 1 Studies in Healthy Volunteers and Phase 2 Studies in Subjects with Rheumatoid or Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 316
Postural Stability Is Associated with Lower Pain, Lower Stiffness, and Higher Muscle Power Among Adults with Symptomatic Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 383
Potential Biomarkers of Disease Activity in Juvenile Idiopathic Arthritis – Data from the Portuguese Register, Reuma.Pt
- 9:00AM-11:00AM
-
Abstract Number: 544
Power Doppler Ultrasound Signal Associates with Abnormal HDL Function and Suppression of Paraoxonase 1 Activity in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 762
Pragmatic Treatment of Patients with Systemic Lupus Erythematosus with Rituximab: Long-Term Effects on Serum Immunoglobulins
- 9:00AM-11:00AM
-
Abstract Number: 351
Pre-Operative Magnetic Resonance Imaging Can Help in Predicting Two-Year Readmission in Acute Severe Osteoporotic Vertebral Fracture after Vertebroplasty
- 9:00AM-11:00AM
-
Abstract Number: 536
Precision Medicine in Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis on the Diagnostic Accuracy of Anti-CCP Tests for the Diagnosis of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 301
Predictive Factors for Response to Ultrasound-Guided Intra-Articular Glucocorticoids in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 398
Predictors of Clinical Remission with Etanercept in Pediatric Patients with Extended Oligoarticular, Enthesitis-Related Arthritis and Psoriatic Arthritis: Findings from the Clipper Study
- 9:00AM-11:00AM
-
Abstract Number: 750
Predictors of Corticosteroid Use in the Systemic Lupus International Collaborating Clinics Inception Cohort – a Multivariate Analysis
- 9:00AM-11:00AM
-
Abstract Number: 334
Predictors of Fragility Fractures in Patients with Rheumatoid Arthritis Not on Steroids: An Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 525
Predictors of Health Care Drop-out in an Inception Cohort of Patients with Early Onset Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 713
Predictors of Treatment Retention Among Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Remicade® (Infliximab) for Long-Term in Canadian Real-World
- 9:00AM-11:00AM
-
Abstract Number: 580
Preferential Distribution of M1 Monocytes in Anti-Cyclic Citrullinated Peptide Antibody Positive Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 52
Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials
- 9:00AM-11:00AM
-
Abstract Number: 893
Preliminary Results of a Multi Modal Imaging Study Suggests a Better Accuracy for the Diagnosis of Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 219
Presence of Monosodium Urate Crystals By Dual-Energy Computed Tomography in Gout Patients Treated with Allopurinol
- 9:00AM-11:00AM
-
Abstract Number: 342
Presence of Vertebral Fractures and Disc Disease in Post Menopausal Females with Height Loss As a Possible Screening Method for Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 719
Prevalence and Incidence of Comorbidities in Patients with Ankylosing Spondylitis Versus General Population
- 9:00AM-11:00AM
-
Abstract Number: 168
Prevalence of Diastolic Dysfunction and Structural Heart Disease in Axial Spondyloarthritis: A Prospective Case Control Study Using Echocardiography
- 9:00AM-11:00AM
-
Abstract Number: 33
Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients
- 9:00AM-11:00AM
-
Abstract Number: 166
Prevalence of Radiographic Thymic Alteration and Its Clinical Association in Systemic Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 888
Prevalence of Takayasu Arteritis in Young Women Presenting with Acute Ischemic Heart Disease
- 9:00AM-11:00AM
-
Abstract Number: 738
Preventive Effect of Combined Treatment with Bisphosphonate and Vitamin D on Atherosclerosis in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 771
Preventive Effects of Glucocorticoids on Progression of Atherosclerosis in Japanese Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 846
Progression of Left Ventricular Myocardial Dysfunction in Systemic Sclerosis: Using Speckle Tracking Strain Echocardiography to Identify Patients at Risk
- 9:00AM-11:00AM
-
Abstract Number: 539
Promis Short Forms Are Relevant to People Living with RA: Results of Cognitive Debriefing Interviews
- 9:00AM-11:00AM
-
Abstract Number: 213
Prophylaxis for Infusion Reactions to Pegloticase: An Analyis of Two Different Corticosteroid Pre-Infusion Regimens in US Community Rheumatology Practices
- 9:00AM-11:00AM
-
Abstract Number: 415
Proposal for a Damage Index for Juvenile Idiopathic Arthritis Related Uveitis from the Multinational Interdisciplinary Working Group for Uveitis in Childhood Group (MIWGUC)
- 9:00AM-11:00AM
-
Abstract Number: 414
Proposal for the Definition of Inactivity of Juvenile Idiopathic Arthritis Related Uveitis from the Multinational Interdisciplinary Working Group for Uveitis in Childhood Group (MIWGUC)
- 9:00AM-11:00AM
-
Abstract Number: 645
Prospective Observational Real-Life Study (STRATEGE) Shows the Efficacy of Treat-to-Target Strategy and Methotrexate Monotherapy Optimization in Patients with Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 636
Prospective, Intervention, Multicenter Study of Utility of Biologic Drug Monitoring with Respect to the Efficacy and Cost of Adalimumab Tapering in Patients with Rheumatic Diseases (34-week descriptive data)
- 9:00AM-11:00AM
-
Abstract Number: 183
Protective Role of Mucosal-Associated Invariant T (MAIT) Cells in an Imiquimod-Induced Psoriasis Model
- 9:00AM-11:00AM
-
Abstract Number: 174
Protein Modified with Citrulline and/or Malondialdehyde-Acetaldehyde Bind to Different Scavenger Receptors
- 9:00AM-11:00AM
-
Abstract Number: 822
Pulmonary Fibrosis in Mixed Connective Tissue Disease – Results from an Unselected Longitudinal Cohort
- 9:00AM-11:00AM
-
Abstract Number: 142
Quality Assessment of Ultrasound Guided Synovial Biopsies Performed in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 642
Quality of Life Outcomes Following Therapy with Chs-0214 and Etanercept (Enbrel): Randomized, Double-Blind Study in Subjects with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 116
Racial Differences in Self-Reported Pain and Disability: A Longitudinal Study of Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 154
Radiographic Knee Osteoarthritis in Patients Complaining of Knee Pain: Ultrasound Features
- 9:00AM-11:00AM
-
Abstract Number: 716
Radiographic Progression and Changes in Inflammation and Structural Damage on Serial MRI Examinations over 5 Years in Patients with Ankylosing Spondylitis Treated with TNF-Alpha Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 588
Radiographic Progression Is Less Significant in Anti-Carbamylated Antibody-Positive Patients with Rheumatoid Arthritis (RA) Who Were Clinically Active and Under the Treatment with Biological Dmards
- 9:00AM-11:00AM
-
Abstract Number: 718
Radiographic Progression of Hip Arthritis in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 428
Random Forest Models Using Electronic Health Record Data Are Predictive of One-Year Outcomes in Lupus Nephritis Patients Taking Mycophenolate Mofetil Induction Therapy
- 9:00AM-11:00AM
-
Abstract Number: 797
Randomized Clinical Trials of Systemic Lupus Erythematosus: Evaluating Differences in the Enrolled Populations
- 9:00AM-11:00AM
-
Abstract Number: 118
Rates and Determinants of Persistent Patient-Physician Discordance in Global Assessment of Disease Activity in Latinos with Rheumatoid Arthritis in the United States
- 9:00AM-11:00AM
-
Abstract Number: 599
Real World United States-Based Clinical Experience with Prior Biologic Use Among First Time Golimumab Intravenous and Infliximab Treated Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 145
Reduction in Musculoskeletal Ultrasound (MSK-US) Payments in 2014: Effects & Consequences
- 9:00AM-11:00AM
-
Abstract Number: 641
Reduction of Concomitant Oral Methotrexate or Corticosteroids in Combination Treatment with Adalimumab Does Not Affect Effectiveness in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 105
Regional Primary Care Rheumatology Networks for Patients with Rheumatic and Musculoskeletal Diseases: Need for a National Approach
- 9:00AM-11:00AM
-
Abstract Number: 664
Regulation of Interferon Signaling By a Calcium-Induced miRNA in Primary Human Salivary Gland Epithelial Cells
- 9:00AM-11:00AM
-
Abstract Number: 291
Relation of Foot Pronation during Walking to Risk of Worsening Lateral Patellofemoral and Medial Tibiofemoral Cartilage Damage
- 9:00AM-11:00AM
-
Abstract Number: 370
Relationship Between Alcohol Consumption and Symptom Severity in Chronic Pain Patients
- 9:00AM-11:00AM
-
Abstract Number: 758
Relationship Between Corticosteroids and Adverse Events in SLE –Data from the Clinical Trial Belimumab in Subjects with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 689
Relationship Between Infliximab Serum Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 229
Relationship Between Patient and Disease Factors and Severity of Gout in a Real-World Population
- 9:00AM-11:00AM
-
Abstract Number: 140
Relationship Between the Prevalence of Subclinical Tenosynovitis and Therapy in Patients with RA in Clinical Remission: Results from Italian Society of Rheumatology Study Group
- 9:00AM-11:00AM
-
Abstract Number: 139
Reliability of Ultrasound in Detecting Cartilage Change in Patients with Rheumatoid Arthritis: A Study By Omeract Ultrasound Task Force
- 9:00AM-11:00AM
-
Abstract Number: 206
Renal Safety of Lesinurad: A Pooled Analysis of Phase III and Extension Studies
- 9:00AM-11:00AM
-
Abstract Number: 443
Repetitive Requisition of Antinuclear Antibody Testing (ANA) in Outpatient Multispecialty Clinics in Patients with a Known Positive ANA
- 9:00AM-11:00AM
-
Abstract Number: 120
Reproductive Tract Infections (RTI) in Indian (Asian) Women of Child Bearing Age Suffering from RA:I Don’t Ask Them, They Don’t Tell Me
- 9:00AM-11:00AM
-
Abstract Number: 459
Resident Non-Classical Monocytes Are Critically Important for Tissue Destruction in Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 769
Response to Belimumab in SLE Patients with High Disease Activity: Data from a Multicentric Clinical-Practice Based Study Cohort
- 9:00AM-11:00AM
-
Abstract Number: 188
Responsiveness to X-Linked Toll-like Receptors Differs Between Mice with XY and XX Sex Chromosome Complement, Regardless of the Gonadal Sex
- 9:00AM-11:00AM
-
Abstract Number: 321
Results of a Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Romosozumab in Men with Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 270
Retinoic Acid-Inducible Gene-I Increased in Peripheral CD3+T Lymphocytes of Patients with Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 783
Review of SLE Cohort to Identify Predictors of Response to B Cell Depletion in Patients with Active SLE
- 9:00AM-11:00AM
-
Abstract Number: 2
Rheumatoid Arthritis (RA)-Related Autoimmunity and Lumbar Bone Mineral Density in a Multi-Ethnic Community-Dwelling Population
- 9:00AM-11:00AM
-
Abstract Number: 4
Rheumatoid Arthritis (RA)-Related Joint Symptoms and Thoracic Bone Mineral Density in an RA-Free Community Dwelling Population
- 9:00AM-11:00AM
-
Abstract Number: 5
Rheumatoid Arthritis and Periodontitis: Association and Characteristics of Chronic Periodontitis
- 9:00AM-11:00AM
-
Abstract Number: 566
Rheumatoid Arthritis Patients’ Ability to Accurately Recall DMARD Information Immediately Following an Office Visit with Their Rheumatologist
- 9:00AM-11:00AM
-
Abstract Number: 26
Rheumatoid Factor Positivity Increases All-Cause and Cancer Mortality Risk in Korean Healthy Examinees: A Kangbuk Samsung Health Study
- 9:00AM-11:00AM
-
Abstract Number: 101
Rheumatology Care Utilization and Geographic Distance from Rheumatology Sites within the United States Veteran Affairs Health Care System
- 9:00AM-11:00AM
-
Abstract Number: 856
Rho Kinase Ezpression in Giant Cell Arteritis: Validating Perm Intensity Score As a Method of Increasing Sensitivity of Temporal Artery Biopsy
- 9:00AM-11:00AM
-
Abstract Number: 773
Risk Factors for Severe Infections in Rituximab Treated Patients: Comparison of Systemic Lupus Erythematosus and Inflammatory Myositis
- 9:00AM-11:00AM
-
Abstract Number: 683
Risk Factors of Uveitis in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 896
Risk for Cardiovascular Disease in Giant Cell Arteritis and Polymyalgia Rheumatica
- 9:00AM-11:00AM
-
Abstract Number: 260
Risk of Cardiovascular Disease Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 877
Risk of Coronary Artery Disease in Patients with Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 29
Risk of Vascular Mortality in Seniors with New-Onset Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 763
Rituximab As a Corticosteroid-Sparing Agent in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 907
Rituximab in Patients with Takayasu Arteritis: A Single Center Experience on Five Patients
- 9:00AM-11:00AM
-
Abstract Number: 259
Rituximab in Refractory Cardiac Sarcoidosis – Single Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 387
Rituximab Should be Considered in Rheumatoid Factor Negative Poly-Articular Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 817
RNA and Protein Cargo of Exosomes Isolated from Serum of Systemic Sclerosis Patients Induce a Profibrotic Phenotype in Cultured Normal Human Dermal Fibroblasts: A Potential Mechanism for the Initiation and Progression of a Profibrotic Phenotype in SSc
- 9:00AM-11:00AM
-
Abstract Number: 669
RNA-Sequencing Reveals Sjogren’s Syndrome Anti-Ro Negative Patients Share Similar Pathways to Multiple Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 469
Role of Microbiota in Development of Autoimmune Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 222
Role of Synovial Biopsy in Diagnosis of Crystal Arthropathies
- 9:00AM-11:00AM
-
Abstract Number: 172
S100A8/A9 Produced during Experimental Osteoarthritis Induces a Systemic Decrease in BM Monocytes and Increases Ly6C High Monocytes Locally in the Joint
- 9:00AM-11:00AM
-
Abstract Number: 173
S100A8/A9, a Potent Serum and Molecular Imaging Biomarker for Synovial Inflammation and Joint Destruction in Seronegative Experimental Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 392
Safety and Clinical Response of Weekly Adalimumab in the Treatment of Juvenile Idiopathic Arthritis, Pediatric Chronic Uveitis and Other Childhood Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 687
Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 211
Safety and Efficacy of Febuxostat in Advanced CKD Patients with Hyperuricemia
- 9:00AM-11:00AM
-
Abstract Number: 255
Safety and Efficacy of Long-Term Canakinumab Therapy in Patients with CAPS: Final Results from Beta-Confident Registry
- 9:00AM-11:00AM
-
Abstract Number: 739
Safety and Efficacy of Rituximab in the Treatment of Refractory Systemic Lupus Erythematosus: Results from a National Register
- 9:00AM-11:00AM
-
Abstract Number: 721
Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 385
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 330
Safety of Denosumab in Postmenopausal Osteoporosis and in Cancer and Bone Metastase Treatment: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 144
Safety, Tolerability and Feasibility of Minimally Invasive Ultrasound-Guided Synovial Biopsyof Wrist and Metacarpophalangeal Joints – an Ultrasound Follow-up Study
- 9:00AM-11:00AM
-
Abstract Number: 665
Salivary Gland Secretome: A Novel Tool to Identify Biomarkers of Dryness and Immunopathology in Primary Sjogren’s Syndrome and Non-Autoimmune Sicca Patients
- 9:00AM-11:00AM
-
Abstract Number: 261
Sarcoidosis Is Associated with Increased Risk of Venous Thromboembolism: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 262
Seasonal Variation in Incidence of Sarcoidosis: A Population-Based Study 1976-2013
- 9:00AM-11:00AM
-
Abstract Number: 695
Secukinumab Sustains Individual Clinical Responses over Time in Patients with Active Ankylosing Spondylitis: 2-Year Results from a Phase 3 Randomized Placebo-Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 462
Selective Inhibition of MMP9 Using a Monoclonal Antibody As a Therapeutic Strategy for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 494
Sensitivity and Specificity of 14-3-3η, Anti-CEP-1 and Anti-Sa Antibodies in a Cohort of Seronegative and Suspected Rheumatoid Arthritis (RA) Patients from a Community Rheumatology Practice
- 9:00AM-11:00AM
-
Abstract Number: 644
Seroprevalence and Its Impact on Radiographic Damage in Korean Rheumatoid Arthritis Patients Starting Biologics
- 9:00AM-11:00AM
-
Abstract Number: 564
Serum Adiponectin and Body Composition in a Group of Patients with Rheumatoid Arthritis: Relationship Between Disease Parameters
- 9:00AM-11:00AM
-
Abstract Number: 364
Serum Sclerostin Levels in Rheumatoid Arthritis (RA) and Its Correlation with Disease Activity and Bone Mineral Density
- 9:00AM-11:00AM
-
Abstract Number: 294
Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients with Medial Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 205
Serum Uric Acid Lowering Treatment Appears Unnecessary during Hemodialysis
- 9:00AM-11:00AM
-
Abstract Number: 827
Severe Gastrointestinal Disease in Early Systemic Sclerosis Is Associated with an Increased Risk of Mortality
- 9:00AM-11:00AM
-
Abstract Number: 485
Sexual Dimorphism of Popliteal Lymph Node Collapse As a Biomarker of Disease Progression in the Tumor Necrosis Factor Transgenic Mouse Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 466
Sexually Dimorphic Dysbiosis of Gut Microbiota in Tumor Necrosis Factor Transgenic Mice with Inflammatory-Erosive Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 228
Sick Leave and Disability Pension in Working-Age Gout Patients before and after Diagnosis – a Population Based Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 696
Significantly Reduced Recurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis during Treatment with Golimumab
- 9:00AM-11:00AM
-
Abstract Number: 806
Single Cell Rnaseq Defines a Unique Transcriptome Profile for Myofibroblasts in the Skin of Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 672
Sjogren Big Data Project: Influence of Geolocation on the Phenotypic Expression at Diagnosis in 8310 Patients (North-to-South Gradient)
- 9:00AM-11:00AM
-
Abstract Number: 673
Sjögren’s Syndrome (SS): The Role of Traditional (SS-A/SS-B) and Novel Antibodies in Diagnosis
- 9:00AM-11:00AM
-
Abstract Number: 210
Skin Events with Febuxostat in Gout Patients and Previous Skin Reactions to Allopurinol. a Retrospective Review
- 9:00AM-11:00AM
-
Abstract Number: 410
Sleep and Its Relationship to Pain and Disease Activity in Turkish Children and Adolescent with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 42
Small Fibre Neuropathy Biopsies (SFN) in Primary Fibromyalgia Revealed Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN) but No Clear Distinction Related to Biopsy Results
- 9:00AM-11:00AM
-
Abstract Number: 45
Small Fiber Neuropathy in Rheumatology Clinics
- 9:00AM-11:00AM
-
Abstract Number: 124
Socioeconomic-Demographic, Disease Activity, Treatment and Immunologic Variables Affect B Cell Subtypes in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 561
Sodium Intake Is Increased in Patients with Early Rheumatoid Arthritis and Is Associated with Radiographic Erosions
- 9:00AM-11:00AM
-
Abstract Number: 274
Splicing Factor Proline/Glutamine-Rich Is a Novel Autoantigen of Dermatomyositis and Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibody.
- 9:00AM-11:00AM
-
Abstract Number: 688
Spondyloarthritis Research Consortium of Canada (SPARCC) Baseline MRI SI Joint Score ≥2 Better Predicts Response to Golimumab Than Does Assessment of Spondyloarthritis International Society (ASAS) MRI Positivity in Nonradiographic Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 671
Steered Screening for Sjögren Syndrome in Patients with Sicca Syndrome. Role of Salival Beta-2 Microglogulin
- 9:00AM-11:00AM
-
Abstract Number: 630
Strategies for Biological Drug Quantification in Biological Drug Immune Responses
- 9:00AM-11:00AM
-
Abstract Number: 684
Subchondral Bone Sclerosis on Computed Tomography – Does It Have Any Value in the Diagnosis of Inflammatory Sacroiliitis or Is It a Non-Specific Finding?
- 9:00AM-11:00AM
-
Abstract Number: 521
Subcutaneous Adipose Tissue from Rheumatoid Arthritis Patients Is Characterized By an Abundance of Macrophages That Are Associated with Autoantibodies, Systemic Inflammation, and Immunomodulation
- 9:00AM-11:00AM
-
Abstract Number: 175
Suppressor of Cytokine Function One (SOCS1) Is Elevated in Non-Classical Monocytes and Correlates with Disease Activity in Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 828
Survival and Health-Related Quality of Life in Incident Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Multicentre Australian Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 604
Sustained Efficacy and Comparable Safety and Immunogenicity after Transition to SB5 (an Adalimumab Biosimilar) Vs. Continuation of SB5 or Reference Adalimumab (Humira®) in Patients with Rheumatoid Arthritis: Results of Phase III Study
- 9:00AM-11:00AM
-
Abstract Number: 626
Switching Biologic Therapy in a Population of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 639
Switching to Biosimilars in Rheumatology: Evidence-Based Practice
- 9:00AM-11:00AM
-
Abstract Number: 676
Syndesmophytes in the Thoracic Spine in Ankylosing Spondylitis As Detected By Computed Tomography and Association with Lumbar Radiographic Involvement
- 9:00AM-11:00AM
-
Abstract Number: 543
Synovial Features of Rheumatoid Arthritis and Psoriatic Arthritis Differ in Patients in Clinical and Ultrasound Remission after Anti-TNF Therapy
- 9:00AM-11:00AM
-
Abstract Number: 573
Synovial Fibroblast-Neutrophil Interactions Promote Pathogenic Adaptive Immunity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 587
Synovial Immunophenotype and Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiological Prognosis
- 9:00AM-11:00AM
-
Abstract Number: 153
Synovial Immunophenotype and Ultrasonography: A Contemporaneous Study of Different Compartments of the Knee Joint
- 9:00AM-11:00AM
-
Abstract Number: 134
Synovitis Assessed By the German 7-Joint Ultrasound Score (US7S) Is Associated with the Reversible Activity-Related Component of Physical Disability in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 157
Synovitis of Sternoclavicular and Peripheral Joints Can be Detected By Ultrasound in Patients with SAPHO Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 121
Systemic Lupus Erythematosus (SLE) Is a Salient Cause of Premature Mortality in the United States: A Sex-Based Exploration
- 9:00AM-11:00AM
-
Abstract Number: 792
Systemic Lupus Erythematosus (SLE) Responder Index [SRI(4)] Response Is Associated with Global Benefit in Patients with Moderate to Severe SLE
- 9:00AM-11:00AM
-
Abstract Number: 50
Tai Chi Significantly Modulates Resting State Functional Connectivity of the Cognitive Control Network in Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 864
Takayasu Arteritis Developed over the Age of 40 Has Lower Levels of Interferon Gamma and Interleukin 17 at Disease Onset and Fewer Subsequent Relapses
- 9:00AM-11:00AM
-
Abstract Number: 852
Targeting Fibroblastoid-like Cells By Drug Loaded Engineered Gold Nanoparticles As a Novel Approach for ILD-SSc Treatment
- 9:00AM-11:00AM
-
Abstract Number: 674
Targeting Glandular IL-21-Production in Primary Sjogren′s Syndrome Patients By Immunomodulatory Treatment
- 9:00AM-11:00AM
-
Abstract Number: 484
Targeting the BTK-JAK Axis in Preclinical Models of Rat Collagen-Induced Arthritis with GS-4059 in Combination with a JAK Inhibitor
- 9:00AM-11:00AM
-
Abstract Number: 460
TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Demonstrates Anti-Inflammatory Effect in Autoimmune Disease Models
- 9:00AM-11:00AM
-
Abstract Number: 577
TCZ Modulates the Production of Ccfdna Derived from RA Synovial Cells
- 9:00AM-11:00AM
-
Abstract Number: 439
Temple University Hospital Rheumatology Narcotic Contract
- 9:00AM-11:00AM
-
Abstract Number: 903
Temporal Arteritis: Is There Any Correlation Between Ultrasonographic Arterial Wall Involvement and the Inflammatory Cellular Infiltrate at Histological Examination?
- 9:00AM-11:00AM
-
Abstract Number: 867
Termination of Tocilizumab-Treatment in Giant Cell Arteritis: Follow-up of Patients after the RCT (ClinicalTrials.gov registration number: NCT01450137)
- 9:00AM-11:00AM
-
Abstract Number: 493
The 2010 ACR/EULAR Criteria Are Not Sufficiently Accurate in the Early Identification of Autoantibody-Negative Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 102
The 2015 American College of Rheumatology (ACR) Workforce Study: A Snapshot of Academic Division Directors
- 9:00AM-11:00AM
-
Abstract Number: 136
The 7-Joints Musculoskeletal Ultrasound Score (US7 score) Predicts Therapeutic Change in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 135
The 8-Joint Ultrasound Score Is a Useful Marker for Monitoring Therapeutic Response in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 322
The Activating Patients at Risk for Osteoporosis Study: A Randomized Trial within the Global Longitudinal Study of Osteoporosis in Women Cohort
- 9:00AM-11:00AM
-
Abstract Number: 449
the Animated Activity Questionnaire to Assess Activity Limitations in Patients with Hip and Knee Osteoarthritis: Reliability, Responsiveness, and Interpretation
- 9:00AM-11:00AM
-
Abstract Number: 165
The Apparent Diffusion Coefficient As a Quantitative Imaging Biomarker of Therapeutic Response in Enthesitis-Related Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 515
The Association of Body Mass Index with the Severity of Magnetic Resonance Imaging-Detected Inflammation at Presentation; Opposite Effects in Early Rheumatoid Arthritis Compared to Other Arthritides and an Asymptomatic Population
- 9:00AM-11:00AM
-
Abstract Number: 359
The Association of Scheuermann’s Disease with Osteoporotic Vertebral Fracture Risk
- 9:00AM-11:00AM
-
Abstract Number: 314
The Clinical Efficacy and Safety of the Gumiganhwal-Tang in Knee Osteoarthritis: A Phase II Randomized Double Blind Placebo Controlled Study
- 9:00AM-11:00AM
-
Abstract Number: 607
The Clinical Response to Biologic and Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) According to Gender in a French-Canadian Population with Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 532
The DAS28 Score May Misread Disease Activity in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 711
The Diagnostic Value of the Symptom of Inflammatory Back Pain in the Rheumatology Setting
- 9:00AM-11:00AM
-
Abstract Number: 854
The Ducas: Proposal for a Digital Ulcer Assessment Score in Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 754
The Duration of Anti-Malarial Agent Intake in the First 5 Years of the Disease and Prognosis in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 361
The Effect of Immunosuppressive and Antiresorptive Therapy on Bone Mineral Density in Lung Transplant Patients
- 9:00AM-11:00AM
-
Abstract Number: 217
The Effect of Regular Treatment on Disability in a Cohort of Patients with Gout.
- 9:00AM-11:00AM
-
Abstract Number: 114
The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario
- 9:00AM-11:00AM
-
Abstract Number: 452
The Efficacy of Motivational Counselling and SMS-Reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis: A Randomised Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 520
The HAQ Reversible and Irreversible Components Measuring Function in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 497
The Identification of an ACR Score with the Optimal Discriminatory Ability Between Treatments in Patients with Early and Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 269
The Immunoproteasomes Are Essential for Maintaining Myokine Production and MHC Class I Expression in Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 18
The Impact of Disease-Related and Contextual Factors on Work Outcomes in Chronic Inflammatory Arthritis Patients Treated with Biologics: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 17
The Importance of Achieving Clinical Response to Treatment and Changes in Physical Ability and Quality of Life on Worker Productivity Outcomes in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register
- 9:00AM-11:00AM
-
Abstract Number: 540
The Importance of Outcome Measures in Rheumatoid Arthritis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Setting
- 9:00AM-11:00AM
-
Abstract Number: 395
The Influence of Early Achievement of “Clinically Inactive Disease” or “Minimal Disease Activity” on Long-Term Disability Outcomes in JIA
- 9:00AM-11:00AM
-
Abstract Number: 447
The Influence of Risk Presentation Format on Willingness to Start a Medication
- 9:00AM-11:00AM
-
Abstract Number: 185
The Interferon Gene Signature Is Increased in Early DMARD Naive Rheumatoid Arthritis and Predicts a Poorer Response to Initial Therapy
- 9:00AM-11:00AM
-
Abstract Number: 791
The International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns (ICAP) Initiative – Update and Its Impact
- 9:00AM-11:00AM
-
Abstract Number: 654
The Level of B-Cell Active Cytokines and Soluble B-Cell Activating Factor/a Proliferation-Inducing Ligand Receptors in Patients with Primary Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 747
The Long-Term Outcomes on Leflunomide Treatment in Patients with Lupus Nephritis: A Twelve-Year Follow-up Study
- 9:00AM-11:00AM
-
Abstract Number: 505
The Longitudinal Stability of the RA Biomarkers RF and ACPA in Classifying RA Subtypes over Extended Follow up
- 9:00AM-11:00AM
-
Abstract Number: 440
the Majority of Biologic Injectors Are Stored Under Suboptimal Conditions at Home
- 9:00AM-11:00AM
-
Abstract Number: 815
The Novel Anti-BICD2 Autoantibody Potentially Predicts a Favorable Disease Course in SSc
- 9:00AM-11:00AM
-
Abstract Number: 900
The Phenotype of Macrophages in the Inflamed Vascular Wall of Giant Cell Arteritis Resembles the Phenotype of Non-Classical Monocytes
- 9:00AM-11:00AM
-
Abstract Number: 3
The Presence of Rheumatoid Factor Is Associated with Lower Bone Mass in Korean Health Screening Male Subjects without Clinically Apparent Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 693
The Prevalence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 433
The Prevalence of Latent Tuberculosis and Hepatitis B Found after Systematic Screening of Patients Starting with Biological Therapy in a Low-Endemic Area
- 9:00AM-11:00AM
-
Abstract Number: 652
The Reasons for Discontinuation of Combination Therapy with Methotrexate and Tumor Necrosis Factor Inhibitors Versus Triple Therapy Differ Significantly Because of Higher Adverse Events with Triple Therapy
- 9:00AM-11:00AM
-
Abstract Number: 814
The Regulatory B Cells Ameliorate Skin Sclerosis, Lung Fibrosis, and Autoimmunity Via an Anti-Oxidative Effect in Systemic Sclerosis Model Mice
- 9:00AM-11:00AM
-
Abstract Number: 313
The Relation of Serum Urate to Radiographic Knee and Hand Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 345
The Relationship Between Anti-Cyclic Citrullinated Peptide (anti-CCP) Levels and Bone Mineral Density (BMD) or Fragility Fracture in Patients with Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 506
The Relationship Between Elevations in CRP with Physical Function and Radiographic Progression over the Long-Term in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 529
The Relationship Between Promis and CDAI Scores, Disease Duration, Age and Gender in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 240
The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease
- 9:00AM-11:00AM
-
Abstract Number: 117
The Relationship Between Socioeconomic Factors and Dmards Use in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 855
The Relationship Between Systemic Sclerosis and Breast Cancer and the Effects on Treatment Outcome
- 9:00AM-11:00AM
-
Abstract Number: 495
The Relative Performance of 28-Joint Disease Activity Score Based on C-Reactive Protein with Three Versus Four Components in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 402
The Risk of Hospitalized Infection Associated with Initiation of Abatacept Versus TNF Inhibitors in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 336
The Risk of Subsequent Osteoporotic Fractures Is Decreased in Patients Experiencing Fracture While on Denosumab
- 9:00AM-11:00AM
-
Abstract Number: 818
The Role of Endothelin 1 in Activation of Vascular Smooth Muscle Cells in Systemic Sclerosis; Increased Cell Proliferation and Resistance to Apoptosis Mediated By Endotehlin B Receptors
- 9:00AM-11:00AM
-
Abstract Number: 204
The Safety and Efficacy of Allopurinol Dose Escalation in People with Gout, a Randomised Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 200
The Safety and Efficacy of Benzbromarone in Gout in Aotearoa New Zealand
- 9:00AM-11:00AM
-
Abstract Number: 527
The Summed Bilateral Elbow Extension Angle in Rheumatoid Arthritis Correlates with the DAS28-CRP(4) and May be an Independent Marker of Bad Prognosis
- 9:00AM-11:00AM
-
Abstract Number: 458
The TAM Receptors Axl and Mer Play a Protective Role in a Temporal and Spatial Manner in Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 668
The TNFAIP3 F127C Coding Variation in Sjogren’s Syndrome: Results from a Greek Cohort
- 9:00AM-11:00AM
-
Abstract Number: 662
The Unusual Cross-Reactivity of Anti Muscarinic Receptor 3 Monclonal Antibodies Derived from Salivary Glands of Sjögren’s Syndrome Patients to Ro Peptides
- 9:00AM-11:00AM
-
Abstract Number: 781
The Use of Rituximab in Newly Diagnosed Systemic Lupus Erythematosus Patients: Long Term Steroid Saving Capacity and Clinical Effectiveness
- 9:00AM-11:00AM
-
Abstract Number: 141
The Usefulness of SMI Technology on Ultrasound for the Evaluation of Active Synovitis in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 889
The Utility of Patient-Reported Outcomes in Predicting Disease Activity in Patients with Takayasu’s Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 10
The Utility of Screening for Infectious Diseases in Recipients of Anti-TNF-α Therapy
- 9:00AM-11:00AM
-
Abstract Number: 320
The Value of Adjusting for Physical Activity When Measuring Osteoarthritis-Related Pain
- 9:00AM-11:00AM
-
Abstract Number: 617
Therapy in Patients with Rheumatoid Arthritis (RA) with Inadequate Response to Tumor Necrosis Factor Alpha Inhibitors (TNFi): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs
- 9:00AM-11:00AM
-
Abstract Number: 560
There Is No Further Gain from Calculating Disease Activity Score in 28 Joints with High Sensitivity Assays of C-Reactive Protein Because of High Intraindividual Variability of CRP: A Cross Sectional Study and Theoretical Consideration
- 9:00AM-11:00AM
-
Abstract Number: 653
Thrombospondin-1 Is Highly Expressed By Salivary Gland Epithelial Cells of Sjögren’s Syndrome Patients, Both Constitutively and upon Exposure to Necrotic Cells Debris
- 9:00AM-11:00AM
-
Abstract Number: 840
Time Trends in Incidence and Mortality of Systemic Sclerosis in Denmark from 1995-2011: A Nationwide Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 96
Transforming Healthcare in Rheumatology: From Inpatient to Outpatient Care without Reductions in Healthcare Quality
- 9:00AM-11:00AM
-
Abstract Number: 898
Treatment and Outcome of Patients with a Diagnosis of Healed Arteritis on Temporal Artery Biopsy
- 9:00AM-11:00AM
-
Abstract Number: 84
Treatment Outcomes and Predictors of Patient Support Program Use Among Patients with Rheumatoid Arthritis: Results from a Post-Marketing Observational Study (PMOS)
- 9:00AM-11:00AM
-
Abstract Number: 177
Treatment with Dexamethasone and Monophosphoryl Lipid a Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers the Ability to Modulate CD4+ T Cell Responses
- 9:00AM-11:00AM
-
Abstract Number: 702
Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in a Large, Prospective Real-Life Cohort
- 9:00AM-11:00AM
-
Abstract Number: 906
Treatment with Methotrexate and Risk of Relapses in Patients with Giant Cell Arteritis in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 568
Triggering Receptor Expressed on Myeloid Cells (TREM) As a Novel Indicator of Disease Progression in ‘at-Risk’ Individuals
- 9:00AM-11:00AM
-
Abstract Number: 382
Tumor Necrosis Factor-α -308 a/G Gene Polymorphism in Children with Juvenile Idiopathic Arthritis: Relation to Disease Activity, Damage and Disability
- 9:00AM-11:00AM
-
Abstract Number: 19
Tumour Necrosis Factor Inhibition Is Associated with Weight Gain in Patients with Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 479
Type II Collagen Secreted from Articular Chondrocytes Is Mainly Destroyed By Cathepsin S in RA Mice
- 9:00AM-11:00AM
-
Abstract Number: 147
Ultrasonographic Evaluation of Subclinical Enthesitis in Patients with Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 150
Ultrasonography and Magnetic Resonance Imaging Changes in Polymyalgia Rheumatica Patients Treated By Tocilizumab
- 9:00AM-11:00AM
-
Abstract Number: 169
Ultrasound and Magnetic Resonance Imaging Fusion of Images and B-Flow Evaluation of Tenosynovitis – a Pilot Study on New Imaging Techniques in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 160
Ultrasound Assessment of Rheumatoid Arthritis Patients. External Validation and Inter-Rater Reliability of a 4-Joint Ultrasonographic Scoring System
- 9:00AM-11:00AM
-
Abstract Number: 857
Ultrasound Cut-Off Values for Intima-Media Thickness of Temporal, Facial and Axillary Arteries in Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 146
Ultrasound Features of the Posterior Tibialis Tendon and Peroneus Brevis Tendon Entheses: A Comparison Study Between Healthy Adults and Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 221
Ultrasound in Gout: The Clinical Application
- 9:00AM-11:00AM
-
Abstract Number: 129
Ultrasound Is More Reliable Than Inflammatory Parameters (ESR and CRP) to Evaluate Disease Activity in Rheumatoid Arthritis Patients on Tocilizumab Therapy
- 9:00AM-11:00AM
-
Abstract Number: 132
Ultrasound Performed Among RA Patients in Real Life Setting Can Predict Loss of Remission, Especially When Done Early after Reaching Remission
- 9:00AM-11:00AM
-
Abstract Number: 567
Understanding Contextual Factors That Influence Decisions Related to Health and Work Among People with Recently Diagnosed Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 81
Understanding the Importance of a Patient’s Role in the Management of RA: Physician- and Patient-Based Survey
- 9:00AM-11:00AM
-
Abstract Number: 258
Unmet Psychosocial Needs in Patients with CAPS
- 9:00AM-11:00AM
-
Abstract Number: 788
Unresolving C4 Hypocomplementemia Associates with a Different Spectrum of Disease in SLE and Is More Important Than Transiently Low Levels
- 9:00AM-11:00AM
-
Abstract Number: 184
Upregulation and Activation of the IFI16-Sting-IRF3-IFN Pathway in Sjogren’s Salivary Glands
- 9:00AM-11:00AM
-
Abstract Number: 220
Urate Lowering Therapy Regresses Ultrasound Abnormalities in Gout
- 9:00AM-11:00AM
-
Abstract Number: 634
Use of Biosimilars in Clinical Practice: A Swedish National Register-Based Assessment
- 9:00AM-11:00AM
-
Abstract Number: 429
Use of Electronic Medical Record to Identify Immunocompromised Patients in a Pediatric Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 789
Use of Nominal Group Technique to Determine Candidate Items for SLE Classification Criteria Development
- 9:00AM-11:00AM
-
Abstract Number: 501
Use of Rheumatologic Testing By Primary Care Physicians in Patients with Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 417
Use of Tumor Necrosis Factor-α Inhibitors in Pediatric HLA-B27-Associated Uveitis
- 9:00AM-11:00AM
-
Abstract Number: 390
Use, Safety and Efficacy of Zrc 3197, a Biosimilar Candidate for Reference Adalimumab (Humira) from a Tertiary Pediatric Rheumatology Centre in India
- 9:00AM-11:00AM
-
Abstract Number: 502
Use, Usability and Feasibility of a Mapp for Patients with Rheumatoid Arthritis – First Results
- 9:00AM-11:00AM
-
Abstract Number: 305
Using a Large Prospective Cohort of Patients to Examine Differences in Performance and Self-Reported Outcomes Following Total Knee Replacement
- 9:00AM-11:00AM
-
Abstract Number: 787
Using the American College of Rheumatology and Systemic Lupus International Collaborating Clinics Criteria to Measure Disease Severity in Discoid Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 862
Utility of 18f FDG Positron Emission Tomography (PET) As a Diagnostic Test and Marker of Disease Activity in Large Vessel Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 545
Utility of Power Doppler Ultrasound-Detected Synovitis for the Prediction of Short Term Flare in Rheumatoid Arthritis Patients in Clinical Remission
- 9:00AM-11:00AM
-
Abstract Number: 908
Utilization of Multiple Acute Phase Proteins and Biomarkers for Giant Cell Arteritis – Insight into Diagnosis and Clinical Complications
- 9:00AM-11:00AM
-
Abstract Number: 416
Uveitis Associated to Polyarticular Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 553
Validation of Index of Activity Speed (Timed Up and Go test) for Outcome Measure of Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
- 9:00AM-11:00AM
-
Abstract Number: 455
Validity, Reliability and Sensitivity to Change of Four Different Patient-Reported Outcomes (PROs) to Measure the Domains Pain, Fatigue, Experienced Disease Activity and General Well-Being in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 886
Vascular Inflammation Assessed By 18f-Fludeoxyglucose Positron Emission Tomography (FDG-PET) Is Modified By Treatment in Patients with Large Vessel Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 66
Very Rare X Chromosome Abnormalities in SLE and SjöGren’s May Localize X Gene Dose Effect
- 9:00AM-11:00AM
-
Abstract Number: 290
Viscosupplemenation Efficacy in Knee Oa Is Similar in Single-Injection Vs. Multi-Week Formulations and Across OA Severity and BMI Subgroups, but Better in Younger Patients
- 9:00AM-11:00AM
-
Abstract Number: 307
Visualizing Different Patterns of Cartilage Change: A Two-Year Study of Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 753
Vitamin D Improves Systolic Blood Pressure in SLE
- 9:00AM-11:00AM
-
Abstract Number: 8
What Factors Relate to Patients Contributing Longitudinal Data Using Smartphone Technology? Findings from RA Patients Participating in Arthritispower Registry
- 9:00AM-11:00AM
-
Abstract Number: 785
What Is the Prevalence of Cognitive Impairment in Lupus and Which Instruments Are Used to Measure It? a Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 538
What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 533
What Proportion of Patients Fail to Achieve CDAI and SDAI Remission Based on Physician Global Assessment? an Analysis from the Prospective, Observational Registry
- 9:00AM-11:00AM
-
Abstract Number: 148
Which Are the Ultrasound Lesions Underlying Dactylitis?
- 9:00AM-11:00AM
-
Abstract Number: 682
Which Is the Most Reliable Imaging Method for Detection of Structural Changes in the Sacroiliac Joints of Patients with Ankylosing Spondylitis? a Cross-Sectional Study Comparing MRI, CT and Conventional Radiographs
- 9:00AM-11:00AM
-
Abstract Number: 78
Whole Blood Gene Modules Show Differences Between Active Lupus Nephritis and Quiescent Disease As Well As Absence of Plasmablast Signature in This Adult Population
- 9:00AM-11:00AM
-
Abstract Number: 802
Whole Transcriptome Profiling through RNA Sequencing Reveals Differentially Expressed Sense-Antisense Gene Pairs in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 431
Wide Variations in Hepatitis B Screening Practices for Patients Receiving Rituximab
- 9:00AM-11:00AM
-
Abstract Number: 766
Withdrawal of Mycophenolate Mofetil after Maintenance Treatment of SLE Nephritis Associated with Renal Relapse
- 9:00AM-11:00AM
-
Abstract Number: 549
Work Status in Patients with Rheumatoid Arthritis Who Have Poor Prognostic Factors: Findings from a US Observational Cohort
- 11:00AM-12:30PM
-
Abstract Number: 913
Aggregatibacter Actinomycetemcomitans-Induced Hypercitrullination Links Periodontal Infection to Autoimmunity in Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 911
Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
- 11:00AM-12:30PM
-
Abstract Number: 914
Longitudinal Blood Transcriptomics Uncovers Immune Networks Associated with Complications in Lupus Pregnancy
- 11:00AM-12:30PM
-
Abstract Number: 910
Survival Benefit of Statin Use in Ankylosing Spondylitis and Psoriatic Arthritis: A General Population-Based Cohort Study
- 11:00AM-12:30PM
-
Abstract Number: 912
Urate Lowering Therapy in Moderate to Severe Chronic Kidney Disease
- 2:30PM-4:00PM
-
Abstract Number: 927
2015 ACR/ARHP Workforce Study in the United States: Pediatric Rheumatologist Supply and Demand Projections for 2015-2030
- 2:30PM-4:00PM
-
Abstract Number: 928
2015 ACR/ARHP Workforce Study in the United States: A Maldistribution of Adult Rheumatologists
- 2:30PM-4:00PM
-
Abstract Number: 947
A Multi-Center, Open-Label Study to Assess the Pharmacokinetics, Efficacy and Safety of Certolizumab Pegol in Children and Adolescents with Moderately to Severely Active Polyarticular-Course Juvenile Idiopathic Arthritis: Week 24 Results
- 2:30PM-4:00PM
-
Abstract Number: 942
A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients
- 2:30PM-4:00PM
-
Abstract Number: 951
A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry
- 2:30PM-4:00PM
-
Abstract Number: 944
A New Syndrome in the Spectrum of Cryopyrin-Associated Periodic Syndromes (CAPS) Caused By the Novel R918Q NLRP3 Mutation
- 2:30PM-4:00PM
-
Abstract Number: 978
A Randomized Clinical Trial of CCX168, an Orally Administered C5aR Inhibitor for Treatment of Patients with ANCA-Associated Vasculitis
- 2:30PM-4:00PM
-
Abstract Number: 979
A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Takayasu’s Arteritis
- 2:30PM-4:00PM
-
Abstract Number: 952
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Evaluating Treatment Strategies (Continuation Versus Withdrawal) for Maintaining Low Disease Activity after 1 Year of Certolizumab Pegol in DMARD-Naive Patients with Early and Progressive, Active RA
- 2:30PM-4:00PM
-
Abstract Number: 940
A Trial of XmAb®5871, a Reversible Inhibitor of CD19+ Cells, in IgG4-Related Disease
- 2:30PM-4:00PM
-
Abstract Number: 941
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index
- 2:30PM-4:00PM
-
Abstract Number: 918
Anergic B Cells May Preserve Peripheral Tolerance in Lupus-Prone Congenic Mice
- 2:30PM-4:00PM
-
Abstract Number: 920
Autoantigen-Specific T Cell and Antibody Reactivity to a Human Gut Commensal in Antiphospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 917
B Cells Inhibit Osteoblast Differentiation in Inflammatory Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 939
Circulating IgG4 Antibody Secreting Cells Are Better Biomarker of Disease Activity Compared to Serum IgG4 Levels in Patients with IgG4-Related Disease
- 2:30PM-4:00PM
-
Abstract Number: 965
Clinical and Serologic Variables Associated with Renal Response Among Lupus Nephritis Phase III Trial Patients Treated with Standard of Care Immunosuppression
- 2:30PM-4:00PM
-
Abstract Number: 984
Clinical Characteristics of Inflammatory Myopathies Associated with Cancer: A Report from the Remicam Registry
- 2:30PM-4:00PM
-
Abstract Number: 973
Clinical Characterization of Patients with World Health Organization Group 2 Pulmonary Hypertension in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort
- 2:30PM-4:00PM
-
Abstract Number: 946
Comparative Effectiveness of Second-Line Treatment Strategies for Lyme Arthritis in Children
- 2:30PM-4:00PM
-
Abstract Number: 953
Comparison of 10-Years Disease Outcomes of Rheumatoid Arthritis Patients with Continued Low Disease Activity on Methotrexate with or without Initial Combination Therapy with Infliximab or Prednisone and Sulfasalazine
- 2:30PM-4:00PM
-
Abstract Number: 949
Comparison of Treatment Response, Remission Rate and Drug Adherence in Polyarticular Juvenile Idiopathic Arthritis Patients Treated with Etanercept, Adalimumab or Tocilizumab
- 2:30PM-4:00PM
-
Abstract Number: 925
Complement C5a Receptor Is the Key Initiator of Neutrophil Adhesion and Inflammation in Immune Complex-Induced Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 974
Diffuse Scleroderma, Male Sex, and Myopathy Are Associated with Severe Gastrointestinal Dysmotility in Scleroderma
- 2:30PM-4:00PM
-
Abstract Number: 937
Distal Interphalangeal Joint Erosions Assessed By HR-pQCT in Patients with Psoriatic Onycholysis
- 2:30PM-4:00PM
-
Abstract Number: 981
Effectiveness of a Six-Week Hand Osteoarthritis Program in a Primary Care Setting
- 2:30PM-4:00PM
-
Abstract Number: 985
Effectiveness of a Web-Based Personalized Rheumatoid Arthritis Risk Tool with or without a Health Educator for Knowledge of RA Risk Factors
- 2:30PM-4:00PM
-
Abstract Number: 954
Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study
- 2:30PM-4:00PM
-
Abstract Number: 943
Efficacy and Safety of IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever Who Underwent Kidney Transplantation
- 2:30PM-4:00PM
-
Abstract Number: 959
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52 Week Results from a Phase 3 Study
- 2:30PM-4:00PM
-
Abstract Number: 976
Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
- 2:30PM-4:00PM
-
Abstract Number: 933
Erosion Patterns in Seropositive and Seronegative Rheumatoid Arthritis: A Joint-By-Joint Approach
- 2:30PM-4:00PM
-
Abstract Number: 915
Establishment of a Powerful Method to Identify Autoantigens Expressed on the Cell Surface
- 2:30PM-4:00PM
-
Abstract Number: 950
Flares after Withdrawal of Biotherapies in JIA: Clinical and Laboratory Correlates of Remission Duration
- 2:30PM-4:00PM
-
Abstract Number: 982
High Financial Strain, but Not Poverty or Lower Education, Increases the Risk of Incident Depression in Systemic Lupus Erythematosus (SLE)
- 2:30PM-4:00PM
-
Abstract Number: 932
High Symptom Prevalence and Under-Utilisation of Palliative Care at End-of-Life of Patients with Systemic Rheumatic Diseases
- 2:30PM-4:00PM
-
Abstract Number: 930
How to Implement Cardiovascular Disease Risk Assessment for Patients with Inflammatory Joint Diseases in Daily Rheumatology Practice: An Overview of a Nationwide Norwegian Project
- 2:30PM-4:00PM
-
Abstract Number: 919
IL-17 Receptor a Signaling Impedes NF-ĸB p50/p50 Repressor and Subverts B-Cell Anergy in BXD2 Mice
- 2:30PM-4:00PM
-
Abstract Number: 926
Increased Concentration of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Predate Onset of Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 957
International Patient and Physician Consensus on Psoriatic Arthritis Outcomes for Clinical Trials
- 2:30PM-4:00PM
-
Abstract Number: 924
Intestinal Dysbiosis Influences Gut-Joint Lymphocyte Trafficking
- 2:30PM-4:00PM
-
Abstract Number: 934
Magnetic Resonance Imaging (MRI) Joint Space Narrowing Is an Independent Predictor of Radiographic and MRI Damage Progression in Patients with Early Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 975
Maintenance Therapy Improves Long-Term Outcomes in Patients with Primary Angiitis of the Central Nervous System
- 2:30PM-4:00PM
-
Abstract Number: 922
Negative Regulation of IL-17 Receptor Signaling By Regnase-1 Limits Immunopathology in a Mouse Model of Psoriatic Skin Disease
- 2:30PM-4:00PM
-
Abstract Number: 962
No Increased Risk of Inflammatory Bowel Disease Among Secukinumab-Treated Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis: Data from 14 Phase 2 and Phase 3 Clinical Studies
- 2:30PM-4:00PM
-
Abstract Number: 916
Novel Immunosignature Stratifies Patients with Rheumatoid Arthritis into Distinct Disease Sub-Groups and Predicts Response to Anti-Tnfα Therapies
- 2:30PM-4:00PM
-
Abstract Number: 983
Objectively Assessed Sedentary Behaviour and Light Physical Activity Are Associated with Long-Term Cardiovascular Risk in People Living with Rheumatoid Arthritis Independently of Moderate-to-Vigorous Physical Activity
- 2:30PM-4:00PM
-
Abstract Number: 972
Outcome of the Scleroderma Population “at Risk” to Develop Pulmonary Hypertension in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort Study
- 2:30PM-4:00PM
-
Abstract Number: 935
Pretreatment Plasma IL-6 Levels Are Responsible for Bone Erosion Progression on Magnetic Resonance Imaging in Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 938
Prevalence of Non-Radiographic Axial Spondyloarthritis in Psoriatic Arthritis – a Single Center Observational Study
- 2:30PM-4:00PM
-
Abstract Number: 931
Rates of Lipid Testing and Statin Prescriptions Among SLE and Diabetes Mellitus Patients in a Nationwide Medicaid Cohort
- 2:30PM-4:00PM
-
Abstract Number: 971
Reliability and Minimal Clinically Important Differences (MCID) of Forced Vital Capacity: Post-Hoc Analyses from the Scleroderma Lung Studies (SLS-I and II)
- 2:30PM-4:00PM
-
Abstract Number: 936
Reliability and Responsiveness of an Omeract Tenosynovitis Magnetic Resonance Imaging Scoring System for the Rheumatoid Arthritis Wrist and Hand
- 2:30PM-4:00PM
-
Abstract Number: 966
Renal Activity in Lupus (RAIL) Urinary Biomarkers Predict Treatment Response
- 2:30PM-4:00PM
-
Abstract Number: 929
Retinal Examinations Among SLE Patients Newly-Initiating Hydroxychloroquine in a U.S. Medicaid SLE Population, 2000-10
- 2:30PM-4:00PM
-
Abstract Number: 923
Retinoic Acid Inhibits Expression of Interleukin 9 By Altering Enhancer Architecture
- 2:30PM-4:00PM
-
Abstract Number: 958
Safety and Efficacy of ABT-122, a TNF and IL-17–Targeted Dual Variable Domain (DVD)–Ig™, in Psoriatic Arthritis Patients with Inadequate Response to Methotrexate: Results from a Phase 2 Trial
- 2:30PM-4:00PM
-
Abstract Number: 969
Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from the Open-Label Period of a Phase 2 Randomized, Controlled Trial
- 2:30PM-4:00PM
-
Abstract Number: 961
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial
- 2:30PM-4:00PM
-
Abstract Number: 986
Sex-Specific Associations Between Improvement in Gait Mechanics and Improvement in Pain, Function, and Abductor Strength after Total Hip Arthroplasty
- 2:30PM-4:00PM
-
Abstract Number: 980
Short-Course Glucocorticoids in ANCA-Associated Vasculitis: A Proof of Concept Study
- 2:30PM-4:00PM
-
Abstract Number: 948
Subcutaneous Abatacept in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis and Inadequate Response to Biologic or Non-Biologic Disease-Modifying Antirheumatic Drugs: Pharmacokinetics, Efficacy and Safety
- 2:30PM-4:00PM
-
Abstract Number: 921
The Anti-IL-17A Antibody Secukinumab (Cosentyx®, AIN457) Diminishes the Expression of the NFκB Pathway Modulator Iκbζ
- 2:30PM-4:00PM
-
Abstract Number: 956
The Effect of Treatment Adjustments Aimed at DAS Remission on Physical Functioning in Undifferentiated and Rheumatoid Arthritis Patients in Low Disease Activity
- 2:30PM-4:00PM
-
Abstract Number: 970
The Serotonin Receptor 2 Inhibitor Terguride Has Beneficial Effects on Skin Fibrosis: Results from a Phase 2 Proof of Concept Study
- 2:30PM-4:00PM
-
Abstract Number: 977
Tocilizumab As an Add-on Therapy to Glucocorticoids during the First 3 Months of Treatment of Giant Cell Arteritis: Results of a French Multicenter Prospective Open-Label Study
- 2:30PM-4:00PM
-
Abstract Number: 955
Tocilizumab Infusion Intervals Can be Extended to 5 or 6 Weeks in RA Patients Who Sustained Low Disease Activity By 4 Weeks Interval of Tocilizumab Infusion
- 2:30PM-4:00PM
-
Abstract Number: 963
Treatment of Homocysteine Improves Urine Protein/Cr Ratio in SLE
- 2:30PM-4:00PM
-
Abstract Number: 964
Tubulointerstitial Damage Is an Independent Predictor of End Stage Renal Disease in Lupus Nephritis Patients with Mild to Moderate Renal Impairment
- 2:30PM-4:00PM
-
Abstract Number: 960
Ultrasonographic Improvement of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated with Ustekinumab for Chronic Plaque Psoriasis: A 52-Week, Prospective, Open Label, Controlled Cohort Study
- 2:30PM-4:00PM
-
Abstract Number: 968
Urinary Soluble CD163, an M2 Macrophage Marker, Reflects the Renal Disease Activity in Lupus Nephritis: A Cross Sectional and Longitudinal Assessment
- 2:30PM-4:00PM
-
Abstract Number: 967
Using a Hazard Index Tool Based on Short Term Renal Parameters to Predict Long Term Outcomes in Lupus Nephritis: A Novel Way to Assess New Therapies
- 2:30PM-4:00PM
-
Abstract Number: 945
When and Where Musculoskeletal Ultrasound Might Replace Magnetic Resonance in the Assessment of Patients with Juvenile Idiopathic Arthritis?
- 4:30PM-6:00PM
-
Abstract Number: 997
2016 Revisions to the 2010/2011 Fibromyalgia Diagnostic Criteria
- 4:30PM-6:00PM
-
Abstract Number: 1045
2016 Update of the ASAS-EULAR Management Recommendations for Axial Spondyloarthritis
- 4:30PM-6:00PM
-
Abstract Number: 989
A Randomized Controlled Trial of Rheumatoid Arthritis Risk Disclosure Personalized to Genetics, Autoantibodies, and Lifestyle Among Unaffected First-Degree Relatives: The Personalized Risk Estimator for RA (PRE-RA) Family Study
- 4:30PM-6:00PM
-
Abstract Number: 1041
Abatacept in the Treatment of Active Psoriatic Arthritis: 24-Week Results from a Phase III Study
- 4:30PM-6:00PM
-
Abstract Number: 1058
Adjustment Profiles Comprising Objective and Subjective Measures in Fibromyalgia Patients
- 4:30PM-6:00PM
-
Abstract Number: 1008
Advantageous Effect of an Endogenous Retroviral Envelope Protein in Systemic Lupus Erythematosus with Ex Vivo and In Vivo Anti-Inflammatory Potential
- 4:30PM-6:00PM
-
Abstract Number: 1046
Anti-TNF Therapy in Axial Spondyloarthritis: Prediction of Therapeutic Responses Using Immunological Signatures
- 4:30PM-6:00PM
-
Abstract Number: 1025
Assessment of the Effects of Switching Bisphosphonates to Denosumab or Daily Teriparatide in Patients with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 990
Autoimmunity to Multiple Antigens Is Expanded in at-Risk Family Members Beyond the Disease Specific Patterns of the SLE or RA Proband
- 4:30PM-6:00PM
-
Abstract Number: 1005
Biallelic Hypomorphic Mutations in a Linear Deubiquitinase Define Otulipenia, an Early-Onset Systemic Autoinflammatory Disease
- 4:30PM-6:00PM
-
Abstract Number: 998
Brain Responses to Other’s Pain in Fibromyalgia – a Magnetoencephalography (MEG) Study
- 4:30PM-6:00PM
-
Abstract Number: 993
Chronic Widespread Pain Associated with Premature Mortality in a UK National Prospective Study
- 4:30PM-6:00PM
-
Abstract Number: 1011
Correlations Between B Cell Epitope Specificity and Clinical Features in Patients with Jo-1 Antibodies and the Anti-Synthetase Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 1001
Cytomegalovirus Reactivation in Connective Tissue Disease By Immunosuppressive Therapy Predicts Severe Infection and High Mortality
- 4:30PM-6:00PM
-
Abstract Number: 1050
Defining Low Disease Activity in Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 1051
Determining the Minimal Clinically Important Difference for Improvement for Systemic Lupus Erythematosus Disease Activity Index-2000 Responder Index-50 (S2K RI-50)
- 4:30PM-6:00PM
-
Abstract Number: 1018
Dietary Intake of Fiber and Risk of Knee Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 1048
Differences in Clinical Manifestations of SLE Across Four Racial/Ethnic Groups: The California Lupus Surveillance Project (CLSP)
- 4:30PM-6:00PM
-
Abstract Number: 1028
Discontinuation of Denosumab and Associated Vertebral Fracture Incidence: Analysis from a Phase 3 Placebo-Controlled Study of Denosumab and Its Open-Label Extension
- 4:30PM-6:00PM
-
Abstract Number: 1036
Dominant B-Cell Receptor Clones in Peripheral Blood Predict Onset of Arthritis in Individuals at Risk for Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1032
Early In Vivo Induction of Mouse Interferon-alpha1 Overexpression Triggers an Expansion of Highly Suppressive Regulatory T Lymphocytes Protecting Against Experimental Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1057
Effect of Quantitative Information Concerning Medication Side-Effects on Risk Perception
- 4:30PM-6:00PM
-
Abstract Number: 1010
Elucidating the Activation Profile of Systemic Sclerosis Macrophages
- 4:30PM-6:00PM
-
Abstract Number: 1039
Estimation of the Risk of Developing Rheumatoid Arthritis in High-Risk Subjects : Systematic Review and Meta-Analysis
- 4:30PM-6:00PM
-
Abstract Number: 1053
Evaluating the Charla De Lupus (Lupus Chat)® Program’s Teen, Young Adult and Parent Support Group: Reaching the Hispanic/Latino Community through a Family Model of Support
- 4:30PM-6:00PM
-
Abstract Number: 1037
Evaluation of 14-3-3η As a Tool for Diagnosis of Early RA in a European Cohort
- 4:30PM-6:00PM
-
Abstract Number: 991
Familial Aggregation of Rheumatoid Arthritis in Sarcoidosis: A Register-Based Case-Control Study in Sweden
- 4:30PM-6:00PM
-
Abstract Number: 1042
Four Year Imaging Outcomes in Patients with Axial Spondyloarthritis Treated with Certolizumab Pegol, Including Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
- 4:30PM-6:00PM
-
Abstract Number: 1023
Fracture Risk Reduction with Romosozumab: Results of a Phase 3 Study in Postmenopausal Women with Osteoporosis
- 4:30PM-6:00PM
-
Abstract Number: 1038
Functional Disability in Patients Presenting with Clinically Suspect Arthralgia and Progression to Clinical Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1029
Functional Genetics of PTPN2 in Rheumatoid Arthritis: Haploinsufficiency of PTPN2 Promotes Severity of Th17-Cell Mediated Autoimmune Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1031
Glucocorticoid Receptor Dimerization in Stromal Cells Modulates Macrophage Polarization during Serum Transfer-Induced Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1004
Herpes Zoster Virus Infection in Patients Treated with Biological Therapies (BIOBADASAR)
- 4:30PM-6:00PM
-
Abstract Number: 1049
High Titer ANA Not Necessarily a Valid Criterion for Lupus – Proposal of a Modification to the Criteria for Classification of SLE
- 4:30PM-6:00PM
-
Abstract Number: 1006
Immune Complex-Mediated TLR8 Activation Shifts Neutrophils from Phagocytosis to Netosis through Furin-Dependent Shedding of Fcgriia
- 4:30PM-6:00PM
-
Abstract Number: 1007
Interferon Regulatory Factor 1 Is the Key Driver of Inflammasome Activity in Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 1014
Juvenile Dermatomyositis: What Comes Next?
- 4:30PM-6:00PM
-
Abstract Number: 1052
Longitudinal Patterns in SLE Response to Standard of Care Therapy: Implications for SLE Clinical Trial Design
- 4:30PM-6:00PM
-
Abstract Number: 1021
Maintaining Sufficient Serum Vitamin D Levels over 2 Years Is Associated with Reduced Knee Structural and Symptomatic Changes in Patients with Knee Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 1034
Microrna-146a Controls Local Bone Destruction By Regulating Fibroblast Induced Osteoclastogenesis in Inflammatory Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1056
Mind-Body Skills Training and Supportive Counseling for Depression in SLE: Positive Effects in a Randomized Controlled Trial
- 4:30PM-6:00PM
-
Abstract Number: 1026
Morphea-like Skin Lesions Reported in the Phase 3 Long-Term Odanacatib Fracture Trial and Extension in Postmenopausal Women with Osteoporosis
- 4:30PM-6:00PM
-
Abstract Number: 1047
Negative Results of Antinuclear Antibody (ANA) Testing in Clinical Trials of Systemic Lupus Erythematosus (SLE) May be Due to Assay Variability
- 4:30PM-6:00PM
-
Abstract Number: 1027
Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-Term Odanacatib Fracture Trial
- 4:30PM-6:00PM
-
Abstract Number: 987
Pesticide Exposure and Risk of Rheumatoid Arthritis in Licensed Male Pesticide Applicators in the Agricultural Health Study
- 4:30PM-6:00PM
-
Abstract Number: 1055
Physical Activity Behavior in Men with Inflammatory Arthritis: A Cross-Sectional Register Based Study of Physical Activity Correlates, Motivators, Barriers and Preferences
- 4:30PM-6:00PM
-
Abstract Number: 1009
Plasmacytoid Dendritic Cells Are Activated in Systemic Sclerosis and Contribute to the Disease By Inducing Ifnα and CXCL4
- 4:30PM-6:00PM
-
Abstract Number: 1002
Pneumocystis Jiroveci in Rheumatic Disease: A 20 Year Single-Center Experience
- 4:30PM-6:00PM
-
Abstract Number: 1015
Pro-Inflammatory Cytokines Produced By Different Subsets of Peripheral Blood Mononuclear Cells Are Associated with Ro52/TRIM21 Deficiency in Patients with Inflammatory Myopathies
- 4:30PM-6:00PM
-
Abstract Number: 1020
Risk Factors Can Classify Individuals Who Develop Accelerated Knee Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 988
Risk of Rheumatoid Arthritis after Transfusion of Blood from Donors Later Diagnosed with Rheumatoid Arthritis: A Retrospective Cohort Study
- 4:30PM-6:00PM
-
Abstract Number: 1043
Safety and Efficacy of Intravenous Golimumab in Adult Patients with Active Ankylosing Spondylitis: Results through Week 28
- 4:30PM-6:00PM
-
Abstract Number: 1054
Self-Reported Psychological Impact and Coping Strategies of Men with RA
- 4:30PM-6:00PM
-
Abstract Number: 1016
Soluble BAT-3: A New Biomarker for Antisynthetase Syndrome
- 4:30PM-6:00PM
-
Abstract Number: 1017
Statistical Simulation Using Data from the Foundation for the National Institute of Health/Osteoarthritis Initiative Biomarkers Consortium to Evaluate the Clinical Utility of Prognostic Knee Osteoarthritis Biomarkers in Designing a Knee Osteoarthritis Clinical Trial
- 4:30PM-6:00PM
-
Abstract Number: 1040
Stressful Life Events : A Trigger for Rheumatoid Arthritis Onset within a Year. a Case-Control Study
- 4:30PM-6:00PM
-
Abstract Number: 1000
Subclinical Cytomegalovirus Viremia Is Associated with Increased Nosocomial Infections and Prolonged Hospitalization in Patients with Systemic Autoimmune Diseases
- 4:30PM-6:00PM
-
Abstract Number: 1024
Superior Gains in Bone Mineral Density and Estimated Strength at the Hip for Romosozumab Compared with Teriparatide in Women with Postmenopausal Osteoporosis Transitioning from Bisphosphonate Therapy: Results of a Phase 3, Open-Label Clinical Trial
- 4:30PM-6:00PM
-
Abstract Number: 1030
Synovial Tissue Resident Macrophages Play the Protective Role in the Development of Inflammatory Arthritis in CD11c-Flip-KO Mice
- 4:30PM-6:00PM
-
Abstract Number: 1033
Targeting Notch-Activated M1 Macrophages Attenuates Joint Tissue Damage in a Mouse Model of Inflammatory Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1019
The Impact of Hip and Knee Osteoarthritis on the Subsequent Risk of Incident Diabetes: A Population-Based Cohort Study
- 4:30PM-6:00PM
-
Abstract Number: 992
The Impact of Inflammatory Arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, reactive arthritis) on Maternal and Neonatal Outcomes: A Population-Level Analysis
- 4:30PM-6:00PM
-
Abstract Number: 1035
The Prognostic Value of Different Auto-Antibodies for Arthritis Development in Patients with Clinically Suspect Arthralgia
- 4:30PM-6:00PM
-
Abstract Number: 1013
The Risk of Colchicine Associated Myopathy in Gout: Influence of Concomitant Use of Statin
- 4:30PM-6:00PM
-
Abstract Number: 1022
The Risk of Symptomatic Knee Osteoarthritis after Arthroscopic Meniscus Repair Vs Partial Meniscectomy Vs the General Population
- 4:30PM-6:00PM
-
Abstract Number: 1044
Treatment with Tofacitinib Is Associated with Clinically Meaningful Reductions in Axial MRI Inflammation in Patients with Ankylosing Spondylitis
- 4:30PM-6:00PM
-
Abstract Number: 1003
Ultrasonography Changes during the Course of Septic Arthritis ARE Associated with Functional Outcome
- 4:30PM-6:00PM
-
Abstract Number: 996
Use of a Shared Medical Appointment for Patients with Fibromyalgia in a Rural, Academic Medical Center: A Process Improvement Initiative for the Development of a New Care Model
- 4:30PM-6:00PM
-
Abstract Number: 995
Use of Opiate Diminished the Treatment Benefits of Motivational Interviewing for Fibromyalgia
- 4:30PM-6:00PM
-
Abstract Number: 999
Utility of Neutrophil CD64 Expression & sTREM-1 in Distinguishing Bacterial Infection from Disease Flare in SLE and ANCA Associated Vasculitis
- 4:30PM-6:00PM
-
Abstract Number: 994
Validation Studies of the American College of Rheumatology (ACR) 2010 Fibromyalgia Diagnostic Criteria and the 2011 Self-Report Modification for Survey and Clinical Research
- 9:00AM-11:00AM
-
Abstract Number: 1452
18 F-FDG PET Imaging: An In Vivo quantitative Drug Screening Tool for Novel Antiinflammatory Therapies
- 9:00AM-11:00AM
-
Abstract Number: 1540
“I Am Always in Pain Somewhere”: Continuing Unmet Need in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1249
“There Are Still a Lot of Things That I Need”: A Qualitative Study Exploring Opportunities to Improve the Health Outcomes of First Nations People with Arthritis Seen at an on-Reserve Outreach Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 1145
#Rheumjc: Impact of Invited Authors on a Twitter Based Rheumatology Journal Club
- 9:00AM-11:00AM
-
Abstract Number: 1304
2D and 3D Measurements of Osteoarthritis Joint Space Width Have Good Agreement in Radiographically Normal Knees but Poor Agreement with Advancing Kellgren-Lawrence Grade: Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 1557
3-D Explant Method Facilitates the Study of Lymphocytes in Synovium and Reveals a Population of Resident Memory-like T Cells in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1651
A Case Series on Patients on Tofacitinib in Combination with a Biologic
- 9:00AM-11:00AM
-
Abstract Number: 1212
A Combined Large Scale Meta-Analysis Identifies COG6 As a Novel Shared Risk Locus for Rheumatoid Arthritis and Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1233
A Descriptive Analysis of Real-World Treatment Patterns of Innovator Infliximab (Remicade) and Biosimilar Infliximab in a Treatment NaïVe Turkish Rheumatologic Disease Population
- 9:00AM-11:00AM
-
Abstract Number: 1840
A Dichotomy of Regulatory Immunome Is Related to Disease Activity in Juvenile Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1094
A Dual Role of Bromodomain Containing 1 Protein in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1604
a First-in-Human Study of CR6086, a New Potent EP4 Prostanoid Receptor Antagonist, Demonstrates Good Safety and Tolerability at Therapeutically Relevant Exposures
- 9:00AM-11:00AM
-
Abstract Number: 1375
A Five Year Study of 102 Children with Juvenile Myositis: Disease Course and Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 1567
A Functional Genomic Screen of Rheumatoid Arthritis Risk Genes in Primary Human T Cells Reveals DDX6 As a Negative Modulator of Cytokine Expression
- 9:00AM-11:00AM
-
Abstract Number: 1199
A Genome-Wide Association Study of Methotrexate-Pneumonitis in Rheumatoid Arthritis: Results from the Pneumonitis Study Consortium
- 9:00AM-11:00AM
-
Abstract Number: 1210
A Genome-Wide Association Study of Psoriatic Arthritis in Italian Population
- 9:00AM-11:00AM
-
Abstract Number: 1880
A Large Proportion of Patients in an Early Systemic Sclerosis-Associated Interstitial Lung Disease Cohort Have Coexisting Pulmonary Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 1817
A Longitudinal Analysis of Change in Lupus Disease Activity Pattern in Hopkins Lupus Cohort Using a Multistate Markov Model Approach
- 9:00AM-11:00AM
-
Abstract Number: 1240
A Minority of Patients Utilize Most of Healthcare Resources in Rheumatoid Arthritis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis, and Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1912
A New Avenue of Immune Regulation Conferred By Self-Glycerophospholipids Via Mobilization and Migration of Myeloid-Derived Suppressor Cells
- 9:00AM-11:00AM
-
Abstract Number: 1831
A Novel Graph Theoretic Approach Applied to Modular Repertoire Analysis Identifies a Dual Molecular Progression in Adult SLE Patients, with Distinct Interferon and Neutrophil Transcription Patterns
- 9:00AM-11:00AM
-
Abstract Number: 1857
A Novel Highly Selective 5-Hydroxytryptamine 2B (5-HT2B) Receptor Antagonist Ameliorating Fibrosis in Preclinical Models of Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1147
A Novel Survey Tool to Assess Inpatient Consult Service Performance
- 9:00AM-11:00AM
-
Abstract Number: 1151
A Pediatric Rheumatology Fellow Educating Pediatric Primary Care and Emergency Room Providers about Pediatric Lupus: A Local, Pilot Adaptation of the Lupus Education Advancement Project (LEAP)
- 9:00AM-11:00AM
-
Abstract Number: 1587
A Phase 2a, 4-Week Double-Blind, Proof-of-Concept Efficacy and Safety Study of CC-292 Versus Placebo As Co-Therapy with Methotrexate in Active Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 1621
A Phase I, Randomized, Double Blind, Placebo-Controlled, Dose Escalating Study of the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Hmpl‑523 in Australian Male Healthy Subjects
- 9:00AM-11:00AM
-
Abstract Number: 1394
A Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1065
A Practical Application of Antiphospholipid Antibodies Profiles in the Diagnosis and Managements of Antiphospholipid Syndrome: The Modified Antiphospholipid Score
- 9:00AM-11:00AM
-
Abstract Number: 1592
A Randomized, Double-Blind, Parallel-Group, Phase III Study of Shortening the Dosing Interval of Subcutaneous Tocilizumab Monotherapy in RA Patients with an Inadequate Response to Subcutaneous Tocilizumab Every Other Week
- 9:00AM-11:00AM
-
Abstract Number: 1206
A Replication Study and Meta-Analysis Demonstrate the Influence of the mtDNA Haplogroups in the Rate of Incident Knee Osteoarthritis. Functional Explanation of This Association Using Transmitochondrial Cybrids
- 9:00AM-11:00AM
-
Abstract Number: 1222
A Systematic Review of Consumer Perceived Health Service Needs Related to Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1063
A Systematic Review of Direct Oral Anticoagulant Use in Antiphospholipid Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1169
A Systematic Review of Rheumatic Disease Epidemiology in the Indigenous Populations of Canada, the United States, Australia and New Zealand
- 9:00AM-11:00AM
-
Abstract Number: 1443
A Therapeutic Peptide Vaccine Reduces Pro-Inflammatory Responses and Suppresses Arthritis in the Cartilage Proteoglycan G1 Domain-Induced Mouse Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1560
A Unique Immune Signature in Patients with Active Rheumatoid Arthritis but Normal C-Reactive Protein Levels: Potential for New Therapeutic Targets?
- 9:00AM-11:00AM
-
Abstract Number: 1196
AA Amyloidosis: An Evaluation of Epidemiology and Prevalence in the US and EU5 Countries
- 9:00AM-11:00AM
-
Abstract Number: 1612
Abatacept Targets T Follicular Helper Cells in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1715
ABT-122, an Immunoglobulin Targeting Both TNF-α and IL-17A, Does Not Provide Significantly Greater Efficacy Compared with Adalimumab in Subjects with Psoriatic Arthritis: Results from Exposure-Response Analyses
- 9:00AM-11:00AM
-
Abstract Number: 1424
Acceptability of a Connected Activity Tracker in 92 Patients with Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA): A 3-Months Study
- 9:00AM-11:00AM
-
Abstract Number: 1414
Access to an Active, Interactive Self-Assessment e-Health Platform Improves Patient-Physician Communication in Rheumatoid Arthritis: Results of a Randomized Controlled Trial Including 320 Patients over 1 Year
- 9:00AM-11:00AM
-
Abstract Number: 1248
Access to Care: The Patient Perspective from the 2015 ACR/ARHP Workforce Study
- 9:00AM-11:00AM
-
Abstract Number: 1790
Accrual of Disease Comorbidities over 8 Years in a Multicentre Inception SLE Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1923
Activated Partial Thromboplastin Time Reflects Disease Activity in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1860
Activating Transcription Factor 3 – a New Linkage Between Vasculopathy and Organ Fibrosis in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1101
Adalimumab:TNF Complexes Induce a Divergent Proteomic Profile in Human Osteoclast Precursors to That Resembling a Monocytic Cell
- 9:00AM-11:00AM
-
Abstract Number: 1848
Adenosine A2A Receptor (A2AR) Stimulates Collagen Type III Synthesis Via β-Catenin Activation in Vitro and in Vivo
- 9:00AM-11:00AM
-
Abstract Number: 1737
Adherence to Subcutaneous Biological Therapies Among Inflammatory Arthropaty Patients from a University Hospital
- 9:00AM-11:00AM
-
Abstract Number: 1430
Adherence to the International Consensus Quality Indicators for Longitudinal Health Maintenance and Preventative Care in a Pediatric Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 1806
Adherence to Treatment and Social, Educational Levels in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1143
Adressing Medical Students’ Concerns in the Patient/Physician Interaction with People with Rheumatic and Musculoskeletal Diseases Leading to Handicap – a Pilot Experience Including Student Focus Groups and Interactions with Patient Associations
- 9:00AM-11:00AM
-
Abstract Number: 1150
Advocacy 101: Engaging Rheumatology Fellows in Health Policy and Advocacy
- 9:00AM-11:00AM
-
Abstract Number: 1823
African American and European American SLE Patients with Variable Disease Activity Reveal Distinct Differences in CD4+ T Cell and Monocyte Pathways
- 9:00AM-11:00AM
-
Abstract Number: 1211
Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants
- 9:00AM-11:00AM
-
Abstract Number: 1230
Allopurinol Use and the Risk of Stroke in the Elderly
- 9:00AM-11:00AM
-
Abstract Number: 1389
Alterations in Nailfold Capillaroscopy in Childhood-Onset Systemic Lupus Erythematosus: The Role of Disease Activity in a Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1788
Alterations in Sense of Smell and Limbic Structures in Patients with Systemic Lupus Erythematosus during 3-Years Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 1571
Altered Bioenergetics, Mitochondrial Function and Pro-Inflammatory Pathways in RA Synovium in Response to Tofacitinib
- 9:00AM-11:00AM
-
Abstract Number: 1130
Aminopeptidase N/CD13 Induces Monocyte Migration in Vitro and In Vivo and Signals through GPCR, Erk1/2, Jnk, Src, and NFκB
- 9:00AM-11:00AM
-
Abstract Number: 1867
An Abnormal Nailfold Capillaroscopy Pattern Is Common in Patients with Connective Tissue Disease and Is Associated with Pulmonary and Oesophageal Involvement, Even in the Absence of Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1411
An Electronic MDHAQ (multidimensional health assessment questionnaire) Beyond an Electronic RAPID (routine assessment of patient index data): 21.3% of Rheumatoid Arthritis Patients Identified As Having Secondary Fibromyalgia Versus 3.5% By Clinicians
- 9:00AM-11:00AM
-
Abstract Number: 1726
An Integrated Safety Data Analysis Across All Phase II and Phase III Clinical Programs for Ustekinumab in Psoriatic Arthritis, Crohn’s Disease, and Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 1577
An Investigation of Translocator Protein As a Tissue and Peripheral Blood Biomarker of Inflammation in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1625
Analysis of a Phase 3 Study Evaluating the Efficacy of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, Across Subgroups in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 1301
Analysis of Anatomical Sites Causing Dactylitis and Their Responsiveness to Change Under TNF-Therapy in Psoriatic Arthritis By High Resolution MRI
- 9:00AM-11:00AM
-
Abstract Number: 1781
Analysis of Influences of Various Factors on the Prognosis of Acute Confusional State of Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1937
Analysis of Innate and Adaptive Immune Responses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
- 9:00AM-11:00AM
-
Abstract Number: 1776
Analysis of Progressive Brain and Corpus Callosum Atrophy and Association with Th1 and Th2 Cytokines in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1919
Analysis of T Cell Repertoire Diversity of CD4+ Memory and NaïVe T Cells By Next Generation Sequencing and Its Association with Rheumatoid Arthritis Disease Parameters
- 9:00AM-11:00AM
-
Abstract Number: 1086
Analysis of the Naive B Cell Repertoire in Belimumab Treated SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 1307
Anatomical Patterns Suggest the Involvement of Biomechanical Stress in the Pathogenesis of Erosions in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1950
ANCA-Associated Vasculitides and IgG4-Related Disease: An Overlapping Syndrome? a European Observational Study of 18 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1116
Anti-Citrullinated Protein Antibodies Promote Synovial Fibroblasts Migration and Adhesion through a Peptidylarginine Deiminases (PAD) Dependent Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1499
Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1128
Anti-Fractalkine Monoclonal Antibody Inhibits Cartilage Destruction and Bone Erosion in Collagen-Induced Arthritis Model
- 9:00AM-11:00AM
-
Abstract Number: 1383
ANTI-RO/SSA and/or ANTI-La/SSB Antibodies: Association with Mild LUPUS Manifestations in 645 Childhood-Onset Systemic LUPUS Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1440
Anti-TNF Vaccination Protects from Experimental Arthritis without Affecting Resistance to Mycobacterium Tuberculosis or Listeria Monocytogenes infection
- 9:00AM-11:00AM
-
Abstract Number: 1900
Anti-Topoisomerase Positive Systemic Sclerosis – Prognosis Infaust?
- 9:00AM-11:00AM
-
Abstract Number: 1071
Anti-β2GP-I-Domain 3 and Aps/PT-IgG Antibodies Identify Primary APS Patients with Both Thrombotic and Hematological Manifestations
- 9:00AM-11:00AM
-
Abstract Number: 1838
Antibodies Against Bacterial Products Curli/DNA Are Found in Lupus Patients and Are Associated with Disease Flares
- 9:00AM-11:00AM
-
Abstract Number: 1547
Antibodies Against Carbamylated Proteins in Belgian RA Patients and in Other Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1084
Antibodies to Native Vimentin in Lupus: Characterization, Isotypes, Origins, and Associations with Other Autoimmune Pathways
- 9:00AM-11:00AM
-
Abstract Number: 1638
Antibody Mediated Immunity Drives Response to Methotrexate Treatment in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1946
Antineutrophil Cytoplasmic Antibody (ANCA) Type and Body Mass Index in ANCA-Associated Vasculitis (AAV)
- 9:00AM-11:00AM
-
Abstract Number: 1060
Antiphospholipid Antibodies and Related Clinical Events Following Infection in Children: A Systematic Review of Case Reports
- 9:00AM-11:00AM
-
Abstract Number: 1073
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking (APS ACTION) Clinical Database and Repository Analysis: The Comparison of Real World and Core Laboratory Antiphospholipid Antibody ELISA Results
- 9:00AM-11:00AM
-
Abstract Number: 1072
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking Registry Analysis: Cardiovascular Risk Factors Among Different Groups of Antiphospholipid Antibody-Positive Patients
- 9:00AM-11:00AM
-
Abstract Number: 1064
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking Registry Analysis: Direct Oral Anticoagulant Use Among Antiphospholipid Syndrome Patients
- 9:00AM-11:00AM
-
Abstract Number: 1527
Anxiety Sensitivity on Indicators of Disease Severity Among Patients with Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1267
Application of the Spondyloarthritis Research Consortium of Canada Magnetic Resonance Imaging Sacroiliac Joint Structural Score in Chinese Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1734
Apremilast Is Associated with Long-Term DAS-28 (CRP) Remission and Improvements in Skin Disease: Results from a Phase III Study in DMARD/Biologic-Experienced Active Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1680
Apremilast Monotherapy As the First Systemic Treatment in DMARD-Naive Patients with Active Psoriatic Arthritis: 3-Year Treatment Results
- 9:00AM-11:00AM
-
Abstract Number: 1711
Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 1732
Articular and Axial Involvement Differences in Psoriatic Arthritis Patients Treated with Golimumab in Canadian Real-World Practice
- 9:00AM-11:00AM
-
Abstract Number: 1355
ASAH1 Gene Mutations Cause Acid Ceramidase Deficiency (Farber Disease), with Symptoms Including Arthritis and Subcutaneous Nodules. Patients Are Often Misdiagnosed with JIA, and Slowly Progressive Disease May Only be Diagnosed in Adulthood
- 9:00AM-11:00AM
-
Abstract Number: 1238
Assessment of Mortality and Healthcare Costs Associated with Systemic Sclerosis with and without Lung Involvement
- 9:00AM-11:00AM
-
Abstract Number: 1582
Assessment of Safety, Pharmacokinetics and Pharmacodynamics of a Novel Anti-CD40 Monoclonal Antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1663
Assessment of Serum Calprotectin and Osteoprotegerin Levels in a Cohort of Spanish Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1556
Assessment of the Burden of Comorbidities By the Rheumatic Disease Comorbidity Index in Early Rheumatoid Arthritis Patients at Disease Onset
- 9:00AM-11:00AM
-
Abstract Number: 1534
Assessment of the Relationship of the Static and Dynamic Balance Parameters with Clinical, Functional and Radiological Findings in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1727
Association Between Biologic Therapies and Major Adverse Cardiac Events or Cardiac Heart Failure in Psoriatic Arthritis or Psoriasis: A Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1686
Association of Early Skin Improvement with ACR Responses Among Biologic DMARD-Naive Psoriatic Arthritic Patients Treated with Ixekizumab
- 9:00AM-11:00AM
-
Abstract Number: 1757
Association of the Lupus Low Disease Activity State (LLDAS) with Health-Related Quality of Life
- 9:00AM-11:00AM
-
Abstract Number: 1260
Association of Traditional Chinese Medicine Use and Adherence to Prescribed Western Medications in Chinese-American Rheumatology Patients
- 9:00AM-11:00AM
-
Abstract Number: 1362
Associations Between 25-Hydroxyvitamin D, Parathyroid Hormone, and Cathelicidin Concentrations with Inflammation and Cardiovascular Risk in Subjects with Pediatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1486
Associations Between Heart Rate Adjusted ST Segment and Heart Rate Variability in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1561
Associations of HLA-DRB1 Haplotypes with Disease Characteristics and All-Cause Mortality in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1350
Asymptomatic Coccidioidomycosis in Patients with Rheumatic Disease: 8 Years of Experience
- 9:00AM-11:00AM
-
Abstract Number: 1096
Augmentation of Wnt Signaling By IL-1β in Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 1214
Autoantibody Reactivities Correlated with SLE Disease Activity Identified By the SLE-key® iCHIP® Platform
- 9:00AM-11:00AM
-
Abstract Number: 1833
Autoantibody Response to TROVE2 in Systemic LUPUS Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1326
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthropathy, Following Lyme Disease
- 9:00AM-11:00AM
-
Abstract Number: 1172
Azathioprine and Mycophenolate Mofetil Adherence in a Nationwide Medicaid Cohort with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1913
B Cell Depletion Therapy Impact CD8 T Cells in ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1080
B-Cell Clonal Expansions in Parotid Glands of Sjogren’s Patients Are Associated with Increased Numbers of N-Glycosylation Motifs in the Immunoglobulin Heavy Chain Genes
- 9:00AM-11:00AM
-
Abstract Number: 1417
Back to Feeling Normal Again: Patients with Rheumatoid Arthritis in Remission
- 9:00AM-11:00AM
-
Abstract Number: 1076
BAFF Receptor Antagonists Suppress Differentiation of B Cells in Vitro and Are Drug Candidates for Primary SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1584
Bari-00074565
- 9:00AM-11:00AM
-
Abstract Number: 1593
Baricitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1702
Baseline Patient Characteristics Associated with Response to Biologic Therapy in Patients with Psoriatic Arthritis Enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 1652
Basement Membrane Remodeling Is Significantly Increased with Rheumatoid Arthritis and Suppressed By IL6 Inhibition: Analysis of Two Phase III Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 1681
Beneficial Effect of n-3 Polyunsaturated Fatty Acids on Inflammation and Analgesic Use in Psoriatic Arthritis – a Randomised, Double Blind, Placebo-Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 1492
Biomarker-Related Risk for Myocardial Infarction and Serious Infections in Patients with Rheumatoid Arthritis: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1583
Body Mass Index Does Not Affect Response to Subcutaneous or Intravenous Abatacept in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1589
Body Mass Index Does Not Impact Abatacept Retention in Biologic-Naive Patients with Rheumatoid Arthritis Who Have Poor Prognostic Factors: A 12-Month Interim Analysis of an Observational, Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1105
Bone Metabolism in Rheumatic Diseases May be Affected By Free Fatty Acids
- 9:00AM-11:00AM
-
Abstract Number: 1512
Bone Structural Deficits in Rheumatoid Arthritis: Impact of Muscle Mass and Density
- 9:00AM-11:00AM
-
Abstract Number: 1938
Bronchiectasis Are Highly Prevalent in Anti-MPO ANCA-Associated Vasculitis and Associate with a Distinct Disease Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 1272
Can Histologically Defined Peri-Articular Vascular Channels be Identified on High-Resolution Computed Tomography? – a Study in Cadaveric Finger Joints
- 9:00AM-11:00AM
-
Abstract Number: 1885
Can Nailfold Videocapillaroscopy Images be Interpreted Reliably By Different Observers? Results of an Inter-Reader and Intra-Reader Exercise Among Rheumatologists with Different Experience in This Field
- 9:00AM-11:00AM
-
Abstract Number: 1133
Can Patient Videos in Lectures Increase Interest and Improve Learning in Rheumatology Among Second Year Medical Students?
- 9:00AM-11:00AM
-
Abstract Number: 1299
Can the 3D-Modified Dixon Methods Replace the Conventional Sacroiliac Joint Magnetic Resonance Imaging?
- 9:00AM-11:00AM
-
Abstract Number: 1735
Canadian Humira Post-Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (Complete-PsA): Interim Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1792
Cardiac Surgery in Systemic Lupus Erythematosus Patients: Clinical Characteristics and Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 1479
Cardiovascular Diseases and Mortality Are Independently Influenced By Carotid Plaque Presence in Rheumatoid Arthritis: The 5-Year Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1466
Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: A Correlative Study of Non-Invasive Arterial Health Testing with the Inflammatory Burden of Disease
- 9:00AM-11:00AM
-
Abstract Number: 1467
Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: Non-Invasive Arterial Health Testing to Assess Subclinical Risk of Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 1311
Causative Pathogens, Antibiotic Susceptibility, and Characteristics of Patients with Bacterial Septic Arthritis over Time
- 9:00AM-11:00AM
-
Abstract Number: 1246
Causes and Predictors of Early Readmission in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1822
CD4+ T Cell Lymphopenia Is Associated with Deficient Ubiquitination of the Cell Cycle Inhibibitor p27kip1 By the E3 Ligase Casitas B-Lineage Lymphoma-b in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1075
CD40-Pathway Activation in Ectopic Lymphoid Structure (ELS)-Resident B Cells Contributes to Disease Pathology in Primary SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1197
Certain Serum Micro-RNAs Are Associated with Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1918
Characterising the Specificity, Function and Behavior of CD4+ T Cells Initiating Inflammation in a Murine Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1202
Characteristic Compositional and Functional Alteration of Gut Microbiota in Patients with Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 1673
Characteristic Phenotypes of Peripheral T Cells and Efficacy of Biological Dmards in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1314
Characteristics of the Musculoskeletal Symptoms Observed Among Survivors of Ebola Virus Disease (EVD) in the Postebogui Cohort in Guinea
- 9:00AM-11:00AM
-
Abstract Number: 1344
Characteristics, Treatment and Outcome of Severe Pulmonary Hemorrhage Related to Systemic Disease: French Multicentric Study
- 9:00AM-11:00AM
-
Abstract Number: 1319
Chikungunya Fever in Patients on Biological and on Conventional Dmards Therapy – Results from the Brazilian Register Biobadabrasil
- 9:00AM-11:00AM
-
Abstract Number: 1320
Chikungunya Fever Outbreak in Brazil: Preliminary Assessment in a Cohort of Patients with Rheumatological Manifestations
- 9:00AM-11:00AM
-
Abstract Number: 1693
Chronic Back Pain in Early Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1774
Chronological Analysis of Damage Accrual in Patientes with Systemic Lupus Erythematosus: Results from the Spanish Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER)
- 9:00AM-11:00AM
-
Abstract Number: 1180
Class V Lupus Nephritis Results in Significant Numbers of End Stage Renal Disease and Death in a Population-Based Registry
- 9:00AM-11:00AM
-
Abstract Number: 1349
Clinical Analysis of Hypertrophic Pachymeningitis
- 9:00AM-11:00AM
-
Abstract Number: 1633
Clinical and Radiographic Outcomes after 3 Years of Sarilumab in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1936
Clinical Characteristics of Inflammatory Eye Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1368
Clinical Course of Juvenile Dermatomyositis Presenting As Skin Predominant Disease
- 9:00AM-11:00AM
-
Abstract Number: 1357
Clinical Description of Patients with Cytoplasmic Discrete Speckles on Indirect Immunofluorescence on HEp-2 Cells in a Universitary Hospital
- 9:00AM-11:00AM
-
Abstract Number: 1954
Clinical Features and Long Term Outcome of 105 Patients of Granulomatosis with Polyangiitis: A Single Centre Experience from North India
- 9:00AM-11:00AM
-
Abstract Number: 1924
Clinical Features and Outcome in Patients with Elderly Onset ANCA Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1316
Clinical Features and Outcomes of Prosthetic Joint Septic Arthritis: The Gender Effect
- 9:00AM-11:00AM
-
Abstract Number: 1546
Clinical Features at the Onset of Lymphoproliferative Disorder in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1801
Clinical Implications of Persistent Sinus Tachycardia in Systemic Lupus Erythematous: A Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1330
Clinical Presentations of Relapsing Polychondritis: More Than a Swollen Ear
- 9:00AM-11:00AM
-
Abstract Number: 1603
Clinical Responses to Tocilizumab Analyzed By Serologic Status in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1136
Clinician Training in Motivational Communication Skills: The Impact of the Language of Change Program Among Rheumatologists from Across Canada
- 9:00AM-11:00AM
-
Abstract Number: 1227
Clinician-Led Development of a Standardised Term Set for Rheumatic and Musculoskeletal Disorders Allows Easy Creation of Large-Scale ICD-10 and Snomed CT Mapped Datasets from Routinely Collected Clinical Data
- 9:00AM-11:00AM
-
Abstract Number: 1751
Coagulation Pathway Function in Ischemia/Reperfusion Tissue Injury in Autoimmune Prone Mice
- 9:00AM-11:00AM
-
Abstract Number: 1396
Cognitive Function in Children with SLE Nephritis: A Cross-Sectional Comparison to Children with Other Glomerular Chronic Kidney Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1455
Collagen-Induced Arthritis and Uveitis in Mice Lacking TNF Receptors
- 9:00AM-11:00AM
-
Abstract Number: 1454
Combination of the SYK Inhibitor, GS-9876, with a JAK Inhibitor Increases Efficacy in a Chronic Rat Model of Collagen-Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1725
Combination Therapy of Apremilast and Biologic Agent As a Safe Option of Psoriatic Arthritis and Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 1278
Combined Positron Emission Tomography and Magnetic Resonance Imaging in Assessing Gastrointestinal Involvement in Systemic Sclerosis: A Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 1107
Combining Scaffold-Free Cartilage Transplants to Controlled Gene Expression for Therapeutic Application in Rheumatic Disorders
- 9:00AM-11:00AM
-
Abstract Number: 1834
Commensal Ro60 Autoantigen Ortholog Cross-Reactivity in Human Lupus and Gnotobiotic Models
- 9:00AM-11:00AM
-
Abstract Number: 1550
Comorbidities of Rheumatoid Arthritis: Results from the Korean National Health and Nutrition Examination Survey
- 9:00AM-11:00AM
-
Abstract Number: 1739
Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis As Assessed By Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data
- 9:00AM-11:00AM
-
Abstract Number: 1596
Comparative Effectiveness of Tocilizumab Monotherapy with Tumor Necrosis Factor Inhibitors in Combination with Methotrexate in Patients with Rheumatoid Arthritis and Prior Exposure to Tumor Necrosis Factor Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 1475
Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Non-Selective Nsaids in Taiwanese Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1656
Compare the Potential of Osteoclast Precursors (OCPs) Residing in Bone Marrow and Peripheral Blood As the Surrogates of Psoriasis Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 1472
Comparison Between Carotid Plaque and Carotid Intima-Media Thickness to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1488
Comparison Between Carotid Ultrasonography and Coronary Artery Calcification Score to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1487
Comparison Between Intima-Media Thickness and Coronary Artery Tomography in Subclinical Atheroesclerosis Detection in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1728
Comparison of Adherence to Disease Modifying Antirheumatic Drugs in Psoriatic Arthritis and Other Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1289
Comparison of Clinical Parameters and PET/MRI in Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1220
Comparison of Healthcare Utilization of Patients with Rheumatoid Arthritis Who Are Anti-Cyclic Citrullinated Peptide Antibody Positive Versus Negative
- 9:00AM-11:00AM
-
Abstract Number: 1371
Comparison of Patient and Physician Reported Global Disease Activity Measures in Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1245
Comparison of Secukinumab Vs Adalimumab in a Cost per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthritis at 48 Weeks from the US Perspective
- 9:00AM-11:00AM
-
Abstract Number: 1372
Comparison of the Printo 2010 and Printo/International Myositis and Clinical Studies Group (IMACS) 2016 Improvement Criteria in the Printo Trial in New Onset Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1384
Comparison of the Systemic Lupus Collaborating Clinics-Damage Index Score with a Physician Global Assessment of Damage in an International Cohort of Patients with Childhood-Onset Systemic Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1929
Comparison of Two Different ANCA Iif Methods with EIA and Disease Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 1723
Composite Psoriatic Disease Activity Index (CPDAI), Defining Remission and Disease Activity States Using Data from Daily Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 1500
Concomitant Development of Interstitial Pneumonia Associated with Dermatomyositis and Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1134
Confidence and Competence of Medicine Trainees’ Musculoskeletal Skills: A Report of the Relationship from a Large Multi-Year, Multidisciplinary Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1877
Confirmatory Factor Analysis and Assessment of Differential Item Functioning of the Satisfaction with Appearance Scale in Systemic Sclerosis: A Comparison Across Sex, Race/Ethnicity and Disease Subtype
- 9:00AM-11:00AM
-
Abstract Number: 1630
Consistent Pharmacodynamic Effects of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, on Serum Analytes Across Four Phase 3 Clinical Trials in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1704
Consistent Safety and Tolerability of Secukinumab over Long-Term Exposure in Patients with Active Psoriatic Arthritis and Moderate to Severe Plaque Psoriasis: Updated Pooled Safety Analyses
- 9:00AM-11:00AM
-
Abstract Number: 1334
Contribution of Diagnostic Investigations in the Management of Uveitis: Retrospective Analysis of 300 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1478
Coronary Artery Calcification in Rheumatoid Arthritis Patients Is Not Characterized By an Increase in Genes Associated with Coronary Artery Disease in the General Population
- 9:00AM-11:00AM
-
Abstract Number: 1469
Coronary Territories Are Not Affected in Mexican Mestizo Patients with Rheumatoid Arthritis in Comparison to Matched Controls: Evaluation Using Speckle Tracking Echocardiography
- 9:00AM-11:00AM
-
Abstract Number: 1548
Correlates of Fatigue in People Living with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1397
Correlation and Responsiveness of Cutaneous Lupus Disease Area and Severity Index (CLASI) and Skindex-29 with Cutaneous Childhood Lupus Erythematosus (cSLE)
- 9:00AM-11:00AM
-
Abstract Number: 1356
Correlation of Erythrocyte Sedimentation Rate with Glycohemoglobin Values and Other Patient Factors
- 9:00AM-11:00AM
-
Abstract Number: 1515
Could Increase Levels of Dickkopf-1 Protein be Considered As a Potential Biomarker for Bone Resorption in Joint and Periodontal Disease in Patients with Early Rheumatoid Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 1090
CpG-Stimulated B Cells Require Glutaminolysis for Glycolysis, Mitochondrial Respiration, and Cytokine Production
- 9:00AM-11:00AM
-
Abstract Number: 1846
Cutaneous and Visceral Fibrosis Induced By Endothelial Cell-Specific Constitutive Activation of TGF-β1 Signaling in Mice
- 9:00AM-11:00AM
-
Abstract Number: 1934
Cutaneous Manifestations of ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1708
Cutaneous Microbiota Features Distinguish Psoriasis from Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1670
Cytokine Expression in Groups of Psoriatic Arthritis Patients Characterised By Specific HLA Genotypes and Clinical Features
- 9:00AM-11:00AM
-
Abstract Number: 1553
Declining Flare Rates in the First Five Years of RA Disease, but Not after
- 9:00AM-11:00AM
-
Abstract Number: 1201
Deconvolution of Immune Cell Proportions from Whole Blood RNA Using Next-Generation Sequencing
- 9:00AM-11:00AM
-
Abstract Number: 1531
Decrease in Bone Mineral Density during Three Months of Early RA Measured By DXR Predicts Radiographic Joint Damage after One Year
- 9:00AM-11:00AM
-
Abstract Number: 1636
Decrease of Tocilizumab in Rheumatoid Arthritis in Remission : A Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 1089
Decreased B Cell Activation-Induced Apoptosis in Cells Overexpressing Interferon Regulatory Factor 5 (IRF5), a Gene Associated with Risk for Systemic Lupus Erythematosus and Other Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1852
Decreased Expression of Sirtuin 7 By Lung Fibroblasts from Patients with Scleroderma Contributes to Elevated Collagen Production
- 9:00AM-11:00AM
-
Abstract Number: 1820
Dectin-1 on Monocytic Cells Mediates Aberrant Innate and Adaptive Immune Responses in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1653
Delineating the Effects of Rheumatoid Arthritis Pharmacotherapies on Vascular Inflammation: Rationale and Design of a Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 1821
Demethylated CD4+CD28+KIR+CD11ahi T Cells Are Characterized By a Pro-Inflammatory Transcriptome and Interact with Genetic Risk to Predict Disease Activity in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1755
Dendritic Cell-Specific Loss of Caspase 8 Incites Symptoms of Neuropsychiatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1441
Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Knockout Attenuates Arthritis Progression and Systemic Inflammation in TNF-Tg Arthritis Mouse Models
- 9:00AM-11:00AM
-
Abstract Number: 1535
Depression in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1771
Depression Is Associated with a Poorer with Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1269
Description of Radiographic Hip Measurements By OA Status in a Large Community-Based Study of African American and White Men and Women
- 9:00AM-11:00AM
-
Abstract Number: 1207
Design of a Multiplex Serum Proteome Assay to Monitor Biologic Drug Response in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1902
Detecting the Pulmonary Vascular Involvement and the Changes in Gene Activation Profiles at Early Stage of Systemic Sclerosis in Patients with Raynaud Phenomenon
- 9:00AM-11:00AM
-
Abstract Number: 1480
Determination of the Lipid Profile in Active Disease Leads to Incorrect Cardiovascular Risk Prediction in Early Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1903
Determining Disease Course in Localized Scleroderma: A Prospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1370
Development and Validation of a Composite Disease Activity Score for Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1298
Development and Validation of Berlin and Sparcc MRI Sacroiliac Joint Scoring Methods for the Semi-Axial Scan Plan
- 9:00AM-11:00AM
-
Abstract Number: 1945
Development and Validation of Case-Finding Algorithms for the Identification of Patients with ANCA-Associated Vasculitis and Large-Vessel Vasculitis in Healthcare Administrative Databases
- 9:00AM-11:00AM
-
Abstract Number: 1160
Development of a Shared Decision Making Tool for Osteoporosis Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1156
Development of a Taxonomy of Patient Engagement in Health Research
- 9:00AM-11:00AM
-
Abstract Number: 1247
Diagnostic Modeling of Rheumatoid Arthritis in Oklahoma Tribal Members Using Soluble Mediators
- 9:00AM-11:00AM
-
Abstract Number: 1667
Diagnostic Value of Anti-CD74 Antibodies in Axial Spondyloarthritis: Results from a Population with Low HLA-B27 Prevalence Background
- 9:00AM-11:00AM
-
Abstract Number: 1476
Diastolic Dysfunction in Patients with Rheumatoid Arthritis: Predictors of Longitudinal Progression over Five Years
- 9:00AM-11:00AM
-
Abstract Number: 1778
Differences Between Early and Late Cardiovascular Disease in a Population-Based Cohort of Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1444
Differential Expression of Wnt Inhibitors before and after Joint Inflammation Onset in Rat Arthritis Could Partly Explain Paradoxical Effect of Sclerostin Inhibition
- 9:00AM-11:00AM
-
Abstract Number: 1219
Differential Peripheral Blood DNA Methylation Patterns Are Predictive of Radiographic OA Progression
- 9:00AM-11:00AM
-
Abstract Number: 1654
Differential Serum Protein Expression in Groups of Psoriatic Arthritis Patients Characterised By Specific HLA Genotypes and Clinical Features
- 9:00AM-11:00AM
-
Abstract Number: 1203
Differential Synovial Expression Patterns in Early Osteoarthritis Predict Pain and Progression of Joint Damage
- 9:00AM-11:00AM
-
Abstract Number: 1102
Differentiation of Spongiosa-Derived Mesenchymal Stromal Cells from Osteoporosis and Osteoarthritis Patients Are Influenced By Adipokines
- 9:00AM-11:00AM
-
Abstract Number: 1360
Discontinuation Causes of Biological Therapies: Over a Five-Year Period. Biobadasar
- 9:00AM-11:00AM
-
Abstract Number: 1646
Discontinuation of Methotrexate or Glucocorticoids in Patients with Rheumatoid Arthritis Treated with Tofacitinib: Clinical Efficacy Data from Long-Term Extension Studies
- 9:00AM-11:00AM
-
Abstract Number: 1083
Discovery and Subsequent Diagnostic Verification of Autoantibodies Against the Major Vault Protein (MVP) in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1104
Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Chronic Tendinopathy
- 9:00AM-11:00AM
-
Abstract Number: 1856
Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 1079
Discovery of Novel Autoantigens in Sjogren’s Syndrome with Potential for Subgrouping of Disease
- 9:00AM-11:00AM
-
Abstract Number: 1407
Disease Activity Trackers to Support Treat to Target Strategies: A Needs Assessment Survey
- 9:00AM-11:00AM
-
Abstract Number: 1944
Disease Activity, Glucocorticoid Exposure, and Rituximab Determine Body Composition Changes during Induction Treatment of ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1731
Disease Burden and Impact of Certolizumab Pegol Treatment on Workplace and Household Productivity Across Working Age Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1522
Disease Burden in Rheumatoid Arthritis (RA) Patients Who Have Secondary Osteoarthritis (OA) Is Lower Than in OA but Higher Than in RA with No Secondary OA
- 9:00AM-11:00AM
-
Abstract Number: 1521
Disease Characteristics and Change of Arthritis Activity According to Treatment in Hepatitis B Surface Antigen Positive Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1331
Disease Patterns and Long Term Outcome Amongst Patients with Relapsing Polychondritis – Single Centre Experience
- 9:00AM-11:00AM
-
Abstract Number: 1730
Disease Progression Among Non-Achievers of Minimal Disease Activity in Psa Patients Treated with Infliximab or Golimumab
- 9:00AM-11:00AM
-
Abstract Number: 1256
Disparities in Total Knee Replacement: Population Losses in Quality-Adjusted Life Years Due to Differential Offer, Acceptance, and Complication Rates in African Americans
- 9:00AM-11:00AM
-
Abstract Number: 1747
Dissecting the Role of Single Complement Deficiencies in a Novel Model for Apoptotic Cell-Induced Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1628
Distinct Baseline Serum Molecular Profile and Pharmacodynamic Effects of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Asian-Pacific Patients with Active Rheumatoid Arthritis Despite DMARD or Anti-Tnfα Therapy Across Two Global Phase 3 Trials
- 9:00AM-11:00AM
-
Abstract Number: 1388
Distinct Clinical Correlates of Immune Thrombocytopenic Purpura at Diagnosis of Childhood-Onset and Adult SLE
- 9:00AM-11:00AM
-
Abstract Number: 1321
Distinguishing Features of Polymicrobial Septic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1745
Disturbance of Renal Circadian Rhythm in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1093
DNA Methylation Defines Joint Specific Differences in Synovial Fibroblasts from OA and RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 1317
Do Patients with MRSA-Positive Septic Arthritis Differ Clinically from Non-MRSA-Positive Counterparts?
- 9:00AM-11:00AM
-
Abstract Number: 1674
Do TNF Inhibitors Change the Progression of Sacroiliitis?
- 9:00AM-11:00AM
-
Abstract Number: 1517
Does Inflammatory Arthritis Really Improve during Pregnancy? a Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1251
Does Preconsult Electronic Exchange Affect Postconsult Diagnosis?
- 9:00AM-11:00AM
-
Abstract Number: 1234
Does SLE Care in a Lupus Clinic Result in Higher Quality Scores Than in General Rheumatology Clinics?
- 9:00AM-11:00AM
-
Abstract Number: 1694
Does Treat to Target or Achieving Remission Improve Radiographic Outcome in Psa?
- 9:00AM-11:00AM
-
Abstract Number: 1644
Dose Selection of Filgotinib, a Selective JAK1 Inhibitor, for Rheumatoid Arthritis Phase 3 Studies: Exposure-DAS28 and ACR Modeling Approach
- 9:00AM-11:00AM
-
Abstract Number: 1597
Dose-Response Modeling Is a Useful Tool to Determine Doses for Phase 3: Experience from Olokizumab
- 9:00AM-11:00AM
-
Abstract Number: 1754
Double-Negative T (DNT) Cell over-Expressing PD-1 and Helios Is Responsible for Lupus Tissue Injury in Systemic Lupus Erythematosus (SLE): Direct Proof That Increased Interferon Alpha (IFNα) Expression Is Sufficient to Induce SLE in Ifnα-Transgenic Mice
- 9:00AM-11:00AM
-
Abstract Number: 1750
Down-Regulation of microRNA-200a-3p, Targeting C-Terminal Binding Protein-2 (CtBP2), Is Involved in Hypoproduction of IL-2 in SLE-Derived T Cells
- 9:00AM-11:00AM
-
Abstract Number: 1841
Dysregulation of the Splicing Machinery Components in Leukocytes from Patients with Systemic Lupus Erythematosus: Influence on Autoimmune and Atherothrombotic Mechanisms
- 9:00AM-11:00AM
-
Abstract Number: 1555
E-Comorbidity: Evaluation of the Validity of Electronic Comorbidity Assessment in Identifying Comorbid Conditions Among Patients with Rheumatoid and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1623
Early Effects of Tofacitinib on Bone Homeostasis in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1457
Early Onset Morbidity and Mortality in Female Tumor Necrosis Factor Transgenic Mice with Inflammatory-Erosive Arthritis and Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1703
Early Onset of Efficacy with Apremilast Monotherapy in Biologic-Naive Patients with Active Psoriatic Arthritis: A Phase IIIb, Randomized, Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 1619
EARTH EXPLORER 2, a Phase IIb Exploratory Study Evaluating Efficacy and Safety of Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-Alpha Monoclonal Antibody, and the Tumor Necrosis Factor Antagonist Golimumab in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1273
Effect of Anti-Cyclic Citrullinated Protein Antibodies and Rheumatoid Factor on Bone Erosions in Early Rheumatoid Arthritis Patients Using HR-pQCT: A Cross-Sectional Study
- 9:00AM-11:00AM
-
Abstract Number: 1640
Effect of BMI on Baricitinib Efficacy: Pooled Analysis from Two Phase 3 Rheumatoid Arthritis Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 1687
Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (DMARDs) on the Efficacy and Safety of Ixekizumab in Biologic DMARD-Naive Patients with Active Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1764
Effect of Disease Remission on Organ Damage and Quality of Life in Chinese Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1742
Effect of DMARD Therapies on NSAID Intake, Quality of Life, and Physical Functioning in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1382
Effect of Lupus Anticoagulant on Rotational Thromboelastometry in Juvenile Systemic Lupus Erythematosus: Preliminary Data on a Single Center Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1434
Effect of Systemic and Local Inflammation on the Insulin Resistance and Glucose/Lipid Metabolism in Rheumatoid Arthritis: Humans and CIA Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 1337
Effectiveness of Certolizumab Pegol in Patients with Uveitis Refractory to Other Tumor Necrosis Factor Inhibitors. Report of 22 Cases
- 9:00AM-11:00AM
-
Abstract Number: 1158
Effects of an Educational Program Using Treat to Target Strategy in Korean Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1748
Effects of Anti-High Mobility Group Box 1 Antibody for MRL/Lpr lupus-Prone Mice
- 9:00AM-11:00AM
-
Abstract Number: 1690
Efficacy and Safety of Apremilast and Switch from Etanercept in Patients with Moderate to Severe Psoriasis: 52-Week Results
- 9:00AM-11:00AM
-
Abstract Number: 1586
Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs: A United States Subpopulation Analysis from Two Phase 3 Trials
- 9:00AM-11:00AM
-
Abstract Number: 1329
Efficacy and Safety of Biologics in Relapsing Polychondritis: A National Multicenter Study in France
- 9:00AM-11:00AM
-
Abstract Number: 1635
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks
- 9:00AM-11:00AM
-
Abstract Number: 1632
Efficacy and Safety of Sarilumab in Subgroups of Patients with Rheumatoid Arthritis from 2 Phase 3 Studies
- 9:00AM-11:00AM
-
Abstract Number: 1591
Efficacy and Safety of Switching from Adalimumab to Baricitinib: Phase 3 Data in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1364
Efficacy and Safety of Tumour Necrosis Factor Antagonists in a Large Cohort of Juvenile Dermatomyositis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1343
Efficacy of Biological-Targeted Treatments in MDS-Related Systemic Autoimmune Diseases: Multicenter Retrospective Study of 28 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1896
Efficacy of Pulmonary Arterial Hypertension-Specific Drugs Combination Therapy in Survival of Patients with Pulmonary Arterial Hypertension Associated with Systemic Sclerosis and Other Connective Tissue Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1736
Efficacy of TNF Inhibitors in Axial Spondyloarthritis According to the Presence of Objective Signs of Inflammation: A Multicentric Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1609
Efficacy of Tofacitinib in Patients Who Are Inadequate Responders to Disease-Modifying Antirheumatic Drugs According to Early Versus Late Duration of Rheumatoid Arthritis: Post-Hoc Analysis of Data from Phase 3 Trials
- 9:00AM-11:00AM
-
Abstract Number: 1117
EGCG Down-Regulates TNF-α-Induced Mcl-1 Expression By Modulating Mule/Huwe1, β-TrCP, and USP9X Ubiquitin/De-Ubiquitin Ligases in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1483
Elevated Anti-Cyclic Citrullinated Peptide Antibody Titer Is Associated with Increased Cardiovascular Risk
- 9:00AM-11:00AM
-
Abstract Number: 1904
Elevated GITRL Is Associated with Multi-Organ Involvement and Increased Disease Activity of Primarty Sjogren’s Syndrome and Promotes Pathogenic Th1/17 Differentiation
- 9:00AM-11:00AM
-
Abstract Number: 1839
Elevated Plasma Cell-Free Mitochondrial DNA Defines a Subgroup of Lupus Patients with Membranous Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 1078
Elevated Proportion of CD38highIgD+ b Cells in Peripheral Blood Is Related to Disease Activity in Patients with Primary SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1459
Enhanced Efficacy of Early Vs. Late IL-1β Antagonism in Murine Arthritis Mediated By Deficiency of the IL-1 Receptor Antagonist IL-1ra
- 9:00AM-11:00AM
-
Abstract Number: 1563
Enhanced Expression of mRNA for Response Gene to Complement 32 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1137
Enhancing Pediatric Rheumatology Education through Computer-Assisted Fellow-Taught Case Modules
- 9:00AM-11:00AM
-
Abstract Number: 1305
Enriching Rheumatoid Arthritis Trial Cohorts with Erosion Progressors By Screening for Active Erosions (Erosions with Osteitis) with MRI
- 9:00AM-11:00AM
-
Abstract Number: 1221
Environmental Scan of Rheumatoid Arthritis Patient Registries Around the World: An Omeract Initiative
- 9:00AM-11:00AM
-
Abstract Number: 1814
Epidemiology and Microbiology of Pneumonia in Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 1884
Esophageal Dilation and Interstitial Lung Disease Incidence and Progression in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1244
Establishing a Case Report Form (CRF) for Systemic Autoimmune Diseases Studies
- 9:00AM-11:00AM
-
Abstract Number: 1413
Establishing Clinical Severity for Patient Reported Outcomes Measurement Information System Measures in Adult Patients with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1431
Estimates of Global Status By Physicians and Patients Are More Likely to be Discordant in Osteoarthritis Than in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1288
Evaluating Rheumatoid Arthritis Disease Activity Using Global Assessment of 18f-FDG Uptake in the Joints
- 9:00AM-11:00AM
-
Abstract Number: 1253
Evaluation of a Pre-Assessment Tool to Define the Spectrum of Autoimmune Diseases in an Underserved Environment
- 9:00AM-11:00AM
-
Abstract Number: 1948
Evaluation of Body Composition Parameters in Granulomatosis with Polyangiitis: Association of Fat Mass Parameters with Disease Activity and Inflammatory Markers
- 9:00AM-11:00AM
-
Abstract Number: 1600
Evaluation of Disease Activity in Patients with Rheumatoid Arthritis Treated with Tofacitinib By RAPID3: An Analysis of Data from 6 Phase 3 Studies
- 9:00AM-11:00AM
-
Abstract Number: 1387
Evaluation of Mild to Moderate SLE Flare in Patients with Childhood-Onset Disease
- 9:00AM-11:00AM
-
Abstract Number: 1379
Evaluation of S100 Proteins As Potential Biomarkers of Global and Renal-Specific Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1275
Evaluation of Spine and Tibia Bone Microarchitecture Using Trabecular Bone Score (TBS) and HR-pQCT in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1226
Evaluation of the Association Between C-Reactive Protein and Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: Analysis of Two Clinical Practice Data Sets
- 9:00AM-11:00AM
-
Abstract Number: 1373
Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologists
- 9:00AM-11:00AM
-
Abstract Number: 1366
Evidence Based Criteria for Corticosteroid Tapering/Discontinuation. an Analysis of the Paediatric Rheumatology International Trials Organization (PRINTO) Trial in New Onset Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1921
Evidence for Prevotella Copri As an Immune-Relevant Bacterium in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1516
Evidence of Labial Salivary Gland Epithelial Cell Activation from Patients with Rheumatoid Arthritis and Sicca Symptomatology
- 9:00AM-11:00AM
-
Abstract Number: 1891
Excellent Reliability of Semiquantitative Nailfold Capillaroscopy Assessment in a Systemic Sclerosis Cohort – a Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 1883
Exercise Habits and Factors Associated with Exercise in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1092
Expansion of Age Associated B Cells in Murine Lupus Is Regulated By DEF6 and Its Homologue Swap-70
- 9:00AM-11:00AM
-
Abstract Number: 1088
Expansion of Transitional B Cells in SLE Patients Correlates with Increased Toll-like Receptor 7 Expression
- 9:00AM-11:00AM
-
Abstract Number: 1153
Exploring Perceptions of a Rheumatoid Arthritis Specific Smoking Cessation Programme
- 9:00AM-11:00AM
-
Abstract Number: 1477
Exploring the Inadequate Cardiovascular Disease Prevention in Inflammatory Joint Diseases: Results from a Nationwide Norwegian Project
- 9:00AM-11:00AM
-
Abstract Number: 1484
Exploring the Link Between RA Disease Activity, Lipid Levels, and Cardiovascular Disease in an Early Inflammatory Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1744
Expression of C1q By Podocytes at Late Stages of Proliferative Lupus Glomerulonephritis
- 9:00AM-11:00AM
-
Abstract Number: 1473
Expression of Vitamin D Receptor Associated Genes in the Aorta of Coronary Artery Disease Patients with and without Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1303
Extended T2-Times in Cardiovascular Magnetic Resonance (CMR) in Patients with Systemic Lupus Erythematosus (SLE) and Persisted Dyspnoea: Is SLE-Associated Myocarditis an Underestimated Problem?
- 9:00AM-11:00AM
-
Abstract Number: 1218
Extensive Genetic Overlap of Traits Related to Gout, Hyperuricemia and Its Comorbidities
- 9:00AM-11:00AM
-
Abstract Number: 1127
Extracellular Macrophage Migration Inhibitory Factor Is Essential for Hypoxia-Induced Angiogenesis in a Hypoxia Inducible Factor Independent Manner
- 9:00AM-11:00AM
-
Abstract Number: 1114
Extracellular Vesicles in the Circulating of Rheumatoid Arthritis Patients Are Pro-Inflammatory
- 9:00AM-11:00AM
-
Abstract Number: 1805
Factors Associated with Complete Remission in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study in One Center
- 9:00AM-11:00AM
-
Abstract Number: 1930
Factors Associated with Glucocorticoid Exposure in ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1259
Factors Influencing Patient’s Participation in Rheumatology Research Studies: Experience from a Single Academic Centre
- 9:00AM-11:00AM
-
Abstract Number: 1943
Factors Predictive of ANCA-Associated Vasculitis Relapse
- 9:00AM-11:00AM
-
Abstract Number: 1346
Factors That Influence Therapy in Patients with Undifferentiated Connective Tissue Disease
- 9:00AM-11:00AM
-
Abstract Number: 1392
Familial Aggregation of Autoimmune Diseases in Childhood and Adulthood Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1769
Fatigue in Anti-Nuclear Antibody Positive Individuals with Insufficient Criteria to Diagnose a Systemic Autoimmune Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1761
Fatigue in Patients with Systemic Lupus Erythematosus Is Independent of Their Disease Activity but Dependent on Their Damage Accrual and Body Mass Index
- 9:00AM-11:00AM
-
Abstract Number: 1768
Fatigue in SLE Is Associated with Neuropsychiatric Involvement, Pain, Impaired Sleep and a Reduced Quality of Life
- 9:00AM-11:00AM
-
Abstract Number: 1281
Feasibility and Reliability of the Spondyloarthritis Research Consortium of Canada Sacroiliac Joint Inflammation Score for Children with Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1282
Feasibility and Reliability of the Spondyloarthritis Research Consortium of Canada Sacroiliac Joint Structural Score for Children with Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1369
Features Distinguishing Clinically Hypo- and Amyopathic Juvenile Dermatomyositis (CAJDM) from Juvenile Dermatomyositis (JDM)
- 9:00AM-11:00AM
-
Abstract Number: 1258
Female Gender Is Associated with a Poorer Response to TNF-Inhibitors in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1849
Fibroblast Growth Factor 9/ Fibroblast Growth Factor Receptor 3 Signaling Is Upstream of Several Profibrotic Pathways and Induces Fibroblast Activation and Tissue Fibrosis in SSc
- 9:00AM-11:00AM
-
Abstract Number: 1870
First Pilot Study of an Implantable Loop Recorder (ILR) in Systemic Sclerosis Detects Significant Cardiac Arrhythmias with CMR Abnormalities
- 9:00AM-11:00AM
-
Abstract Number: 1594
First-in-Human Pharmacokinetics and Safety of Escalating Single- and Multiple-Doses of GS-9876, a Novel, Oral SYK Inhibitor, in Healthy Subjects
- 9:00AM-11:00AM
-
Abstract Number: 1504
Fluoroquinolone Resistance in Escherichia coli Urinary Tract Infections Among Patients with Rheumatoid Arthritis: Does Use of Hydroxichloroquine Matter?
- 9:00AM-11:00AM
-
Abstract Number: 1795
Four Years Follow-up of Subclinical Atherosclerosis in Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1541
Frailty Is Associated with Decreased Physical Function in Adults with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1513
FRAX Fracture Risk in Rheumatoid Arthritis – Assessments with and without Bone Mineral Density May Lead to Very Different Results in Individual Patients
- 9:00AM-11:00AM
-
Abstract Number: 1808
Frequency and Factors Associated with Thirty Day Hospital Readmissions Among Systemic Lupus Erythematosus Patients in a Community Hospital in the California Central Valley
- 9:00AM-11:00AM
-
Abstract Number: 1815
Frequency and Predictors of Attaining the Lupus Low Disease Activity State (LLDAS) in a Multinational SLE Cohort from the Asia Pacific
- 9:00AM-11:00AM
-
Abstract Number: 1385
Frequency of the Systemic Lupus Collaborating Clinics- Damage Index Items in Three Registries of Childhood-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1859
Fucosyltransferase-1 Mediated Fucosylation of TGF-βR1 Is Critical to TGF-β Signaling in Scleroderma and in Bleomycin-Induced Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 1890
Functional Disability and Its Predictors in Systemic Sclerosis: A Study from the Desscipher Project within the European Scleroderma Trials and Research Group
- 9:00AM-11:00AM
-
Abstract Number: 1578
Functional Screening of Micrornas Using the Inhibitor Library Identified Micrornas to Regulate Expression of MMP-3 and IL-6 in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1257
Gender Differences in Ankylosing Spondylitis Patients Treated with Anti-TNF in Daily Practice with Ten Year Follow up
- 9:00AM-11:00AM
-
Abstract Number: 1198
Gene Enrichment Analysis Identifies Active CD40-CD40L Signaling in Early and Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1565
Gene Modules Correlated with Disease Activity and Abatacept Treatment Identified with Weighted Gene Co-Expression Network Analysis of CD4+ T Cell Subsets of RA
- 9:00AM-11:00AM
-
Abstract Number: 1803
General Features of SLE Patients Presenting with Autoimmune Hemolytic Anemia
- 9:00AM-11:00AM
-
Abstract Number: 1485
Generation of New Carotid Plaque Is Determined By the Prexisting Carotid Atherosclerosis and Ongoning Disease Activity of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1837
Genetic Susceptibility Loci for Systemic Lupus Erythematosus in the Dominican Republic Population
- 9:00AM-11:00AM
-
Abstract Number: 1103
Gingival Tissue-Derived MSC Cells (GMSC) Suppress Osteoclastogenesis and Bone Erosion in Collagen-Induced Arthritis Thought CD73 Signal Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1451
Glutamine Metabolism Plays a Crucial Role in the Pathogenesis of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1268
Hand Bone Loss in Early Rheumatoid Arthritis Is Independent of Adalimumab Treatment – Results from a Randomized Controlled Clinical Trial.
- 9:00AM-11:00AM
-
Abstract Number: 1810
Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth
- 9:00AM-11:00AM
-
Abstract Number: 1224
Healthcare and Research Priorities of Adolescents and Young Adults with Systemic Lupus Erythematosus: A Mixed-Methods Study
- 9:00AM-11:00AM
-
Abstract Number: 1235
Healthcare Utilization and Multimorbidities Among Adult Patients with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1916
Heightened MAIT Cell Sensitivity to MR1 Ligands Could Impact Control of Dysbiosis in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1463
Helminths Based Tuftsin-Phosphorylcholine Prevent Development of Mouse Collagen Induced Arthritis, While Maintaining Normal Gut Microbiota
- 9:00AM-11:00AM
-
Abstract Number: 1789
Herpetic Viruses in Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1446
High Fat Diet Alleviates Antigen-Induced Arthritis Severity in Male Mice By Enhancing Both Treg and B10 Cells
- 9:00AM-11:00AM
-
Abstract Number: 1940
High Prevalence of Inflammatory Heart Disease in Eosinophillic Granulomatosis with Polyangiitis (Churg Strauss) Patients
- 9:00AM-11:00AM
-
Abstract Number: 1208
High-Throughput Screening Discovers Multiple Novel Autoantibodies in Rheumatoid Arthritis, Systemic Lupus, Systemic Sclerosis and Sjogrens Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1716
Higher Frequency and Severity of Coronary Plaques on Coronary CT Angiography in Psoriatic Arthritis Patients without Symptoms of Coronary Artery Disease Compared to Controls
- 9:00AM-11:00AM
-
Abstract Number: 1566
Histone Lysine Methylation and STAT3 Differentially Regulate Constitutive and IL-6-Induced MMPs Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1066
History of Lupus Nephritis Is an Independent Risk Factor for Thrombosis in Systemic Lupus Erythematosus Patients with Antiphospholipid Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 1067
History of Thrombocytopenia Is Associated with Lower Prevalence of Thrombotic Events in Systemic Lupus Erythematosus Patients with Antiphospholipid Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 1162
How Ehealth Technologies Are Changing the Office Visit: Perspectives from Healthcare Professionals in Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 1519
How Much, and When, Does Autoimmune Thyroid Disease Increase the Risk of RA, and Does RA-Onset Impact the Risk of Autoimmune Thyroid Disease?
- 9:00AM-11:00AM
-
Abstract Number: 1866
Human and Experimental Tracheal Stenosis Is Characterized By a TGF-β-Dependent Fibrotic Component
- 9:00AM-11:00AM
-
Abstract Number: 1445
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Ameliorate Rheumatoid Arthritis Via Regulation of Macrophage Activation and Polarization
- 9:00AM-11:00AM
-
Abstract Number: 1381
Humoral Immune Response and Cytokine Profile after a Booster Dose with Tdap Vaccine in Juvenile Systemic Lupus Erythematosus and Controls
- 9:00AM-11:00AM
-
Abstract Number: 1111
Huntingtin Interactin Protein 1 (HIP1) Regulates Receptor Tyrosine Kinases Mediated Activity and Cell Invasiness in Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 1829
Hyper-Responsiveness to TLR-4 Stimulation in SLE: Association with High Levels of Serum IFN-Alpha and a Distinct Inflammatory Cytokine Profile
- 9:00AM-11:00AM
-
Abstract Number: 1935
Hypertrophic Pachymeningitis in a Population with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Study in a Single Japanese Institution
- 9:00AM-11:00AM
-
Abstract Number: 1112
Hypoxia Modulates Neutrophil Integrin Expression, Adhesion and Trans-Endothelial Migration
- 9:00AM-11:00AM
-
Abstract Number: 1908
Identification of a Novel Pro-Inflammatory T Cell Epitope from His-tRNA-Synthetase Associated with Interstitial Lung Disease in Anti-Jo-1 Positive Patients
- 9:00AM-11:00AM
-
Abstract Number: 1456
Identification of a Unique Population of B220hi B-Cells in Inflamed Lymph Nodes (Bin) As a Potential Biomarker of Arthritic Progression in the Tumor Necrosis Factor Transgenic Mouse Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1217
Identification of Sjogren’s Syndrome-Associated Long Non-Coding RNAs That Are Co-Expressed with Key Protein-Coding Transcripts Involved in Dysregulated Interferon Responses
- 9:00AM-11:00AM
-
Abstract Number: 1061
Identifying Clinical and Epidemiological Risk Factors Associated with Thrombosis and Pregnancy Morbidity in a Large Cohort of Chinese APS Patients
- 9:00AM-11:00AM
-
Abstract Number: 1422
Identifying Generic and Specific Patients’ Perspectives on Disease- and Treatment-Related Issues in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis: A Qualitative Concept Mapping Study
- 9:00AM-11:00AM
-
Abstract Number: 1576
Identifying Rheumatoid Arthritis Subtypes Using Synovial Tissue Gene Expression Profiling, Histologic Scoring and Clinical Correlates
- 9:00AM-11:00AM
-
Abstract Number: 1121
IFN Regulatory Factor-5 Signaling Increases IFN-Gamma Production and Suppresses IL-2 Production from CD4+ T Cells, and Controls IgG Production in B Cells
- 9:00AM-11:00AM
-
Abstract Number: 1910
IL-21 Inhibits Treg Differentiation and Function in SLE By Modulating GATA-3 and CTLA-4
- 9:00AM-11:00AM
-
Abstract Number: 1752
IL-23 Promotes the Generation of DNT Cells and Shifts the Balance Between IL-2 and IL-17 Production in Murine and Human SLE
- 9:00AM-11:00AM
-
Abstract Number: 1124
IL37 Rescues Human OA Cartilage Explants from GAG Release
- 9:00AM-11:00AM
-
Abstract Number: 1279
Imaging of Ankylosing Spondylitis By [18f]Fluoride PET-CT to Assess Bone Formation Activity and to Monitor Anti-TNF Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1746
Immune Complex-Induced IL-6 Production By Lupus Prone Mesangial Cells Is Mediated By Neuraminidase Activity
- 9:00AM-11:00AM
-
Abstract Number: 1914
Immune Recognition of a Novel Citrullinated Epitope of Cartilage Proteoglycan Aggrecan in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1518
Immunoglobulin Binding Protein (BiP), an Antigen for CCP Sero-Positive Rheumatoid Arthritis Patients, Can Result in a False Positive Quantiferon-Gold Tuberculosis Test
- 9:00AM-11:00AM
-
Abstract Number: 1939
Immunologic, Clinical and Demographic Correlates in 51 Cocaine Users with Serum Anti-Neutrophil Cytoplasmic Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 1892
Immunosignature Technology Differentiates Patients with Systemic Sclerosis and Internal Organ Involvement
- 9:00AM-11:00AM
-
Abstract Number: 1142
Impact of a Student Led Rheumatology Interest Group on Medical Student Interest in Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 1231
Impact of Comorbidity on Health-Related Quality of Life and Healthcare Expenditure in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1144
Impact of Decision-Making Role Preferences in the Efficacy of a Multimedia Patient Education Tool for Patients with Common Rheumatologic Conditions
- 9:00AM-11:00AM
-
Abstract Number: 1766
Impact of Depression on SLE Flares
- 9:00AM-11:00AM
-
Abstract Number: 1164
Impact of E-Learning on Knowledge, Self-Efficacy and Exercise Behaviours of Patients with Axial Spondyloarthritis: Results from a Longitudinal Randomized Control Trial
- 9:00AM-11:00AM
-
Abstract Number: 1163
Impact of E-Learning on Perceived Social Role Participation of Patients with Axial Spondyloarthritis: Results from a Longitudinal Randomized Control Trial
- 9:00AM-11:00AM
-
Abstract Number: 1906
Impact of Environmental Factors and Inflammation on Alterations of the Total Peripheral T-Cell Compartment in Granulomatosis with Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 1408
Impact of Participation in the Adalimumab (Humira) Patient Support Program on Patient Reported Outcomes Among Patients with Rheumatoid Arthritis: Passion Study
- 9:00AM-11:00AM
-
Abstract Number: 1580
Impact of Rituximab on Patient-Reported Outcomes in Patients with Rheumatoid Arthritis from the US Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 1812
Impact of Severe Organic CNS Involvement in Cognitive Function in a Cohort of Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1415
Impact of the Clinical Disease Activity Index to Treat to Target Rheumatoid Arthritis in the Ambulatory Setting
- 9:00AM-11:00AM
-
Abstract Number: 1511
Impacts of Disease Activity and Serum Level of Neurotrophic Factors on Depression in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1148
Implementation of a Gout Knowledge Based Assessment Tool in an Inter-Professional, Multi-Disciplinary Musculoskeletal Training Program
- 9:00AM-11:00AM
-
Abstract Number: 1152
Implementation of a Musculoskeletal Ultrasound Teaching Program Is Not Determined By Fellowship Program Size
- 9:00AM-11:00AM
-
Abstract Number: 1263
Implicit Biases Influencing Service Provision in Physical Therapy for Low Back Pain
- 9:00AM-11:00AM
-
Abstract Number: 1376
In Juvenile Dermatomyositis, Organ Damage Is Comparable after Median 13.5 and 21.5 Years Follow-up Time, Despite Sustained Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 1626
In Real Life Rheumatoid Arthritis Patients, Leflunomide Has Limited Impact As a Second Line DMARD after Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 1205
In silico Drug Repurposing Analysis Supports Phosphoinositol 3 Kinase Inhibitors As Treatment of LUPUS
- 9:00AM-11:00AM
-
Abstract Number: 1611
In Vitro Cellular Profiling of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, Reveals a Distinct Phenotypic Signature Compared to Tocilizumab, an Anti–IL-6 Receptor Monoclonal Antibody
- 9:00AM-11:00AM
-
Abstract Number: 1110
Inactive Rhomboid Family Member 2/Tnfα Convertase/Tnfα Pathway Is Essential to the Pathogenesis of Haemophilic Arthropathy
- 9:00AM-11:00AM
-
Abstract Number: 1190
Incidence and Prevalence of Polymyalgia Rheumatic and Giant Cell Arteritis: A 15-Year Study in a Health Care Management Organization
- 9:00AM-11:00AM
-
Abstract Number: 1167
Incidence of Primary Chronic Cutaneous Lupus Erythematosus in a Metropolitan Area of the Southeastern United States: The Georgia Lupus Registry
- 9:00AM-11:00AM
-
Abstract Number: 1312
Incidence of Reactive Arthritis, Uveitis and Conjunctivitis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy: A 20 Years’ Two-Center Retrospective Study
- 9:00AM-11:00AM
-
Abstract Number: 1489
Incident Hypertension and Associated Factors in a Hispanic Group with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1409
Increase in the Use of Validated Disease Activity Scores in Current Daily Clinical Practice Compared to 2007
- 9:00AM-11:00AM
-
Abstract Number: 1569
Increased Circulating CD14brightCD16+ Intermediate Monocytes Are Regulated By Interleukin-10 in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1895
Increased CXCL4/PF4 Presence in Systemic Sclerosis and Absence of Heparin Directed Autoantibodies
- 9:00AM-11:00AM
-
Abstract Number: 1077
Increased Expression of B-Cell Lipid Rafts in Patients with Primary Sjogren’s Syndrome Correlated Positively with Disease Activity Score, Suggesting a B Cell Activated State Potentially Relevant for the Disease Pathogenesis and Response to Biologic Therapies
- 9:00AM-11:00AM
-
Abstract Number: 1509
Increased Fracture Risk in Patients with Early Rheumatoid Arthritis in the 1990s As Well As in the 2000s: A Prospective General Population-Matched Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1787
Increased Heart Rate Variability Reflects Improvement in Clinical Status of Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1832
Increased Interferon b Expression in Bone Marrow Mediates a Senescent Phenotype and Impaired Production of Immunomodulatory Factors By SLE Mesenchymal Stromal Cells
- 9:00AM-11:00AM
-
Abstract Number: 1474
Increased Levels of Lipoprotein(a) in RA Patients with Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 1468
Increased Mitral and Tricuspid Valve Regurgitation Among Mexican Mestizo Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1894
Increased Mortality in Systemic Sclerosis Patients with Fibrosing Myopathy
- 9:00AM-11:00AM
-
Abstract Number: 1854
Increased Percentage of CD204/CD206 Double Positive Monocytes Correlates with Specific Lung and Skin Involvement Parameters and an “Active” Capillaroscopic Pattern of Microangiopathy in Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1118
Increased Population of Myeloid Dendritic Cells and Upregulated Gene Expression of Tnfα Is Associated with Poor Response to Hydroxychloroquine
- 9:00AM-11:00AM
-
Abstract Number: 1185
Increased Risk of Osteoporotic Fractures in Patients with Primary SjöGren Syndrome: A Nationwide Population-Based Study in Taiwan
- 9:00AM-11:00AM
-
Abstract Number: 1528
Incretin Axis in Non Diabetic Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1926
Indications for Testing and Diagnostic Outcome in Patients with Positive ANCA at a Canadian Tertiary Care Centre
- 9:00AM-11:00AM
-
Abstract Number: 1328
Infective Endocarditis with Septic Arthritis: A Single-Center Experience
- 9:00AM-11:00AM
-
Abstract Number: 1286
Inflammatory Activity of IgG4-Related Disease Lesions Assessed By Quantitative Positron Emission Tomography Correlates with Circulating Plasmablasts Levels
- 9:00AM-11:00AM
-
Abstract Number: 1122
Infliximab Suppresses the Monocyte Chemotaxis in Human TNF-Transgenic Mice
- 9:00AM-11:00AM
-
Abstract Number: 1683
Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis—Descriptive Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 1649
Influence of Modifiable Risk Factors on the Response to MTX Alone in Early RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 1809
Influence of Solar Radiation in Cutaneous Manifestations of Lupus: Data from the Gladel Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1189
Inpatient Trends for Adults with Scleroderma in the United States: A 20 Year Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1562
Interaction Between Antibodies to Paraoxonase 1 and PON1 rs662 Polymorphism: New Clues to Understand HDL Dysfunction and Oxidative Stress in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1639
Interchangeability of Innovator Rituximab and Its Biosimilar: Results from International Controlled Comparative 1-Year Study in Patients with Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1232
Interdisciplinary Osteoporosis Clinical Working Group and Fracture Liaison Service at Loma Linda University Medical Center (LLUMC): Laying the Groundwork
- 9:00AM-11:00AM
-
Abstract Number: 1925
Interest of Procalcitonin for the Follow-up of ANCA-Associated Vasculitis: Data from a Cohort of 99 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1215
Interferon Signature Genes Are Differentially Expressed Between Microscopic Polyangiitis and Systemic Lupus Erythematosus Peripheral Blood Transcriptomes
- 9:00AM-11:00AM
-
Abstract Number: 1126
Interleukin-1 Is Not Involved in Synovial Inflammation and Cartilage Destruction in Collagenase-Induced Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1120
Interleukin-1β Stabilize CXCL2 mRNA and Increase Its Expression
- 9:00AM-11:00AM
-
Abstract Number: 1284
International Multi-Observer Ultrasound Reliability Study of Age Related Vascularization and Ossification in Healthy Children: The Omeract Pediatric Ultrasound Task Force
- 9:00AM-11:00AM
-
Abstract Number: 1458
Intraadrenal Dendritic Cells Inhibit Corticosterone Response during Collagen-Induced Arthritis – a Role for IL-1β and CXC Chemokines?
- 9:00AM-11:00AM
-
Abstract Number: 1178
Is Subclinical Atherosclerosis Prevalent in a French Patient Cohort with Systemic Lupus Erythematosus?
- 9:00AM-11:00AM
-
Abstract Number: 1410
Is the Self-Assessment of Disease Activity (auto-DAS28) By Patients a Feasible and Acceptable Measure over the Long Term in Rheumatoid Arthritis (RA)? Three-Year Follow-up of a Nurse-Led Program in 771 Patients with Established RA
- 9:00AM-11:00AM
-
Abstract Number: 1689
Ixekizumab Provides Improvements through 52 Weeks in Physical Function, Quality of Life, and Work Productivity in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1688
Ixekizumab Provides Sustained Improvement up to 52 Weeks of Disease Activity As Assessed By Composite Measure Scores in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1678
JAK STAT Kinase Cascade Regulates the IL-23/IL-17 Cytokine Axis in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1435
KCa1.1 Potassium Channels Are a Novel Therapeutic Target on Fibroblast-like Synoviocytes in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1853
Klf5+/-;Fli1+/- Mice Recapitulate Protracted Wound Healing and Cardiac and Intestinal Involvement Associated with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1254
Knee Pain and Patient Preference for Knee Replacement: Healthcare Access Matters
- 9:00AM-11:00AM
-
Abstract Number: 1952
Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 1183
Lack of Awareness of Sexual Health in Rheumatology. High Prevalence of Sexual Dysfunction Among Women with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1608
Lack of Early Change in Disease Activity Score Predicts the Likelihood of Achieving Low Disease Activity at Month 6: Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1698
Late Onset Psoriatic Arthritis in a Longitudinal Cohort: Disease Presentation, Activity over Time and Prognosis
- 9:00AM-11:00AM
-
Abstract Number: 1618
Leflunomide, Sulfasalazine and Hydroxychloroquine for Rheumatoid Arthritis: Efficacious but Poorly Tolerated
- 9:00AM-11:00AM
-
Abstract Number: 1113
Leptin Promotes Distribution of Mast Cells in Salivary Glands of Patients with Primary Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1495
Lipoprotein(a) Concentrations in Rheumatoid Arthritis on Biologic Therapy: Results from the Cardiovascular in Rheumatology [CARMA] Study Project
- 9:00AM-11:00AM
-
Abstract Number: 1713
Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 1648
Long-Term Clinical, Radiographic and Patient-Reported Outcomes Based on RAPID3 Responses with Tofacitinib at 6 Months
- 9:00AM-11:00AM
-
Abstract Number: 1786
Long-Term Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus in a Large Case Control Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1135
Long-Term Impact of an Enhanced Rheumatology Curriculum for Internal Medicine Residents
- 9:00AM-11:00AM
-
Abstract Number: 1763
Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus Following 7 Years of Treatment Exposure: Impact of Clinical Characteristics over Time
- 9:00AM-11:00AM
-
Abstract Number: 1740
Long-Term Improvements in Physical Function of DMARD-Naive and DMARD/Biologic-Experienced Psoriatic Arthritis Patients Treated with Apremilast: Data from a Large Database of 4 Phase III Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 1367
Long-Term Outcomes and Their Predictors in Patients with Juvenile Idiopathic Inflammatory Myopathies of Adult Age: A Referral Population Study
- 9:00AM-11:00AM
-
Abstract Number: 1335
Long–Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study
- 9:00AM-11:00AM
-
Abstract Number: 1873
Longitudinal Analysis of Modified Rodnan Skin Score in Systemic Sclerosis Using Group-Based Trajectory Modelling
- 9:00AM-11:00AM
-
Abstract Number: 1554
Longitudinal Trajectories of the Weighted Lansbury Articular Indices and Standard Joint Counts Are Similarly Correlated with Trajectories of Physical Function in Early Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1791
Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 1194
Low Body Mass Index and Smoking Are Associated with a Lower Risk of Sarcoidosis: A Population-Based Nested Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 1874
Low Rate of Progression in Cases of Isolated Raynaud’s Phenomenon Screened By Nailfold Videocapillaroscopy and Antinuclear Antibody Status Supports Negative Predictive Value of These Tests
- 9:00AM-11:00AM
-
Abstract Number: 1558
Lower Expression of a Novel Cytoplasmic Long Noncoding RNA NR_122076 Contributes to Proliferation, Migration and Invasion of Fibroblast-like Synoviocytes from Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1538
Lower Ratings of Pain Intensity in Older Adults Lead to Underestimation of Disease Activity By Disease Activity Score 28-C-Reactive Protein (DAS28-CRP) in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1491
M-Ficolin and MAp44 As Potential Markers of Subclinical Cardiovascular Comorbidity; Cardiac Evaluation By Coronary Computer Tomography and Myocardial Deformation of Left Ventricle in Early Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1933
M2 Macrophage Is the Predominant Phenotype in Airways Inflammatory Lesions in Patients with Granulomatosis with Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 1462
Magnesium Is a New Mediator Arthritis Severity and Joint Damage
- 9:00AM-11:00AM
-
Abstract Number: 1306
Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1595
Magnitude and Duration of Early Response with Tofacitinib: Post-Hoc Analysis of Two Phase 3, Placebo-Controlled Studies
- 9:00AM-11:00AM
-
Abstract Number: 1601
Maintenance Treatment Using Abatacept with Dose Reduction after Achievement of Low Disease Activity in Patients with Rheumatoid Arthritis (MATADOR) – a Prospective, Multicentered, Single Arm Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 1188
Major Comorbidities of Idiopathic Inflammatory Myositis: A Population-Based Study Using 10 Years of Follow up from the National Health Insurance in Korea
- 9:00AM-11:00AM
-
Abstract Number: 1573
Major Histocompatibility Antigen HLA-DQ6.1 (DQA1*0103/DQB1*0601) Increases Rheumatoid Arthritis Risk Independent of Shared Epitope Among Indians
- 9:00AM-11:00AM
-
Abstract Number: 1953
Management and Outcomes of ANCA-Associated Vasculitis in Unselected Cases within a Large Health Region of England
- 9:00AM-11:00AM
-
Abstract Number: 1310
Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience
- 9:00AM-11:00AM
-
Abstract Number: 1616
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-α Monoclonal Antibody: Long-Term Safety and Efficacy for up to 158 Weeks of Treatment in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1255
Medicare Part B Utilization By Rheumatology Health Care Providers As Related to Population Demographics from 2013
- 9:00AM-11:00AM
-
Abstract Number: 1402
Meeting the Needs of Adolescents with Autoimmune Diseases, the Development of a Clinical Transition Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1869
Mental Health Care in Systemic Sclerosis; Rates of Utilization and Associated Factors in the Scleroderma Patient-Centered Intervention Network Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1141
Mentoring the Pediatric Rheumatology Community through the American College of Rheumatology/Childhood Arthritis and Rheumatology Research Alliance Mentoring Interest Group Network: A Five-Year Status Update
- 9:00AM-11:00AM
-
Abstract Number: 1844
Mesenchymal Stem Cells Ameliorate the Deficiencies in Immunomodulatory and Phagocytic Capacities of Lupus Macrophages
- 9:00AM-11:00AM
-
Abstract Number: 1490
Metabolic and Cardio-Vascular Benefits of Hydroxychloroquine in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1828
Metabolic Reprogramming in CD4+CD28-CXCR3intt-bethi cells and Its Relevance to Pathogenesis in Patients with SLE
- 9:00AM-11:00AM
-
Abstract Number: 1542
Metabolic Syndrome and Cardiovascular Risk Factors in Brazilian Patients with Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1676
Methotrexate and Anti-Tumor Necrosis Treatment Improve Endothelial Function in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1315
Methotrexate and TNF-Blockers for Post Chikungunya Chronic Arthritis : The Martinican Experience
- 9:00AM-11:00AM
-
Abstract Number: 1204
Methotrexate Is an Antibacterial Drug Metabolized By Human Gut Bacteria
- 9:00AM-11:00AM
-
Abstract Number: 1606
Metrotexate Treatment Inmunomodulate the Abnormal Cytokine Expression Present in NaïVe Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1568
Microrna-17 Suppresses TNF-α Signaling By Reducing TRAF2 and cIAP2 Association in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 1672
Microrna-29a Activation of Canonical Wnt Signaling By Targeting LRP6 in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1666
Micrornas Mir-30b-5p, Mir-34a-5p, and Mir-431-3p Are Highly Expressed in the Plasma of Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1765
Minimal Clinically Important Differences for Generic Patient Reported Outcomes Tools in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1696
Minimal Disease Activity Is a Stable Measure of Therapeutic Response in Psoriatic Arthritis Patients Receiving Treatment with Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 1862
Modelling Healthy and Scleroderma Fibrotic Skin in Vitro: Mechanical Stress Alters Macrophage Cytokine Expression and Triggers Signalling Via the Mechano-Sensing Transcription Factor Myocardin-Related Transcription Factor-a
- 9:00AM-11:00AM
-
Abstract Number: 1861
Modelling the Interaction Between Disease Microenvironment and Mesenchymal Cells in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1470
Moderate to Severe Disease Activity in Rheumatoid Arthritis Is Associated with Myocardial 18f-Fluorodeoxyglucose (18F-FDG) Uptake
- 9:00AM-11:00AM
-
Abstract Number: 1461
Modification of Proteins with Malondialdehyde-Acetaldehyde and Citrulline Elicit Antibody Responses in DBA/1J Mice
- 9:00AM-11:00AM
-
Abstract Number: 1614
Monotherapy with Abatacept, Rituximab or Tocilizumab Is Not Associated with a Significantly Lower Long Term Retention Than Combination with Synthetic DMARD: Long-Term Registry Data in 4498 Real-Life Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1170
Month of Birth Affects the Risk of Rheumatic Diseases: A Nationwide Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 1351
Mortality and Prognostic Factors of Pneumocystis Pneumonia in Patients with Connective Tissue Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1192
Mortality and Survival of Patients Diagnosed with GCA in Bergen (Western Norway) 1972-2012
- 9:00AM-11:00AM
-
Abstract Number: 1250
Mortality in Indigenous Populations of Canada, the United States, Australia, and New Zealand with Rheumatic Disease: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 1193
Mortality Rate According to Cause in Patients with Hemophagocytic Lymphohistiocytosis: A Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1931
MRI Findings in Granulomatosis with Polyangiitis: Pachymeningitis and Implications in Quality of Life
- 9:00AM-11:00AM
-
Abstract Number: 1308
MRI of Bilateral Hands Prevents Clinicians from Failing to Detect Joint Damage of Patients with Rheumatoid Arthritis Compared to Scanning Unilateral Hand
- 9:00AM-11:00AM
-
Abstract Number: 1300
MRI-Detected Inflammation Is Associated with Functional Disability in Early Arthritis – Results of a Cross-Sectional Study
- 9:00AM-11:00AM
-
Abstract Number: 1380
Multicenter Prospective Study on the Role of Urinary HER2 As a Lupus Nephritis Biomarker
- 9:00AM-11:00AM
-
Abstract Number: 1325
Musculoskeletal Manifestations in Ebola Survivors
- 9:00AM-11:00AM
-
Abstract Number: 1710
Musculoskeletal Symptoms Preceding the Diagnosis of Psoriatic Arthritis – a Qualitative Exploration of the Patient Journey
- 9:00AM-11:00AM
-
Abstract Number: 1824
Mycophenolate Mofetil Use Associates with Unique Biologic Changes in B Cell and T Regulatory Cell Pathways in SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 1393
Mycophenolic Acid Pharmacokinetics in Childhood-Onset Systemic Lupus Erythematosus Patients of Hispanic Ethnicity in a Single Center
- 9:00AM-11:00AM
-
Abstract Number: 1471
Myocardial 18f-Fluorodeoxyglucose (18F-FDG) Uptake in RA Patients without Clinical Cardiovascular Disease Is Higher Than in Controls and Decreases with Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1494
Myocardial Structure, Function, and Fibrosis in Patients with Rheumatoid Arthritis and Matched Control Subjects
- 9:00AM-11:00AM
-
Abstract Number: 1819
Myocarditis in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1437
Netrin-1 and Its Receptor Unc5b Are Novel Targets for the Treatment of Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1627
Network Meta-Analysis to Assess the Relative Efficacy of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Combination Therapy for Patients with Active Rheumatoid Arthritis Despite Conventional Dmards
- 9:00AM-11:00AM
-
Abstract Number: 1348
Neuromyelitis Optica: Patient Characteristics and Treatment Patterns Among Rheumatologists Versus Non-Rheumatologists
- 9:00AM-11:00AM
-
Abstract Number: 1359
New Markers for Celiac Disease: Anti-Neo-Epitope Human and Microbial Transglutaminases
- 9:00AM-11:00AM
-
Abstract Number: 1864
No Evidence of Association of ATP8B4 F436L missense Variant in a Large Systemic Sclerosis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1062
Non-Conventional Antiphospholipid Antibodies in Patients with Clinical Obstetrical APS: Prevalence and Pregnancies Treatment Efficacy
- 9:00AM-11:00AM
-
Abstract Number: 1115
Non-Esterified Fatty Acids Are Associated with Clinical Features and an Enhanced Th1 Response in Rheumatoid Arthritis: Towards Disease Profiling
- 9:00AM-11:00AM
-
Abstract Number: 1863
Non-Invasive Investigation of Perfusion, Microvascular Structure, Erythema, Oxidative Stress and Oxygenation in Healthy Controls and in Patients with Primary and Secondary Raynaud’s Phenomenon
- 9:00AM-11:00AM
-
Abstract Number: 1087
Nonmemory B Cell Signature Alterations in Belimumab Patients
- 9:00AM-11:00AM
-
Abstract Number: 1391
Novel Electronic Health Record-Based Method Confirms Increased Renal Disease Burden in Pediatric-Onset Vs. Adult-Onset Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1756
Novel Role of Rho Kinase in Neutrophil Netosis during UVB Induced-Skin Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 1543
Obese Patients with RA Have a More Seropositive and a More Active Disease with Less Deformities
- 9:00AM-11:00AM
-
Abstract Number: 1171
Obesity and the Risk of Systemic Lupus Erythematosus in the Nurses’ Health Studies
- 9:00AM-11:00AM
-
Abstract Number: 1294
Oblique Views Radiographs Have Advantages over Antero-Posterior View Radiographs in Assessing Sacroiliitis in Patients with Early Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1947
Ocular Manifestations of ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 1887
Olfactory Impairment Is Associate with Cognitive Dysfunction and Regional Brain Atrophy in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1598
Olokizumab Treatment of Both Western and Asian Patients with Rheumatoid Arthritis Who Have Failed Anti-TNF Treatment Results in Sustained Improvements in Patient-Reported Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 1506
One Third of Patients with Established Rheumatoid Arthritis (RA) Are Correctly Vaccinated Against Influenza and Pneumococcus and This Is Increasing: 3 Year Longitudinal Assessment of 776 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1182
Opiod Use and Death in Chronic Pain Patients with Systemic Lupus Erythematosis
- 9:00AM-11:00AM
-
Abstract Number: 1850
Optimization of a Murine Model to Recapitulate Dermal and Pulmonary Features of SSc
- 9:00AM-11:00AM
-
Abstract Number: 1239
Optimizing Screening for Psoriatic Arthritis through a Shortened Psoriatic Arthritis Screening and Evaluation-2 (PASE-2) Tool
- 9:00AM-11:00AM
-
Abstract Number: 1796
Osteoporosis and Vertebral Fractures in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1507
Our Strategy of Preventing Tuberculosis (TB) in Patients with Rheumatic Diseases Under the Treatment with Biologic Dmards
- 9:00AM-11:00AM
-
Abstract Number: 1386
Outcome of 847 Childhood-Onset Systemic LUPUS Erythematousus Patients in Three Age Groups
- 9:00AM-11:00AM
-
Abstract Number: 1525
Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA
- 9:00AM-11:00AM
-
Abstract Number: 1915
Partial Elimination of Intestinal Microbiota Dampens T Helper 17 Cell Differentiation and Established Collagen-Induced Arthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 1428
Patient Attitudes Towards Being Prescribed Biosimilars in Inflammatory Autoimmune Diseases in Germany
- 9:00AM-11:00AM
-
Abstract Number: 1429
Patient-Reported Outcomes Measures and Economical Burden of Patients with Ankylosing Spondylitis in a Chinese Prospective Cohort with Smart Management System for Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1741
Patients with Active Psoriatic Arthritis Achieving Minimal Disease Activity with Secukinumab Treatment Demonstrate Sustained Improvement of Function and Quality of Life
- 9:00AM-11:00AM
-
Abstract Number: 1327
Patients with Chikungunya Fever Have Increased Serum Levels of Proinflamatory Cytokines
- 9:00AM-11:00AM
-
Abstract Number: 1503
Patterns and Factors Associated with Immunization Among Adult Patients with Rheumatic Diseases in the US
- 9:00AM-11:00AM
-
Abstract Number: 1498
Patterns of Interstitial Lung Disease and Associated Mortality in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1842
Pentraxin 3 Level Positively Correlated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1378
Pentraxin-3 Level Predicts Vasculitis and Mucocutaneous Involvement in Childhood-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1174
Perceived Stress and Reported Cognitive Symptoms Among Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1070
Performance and External Validation of the Damage Index in Antiphospholipid Syndrome in Primary and Secondary APS Patients
- 9:00AM-11:00AM
-
Abstract Number: 1292
Performance of 18fluoride Sodium Positron Emission Tomography with Computed Tomography to Assess Inflammatory and Structural Sacroiliitis Respectively on Magnetic Resonance Imaging and Computed Tomography in Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1291
Performance of Magnetic Resonance Imaging and 18fluoride Sodium Positron Emission Tomography with Computed Tomography to Assess Inflammatory and Structural Abnormalities of the Sacroiliac Joint in Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1095
Periarticular Bone Loss in Arthritis Is Induced By Autoantibodies Against Citrullinated Vimentin
- 9:00AM-11:00AM
-
Abstract Number: 1602
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 8 Years
- 9:00AM-11:00AM
-
Abstract Number: 1285
PET/CT Imaging in Patients with Vascular Behcet Disease
- 9:00AM-11:00AM
-
Abstract Number: 1642
Pharmacokinetic-Pharmacodynamic Analysis of GS-4059-Mediated Bruton’s Tyrosine Kinase Inhibition
- 9:00AM-11:00AM
-
Abstract Number: 1645
Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of ASP5094, an Anti-Alpha-9-Integrin Monoclonal Antibody, Following Single Intravenous Doses in Healthy Subjects
- 9:00AM-11:00AM
-
Abstract Number: 1634
Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks
- 9:00AM-11:00AM
-
Abstract Number: 1629
Pharmacokinetics of ABT-494 with the Once-Daily Extended-Release Tablet Formulation Being Utilized in the Ongoing Rheumatoid Arthritis Phase 3 Trials
- 9:00AM-11:00AM
-
Abstract Number: 1620
Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MEDI4920, a Novel, Engineered CD40 Ligand Antagonist, in Healthy Volunteers
- 9:00AM-11:00AM
-
Abstract Number: 1695
Pharmacological Monitoring of Adalimumab and Etanercept-Treated Psoriatic Arthritis Patients in Predicting Future Treatment Response
- 9:00AM-11:00AM
-
Abstract Number: 1783
Phenome-Wide Association Study Identifies a New Association of Atrial Fibrillation in Males with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1951
Phenotypic and Functional Perturbations of Peripheral B and T Lymphocytes in Granulomatosis with Polyangiitis and Microscopic Polyangiitis
- 9:00AM-11:00AM
-
Abstract Number: 1858
Phenotypical and Functional Characteristics of in Vitro Expanded Adipose-Derived Mesenchymal Stem Cells from Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1855
Phosphodiesterase-5 Inhibitors Attenuate Fibrotic Phenotype and Restore Anti-Fibrotic Resopnses of Cutaneous Fibroblasts in Patients with Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 1758
Physical Activity and Sedentary Behaviour in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1875
Physical Activity in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1539
Physician-Reported and Patient-Reported Anxiety and Depression in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1264
Pilot Evaluation Points to Male Specific Educational Programming for Males with SLE
- 9:00AM-11:00AM
-
Abstract Number: 1671
Pirfenidone Might Inhibit New Bone Formation in Spondyloarthritis: Proof of Concept Study Using Cell Culture Models
- 9:00AM-11:00AM
-
Abstract Number: 1271
Plasma Concentration of S100A8/A9 Proteins Is an Independent Biomarker for Radiological Progression in in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1655
Plasma microRNA Expression Profiles in Ankylosing Spondylitis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1177
Pneumocystis Jirovecii Pneumonia in Systemic Autoimmune Inflammatory Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1605
Pooled Safety and Efficacy of Sarilumab in Rheumatoid Arthritis Patients 65 Years of Age and Older
- 9:00AM-11:00AM
-
Abstract Number: 1767
Poor Body Image in Lupus: Is It Disease Activity, Damage, Sleep, Pain, Fatigue, Stress, Function, Medications, Depression or Fibromyalgia?
- 9:00AM-11:00AM
-
Abstract Number: 1297
Positive Sacroiliac Joint MRI in Asymptomatic Patients with Recurrent Acute Anterior Uveitis: A Proof of Concept
- 9:00AM-11:00AM
-
Abstract Number: 1280
Positron Emission Tomography Images with an Amyloid-Specific Tracer 11C-BF-227 in Systemic Amyloidosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1911
Potent and Selective Tyk2 Inhibitor Highly Efficacious in Rodent Models of Inflammatory Bowel Disease and Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 1398
Practice-Based Differences Between Pediatric Rheumatologists and Dermatologists Caring for Children with Discoid Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1932
Precapillary Pulmonary Hypertension in Granulomatosis with Polyangiitis: A Case Series with Long-Term Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 1871
Predicting Vascular Complications in Systemic Sclerosis: A Prospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1720
Predictive Value of Different Tools for Detection of Psoriatic Arthritis in Patients with Psoriasis in Daily Routine Care Using Questionnaires for Diagnosis of Psoriatic Arthritis and Fluorescence-Optical Imaging Technique
- 9:00AM-11:00AM
-
Abstract Number: 1818
Predictors for Mortality in Hospitalized Patients with Systemic Lupus Erythematosus from 1999 to 2009: A Follow-up Multicenter Study in China
- 9:00AM-11:00AM
-
Abstract Number: 1722
Predictors of Achieving Remission Among Patients with Psoriatic Arthritis Prescribed TNF Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 1889
Predictors of Acro-Osteolysis in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1374
Predictors of Changes in Disease Activity Among Children with Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1352
Predictors of Mortality in Rheumatic Disease Patients with CMV Infection
- 9:00AM-11:00AM
-
Abstract Number: 1679
Predictors of Persistency with TNFi in Biologic-Experienced Versus Biologic-Naive Psa Patients Enrolled in the Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 1266
Predictors of Radiographic Progression in Early Rheumatoid Arthritis Patients Treated By an Aggressive Treat-to-Target Regimen
- 9:00AM-11:00AM
-
Abstract Number: 1882
Predictors of Response to Methotrexate in Patients with Eosinophilic Fasciitis (Shulman’s Disease)
- 9:00AM-11:00AM
-
Abstract Number: 1533
Pregnancy Outcomes in Women with Rheumatoid Arthritis : A Systematic Review and Meta-Analyses
- 9:00AM-11:00AM
-
Abstract Number: 1400
Preliminary Validation of the Turkish Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY) in a Single Center
- 9:00AM-11:00AM
-
Abstract Number: 1228
Prescribing for Children with Rheumatologic Disease: Differences Between Pediatric and Adult Rheumatologists
- 9:00AM-11:00AM
-
Abstract Number: 1942
Presentation and Clinical Features of ANCA-Associated Vasculitis in US African Americans: Experience from a Single Center
- 9:00AM-11:00AM
-
Abstract Number: 1949
Presentation, Prognosis and Clinical-Pathological Correlations of Cutaneous Manifestations in ANCA-Associated Vasculitides
- 9:00AM-11:00AM
-
Abstract Number: 1785
Prevalence and Associated Factors of Low Bone Mass in Adults with Systemic Lupus Erythmatosus
- 9:00AM-11:00AM
-
Abstract Number: 1508
Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients: A Cross-Sectional Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1537
Prevalence and Impact of Inflammatory Multimorbid Conditions on Trajectories of Disease Activity in the First Year of Follow-up in a Multi-Center Era Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1813
Prevalence and Incidence of Systemic Lupus Erythematosus in Tucuman -Argentina
- 9:00AM-11:00AM
-
Abstract Number: 1876
Prevalence of Anti-RNA Polymerase III IgG Antibody in a Cohort of Patients with Delayed Wound Healing
- 9:00AM-11:00AM
-
Abstract Number: 1893
Prevalence of Antiphospholipid Antibodies in Systemic Sclerosis: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1802
Prevalence of CMV in the Ohio State University Lupus Population
- 9:00AM-11:00AM
-
Abstract Number: 1800
Prevalence of ECG Cardiovascular Abnormalities in Lupus Patients: A Novel Approach Using 5 ECG Elements
- 9:00AM-11:00AM
-
Abstract Number: 1743
Prevalence of Inflammatory Neck Pain in a Cohort of Patients with Psoriatic Arthritis and Its Association with Clinical and Radiographic Features
- 9:00AM-11:00AM
-
Abstract Number: 1176
Prevalence of Influenza and Pneumococcal Polysaccharide Vaccine Administration and the Factors Affecting Vaccine Uptake in a Population of Patients with Autoimmune Inflammatory Rheumatic Diseases in a Brooklyn Clinic
- 9:00AM-11:00AM
-
Abstract Number: 1807
Prevalence of Progressive Multifocal Leukoencephalopathy in Adults and Children with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1585
Previous Use of Conventional Disease-Modifying Antirheumatic Drugs and Response to Baricitinib
- 9:00AM-11:00AM
-
Abstract Number: 1318
Profile of Macrophage-Derived Cytokines and Chemokines of Patients with Chikungunya-Induced Chronic Arthralgia/Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1717
Progression of Radiographic Axial Damage in Patients with Psoriatic Arthritis. Relation with Clinical and Analytical Factors
- 9:00AM-11:00AM
-
Abstract Number: 1497
Progressive Decline of Lung Function in Rheumatoid Arthritis Associated Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1184
Projected 2015 Prevalence of Physician-Diagnosed Primary SjöGren’s Syndrome Based on 1976-2005 Annual Incidence Rates in a Well-Defined U.S. Population
- 9:00AM-11:00AM
-
Abstract Number: 1154
Promoting Self-Management Techniques for Osteoarthritis Pain: a Pilot Study of Nurse Practitioner Led Coping Skills Training
- 9:00AM-11:00AM
-
Abstract Number: 1108
Protein Citrullinations By PAD Enzymes Promote Dendritic Cell Transdifferentiation into Osteoclast and Generate Targets for RA-Specific Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 1664
Protein Fingerprinting Screening Specific Proteins in Serum of Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1804
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: a Single Centre Experience
- 9:00AM-11:00AM
-
Abstract Number: 1780
Pulmonary Disease in Late Versus Early Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1405
Quality Measures in High Priority Rheumatologic Diseases: A Systematic Literature Review and Analysis
- 9:00AM-11:00AM
-
Abstract Number: 1706
Quality of Life at Baseline in Early Psoriatic Arthritis Related to Disease Domains
- 9:00AM-11:00AM
-
Abstract Number: 1059
Quality of Life in Patients with Antiphospholipid Syndrome Is Related to Disease Burden and Anticoagulant Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1296
Quantitative Measurements of Cartilage, Osteophyte, and Bone Marrow Lesion Volume in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1520
RA Flare after Total Hip and Total Knee Arthroplasty: Preliminary Outcomes at 1 Year
- 9:00AM-11:00AM
-
Abstract Number: 1709
Randomized, Double-Blind Study Comparing Chs-0214 with Etanercept (Enbrel) in Patients with Psoriasis and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1699
RAPID3 Near Remission Shows Good Agreement with Minimal Disease Activity Criteria in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1242
Rate of Hospitalization for Heart Failure Is Lower in Patients with Controlled Gout Versus Uncontrolled Gout
- 9:00AM-11:00AM
-
Abstract Number: 1868
Rates and Predictors of Physical Therapy and Occupational Therapy Utilization in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1637
Real-World Use of Tofacitinib in Rheumatoid Arthritis: Data from the Swiss Clinical Quality Management RA Registry
- 9:00AM-11:00AM
-
Abstract Number: 1068
Recurrence of Thrombosis Despite Negativization of Antiphospholipid Antibodies in Primary Antiphospholipid Syndrome. a Follow-up to 5 Years
- 9:00AM-11:00AM
-
Abstract Number: 1146
Reducing Imaging Tests for Low Back Pain: Can Patients Choose Wisely?
- 9:00AM-11:00AM
-
Abstract Number: 1395
Regional Brain Gray Matter Volume Loss in Children and Adolescents with SLE
- 9:00AM-11:00AM
-
Abstract Number: 1131
Regulation of Rheumatoid Arthritis Synovial Fibroblast Cytokine Production By Inhibitor of DNA Binding-1 Via Crispr/Cas9 Transfection
- 9:00AM-11:00AM
-
Abstract Number: 1450
Regulatory Mechanisms of Mesenchymal Stem Cell Transplantation on Systemic Osteoporosis in Collagen-Induced Arthritis Mice
- 9:00AM-11:00AM
-
Abstract Number: 1658
Regulatory Role of the IL-9/IL-9R System on Pannus Formation in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1927
Relapses in Patients with ANCA-Associated Vasculitis: A Retrospective Study on Severity and Organ Involvement Compared to Initial Onset
- 9:00AM-11:00AM
-
Abstract Number: 1572
Relationship Between KDR (VEGFR2) Gene Polymorphisms and Serum KDR Protein Levels in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1333
Relevance of Granulomatous Presentation for the Diagnosis and Outcome of Uveitis: Retrospective Case-Control Study of 251 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1261
Reliability and Validity of the Patient Health Questionnaire-9 for Assessment of Depression in Socioeconomically Disadvantaged Latinos with Rheumatoid Arthritis Living in the United States
- 9:00AM-11:00AM
-
Abstract Number: 1888
Reliability, Validity, and Sensitivity to Change of the Simplified Duruoz Hand Index in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1779
Remission and Low Lupus Disease Activity Status (LLDAS) Protect Lupus Patients from Damage Occurrence: Data from a Multi-Ethnic, Multinational Latin American Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1358
Response of Hidradenitis Suppurativa to Biologic Therapy
- 9:00AM-11:00AM
-
Abstract Number: 1421
Responsiveness of Lupus Impact Tracker Among Chinese Patients with Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1191
Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk
- 9:00AM-11:00AM
-
Abstract Number: 1941
Retrospective Survey of Concomitant Autoimmune Diseases and Autoantibodies in a Cohort of Patients with ANCA-Associated Vasculitis (AAV)
- 9:00AM-11:00AM
-
Abstract Number: 1138
Rheumapalooza Update: Applying a Flipped Classroom Instructional Model to an Intensive Rheumatology Curriculum for Second Year Medical Students
- 9:00AM-11:00AM
-
Abstract Number: 1341
Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 1339
Rheumatic Immune Related Adverse Events of Checkpoint Therapy for Cancer: Case Series of a New Nosologic Entity
- 9:00AM-11:00AM
-
Abstract Number: 1549
Rheumatoid Arthritis and Periodontal Disease: Salivary ACPA Levels and Clinical Presentation
- 9:00AM-11:00AM
-
Abstract Number: 1917
Rheumatoid Arthritis Cells Produce Extracellular Vesicles That Incorporate PD-1 and microRNAs Targeting the PD-1 Pathway in Surrounding Cells
- 9:00AM-11:00AM
-
Abstract Number: 1551
Rheumatoid Arthritis Is Associated with Low-/Mid-Frequency Hearing Impairment: Data from the Korean National Health and Nutrition Examination Survey
- 9:00AM-11:00AM
-
Abstract Number: 1236
Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs
- 9:00AM-11:00AM
-
Abstract Number: 1313
Rheumatologic Diseases in HIV-Infected Patients in the Post-Antiretroviral Therapy Era: The County Experience
- 9:00AM-11:00AM
-
Abstract Number: 1418
Rheumatologist: If You Fell Ill with Seropositive Active Rheumatoid Arthritis Yourself, What to Do!
- 9:00AM-11:00AM
-
Abstract Number: 1149
Rheumatology Elective Time in a 4+1 Residency Structure: Evaluating Impact of a Novel Residency Schedule Structure on Rheumatology Resident Education
- 9:00AM-11:00AM
-
Abstract Number: 1886
Right Ventricular Load-Adaptability and Response to Therapy in Scleroderma Versus Idiopathic Pulmonary Arterial Hypertension
- 9:00AM-11:00AM
-
Abstract Number: 1773
Risk Factors for Cerebrovascular Events in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1181
Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis
- 9:00AM-11:00AM
-
Abstract Number: 1798
Risk Factors for Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 1353
Risk Factors of Pulmonary Mycobacterium Avium-Comlex (MAC) Disease and the Significance of Anti-MAC Antibody in Patients with Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1496
Risk for Serious Infection in Rheumatoid Arthritis Associated Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1714
Risk of 10-Year Cardiovascular Disease Assessed By Framingham Risk Score Is Similar in Patients with Psoriatic Arthritis and Psoriasis As Assessed By Atherosclerotic Cardiovascular Disease and Framingham Risk Scores
- 9:00AM-11:00AM
-
Abstract Number: 1195
Risk of Hospitalized Infection Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1660
Role of Immune System Cells and Induction of Netosis-Mediated Cell Death in the Development of Atherosclerosis in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1613
Safe and Effective Tocilizumab Therapy in Elderly Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1590
Safety and Efficacy of Baricitinib in Elderly Patients with Moderate to Severe Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1622
Safety and Efficacy of Iguratimod in Patients with Active Rheumatoid Arthritis: A Multicenter, Single-Arm, Open-Label, Real World Study
- 9:00AM-11:00AM
-
Abstract Number: 1624
Safety of Surgery in Patients Treated with Tocilizumab for Rheumatoid Arthritis : Data from a French Registry
- 9:00AM-11:00AM
-
Abstract Number: 1610
Safety, Tolerability, and Dose-Dependent Inhibition of T-Cell-Dependent Antibody Response with MEDI4920, a Novel, Engineered CD40L Antagonist: Results of a Single-Ascending Dose Study in Healthy Volunteers
- 9:00AM-11:00AM
-
Abstract Number: 1631
Sarilumab Dose Reduction in an Open-Label Extension Study in RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 1173
Screening for Depression and Anxiety in an Outpatient Rheumatology Clinic Using Validated Self-Applied Questionnaires
- 9:00AM-11:00AM
-
Abstract Number: 1901
Screening for Pulmonary Arterial Hypertension in an Unselected Prospective Systemic Sclerosis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1493
Screening Patterns for Hyperlipidemia Among Patients with Rheumatoid Arthritis Based on Patterns of Care from By Primary Care Physicians, Rheumatologists or Both
- 9:00AM-11:00AM
-
Abstract Number: 1797
Seasonal Differences in the Disease Onset and the Exacerbation of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1738
Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison
- 9:00AM-11:00AM
-
Abstract Number: 1729
Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Infliximab Using a Matching-Adjusted Indirect Comparison
- 9:00AM-11:00AM
-
Abstract Number: 1719
Secular Trends in Treatment Patterns for Psoriasis and Psoriatic Arthritis: A Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 1668
Selective Inhibition of Tumor Necrosis Factor-α Receptor 2 (TNFR2) Activity Alleviates Psoriasiform Inflammation in Mouse Models
- 9:00AM-11:00AM
-
Abstract Number: 1433
Self-Perception Reporting to Healthcare Professionals: Do Individuals with Systemic Sclerosis Report Quality of Life Changes Accurately?
- 9:00AM-11:00AM
-
Abstract Number: 1276
Sensitive SPECT/CT Imaging of Fibroblast Activation Protein Expression after Anti-IL-22 Treatment in Experimental Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1526
Serum y-Neuropeptide Levels and Its Relationship with Body Fat Mass and Clinical Characteristics in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1363
Serum Adipokines in Juvenile Dermatomyositis Are Associated with Disease Activities and Cardiac Function
- 9:00AM-11:00AM
-
Abstract Number: 1677
Serum Complement C3 Component As a Potential Disease Activity Marker in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1529
Serum Levels of P-Glycoprotein Are Associated with Disease Activity in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1544
Serum Omentin-1 Levels and Metabolic Syndrome in Women with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1225
Serum Uric Acid Testing Practices over Five Years Among Incident Gout Cases
- 9:00AM-11:00AM
-
Abstract Number: 1332
Severe Complications and Immunosuppressive Treatments in 33 Patients with Relapsing Polychondritis
- 9:00AM-11:00AM
-
Abstract Number: 1559
Shared Genetic Predisposition in Rheumatoid Arthritis–Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: A Genetic Association Study
- 9:00AM-11:00AM
-
Abstract Number: 1753
Signal Transducer and Activator of Transcription (STAT) 3 Regulates Tcrαβ+CD4-CD8- T Cells in Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 1302
Silent Progression in Patients with Rheumatoid Arthritis: Is DAS28 Remission an Insufficient Goal in RA? Results from the German Remission-PLUS Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1843
Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established SLE-Risk Loci in Lupus Patient Monocytes
- 9:00AM-11:00AM
-
Abstract Number: 1615
Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, Significantly Improves Physical Function and Reduces Morning Stiffness in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Global, Randomized, Placebo-Controlled, Phase 3 Trial
- 9:00AM-11:00AM
-
Abstract Number: 1216
Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness
- 9:00AM-11:00AM
-
Abstract Number: 1816
SLE and Uctd in the Rheumatology Informatics System for Effectiveness (RISE) Registry
- 9:00AM-11:00AM
-
Abstract Number: 1836
SLE Bone Marrow Contains Factors That Promote Type I Interferon Activation
- 9:00AM-11:00AM
-
Abstract Number: 1536
Sleep Disturbance in Patients with Rheumatoid Arthritis – a Cross-Section Study
- 9:00AM-11:00AM
-
Abstract Number: 1759
Sleep Disturbance Is Associated with Worsening Patient-Reported Outcomes over Two Years in Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 1532
Sleep Hygiene Practices and Associations with Patient-Reported Outcomes in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1579
Small Rnaseq Reveals Different Plasma miRNA Signature in Patients with RA and SLE: A Pilot Study
- 9:00AM-11:00AM
-
Abstract Number: 1775
Smoking As a Predictor of Cutaneous Activity in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1799
Smoking, Antiphospholipid Antibodies and Thrombosis in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1262
Sociodemographic and Clinical Correlates of Physical Therapy Utilization in Adults with Symptomatic Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1252
Socioeconomic Status and Not Race Associated with Delay in Diagnosis and Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1657
Soluble Biomarkers May Differentiate Psoriatic Arthritis from Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1878
Speckle Tracking Echocardiography: A Sensitive Technique for Detecting Early Left Ventricular Dysfunction in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1599
Speed of Onset of Effect on Patient-Reported Outcomes Assessed through Daily Electronic Patient Diaries in the Baricitinib Phase 3 RA Clinical Program
- 9:00AM-11:00AM
-
Abstract Number: 1209
Sporadic Hemophagocytic Lymphohistiocytosis (sHLH): A Polygenic Disease? a Report of French National, Prospective, Cohort of 205 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1229
Stakeholder Needs Assessment for a New Model of Care for Pediatric Rheumatology in Ontario
- 9:00AM-11:00AM
-
Abstract Number: 1826
STAT3 Phosphorylation Mediates the Stimulatory Effects of Interferon Alpha on B Cell Differentiation and Activation in SLE
- 9:00AM-11:00AM
-
Abstract Number: 1347
Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis: Characteristics, Treatment and Outcome in 251 Cases from the Literature
- 9:00AM-11:00AM
-
Abstract Number: 1835
Study on the Expression of NOD2 in Lupus Nephritis and Its Potential Signaling Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1721
Subclinical Atherosclerosis Evolution during 5 Years of Anti-Tnfalpha Treatment in Psoriatic Arthritis Patients: Preliminary Data
- 9:00AM-11:00AM
-
Abstract Number: 1782
Subclinical Myocarditis in Systemic Lupus Erythematosus Patients without Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 1481
Success Rate of Blood Pressure Goal Achievement in Patients with Inflammatory Joint Diseases
- 9:00AM-11:00AM
-
Abstract Number: 1524
Suppletion Therapy May be Warranted in RA Patients with Co-Existent Subclinical Hypothyroidism
- 9:00AM-11:00AM
-
Abstract Number: 1442
Suppression of Acute Arthritis By N-Methyl-3,4-Dichloropropionaniline (N-MeDCPA), a Reversible Orai Calcium Channel Inhibitor
- 9:00AM-11:00AM
-
Abstract Number: 1460
Suppression of Cholesterol Levels and Impairment in Cholesterol Efflux By HDL in K/BxN Mice Is Associated with a Specific Cytokine/Chemokine Profile
- 9:00AM-11:00AM
-
Abstract Number: 1166
Survey on the Understanding and Practice of T2T for Nurses Engaged in Medical Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1641
Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1733
Sustained Efficacy of Ixekizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1416
Sustained Improvement in Documentation of Disease Activity Measurement As a Quality Improvement Project at an Academic Rheumatology Clinic
- 9:00AM-11:00AM
-
Abstract Number: 1514
Symptoms of Depression and Anxiety Predict Worse Disease Activity and Functional Disability in a Cohort of Established Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1091
Synergistic Immunoregulatory Effects of IL-10 and TGF-β on Humoral Immunity
- 9:00AM-11:00AM
-
Abstract Number: 1099
Synovial Exosomes Induce Osteoclast Differentiation in Rheumatoid arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1403
Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines
- 9:00AM-11:00AM
-
Abstract Number: 1161
Systematic Development of a Patient-Centered Strategy to Improve Tight Control in Daily Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 1404
Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1762
Systemic Lupus Erythematosus and the Evaluation of Poor Sleep
- 9:00AM-11:00AM
-
Abstract Number: 1760
Systemic Lupus Erythematosus in Immigrants: Results from the 1000 Canadian Faces of Lupus Study
- 9:00AM-11:00AM
-
Abstract Number: 1811
Systemic Lupus Erythematosus: Detailed Anatomy of a Cohort (follow-up for more than 35 years).
- 9:00AM-11:00AM
-
Abstract Number: 1323
Systemic Manifestations Associated with Parvovirus B19 Infection in Adults: A Retrospective Study in 23 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1907
T-Bet Regulates Ahr-Mediated Th-17 Differentiation Independently of IFNγ
- 9:00AM-11:00AM
-
Abstract Number: 1097
Tankyrase Regulates Osteoclastogenesis Via SH3BP2
- 9:00AM-11:00AM
-
Abstract Number: 1125
Targeted Lipidomics Reveals Incomplete Activation of Resolution Pathways in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1123
Targeted Mutations Identify the Active Site of Glucocorticoid-Induced Leucine Zipper (GILZ)
- 9:00AM-11:00AM
-
Abstract Number: 1213
Targeted Next-Generation Sequencing of 128 Genes Associated with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1109
Targeting IL-8 and CXCR1/2 Abrogates RANKL- and ACPA-Mediated Osteoclastogenesis
- 9:00AM-11:00AM
-
Abstract Number: 1881
Targeting Oncostatin M in the Target Tissue: Assessment of in-Vivo Affinity and Target Engagement of an Anti-OSM Monoclonal Antibody By Combining Blood and Skin Blister Fluid Data
- 9:00AM-11:00AM
-
Abstract Number: 1436
TAS8274, a Highly Selective Janus Kinase 3 Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1530
Temporal Trend of Total Joint Replacement in Rheumatoid Arthritis Patients: A Survival Study
- 9:00AM-11:00AM
-
Abstract Number: 1100
Tenofovir, a Nucleoside Analog Reverse Transcriptase Inhibitor for Treatment of HIV, Promotes Osteoclast Differentiation and Decreases Osteoblast Formation By a Mechanism Depending on ATP Release and Adenosine
- 9:00AM-11:00AM
-
Abstract Number: 1106
Test of the Spleen Tyrosine Kinase Inhibitor Fostamatinib in a Translational Joint Tissue Model Show Significant Effect on Bone, but Not on Synovial Tissue
- 9:00AM-11:00AM
-
Abstract Number: 1845
TGF-β-Induced Tissue Fibrosis Is Abrogated in Mice Containing a Constitutive Genetic Deletion of Nox4 (Nox4 knockout)
- 9:00AM-11:00AM
-
Abstract Number: 1777
The Accumulation of Organ Damage, Public Insurance Enrollment and Youth Are Associated with Increased Hospitalizations in a Population-Based Cohort of Lupus Patient
- 9:00AM-11:00AM
-
Abstract Number: 1085
The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 1662
The Association Between Radiologic Progression and Serum Levels of Potential Markers of Bone Formation in Ankylosing Spondylitis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1552
The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from French Cohort Study of Comorbidities
- 9:00AM-11:00AM
-
Abstract Number: 1581
The Combination of IL-6 and IL-6 Receptor Levels As a Biomarker of Response to Tocilizumab in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1691
The Comparative Immunogenicity of Biologic Therapy and Its Clinical Relevance in Psoriatic Arthritis: A Systematic Review of the Literature
- 9:00AM-11:00AM
-
Abstract Number: 1564
The Comprehensive Analysis for the Transcriptional Organization of Stimuli Responses in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1879
The Correlation Between Oxidized Low-Density Lipoprotein and Clinical Manifestations in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1223
The Cost of Confronting Osteoporosis:Cost Study of a Fracture Liaison Service
- 9:00AM-11:00AM
-
Abstract Number: 1081
The CRL4CRBN E3 Ubiquitin Ligase Modulator CC-220 Inhibits BAFF-Mediated Plasmablast Differentiation and Immunoglobulin Secretion from Class Switched CD27+IgD- Memory and Lupus-Associated CD27-IgD- Double Negative B-Cells
- 9:00AM-11:00AM
-
Abstract Number: 1607
The Development of a New Anti–Interleukin 6 Blocker for Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1165
The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine
- 9:00AM-11:00AM
-
Abstract Number: 1237
The Economic Burden of Dermatomyositis and Polymyositis in the US
- 9:00AM-11:00AM
-
Abstract Number: 1724
The Effect of Certolizumab Pegol on Skin Manifestations of Psoriatic Arthritis over 4 Years of Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1872
The Effect of Cyclophosphamide on Pulmonary Function and Dependence on Disease Activity of Interstitial Lung Disease Associated with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1851
The Effect of Narrow Band Ultraviolet A1 Light on Bleomycin-Induced Mouse Model of Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 1155
The Effect of Nurse-Led Follow-up in Rheumatoid Arthritis. a Systematic Review and Meta-Analysis of Randomized Controlled Trails
- 9:00AM-11:00AM
-
Abstract Number: 1523
The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR
- 9:00AM-11:00AM
-
Abstract Number: 1449
The Efficiency of the Regulation of Ca2+ Entry through Calcium Release-Activated Calcium Channel in the Treatment of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1119
The Enhanced Expression of mRNA for Calgranulins, S100A8, S100A9 and S100A12, in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1439
The EP4 Receptor Antagonist CR6086 Is More Effective Than Classical NSAID and DMARD Treatment in a Murine Model of Arthritis and in Human RA Synovial Explants
- 9:00AM-11:00AM
-
Abstract Number: 1168
The Epidemiology of Individuals Not Fully Meeting Classification Criteria for Systemic Lupus Erythematosus (SLE): The Georgia Lupus Registry
- 9:00AM-11:00AM
-
Abstract Number: 1432
The EULAR Systemic Sclerosis Impact of Disease Score – a New Patient-Reported Outcome Measure for Patients with Systemic Sclerosis Under Development
- 9:00AM-11:00AM
-
Abstract Number: 1140
The Future of Rheumatology: Pediatric and Adult Fellows-in-Training Results from the 2015 ACR/ARHP Workforce Study
- 9:00AM-11:00AM
-
Abstract Number: 1794
The High Disease Activity State Is an Adverse Prognostic Indicator in SLE and Defines a Clinically Distinct Population
- 9:00AM-11:00AM
-
Abstract Number: 1179
The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1770
The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the First 10 Years
- 9:00AM-11:00AM
-
Abstract Number: 1427
The Importance of Outcome Measures in Ankylosing Spondylitis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Cohort
- 9:00AM-11:00AM
-
Abstract Number: 1501
The Incidence of Interstial Lung Disease and Malignancies in Veterans with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1309
The Incidence of Sexually Acquired Reactive Arthritis: A Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 1899
The Intestinal Involvement in Systemic Sclerosis Is Characterized By a Peculiar Gut Microbiota
- 9:00AM-11:00AM
-
Abstract Number: 1898
The Lack of Association of Osteoporosis with Proton Pump Inhibitor in Scleroderma: A UK Single Centre Cohort Experience
- 9:00AM-11:00AM
-
Abstract Number: 1132
The Musculoskeletal Master Educator Training Program: A New Resource and Professional Development Opportunity for Leaders in Medical Education
- 9:00AM-11:00AM
-
Abstract Number: 1825
the Non-Coding Genome and the Genetics of Systemic Lupus
- 9:00AM-11:00AM
-
Abstract Number: 1069
The Predictive Value of Acl and Anti-β2GPI in Patients with Acute Deep Vein Thrombosis
- 9:00AM-11:00AM
-
Abstract Number: 1701
The Presence of Depression Might be an Important Determinant of Achieving Minimal Disease Activity State in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1295
The Prevalence of Inflammatory and Structural Lesions on MRI of the Sacroiliac Joints in Patients with Very Early Peripheral Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1712
The Relationship Between Physical Functioning and Work for People with Psoriatic Arthritis: Results from a Large Real-World Study in 16 Countries
- 9:00AM-11:00AM
-
Abstract Number: 1274
The Reproducibility of a Semi-Automatic Algorithm in the Detection of Cortical Breaks and Adjacent Trabecular Bone Loss in Scan-Rescan Data from Patients with Early Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1324
The Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital
- 9:00AM-11:00AM
-
Abstract Number: 1705
The Risk of Fracture Among Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1074
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 1784
The Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Lupus Erythematosus: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1749
The Role of Mucosal-Associated Invariant T (MAIT) Cells in Lupus Dermatitis
- 9:00AM-11:00AM
-
Abstract Number: 1377
The Role of Muscle MRI in Detecting a Flare-up of Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1574
The Role of Shelterin Deficiency in the Senescence in T Cells of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1830
The Role of Tripartite Motif-Containing 21 in Interferon Signature of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1361
The Role of Von Willebrand Factor Antigen As a Disease Biomarker in the Clinical Assessment of Children with Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1909
The Transcription Factor Fra2 Is Playing a Key Role in Treg Development and Autoimmunity
- 9:00AM-11:00AM
-
Abstract Number: 1186
The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1290
The Usefulness of Volumetric Parameters of FDG PET/CT for Reflecting Disease Activity in Polymyositis/Dermatomyositis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1139
The Virtual Rheumatology Clinic: Virtual Patients for Resident Education in Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 1447
Therapeutic Blockade of Interleukin-6 Trans-Signalling Restores Vascular Function in Murine Collagen Induced Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1448
Therapeutic Role of a Novel Histone Deacetylase 6 Inhibitor, CKD-M808, in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1905
Therapeutic Targeting of JAK/STAT Pathway Inhibits Follicular Helper T Cell Maturation and Function
- 9:00AM-11:00AM
-
Abstract Number: 1175
Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center
- 9:00AM-11:00AM
-
Abstract Number: 1922
TNF-α and IL-6 Induced Upregulation of CCR5 and CXCR3 Participate in Vδ2 Chemotaxis in RA
- 9:00AM-11:00AM
-
Abstract Number: 1682
Tnfα Inhibitors Are Associated with Reduced Progression of Carotid Atherosclerotic Plaques By Ultrasound and an Improvement in Aortic Arch Vascular Inflammation By 18-FDG PET/CT in Psoriasis and Psoriatic Arthritis Patients – a Prospective Study from Two Cohorts
- 9:00AM-11:00AM
-
Abstract Number: 1336
Tocilizumab for Uveitic Cystoid Macular Edema Refractory to Other Synthetic and Biological Immunosuppressive Drugs. Multicenter Study of 25 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1438
Tofacitinib Restores Reverse Cholesterol Transport Inhibition Induced By Inflammation. Understanding the Lipid Paradox
- 9:00AM-11:00AM
-
Abstract Number: 1647
Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 8 Years
- 9:00AM-11:00AM
-
Abstract Number: 1643
Tofacitinib: Treatment Outcomes in Seropositive Versus Seronegative Patients in a Phase 3 RA Population
- 9:00AM-11:00AM
-
Abstract Number: 1661
Toll-like Receptor 4 Induced IL-20 and IL-24 Stimulate Osteoblast Mineralization and Are Increased in Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1406
Towards Harmonized Data Collection in Rheumatoid Arthritis (RA): The EULAR Task Force for Standardizing a Minimum Data Collection for RA Observational Research
- 9:00AM-11:00AM
-
Abstract Number: 1200
Transcriptional Profiling of Early RA Synovial Tissue Reveals the Impact of Triple DMARD Treatment on T Cell Activation Pathways
- 9:00AM-11:00AM
-
Abstract Number: 1575
Transient Circulatory Existence of Multipotential Stromal Cells Is Unlikely to Contribute to the Pathogenesis of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1399
Transitioning Lupus Patients from Pediatric to Adult Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 1700
Treating Psoriatic Arthritis (PsA) to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects Disease Activity in Psa
- 9:00AM-11:00AM
-
Abstract Number: 1928
Treatment of ANCA Associated Vasculitis in the Very Elderly
- 9:00AM-11:00AM
-
Abstract Number: 1453
Treatment of BAFF Transgenic Mice with Anti-TNF: Monoclonals Are Associated with a Higher Risk of Lymphoma Than Etanercept
- 9:00AM-11:00AM
-
Abstract Number: 1588
Treatment with BI 655064 (Antagonistic Anti-CD40 Antibody) Modulates Clinical and Biomarker Parameters Associated with Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 1617
Treatment with Sirukumab, an Anti-IL6 Cytokine Monoclonal Antibody, Improves Fatigue and Health-Related Physical and Emotional Well Being in Patients with Active Rheumatoid Arthritis Refractory to Conventional or Biologic Therapy: Results of 2 Global, Placebo-Controlled, Phase 3 Trials
- 9:00AM-11:00AM
-
Abstract Number: 1650
Treatment with Tofacitinib Inhibits Human Naive B Lymphocyte Development and Function in Vitro
- 9:00AM-11:00AM
-
Abstract Number: 1505
Trends in Hospitalizations for Infections in US Patients with Rheumatoid Arthritis, 1993-2013
- 9:00AM-11:00AM
-
Abstract Number: 1365
Trends in Medication Usage in Patients with Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1510
Trends in the Occurrence of Malignancy in Japanese Patients with Rheumatoid Arthritis Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort during a 14-Year Observation Period
- 9:00AM-11:00AM
-
Abstract Number: 1675
Triptolide Inhibits Th17 Differentation By JAK2/STAT3 Signal Pathway in Inflammation of Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1129
Tumor Necrosis Factor Receptor 2 Is Crucial for Regulatory T Cells Activity with Consequences in a Model of Chronic Inflammation and in Anti-TNF Treated Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1669
Type 3 Innate Lymphoid Cells Numbers in Peripheral Blood Predict Ustekinumab (Stelara) Therapy Responsiveness in Psoriatic Disease Cases with Subclinical Imaging Enthesopathy
- 9:00AM-11:00AM
-
Abstract Number: 1340
Type and Frequency of Immune-Related Adverse Reactions in Patients Treated with Pembrolizumab (Keytruda), a Monoclonal Antibody Directed Against PD-1, in Advanced Melanoma at a Single Institution
- 9:00AM-11:00AM
-
Abstract Number: 1827
Type I IFN Signature Low and High SLE Subjects with Moderate to Severe Disease Activity Have Distinct Gene Expression Signatures of Immunologic Pathways and Cell Types
- 9:00AM-11:00AM
-
Abstract Number: 1082
Type I/II Interferon Commits to Abnormal Expression of Chemokine Receptor on B Cells in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1265
Ultra-High Field MRI and Biomechanical Investigation of Vertebral Bone Microarchitecture
- 9:00AM-11:00AM
-
Abstract Number: 1401
Ultrasonography of Major Salivary Glands in Juvenile SjöGren’s Syndrome − Preliminary Findings in a Multi-Center Study
- 9:00AM-11:00AM
-
Abstract Number: 1354
Ultrasound Verified Inflammation and Structural Abnormalities in Patients with Hemochromatosis with and without Associated Arthropathy
- 9:00AM-11:00AM
-
Abstract Number: 1187
Ultraviolet Radiation Exposures Are Associated with Dermatomyositis in a National Myositis Registry
- 9:00AM-11:00AM
-
Abstract Number: 1241
Understanding Lupus Patients’ Ability to Work with Numbers
- 9:00AM-11:00AM
-
Abstract Number: 1345
Undifferentiated Connective Tissue Disease: A 121 Patients Audit Focusing on Initial Diagnosis and Changes over Time
- 9:00AM-11:00AM
-
Abstract Number: 1685
Updated Results for All-Cause Mortality and Malignancies in Psoriasis Patients with Psoriatic Arthritis in the Psoriasis Longitudinal Assessment and Registry Study
- 9:00AM-11:00AM
-
Abstract Number: 1684
Updated Results for Serious Infections in Psoriasis Patients with Psoriatic Arthritis in the Psoriasis Longitudinal Assessment and Registry Study
- 9:00AM-11:00AM
-
Abstract Number: 1865
Urinary Cell Adhesion Molecules As Markers of Renal Involvement in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 1322
Use of Biologics in Arthritis Patients with Hepatitis B and C : A Multicentral Retrospective Case Series
- 9:00AM-11:00AM
-
Abstract Number: 1342
Use of Immune Checkpoint Inhibitors in the Treatment of Patients with Cancer and Preexisting Autoimmune Diseases: A Systematic Review of Case Reports
- 9:00AM-11:00AM
-
Abstract Number: 1159
Use of Rheumatology-Specific Patient Navigators for DMARD Adherence: Results from a Pilot Intervention
- 9:00AM-11:00AM
-
Abstract Number: 1338
Use of Subcutaneous Golimumab in Autoimmune Inner Ear Disease
- 9:00AM-11:00AM
-
Abstract Number: 1157
Using Goutpro to Make Medical Trainees Gout Pros
- 9:00AM-11:00AM
-
Abstract Number: 1423
Using Self-Reported Patient Experiences to Evaluate Patient Reported Outcomes (PRO) Instruments: Learnings from Digital Patient Communities in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1426
Using Self-Reported Patient Experiences to Understand Patient Burden: Learnings from Digital Patient Communities in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 1707
Ustekinumab and the Comparative Risk for Acute Myocardial Infarction in Patients with Psoriasis and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1718
Ustekinumab, Apremilast, TNFi and the Risk for Hospitalized Infection in Patients with Psoriasis and Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1293
Utility of Extremity Magnetic Resonance Imaging (eMRI) without Contrast Enhancement in Detecting Preclinical Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1283
Utility of FDG-PET Imaging and Serological Biomarkers for Diagnosing Lymphadenopathy of IgG4-Related Diseas
- 9:00AM-11:00AM
-
Abstract Number: 1464
Utility of Relative Cardiovascular Risk Score Scales and Vascular Age Predictors in Patients with Reumathoid Arthritis UNDER 50 YEARS of Age
- 9:00AM-11:00AM
-
Abstract Number: 1465
Utility of Relative Cardiovascular Risk Score Scales in Patients UNDER the Age of 50 and Its Association with the Presence of Carotid Atherosclerosis in the Ultrasound
- 9:00AM-11:00AM
-
Abstract Number: 1287
Utility of Vascular Findings By PET/CT Scan in the Diagnosis and Activity Assesment of Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 1502
Vaccination Program to Prevent Hospital Admissions Due to Serious Respiratory Infections in Rheumatoid Arthritis Patients. Prosprective Study of 294 Patients
- 9:00AM-11:00AM
-
Abstract Number: 1425
Validation of a Patient Reported Experience Measure (PREM) in Patients with Axial Spondyloarthropathies (AxSpA)
- 9:00AM-11:00AM
-
Abstract Number: 1692
Validation of a Two-Question Patient Reported Outcome Measure for Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 1665
Validation of Germ Line Epigenetic Variants Associated with Psoriatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 1420
Validation of Lupuspro V1.8, Disease Targeted Patient Reported Outcome for Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1412
Validation of the Danish Version of the Stanford Health Assessment Questionnaire Disability Index and Determination of the Minimal Clinically Important Difference in a Cohort of Rheumatoid Arthritis Patients Using the Rasch Measurement Model
- 9:00AM-11:00AM
-
Abstract Number: 1419
Validation of the French Version of Lupus Patient Reported Outcome (LupusPRO), a Disease-Specific Patient Reported Outcome for Lupus Patients
- 9:00AM-11:00AM
-
Abstract Number: 1697
Validity of Diagnostic Codes and Point Prevalence of Psoriatic Arthritis in Israel – a Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 1243
Validity of the Short Form 6D Utility Measure in Early Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1793
Visceral Adiposity Assessed By DXA in Juvenile-Onset Systemic Lupus Erythematosus: A Correlation with Damage Index and Disease Duration
- 9:00AM-11:00AM
-
Abstract Number: 1920
Vitamin D Induces a Type 1 Regulatory T Cell (Tr1)-like Phenotype in Human C-C Chemokine Receptor Type 6 (Ccr6)+ th Cells and Promotes Their Migration to an Inflammatory Environment
- 9:00AM-11:00AM
-
Abstract Number: 1545
Vitamin D Insufficiency in Patients with Rheumatoid Arthritis and Healthy Controls and Correlation Between Vitamin D Levels and Disease Activity and Disability in RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 1897
Vitamin-D Levels and Gastrointestinal (GI) Manifestations in Systemic Sclerosis (SSc)
- 9:00AM-11:00AM
-
Abstract Number: 1482
Web-Based PILOT Intervention Study to Improve Cardiovascular Risk Knowledge Among Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1570
Working in Cold Environment Is Associated with Increased Risk of Developing Rheumatoid Arthritis: Results from a Swedish Population-Based Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 1098
ZCCHC6/TUT7 Negatively Regulates Osterix Activity and Influences Osteoblast-Mediated Regulation of Osteoclastogenesis
- 11:00AM-12:30PM
-
Abstract Number: 1960
2015 ACR/ARHP Workforce Study in the U.S.: The Role of Graduate Medical Education (GME) in Adult Rheumatology
- 11:00AM-12:30PM
-
Abstract Number: 1958
Effect of Poverty Status in 2009, % of Years in Poverty Between 2003 and 2009, and Exiting Poverty Permanently By 2009 on SLE Damage in 2015
- 11:00AM-12:30PM
-
Abstract Number: 1956
High Dose Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Tumor Necrosis Factor Inhibitor Use Results in Less Radiographic Progression in Ankylosing Spondylitis – a Longitudinal Analysis
- 11:00AM-12:30PM
-
Abstract Number: 1959
How Do Bone Marrow Lesions Cause Osteoarthritis Pain? a Structural and Functional Tissue-Based Study
- 11:00AM-12:30PM
-
Abstract Number: 1957
No Increased Risk of Chronic Kidney Disease with Allopurinol Use
- 11:00AM-12:30PM
-
Abstract Number: 1955
Rituximab Versus Azathioprine to Maintain Remission of ANCA-Associated Vasculitides (MAINRITSAN): Follow-up at 60 Months
- 2:30PM-4:00PM
-
Abstract Number: 2018
A Clinical Risk Prediction Model for Skin Thickness Progression in Early Diffuse Scleroderma
- 2:30PM-4:00PM
-
Abstract Number: 2014
A Deep Insight into Causes and Predictors of Death in Systemic Sclerosis
- 2:30PM-4:00PM
-
Abstract Number: 1981
A Pilot Pulsed Arterial Spin Labeling Study of Regional Cerebral Blood Flow in Response to Pain in RA, before and after DMARD Treatment
- 2:30PM-4:00PM
-
Abstract Number: 1968
Adverse Childhood Experiences and Outcomes of Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 1966
Antibodies Against Domain 1 and Domain 4/5 of β2 Glycoprotein I: Clinical Relevance in Obstetric Anti-Phospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 1965
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking Registry Analysis: First and Recurrent Thrombosis Risk after 720 Patient-Years of Follow-up
- 2:30PM-4:00PM
-
Abstract Number: 1962
Antiphospholipid Syndrome Neutrophils Are Characterized By Overexpression of P-Selectin Glycoprotein Ligand 1, a Potential Therapeutic Target
- 2:30PM-4:00PM
-
Abstract Number: 1994
Associations of Chronic Lung Comorbidity with Medications, Disease Activity, and All-Cause Mortality in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2013
BIIB059, a Monoclonal Antibody Targeting BDCA2, Shows Evidence of Biological Activity and Early Clinical Proof of Concept in Subjects with Active Cutaneous SLE
- 2:30PM-4:00PM
-
Abstract Number: 1999
Claims-Based Analysis of Cost-Effectiveness Among Patients with Rheumatoid Arthritis Who Switched from a Tumor Necrosis Factor Inhibitor to Another Targeted Disease-Modifying Antirheumatic Drug
- 2:30PM-4:00PM
-
Abstract Number: 1982
Comparative Safety of Long-Acting Opioids for Non-Cancer Pain
- 2:30PM-4:00PM
-
Abstract Number: 1972
Creatine Kinase in the United States Population: Impact of Demographics, Comorbidities and Body Composition on the Normal Range
- 2:30PM-4:00PM
-
Abstract Number: 1967
Depression Is a Risk Factor for Low Treatment Adherence in African American People with Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2022
Developing a Gout Needs Assessment Incorporating Patient Perspective on Self-Management, Self-Efficacy and Disease Specific Knowledge, to Inform a Patient Education Initiative
- 2:30PM-4:00PM
-
Abstract Number: 2021
Development of an Item Bank on Disease and Treatment Associated Knowledge of Rheumatoid Arthritis to Improve Patient Engagement in Care
- 2:30PM-4:00PM
-
Abstract Number: 2002
Differences in Features of Chronic Back Pain in First Degree Relatives of Patients with Ankylosing Spondylitis (AS) Compared to the U.S. Population
- 2:30PM-4:00PM
-
Abstract Number: 1978
Differential Pattern of Doppler Signals at Lower Extremity Entheses of Healthy Children
- 2:30PM-4:00PM
-
Abstract Number: 1970
Disparities in Access to Specialist Care at the Time of Diagnosis of Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2024
Effect of a Revised Counselor Training on Skills Development and Knowledge of Volunteers with Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2011
Enteric-Coated Mycophenolate Sodium Versus Azathioprine for Patients with Moderate/Severe Active Systemic Lupus Erythematosus: Results from a Phase 3, Randomized, Parallel, Multicentre Study
- 2:30PM-4:00PM
-
Abstract Number: 2016
Esophageal Disease in Systemic Sclerosis: Does Heritability Play a Role?
- 2:30PM-4:00PM
-
Abstract Number: 2005
Exploring the Window of Opportunity for Drug-Free Clinical Remission in Patients with Active, Very Early Peripheral Spondyloarthritis
- 2:30PM-4:00PM
-
Abstract Number: 2019
Faces in Motion: Clinical Subtyping in Scleroderma Using Changes in Forced Vital Capacity
- 2:30PM-4:00PM
-
Abstract Number: 1961
Identification of Novel Genetic Susceptibility Loci in Primary Antiphospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 1985
IL-18 Elevation in Macrophage Activation Syndrome: Human Evidence for a Chronic Set-Point and Murine Evidence for a Non-Hematopoietic Source
- 2:30PM-4:00PM
-
Abstract Number: 1977
Impact of Ultrasound in Treatment Decision of Rheumatoid Arthritis Assessed in Routine Clinical Practice
- 2:30PM-4:00PM
-
Abstract Number: 2000
Incidence of Cancer in Patients with Rheumatoid Arthritis and a History of Cancer Treated with Rituximab or Abatacept
- 2:30PM-4:00PM
-
Abstract Number: 1990
Increased Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis over a 15 Year Time Period That Is Comparable to Type 2 Diabetes
- 2:30PM-4:00PM
-
Abstract Number: 1973
Intramuscular Versus Ultrasound Guided Peritendinous Glucocorticoid Injection for Tenosynovitis in Patients with Rheumatoid Arthritis – a Randomised, Double-Blind, Controlled Study
- 2:30PM-4:00PM
-
Abstract Number: 2004
Is Disease Activity Associated with Work Productivity Loss, Presenteeism and Absenteeism in Patients with Early Axial Spondyloarthritis? Results from the Spondyloarthritis Caught Early (SPACE)-Cohort
- 2:30PM-4:00PM
-
Abstract Number: 1974
Is Ultrasound of the Hands Enough to Reveal Ongoing Subclinical Inflammation in Rheumatoid Arthritis Patients in Clinical Remission According to Composite Scores?
- 2:30PM-4:00PM
-
Abstract Number: 1998
Long-Term Registry Data in 4498 Patients with Rheumatoid Arthritis Indicate a Similar Safety but a Different Drug Retention Between Abatacept, Rituximab and Tocilizumab
- 2:30PM-4:00PM
-
Abstract Number: 2025
Lupus Education Advancement Project (LEAP): Rheumatology Fellows Serving As Educators Increased Knowledge and Efficiency in Lupus Recognition and Referral By Providers in Primary and Emergency Care
- 2:30PM-4:00PM
-
Abstract Number: 2020
Making the Case for Self-Management Education: Marketing Lessons Learned from Qualitative Research
- 2:30PM-4:00PM
-
Abstract Number: 1989
Mechanism of STAT3 Gain-of-Function in a Patient with JIA
- 2:30PM-4:00PM
-
Abstract Number: 1986
Murine Model of Arthritis Flare Identifies Tissue Resident Memory T Cells in Recurrent Synovitis
- 2:30PM-4:00PM
-
Abstract Number: 1997
Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry
- 2:30PM-4:00PM
-
Abstract Number: 1988
Oral Health and Anti-Citrullinated Peptide Antibodies in Juvenile Idiopathic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 1983
Pain and Sensitization in Women with Aromatase Inhibitor-Associated Arthralgias
- 2:30PM-4:00PM
-
Abstract Number: 2023
Patient Barriers to Osteoporosis Screening in a Medical Clinic: Why Underserved Patients Who Follow Recommendations for Colonoscopy and Mammography Fail to Get Their DXA Scans
- 2:30PM-4:00PM
-
Abstract Number: 1969
Peer Approaches to Lupus Self-Management (PALS): A Novel Lupus Peer Mentorship Intervention
- 2:30PM-4:00PM
-
Abstract Number: 2017
Performance of Modified Rodnan Skin Score in Early Diffuse Cutaneous Scleroderma-Analysis from 4 International Cohorts
- 2:30PM-4:00PM
-
Abstract Number: 2001
Perioperative Use of Synthetic Disease-Modifying Anti-Rheumatic Drugs or Tumor Necrosis Factor α Inhibitors Does Not Associate with Increased Rates of Post-Operative Infections
- 2:30PM-4:00PM
-
Abstract Number: 1979
Post-Arthroplasty Pain Trajectories after Total Knee Arthroplasty and Their Association with 6- and 12-Month Pain
- 2:30PM-4:00PM
-
Abstract Number: 2010
Predictive Factors of Adherence to Treatment in an International Prospective Study of Blood Hydroxychloroquine Levels in SLE Patients with Flares
- 2:30PM-4:00PM
-
Abstract Number: 1971
Predictors of Delays to Care and Associated Outcomes in Pediatric Lupus Patients from the Childhood Arthritis and Rheumatology Research Alliance Registry
- 2:30PM-4:00PM
-
Abstract Number: 2008
Rapamycin Elicits Rapid and Lasting Improvement of Disease Activity through Blocking Pro-Inflammatory T Cell Lineage Specification in Patients with Active SLE
- 2:30PM-4:00PM
-
Abstract Number: 1987
Recessive Coding and Regulatory Mutations in FBLIM1 Underlie the Pathogenesis of Sterile Osteomyelitis
- 2:30PM-4:00PM
-
Abstract Number: 1980
Relation of Pain Sensitization to the Evolution from Intermittent to Chronic, Persistent Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
- 2:30PM-4:00PM
-
Abstract Number: 1992
Rheumatoid Arthritis Is an Independent Risk Factor for Increased Insulin Resistance and Impaired Beta-Cell Function: Impact of Disease Activity
- 2:30PM-4:00PM
-
Abstract Number: 1991
Risk of Incident Diabetes Mellitus and Its Association with Disease-Modifying Antirheumatic Drugs and Statins in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2007
Sensitivity and Specificity of Autoantibodies Against CD74 in Early Axial Spondyloarthritis
- 2:30PM-4:00PM
-
Abstract Number: 1975
Severity and Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 1995
Smoking Is Associated with Unfavorable Flare/ Remission Pattern in Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2009
The Effect of Anifrolumab on Cutaneous Manifestations and Arthritis in Moderate to Severe Systemic Lupus Erythematosus (SLE) Using Categorical SLEDAI–2K Responses and Continuous Measures of Activity As Outcome Measures
- 2:30PM-4:00PM
-
Abstract Number: 1964
The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-β2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus
- 2:30PM-4:00PM
-
Abstract Number: 1993
The Risk of Stroke in Patients with Rheumatoid Arthritis and the Association with Competing Adverse Events
- 2:30PM-4:00PM
-
Abstract Number: 2015
The Systemic Sclerosis Disease State Is Associated with Specific Alterations in Gastrointestinal Microbiota in Two Independent Cohorts
- 2:30PM-4:00PM
-
Abstract Number: 1963
Thrombospondin-1 Is Elevated in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Free Active TGF-b1 Levels, IL-1b and IL-17A
- 2:30PM-4:00PM
-
Abstract Number: 2006
Tuberculosis Incidence in Ankylosing Spondylitis, Psoriatic Arthritis, and Other Spondyloarthropathies in Sweden: A Population-Based Cohort Study
- 2:30PM-4:00PM
-
Abstract Number: 1976
Ultrasound Inflammation in Patients Presenting with Arthralgia Is Associated with Developing Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2012
Utility of the Lupus Low Disease Activity State Definition in Discriminating Responders in the Phase IIb Muse Trial of Anifrolumab in Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 2003
Validation of the ASAS Health Index: Results of a Multicenter International Study in 23 Countries
- 2:30PM-4:00PM
-
Abstract Number: 1984
Which Factors Associate with Localized Knee Pain and Generalized Pain: A 10-Year Longitudinal Study?
- 4:30PM-6:00PM
-
Abstract Number: 2033
A Multi-Dimensional Genomic Map for Polyarticular Juvenile Idiopathic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2066
Anti-Ds-DNA Antibodies Regulate Atherothrombosis in Systemic Lupus Erythematosus through the Induction of Netosis, the Prothrombotic and Proinflammatory Activities of Monocytes and the Endothelial Activation
- 4:30PM-6:00PM
-
Abstract Number: 2026
Are Adult Trajectories of Weight over a Lifetime Linked to Foot Problems Years Later?
- 4:30PM-6:00PM
-
Abstract Number: 2039
Assessing Barriers to Uveitis Screening in Patients with JIA: A Qualitative Study
- 4:30PM-6:00PM
-
Abstract Number: 2060
Bim Suppresses the Development of SLE By Limiting Macrophage Inflammatory Responses
- 4:30PM-6:00PM
-
Abstract Number: 2064
Blood and Kidney Molecular Profiles Distinguish Subjects with Lupus Nephritis from Other Kidney Disorders
- 4:30PM-6:00PM
-
Abstract Number: 2056
Choroid Plexus Infiltrates in Lupus Model (MRL/lpr) Mice Represent Tertiary Lymphoid Structures, Shedding Light on the Immunological Mechanisms of Neuropsychiatric Lupus
- 4:30PM-6:00PM
-
Abstract Number: 2083
Comparing the Electronic Patient Reported Outcome (ePro) Tool Versus the Paper Reported Outcome (pPro) Tool in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
- 4:30PM-6:00PM
-
Abstract Number: 2067
Dermal Fibroblasts from Patients with Lupus Nephritis Express an Anti-Fibrotic Transcriptome
- 4:30PM-6:00PM
-
Abstract Number: 2081
Dermal Temperature Is an Excelent Prognostic Indicator to Guide RA Therapy
- 4:30PM-6:00PM
-
Abstract Number: 2031
Dietary Patterns and Radiographic Progression of Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- 4:30PM-6:00PM
-
Abstract Number: 2030
Difference in Risk Factor Profile Between Medial and Lateral Compartment Involvement in Tibiofemoral Knee Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 2069
Dipeptidyl-Peptidase-4 (DPP4) Positive Fibroblast Subpopulation Promotes Fibrosis and Are a Molecular Target for Treatment of Fibrosis
- 4:30PM-6:00PM
-
Abstract Number: 2035
Dosage Contribution of a Non-Classical HLA Gene, HLA-Doa, to the Risk of Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2045
Early Preeclampsia Risk in Lupus Pregnancy: A Swedish Population-Based Register Investigation
- 4:30PM-6:00PM
-
Abstract Number: 2058
Ectonucleotidase-Mediated Protection of Lupus Mice from Exaggerated Immune Responses and Arterial Vasculopathy
- 4:30PM-6:00PM
-
Abstract Number: 2044
Effect of Pregnancy on Disease Flares in Patients with Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 2054
Effect of Temporary Methotrexate Discontinuation on Efficacy of Seasonal Influenza Vaccination in Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
- 4:30PM-6:00PM
-
Abstract Number: 2084
Effects of a Web-Based Patient Decision Aid on Biologics for Rheumatoid Arthritis: A Proof-of-Concept Study
- 4:30PM-6:00PM
-
Abstract Number: 2048
Evaluating Transfer of Certolizumab Pegol into Breast Milk: Results from a Prospective, Postmarketing, Multicenter Pharmacokinetic Study
- 4:30PM-6:00PM
-
Abstract Number: 2071
Expression of Neuraminidase 1 (NEU1) Is Upregulated in the Lungs of Scleroderma Patients with Pulmonary Fibrosis, and Gene Delivery of NEU1 to Mouse Lungs Elicits Accumulation of CD8+ Lymphocytes and Collagen
- 4:30PM-6:00PM
-
Abstract Number: 2043
Feasibility and Accuracy of Translating a Patient Safety Quality Measure into an Automated e-Measure
- 4:30PM-6:00PM
-
Abstract Number: 2072
Fli1-Haploinsufficient Dermal Fibroblasts Promote Skin-Localized Transdifferentiation of Th2- and Th17-like Regulatory T Cells
- 4:30PM-6:00PM
-
Abstract Number: 2032
Genome-Wide Association Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci
- 4:30PM-6:00PM
-
Abstract Number: 2078
Global Ethnic and Geographic Differences in the Clinical Features of ANCA-Associated Vasculitis
- 4:30PM-6:00PM
-
Abstract Number: 2074
Herpes Zoster and the Risk of Incident Giant Cell Arteritis
- 4:30PM-6:00PM
-
Abstract Number: 2082
Identification of Major Clinical Characteristics and Linear Correlations Among DAS28, HAQ and Morning Stiffness Time Using Smart System of Disease Management (SSDM)
- 4:30PM-6:00PM
-
Abstract Number: 2063
Identification of Microrna Predictive of Outcome in Lupus Nephritis
- 4:30PM-6:00PM
-
Abstract Number: 2077
Impact of Diabetes, Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use, and Statin Use on Presentation and Outcomes in Patients with Giant Cell Arteritis
- 4:30PM-6:00PM
-
Abstract Number: 2047
Impact of in Utero Hydroxychloroquine Exposure on the Risk of Cutaneous Neonatal Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 2076
Impact of Vasculitis on Employment and Income: An Online Survey of Participants in the Rare Diseases Clinical Research Network – Vasculitis Clinical Research Consortium Patient Contact Registry
- 4:30PM-6:00PM
-
Abstract Number: 2042
Improving the Overall Pneumococcal Vaccination Rate in Lupus Patients at the Rheumatology Clinic
- 4:30PM-6:00PM
-
Abstract Number: 2079
Incidence and Risk of Pneumocystis Jirovecii Pneumonia Following Rituximab Treatment in Granulomatosis with Polyangiitis in the United States: An Analysis from a National Database
- 4:30PM-6:00PM
-
Abstract Number: 2062
Increased Expression of Response Gene to Complement-32 in Kidney Biopsies from Patients with Lupus Nephritis
- 4:30PM-6:00PM
-
Abstract Number: 2073
Jumonji Domain Containing Protein 3 (JMJD3) As a Novel Epigenetic Mechanism of Fibroblast Activation By Regulation of Fra-2
- 4:30PM-6:00PM
-
Abstract Number: 2070
Long Noncoding RNA H19X Is a Master Regulator of Extracellular Matrix Production in Systemic Sclerosis and Other Fibrotic Disease
- 4:30PM-6:00PM
-
Abstract Number: 2085
Minding the Gap: the Use of Nurse Practitioners and Physician Assistants in U.S. Rheumatology Practice to Affect Rheumatology Workforce Shortages
- 4:30PM-6:00PM
-
Abstract Number: 2055
Myocardial Abnormalities Are Associated with Corrected QT Interval in Patients with Rheumatoid Arthritis without Cardiac Symptoms Assessed Using Cardiac Magnetic Resonance Imaging
- 4:30PM-6:00PM
-
Abstract Number: 2075
No Detection of Varicella-Zoster Virus in Temporal Arteries of Patients with Giant Cell Arteritis
- 4:30PM-6:00PM
-
Abstract Number: 2034
Novel Susceptible Genes for Behçet’s Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure
- 4:30PM-6:00PM
-
Abstract Number: 2038
Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Improvement on Quality Measures for Children with Juvenile Idiopathic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2065
Platelet FcγRIIa Polymorphism H131R Associates with Subclinical Atherosclerosis and Increased Platelet Activity in SLE
- 4:30PM-6:00PM
-
Abstract Number: 2052
Preoperative Timing of Infliximab and Risk of Post-Operative Infection in a Medicare Cohort
- 4:30PM-6:00PM
-
Abstract Number: 2053
Prosthetic Joint Infection with Staphylococcus Aureus: Recurrence after Surgical Treatment in U.S. Veterans with and without Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2037
Proteostasis Dysregulation and Autoinflammation in Patients with TRNT1 Deficiency
- 4:30PM-6:00PM
-
Abstract Number: 2028
Relationship of Limb Length Inequality and Incident and Progressive Knee and Hip Radiographic Osteoarthritis and Symptoms
- 4:30PM-6:00PM
-
Abstract Number: 2040
Responsiveness of Patient Reported Outcomes Measurement Information System Measures in RA Patients Starting or Switching a DMARD
- 4:30PM-6:00PM
-
Abstract Number: 2051
Risk Factors for Cardiovascular Disease Predate the Onset of Symptoms of Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2029
Risk of Knee Pain, Radiographic Osteoarthritis and Knee Arthroplasty in Retired Professional Footballers Compared to the General Population
- 4:30PM-6:00PM
-
Abstract Number: 2050
Screening for and Management of Comorbidities after a Nurse-Led Program: Results of a 3 Year Longitudinal Study in 776 Established RA Patients
- 4:30PM-6:00PM
-
Abstract Number: 2059
Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Factor in T Cell Homeostasis and Its Selective Loss in T Cells Causes Autoimmunity and Lupus-like Nephritis
- 4:30PM-6:00PM
-
Abstract Number: 2049
Serious Infections in RA Offspring Exposed to Tumor Necrosis Factor Inhibitors
- 4:30PM-6:00PM
-
Abstract Number: 2061
Successful Treatment of Murine Lupus Nephritis with Helminths Related Tuftsin-Phosphorylcholine Compound and Its Effect on the Microbiota
- 4:30PM-6:00PM
-
Abstract Number: 2027
The Association of Light and Moderate-to-Vigorous Walking with Incident Poor Health Outcomes over Two Years in People with or at High Risk of Knee Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 2046
The Low-Dose Intravenous Cyclophosphamide Euro-Lupus Regimen Does Not Impact the Ovarian Reserve of Lupus Patients, As Measured By Serum Anti-Mullerian Hormone Levels
- 4:30PM-6:00PM
-
Abstract Number: 2080
Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care
- 4:30PM-6:00PM
-
Abstract Number: 2057
TLR-7-Mediated Lupus Nephritis Flares Are Independent of Type I Interferon Signaling
- 4:30PM-6:00PM
-
Abstract Number: 2068
Type 2 Innate Lymphoid Cells – Cellular Source of Profibrotic Mediators Rapidly and Persistently Recruited in Experimental Fibrosis and Systemic Sclerosis
- 4:30PM-6:00PM
-
Abstract Number: 2041
Validity and Reliability of Patient Reported Outcomes Measurement Information System (PROMIS®) Global Health Short Form in Patients with SLE
- 4:30PM-6:00PM
-
Abstract Number: 2036
Whole Exome Sequencing in Early Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2969
10 Year Retrospective Analysis of 276 Cases of Histopathologically Confirmed Leukocytoclastic Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 2285
12/15-Lipoxygenase Inhibition By ML351 Protects Against Uric Acid Crystal-Induced Acute Arthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2973
A Comparison of Caregiving Burden and Impact in Systemic Vasculitis Versus Other Conditions
- 9:00AM-11:00AM
-
Abstract Number: 2911
A Comparison of Gastrointestinal Disease Severity in African American and Caucasian Scleroderma Patients
- 9:00AM-11:00AM
-
Abstract Number: 2601
A Cytometric Assay for Monitoring Adalimumab Immunogenicity and Drug Concentrations Can Distinguish Anti-Adalimumab Antibodies from Interference
- 9:00AM-11:00AM
-
Abstract Number: 2240
A Descriptive Analysis of Real-World Treatment Patterns in a Turkish Rheumatology Population That Continued Innovator Infliximab (Remicade) Therapy or Switched to Biosimilar Infliximab
- 9:00AM-11:00AM
-
Abstract Number: 2266
A Melanocortin Fusion Peptide (AQB-565) Optimized for Melanocortin Receptor Engagement Significantly Reduces Inflammation in an In Vivo model of Acute Gout
- 9:00AM-11:00AM
-
Abstract Number: 2780
A Modification of the Psoriatic Arthritis Disease Activity Score (mPASDAS) Using SF-12 As a Measure of Quality of Life
- 9:00AM-11:00AM
-
Abstract Number: 2295
A Non-Linear Relationship Between Physical Activity and Serum Uric Acid Concentrations: Nhanes 2003-2004
- 9:00AM-11:00AM
-
Abstract Number: 2561
A Novel Pharmacological Action of MTX on RA Fibroblast-like Synoviocytes Via Circadian Clock Genes
- 9:00AM-11:00AM
-
Abstract Number: 2343
A Phase 2, Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallel Group Study to Evaluate the Safety and Dose Effectiveness of Intradermal Injections of Purified Apis Mellifera Toxin to Improve Pain and Physical Function in Patients with Osteoarthritis of the Knee
- 9:00AM-11:00AM
-
Abstract Number: 2724
A Prospective Study of Ankylosing Spondylitis in China with Smart Management System for Spondyloarthritis: Study Design and Baseline Characteristics of the 449 Recruited Patients
- 9:00AM-11:00AM
-
Abstract Number: 2488
A Randomised Controlled Trial Evaluating the Effect of Adalimumab upon Biomarkers of Cardiovascular Risk in ACPA-Positive Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 8L
A Randomized, Double-Blind, Placebo-Controlled Study of Bimagrumab in Patients with Sporadic Inclusion Body Myositis
- 9:00AM-11:00AM
-
Abstract Number: 2250
A Real World View of Rheumatoid Arthritis Patients Treated with Advanced Therapies: Comparing Patient Profiles and Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 2143
A Small Molecule, SM04690, Has Inhibitory Effects on the Wnt Pathway and Inflammation in Vitro, with Potential Implications for the Treatment of Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2979
a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehçEt’s Syndrome Informing the Eular Recommendations for the Management of BehçEt’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2087
A Type I Interferon Signature in Monocytes and Decreased Levels of Circulating Plasmacytoid Dendritic Cells in Patients with Primary Antiphospholipid Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2806
A Type-I Interferon Signature Is Associated with Autoantibody Profiles in Connective Tissue Diseases: Results from the Lupus Extended Autoimmune Phenotype (LEAP) Study
- 9:00AM-11:00AM
-
Abstract Number: 2583
Abatacept in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicenter Study of 55 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2867
Aberrant Epigenetic Alterations at the Promoter up-Regulate cAMP Responsive Element Modulator Alpha in CD4+ T Cells from Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2232
Above-Label Dosing with Biologics in Treatment-NaïVe and Treatment-Experienced Patients with Moderate-to-Severe Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2524
Achievement of Imaging Remission Among Patients with Rheumatoid Arthritis in Clinical Remission and Their Characteristics
- 9:00AM-11:00AM
-
Abstract Number: 2935
Activation Status of Mucosal-Associated Invariant T Cells Sensitively Reflects Disease Activity of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2947
Adalimumab Versus Infliximab in Cystoid Macular Edema of Uveitis Associated to BehçEt Disease. Multicenter Study of 34 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2895
Adaptation of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Questionnaire into Turkish
- 9:00AM-11:00AM
-
Abstract Number: 2217
Adherence to Drug Therapy in Patients with Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2829
Adherence to Treatment and Renal Transplantation Graft Failure in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2149
Adipokines Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts Adhesion and Endothelial Cells
- 9:00AM-11:00AM
-
Abstract Number: 2745
Adult Axial Spondyloarthritis Screening and Referral Practices Amongst Primary Care Physicians, Physiotherapists, Chiropractors and Nurse Practitioners: Results from a Qualitative Study
- 9:00AM-11:00AM
-
Abstract Number: 2658
Adverse Drug Reactions Due to Disease Modifying Drugs in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2125
Aggrecan Degradation Is Not Just Aggrecan Degradation:a Study of the Neo-Epitopes Tege and Args Released from Cartilage upon Aggrecanase Activity
- 9:00AM-11:00AM
-
Abstract Number: 2936
All-Trans Retinoic Acid Stabilizes Natural T Regulatory Cells Isolated from Patients with Systemic Lupus Erythematosus Under Inflammatory Conditions
- 9:00AM-11:00AM
-
Abstract Number: 2160
Allopurinol Use and the Risk of Acute Cardiovascular Events in Patients with Gout and Diabetes
- 9:00AM-11:00AM
-
Abstract Number: 2159
Allopurinol Use Is Associated with Lower Risk of Peripheral Vascular Disease in the US Elderly
- 9:00AM-11:00AM
-
Abstract Number: 2267
AMP-Activated Protein Kinase: A Target for Methotrexate in Macrophages
- 9:00AM-11:00AM
-
Abstract Number: 2851
An Antigen Microarray to Rule-out Systemic Lupus Erythematosus, the SLE-Key® Rule-out Test, Performs Well As an Aid in Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 2915
An Increased Circulating Level of Periostin in Patients with Systemic Sclerosis: Associations with Functional Impairment in Various Affected Organs
- 9:00AM-11:00AM
-
Abstract Number: 2974
An Outcome Survey of 100 Patients with Cerebral Venous Sinus Thrombosis Due to Behcet’s Syndrome Followed up at a Single, Dedicated Center
- 9:00AM-11:00AM
-
Abstract Number: 2186
Analgesic Use and Subsequent Risk of Falls in Participants with or at Risk of Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2539
Analysis of Joints Susceptible to Rheumatoid Arthritis (RA) and Their Recovery Sequence Based on DAS28 and Physical Function Based on HAQ with Smart System of Disease Management (SSDM) in China：a Prospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2368
Analysis of Pain and Function Components in Omeract-Oarsi Strict Responders from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
- 9:00AM-11:00AM
-
Abstract Number: 2383
Analysis of the Use of Anticoagulants and Antiplatelet Agents in Strokes Caused By the Deficiency of Adenosine Deaminase 2
- 9:00AM-11:00AM
-
Abstract Number: 2113
Anti-Carbamylated Protein Antibody (cross)-Reactivity Against Multiple Carbamylated Protein Antigens
- 9:00AM-11:00AM
-
Abstract Number: 2608
Anti-CCP Antibody Titers Decrease with Altered B-Cell Subpopulation in RA Patients Treated with Tocilizumab
- 9:00AM-11:00AM
-
Abstract Number: 2624
Anti-Citrullinated Protein Antibodies Titers Are Independently Modulated By Disease Activity and Synthetic or Biologic Dmards in a Seropositive Early Arthritis Population
- 9:00AM-11:00AM
-
Abstract Number: 2325
ANTI-Hmgcr Antibodies Demonstrate High Diagnostic VALUE in the Diagnosis of Immune Mediated Necrotizing Myopathy Following Statin Exposure
- 9:00AM-11:00AM
-
Abstract Number: 2954
Anti-IL6-R Tocilizumab in Refractory Uveitis Associated with BehçEt’s Disease. Multicenter Study of 11 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2260
Anti-Inflammatory Role of Lubricin/Proteoglycan 4 (PRG4) in Monosodium Urate (MSU)-Crystal Induced Arthritis.
- 9:00AM-11:00AM
-
Abstract Number: 2314
Anti-Mi2 Dermatomyositis Revisited: Pure DM Phenotype with Muscle Fiber Necrosis and High Risk of Malignancy
- 9:00AM-11:00AM
-
Abstract Number: 2898
Anti-Reflux Medications in Diffuse Cutaneous Systemic Sclerosis: Is Empiric Use of Proton Pump Inhibitors Supported?
- 9:00AM-11:00AM
-
Abstract Number: 2841
Anti-Ro52/TRIM21 Antibodies Are Associated with QT Interval Prolongation in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2312
Anti-TIF1-Gamma Antibodies Are Not Associated with Other Paraneoplastic Rheumatic Syndromes Than Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 2602
Anti-TNF Therapy Is Associated with an Impaired Function of NK Cells and a Defective Immunosurveillance Against B-Cell Lymphomas
- 9:00AM-11:00AM
-
Abstract Number: 2908
Anti-Vinculin Antibodies: A Novel Biomarker in Systemic Sclerosis, and Its Association with Vascular Involvement
- 9:00AM-11:00AM
-
Abstract Number: 2416
Antibodies to Citrullinated Peptides in Patients with Juvenile Idiopathic Arthritis and Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype
- 9:00AM-11:00AM
-
Abstract Number: 2847
Antibodies to Double Stranded DNA: Combined Standard ELISA and High-Salt ELISA Assays for the Detection of SLE Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2663
Antimalarials Protect Against Damage Accrual in Primary SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2845
Antineutrophil Cytoplasmic Antibodies in Systemic Lupus Erythematosus: Incidence, Outcome and Prognosis
- 9:00AM-11:00AM
-
Abstract Number: 2091
Antiphospholipid Syndrome Patients’ Time within Therapeutic Range of International Normalized Ratio (INR)
- 9:00AM-11:00AM
-
Abstract Number: 2961
Antiphospoholipid Antibodies in Adult IgA Vasculitis: Aps/PT Antibodies As a Potential Marker of Renal Involvement?
- 9:00AM-11:00AM
-
Abstract Number: 2263
Apolipoprotein E Regulates Inflammation and Joint Destruction during Antigen-Induced Arthritis (AIA)
- 9:00AM-11:00AM
-
Abstract Number: 2865
Apoptotic Microparticles, but Not Exosomes, Induce an Inflammatory Response in Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 2846
Application of a Novel Anti-Nuclear Antibody Multiplex Test Using Finger Stick and Venous Whole Blood in a Rheumatology Clinic – Demonstration of Feasibility
- 9:00AM-11:00AM
-
Abstract Number: 2703
Apremilast May Improve Atherosclerosis By Promoting Cholesterol Efflux and Inhibiting Foam Cell Formation in Atherosclerotic Plaques
- 9:00AM-11:00AM
-
Abstract Number: 2533
Are There Differences in Baseline Comorbidities Between Rheumatoid Arthritis Patients Treated with Abatacept and Those Treated with Tumor Necrosis Factor Inhibitors?
- 9:00AM-11:00AM
-
Abstract Number: 2840
Are There Genetic Predispositions to Diffuse Large B-Cell Lymphoma (DLBCL) in Systemic Lupus (SLE)?
- 9:00AM-11:00AM
-
Abstract Number: 2568
ARL15 expressed By Rheumatoid Arthritis Synovial Fibroblasts Regulates IL6 and Plays a Role in Apoptosis and Hypoxia
- 9:00AM-11:00AM
-
Abstract Number: 2191
Arthritis As a Potential Barrier to Physical Activity Among Adults with Depression – United States, Behavioral Risk Factor Surveillance System, 2013
- 9:00AM-11:00AM
-
Abstract Number: 2966
Assessment of Damage in Behcet’s Disease: Do We Need a Specific Damage Index?
- 9:00AM-11:00AM
-
Abstract Number: 2760
Assessment of Inflammatory Back Pain and Axial Spondyloarthritis in Brazil
- 9:00AM-11:00AM
-
Abstract Number: 2507
Assessment of Liver Fibrosis Using Transient Elastography in Patients with Rheumatoid Arthritis Exposed to Long Term Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 2468
Assessment of the American-English Version of the French FLARE in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2773
Assessment of the Static and Dynamic Balances in Psoriatic Arthritis (PsA) and Their Relations with Clinical, Radiological and Functional Parameters of Feet
- 9:00AM-11:00AM
-
Abstract Number: 2188
Association Between Extent of Symptomatic Joint Involvement in Osteoarthritis and Comorbid Lung Disease in Patients Scheduled for Joint-Replacement Surgery
- 9:00AM-11:00AM
-
Abstract Number: 2591
Association Between Flare and Radiographic Progression in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2463
Association Between High Sodium Intake and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2161
Association Between Inflammation and Systolic Blood Pressure at Normal and High C-Reactive Protein Levels
- 9:00AM-11:00AM
-
Abstract Number: 2367
Association Between MRI-Detected Osteophytes and Changes in Knee Pain and Structures in Older Adults: A Population Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2361
Association Between Osteoarthritis and Dyslipidemia: A Systematic Literature Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2192
Association Between Quality of Sleep and Quality of Life Among Japanese Systemic Lupus Erythematosus Outpatients
- 9:00AM-11:00AM
-
Abstract Number: 2654
Association Between Rheumatoid Factor Positivity and Effects of Treatment with a First Biologic Agent in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2200
Association of Active Commuting and Physical Activity in Women with Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2180
Association of Anterior Cruciate Ligament/Meniscal Injury with Knee Function, Knee Pain, and Knee Osteoarthritis in Military Officers
- 9:00AM-11:00AM
-
Abstract Number: 2093
Association of Conventional Risk Factors and Antiphospholipid Antibodies to Thrombosis in Patients with Autoimmune Diseases: Lessons Learned from a Year-Long Systematic Assessment
- 9:00AM-11:00AM
-
Abstract Number: 2714
Association of Polymorphisms of Activation-Induced Cytidine Deaminase with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2914
Association of Radiographic Findings in Hand X-Ray with Autoantibodies in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2497
Associations Between Dietary Intake of Vitamin D, Omega-3 Fatty Acids, Folate and EULAR Response in Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2886
Associations Between Type I Interferon and Antiphospholipid Antibody Status Differ Between Ancestral Backgrounds
- 9:00AM-11:00AM
-
Abstract Number: 2831
Associations of BAFF and Anti-BAFF Autoantibodies with Disease Activity in Oriental Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2909
Attitudes Toward Patient-Reported Outcome Instruments for the Assessment of Raynaud’s Phenomenon in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2707
Autoantibodies Against CD74 – a New Diagnostic Marker for Spondyloarthritis (SpA)
- 9:00AM-11:00AM
-
Abstract Number: 2095
Autoantibodies Against High Density Lipoprotein-Associated Proteins Are Related to Elevated Oxidized Low Density Lipoprotein Levels in Antiphospholipid Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2428
Autoantibody Diversity in Pediatric Patients Undergoing Evaluation for Autoimmune Encephalitis: A Retrospective Investigation
- 9:00AM-11:00AM
-
Abstract Number: 2105
Autoimmune Pancreatitis-Associated Autoantigens Among 100 IgG4-Related Diseases Patients
- 9:00AM-11:00AM
-
Abstract Number: 2150
Autoimmune Uveitis : Potential Role of Interleukin-22 (IL-22) in Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 2128
Autophagic Clearance of Dysfunctional Mitochondria Requires Parkin in Human Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 2564
Autophagy Alteration Affects Migration and Proliferation of Rheumatoid Arthritis Fibroblast-like Synoviocytes Stimulated By IL-17A
- 9:00AM-11:00AM
-
Abstract Number: 2117
B Cell Phenotype and in Vitro Function in Patients with Rheumatoid Arthritis Developing Low Serum Immunoglobulins after Multiple Cycles of Rituximab
- 9:00AM-11:00AM
-
Abstract Number: 2873
B-Cell activating Factor Genetic Variants in Systemic Lupus Erythematosus and Lupus Related Atherosclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2772
Back Pain in Psoriatic Arthritis: Defining Prevalence, Characteristics and Performance of the Different Inflammatory Back Pain Criteria in a Psoriatic Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2710
Bacterial Dysbiosis Associates with Functional Intraepithelial Lymphocyte Changes in Inflammatory Bowel Disease and Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2959
Baseline Endothelial Dysfunction Might Predict Immunosuppressive Need in Young, Male Behcet’s Patients with Early Disease: A Prospective Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 2940
Bechet’s Disease and Sleep Quality in Korean Patients
- 9:00AM-11:00AM
-
Abstract Number: 2963
BehçEt’s Disease in Children: Eastern Mediterranean Experience
- 9:00AM-11:00AM
-
Abstract Number: 2779
Better Health-Related Quality of Life and Work Capacity in Patients Achieving Inactive Disease and Clinical Response in Patients with Non-Radiographic Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2237
Biologic DMARD Use Among U.S. Patients in an Online Rheumatoid Arthritis Community
- 9:00AM-11:00AM
-
Abstract Number: 2955
Biologic Therapy in Severe Peripheral Ulcerative Keratitis (PUK). Multicenter Study of 27 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2375
Biologic Therapy Modifies Clinical and Laboratory Features of Macrophage Activation Syndrome Associated with Systemic Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2669
Biological Treatments in Primary SjöGren Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2286
Bioresponsive Glucocorticoid-Loaded Microparticles to Prevent Acute Gout Flares
- 9:00AM-11:00AM
-
Abstract Number: 19L
Biosimilar Infliximab (CT-P13) Is Not Inferior to Originator Infliximab: Results from a 52-Week Randomized Switch Trial in Norway
- 9:00AM-11:00AM
-
Abstract Number: 2436
Birth Outcomes Significantly Worsen after the Development of Systemic Lupus Erythematosus in a Population-Based Registry
- 9:00AM-11:00AM
-
Abstract Number: 11L
BMS-986165 Is a Highly Potent and Selective Allosteric Inhibitor of Tyk2, Blocks IL-12, IL-23 and Type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Systemic Lupus Erythematosus and Inflammatory Bowel Disease
- 9:00AM-11:00AM
-
Abstract Number: 2134
Bone Replaces Cartilage in Non-Weight Bearing Regions of Immobilized Knees
- 9:00AM-11:00AM
-
Abstract Number: 2787
Bortezomib Treatment Induces Higher Mortality Rate in Lupus Model Mice with High Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2782
Bortezomib Treatment Prevents Glomerulosclerosis Associated with Lupus Nephritis in a Murine Model through Suppressive Effects on the Immune and Renin-Angiotensin Systems
- 9:00AM-11:00AM
-
Abstract Number: 2816
Broad Autoantibody Profiling in Ethnically Diverse SLE Cohorts Reveals a Set of Conserved Autoantibodies That Are Correlated to a Type I Interferon Signature
- 9:00AM-11:00AM
-
Abstract Number: 2740
Cam Type Femoroacetabular Impingement Morphology Is More Frequent in Patients with Axial Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2223
Can Fibromyalgia be Empirically Defined By the Number of Pain Locations Plus Symptoms?
- 9:00AM-11:00AM
-
Abstract Number: 2640
Can GP88 (Progranulin) be Used to Predict the Efficacy of Infliximab?
- 9:00AM-11:00AM
-
Abstract Number: 2381
Canakinumab Monotherapy for the Treatment of Majeed Syndrome. Five-Year Experience
- 9:00AM-11:00AM
-
Abstract Number: 2327
Cardiac Involvement in Inflammatory Myopathies: A Report from the Remicam Registry
- 9:00AM-11:00AM
-
Abstract Number: 2097
Cardiolipin-Producing Candidate Commensals in the Gut Microbiome of Antiphospholipid Syndrome Patients
- 9:00AM-11:00AM
-
Abstract Number: 2293
Cardiometabolic Risk and Subclinical Urate Deposits in Patients with Symptomatic Hyperuricemia and Metabolic Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2170
Cardiovascular Risk in Patients with Psoriasis, Psoriatic and Rheumatoid Arthritis: A Prospective Study Using Secured Anonymised Information Technology Databank in Wales, United Kingdom
- 9:00AM-11:00AM
-
Abstract Number: 2611
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2437
Causes of Cesarean Section and Labor Induction in Systemic Lupus Erythematosus and Rheumatoid Arthritis Pregnancies
- 9:00AM-11:00AM
-
Abstract Number: 2136
CD14 Deficiency Delays Progression of Cartilage Degeneration and Protects Against Early Deficits in Functional Outcomes in a Murine Osteoarthritis Model
- 9:00AM-11:00AM
-
Abstract Number: 2874
CD16+monocytes Are Enriched and Functionally Exacerbated in Driving B Cell Activation Under Systemic Lupus Erythematosus Condition
- 9:00AM-11:00AM
-
Abstract Number: 2882
CD4+ T Helper Cells and Regulatory T Cells in Active Lupus Nephritis – an Imbalance Towards a Predominant Th1 Response?
- 9:00AM-11:00AM
-
Abstract Number: 2421
Cell-Bound Complement Activation Products Correlate with Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2800
Cell-Bound Complement Activation Products in Multi-Analyte Assay with Algorithm Aid the Diagnosis of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2884
Cell-Type Specific Epigenetic Features of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2231
Change in Health Care Utilization after Etanercept Initiation in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2554
Changes in Blood Pressure Following the Initiation of Disease Modifying Therapies in US Veterans with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2676
Changes in Salivary Gland Echostructure in Patients with Primary SjöGren’s Syndrome over the Time: A Four-Year Longitudinal Study
- 9:00AM-11:00AM
-
Abstract Number: 2850
Changes in Urinary Biomarker Levels Can Predict Treatment Responses in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2753
Characteristic and Outcomes of Psoriatic Arthritis Patients with Hyperuricemia, Whether We Should Treat or Not?
- 9:00AM-11:00AM
-
Abstract Number: 2971
Characteristics and Management of IgA Vasculitis (Henoch-Schönlein purpura) in Adults: Data from the 260 Patients Included in the Igavas Survey
- 9:00AM-11:00AM
-
Abstract Number: 2749
Characteristics of Ankylosing Spondylitis Patients with Primary and Secondary Lack of Efficacy to TNF-Inhibitor Treatments
- 9:00AM-11:00AM
-
Abstract Number: 2688
Characteristics, Treatment and Outcome of Joint Involvement with Synovitis in Primary SjöGren’s Syndrome: French Multicentric Retrospective Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2431
Characterization of Innate Immune Cells in Patients with the Interferon-Mediated Autoinflammatory Diseases Sting Associated Vasculopathy with Onset in Infancy (SAVI) and Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature (CANDLE)
- 9:00AM-11:00AM
-
Abstract Number: 2255
Characterization of Low-Density Granulocytes in Autoinflammatory Disorders
- 9:00AM-11:00AM
-
Abstract Number: 2839
Circulating CD4+CD28null T-Cells Predict the Occurrence of New Lung Damage in Systemic Lupus Erythematosus (SLE) Patients
- 9:00AM-11:00AM
-
Abstract Number: 2681
Clinical and Immunological Characteristics of Primary Sjogren´s Syndrome in Men
- 9:00AM-11:00AM
-
Abstract Number: 2219
Clinical and Radiological Characteristics of Patients with Adhesive Capsulitis and Shoulder Impingement Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2400
Clinical and Treatment Factors Associated with Antibiotic-Refractory Lyme Arthritis in Children
- 9:00AM-11:00AM
-
Abstract Number: 2934
Clinical Assessment of the Monoclonal Anitbody, PRX003, a Potential Novel Treatment for Th17-Mediated Inflammatory Disease
- 9:00AM-11:00AM
-
Abstract Number: 2388
Clinical Characterization and Outcomes of Pediatric Chronic Nonbacterial Osteomyelitis
- 9:00AM-11:00AM
-
Abstract Number: 2146
Clinical Characterization of Itch in Dermatomyositis and the Role of Increased Skin Interleukin-31
- 9:00AM-11:00AM
-
Abstract Number: 2677
Clinical Features of Primary Sjogren’s Syndrome Associated Lung Involvement with Extro-Glandular Manifestations at Onset
- 9:00AM-11:00AM
-
Abstract Number: 2887
Clinical Predictors for Development of Interstitial Lung Disease in Mixed Connective Tissue Disease
- 9:00AM-11:00AM
-
Abstract Number: 2812
Clinical Trial Simulation Identifies Factors for Patient Engagement in Systemic Lupus Erythematosus and Lupus Nephritis Trials By African-Americans
- 9:00AM-11:00AM
-
Abstract Number: 2637
Clinical Trials Aiming to Prevent the Development of Rheumatoid Arthritis Cannot Detect Prevention without Adequate Risk Stratification; A Trial Performed in UA-Patients As Example
- 9:00AM-11:00AM
-
Abstract Number: 2819
Clinical Utility of Anti-Aquaporin 4 Antibody Measurement in Patients with Neuropsychiatric Systemic Lupus Erythematosus with Neuromyelitis Optica Spectrum Disorder Manifestations
- 9:00AM-11:00AM
-
Abstract Number: 2826
Clinical Utility of Circulating Anti-N-Methyl-D-Aspartate Receptor Subunits NR2A/B Antibody for the Diagnosis of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Sjogren’s Syndrome: An Updated Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2691
Clinical, Radiological and Functional Characteristics of Clinically Significant Pulmonary Involvement in Primary SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2679
Clinically Meaningful Improvement of Essdai and Esspri in Patients with Primary SjöGren’s Syndrome in Real Life: A 12-Month Longitudinal Study
- 9:00AM-11:00AM
-
Abstract Number: 2950
Cogan Syndrome: Treatment and Outcome from French Nationwide Retrospective Study and Literature Review of 62 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2205
Cognitive Functioning in Fibromyalgia: The Central Role of Effort
- 9:00AM-11:00AM
-
Abstract Number: 2454
Cohort of Pregnant Women with Ro/La Antibodies: Risk of Fetal Third Degree Atrioventricular Block and Use of Hydroxychloroquine
- 9:00AM-11:00AM
-
Abstract Number: 2565
Common Biomarker Elevations in Idiopathic Pulmonary Fibrosis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 2176
Comorbidities and DMARD, NSAID and Steroid Use in a Real Life Cohort of 8,981 Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2776
Comparability of Patients Classified As Non-Radiographic Axial Spondyloarthritis By the Imaging Vs Clinical Arms of the ASAS Criteria
- 9:00AM-11:00AM
-
Abstract Number: 2596
Comparable Safety and Immunogenicity and Sustained Efficacy after Transition to SB2 (An Infliximab Biosimilar) Vs Ongoing Reference Infliximab (Remicade®) in Patients with Rheumatoid Arthritis: Results of Phase III Transition Study
- 9:00AM-11:00AM
-
Abstract Number: 2809
Comparative Analysis of Anti-Nuclear Antibody Testing Using Blinded Replicate Samples Reveals Variability Between Commercial Testing Laboratories
- 9:00AM-11:00AM
-
Abstract Number: 2529
Comparative Effectiveness of Tofacitinib, Biologic Drugs and Traditional Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2746
Comparing Prevalence of Comorbidities in Patients with Psoriatic Arthritis By Biologic Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2242
Comparison of Assessment and Management of RA and Other Rheumatic Diseases By Rheumatologists in Private Practices or an Academic Medical Center
- 9:00AM-11:00AM
-
Abstract Number: 2803
Comparison of Clinical and Serological Differences According to the Autoantibody Cluster in Women with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry
- 9:00AM-11:00AM
-
Abstract Number: 2333
Comparison of Clinical Outcomes of Total Ankle Arthroplasty Between Biologics and NON-Biologics Treatment Groups in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2755
Comparison of Clinical Profile of Geriatric and Non-Geriatric Ankylosing Spondylitis (AS) Patients
- 9:00AM-11:00AM
-
Abstract Number: 2249
Comparison of Discontinuation Rates Among Patients with RA Initiating Biologics
- 9:00AM-11:00AM
-
Abstract Number: 2464
Comparison of Disease Activity Score (DAS) 28-CRP to DAS28-ESR in Patients with Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2586
Comparison of Intra-Articular Methylprednisolone Acetate with Triamcinolone Acetonide in Acutely Swollen Knee Joint of Patients with Chronic Inflammatory Arthritis – a Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2538
Comparison of Intravenous Versus Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis in a Routine Clinical Care Setting: A Preliminary, Time to Response Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2815
Comparison of Lupus Nephritis Induction Therapy with Cyclophosphamide High Dose Versus Low Dose
- 9:00AM-11:00AM
-
Abstract Number: 2202
Comparison of New and Old American College of Rheumatology Classification Criterion for Diagnosis of Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2197
Comparison of Objectively Measured Physical Activity Among People with Symptomatic Knee Osteoarthritis with the General US Population
- 9:00AM-11:00AM
-
Abstract Number: 2953
Comparison of Patient Outcomes in Primary Angiitis of the Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2356
Comparison of Spa Therapy with or without Physical Rehabilitation for Knee Osteoarthritis: A Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 16L
Comparison of Systematic Vs Individually Tailored Rituximab Regimen to Maintain ANCA-Associated–Vasculitis Remission: Results of a Prospective, Randomized–Controlled, Phase 3 Trial
- 9:00AM-11:00AM
-
Abstract Number: 2689
Comparison of the 2016 ACR/EULAR and the 2002 AECG Classification Criteria in a Cohort of Patients with Suspected Primary SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2802
Comparison of the Clinical, Serological, and Prognostic Differences Among Juvenile-, Adult-, and Late-Onset Lupus Nephritis in Korean Patients: A Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2589
Comparison of Two Enzyme-Linked Immunosorbent Assays Used for Drug Concentration Monitoring in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
- 9:00AM-11:00AM
-
Abstract Number: 2175
Comparisons of Patients Prescribed Biosimilars or BIO-Originators for Autoimmune Diseases in Germany
- 9:00AM-11:00AM
-
Abstract Number: 2094
Complement Activation in Antiphospholipid Syndrome Due to the Multi-Activated Pathways of the Complement System
- 9:00AM-11:00AM
-
Abstract Number: 2820
Comprehensive Aptamer-Based Screening of 1129 Proteins Reveals Novel Urinary Biomarkers of Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2195
Conceptualizing the Life Course in the Employment Experiences of Working-Aged Adults with Arthritis: A Qualitative Study
- 9:00AM-11:00AM
-
Abstract Number: 2516
Concomitant Use of Oral Vs. Subcutaneous Methotrexate at Biologic Initiation: A Comparison of Biologic Treatment Survival in a Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2750
Concordance Between Patient and Physician Global Assessment of the Disease in Patients with Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2473
Concordance Between the Patient, Nurse and Physician Assessment of Clinical Outcomes in a Cohort of Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
- 9:00AM-11:00AM
-
Abstract Number: 2775
Conductive Hearing Loss Is Common in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2448
Contraceptive Methods in Women with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2598
Conversion Rate of Tuberculosis Screening Tests in Patients with Rheumatic Diseases While Receiving Anti-Tumor Necrosis Factor Alpha (anti-TNFα) Agents
- 9:00AM-11:00AM
-
Abstract Number: 2810
Correlates of Spontaneous Cytokine Production in Individuals Undergoing Interferon-Gamma Release Assay Testing
- 9:00AM-11:00AM
-
Abstract Number: 2485
Correlates of Successful Flare Management: The Role of Clinician-Driven Treatment, Home-Based Strategies, and Medication Change
- 9:00AM-11:00AM
-
Abstract Number: 2435
Counseling on Family Planning and Contraception, and Pregnancy Outcome in Women with Rheumatic Diseases: Analysis of 398 Patient-Reported Questionnaires from a Multicenter Italian Study
- 9:00AM-11:00AM
-
Abstract Number: 2262
CR6086 a New Potent EP4 Receptor Antagonist with Immunomodulatory Activities
- 9:00AM-11:00AM
-
Abstract Number: 2869
Critical Roles of IRAK4 Kinase Activity in Inflammation but Not B Cell Response in SLE
- 9:00AM-11:00AM
-
Abstract Number: 2155
Crosstalk Between IL-6 and TNF-Alpha Signaling Pathway in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 2290
Crystal-Proven Gout and Disease Severity Factors Influencing the Prevalence of Cardiovascular Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2422
Cyclic Amp, Erk5, and Transdifferentiation of Cardiac Fibroblasts in the Pathogenesis of Autoimmune Congenital Heart Block
- 9:00AM-11:00AM
-
Abstract Number: 2126
Cytokine Dependent Effects of Anti-Inflammatory Inhibitors Targeting JAK and p38 on Cartilage Turnover
- 9:00AM-11:00AM
-
Abstract Number: 2116
Cytokines Inhibition Modulates Activation and Homing Receptor of Different Peripheral Memory B Cell Subsets in RA
- 9:00AM-11:00AM
-
Abstract Number: 2747
Dapsa-28 May be Used Instead of Dapsa-66/68 in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2206
Data on Treatment from Brazilian Fibromyalgia Patients Registry (EpiFibro)
- 9:00AM-11:00AM
-
Abstract Number: 2292
Decreased Endothelial and Smooth Muscle Responsiveness in the Vasculature of Gout Patients Compared with Healthy Controls: Relationship Between Flow- and Nitrate-Mediated Dilation, Serum Urate and CRP
- 9:00AM-11:00AM
-
Abstract Number: 2705
Decreased Expression of Autophagy Genes and Their Association with Spinal Damage in Patients with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2304
Decreased Occurrence of Colon Cancer Among Gout Patients: Assessment By Physician Diagnosis and Colonoscopy
- 9:00AM-11:00AM
-
Abstract Number: 2132
Deficient Autophagy Induces Premature Senescence in Aging and Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2556
Deficient Expression of the Novel Rheumatoid Arthritis (RA) Risk Gene, LBH, Induces S Phase Arrest in RA Fibroblast-like Synoviocytes (FLS)
- 9:00AM-11:00AM
-
Abstract Number: 2875
Depressed Serum IgM Levels in SLE Are Restricted to Defined Subgroups
- 9:00AM-11:00AM
-
Abstract Number: 2164
Depression and the Risk of Psoriatic Arthritis Among Patients with Psoriasis: A Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2752
Depression Is Associated with Worse Outcomes in Axial Spondyloarthropathy Population
- 9:00AM-11:00AM
-
Abstract Number: 2163
Depressive Symptoms in Patients Consulting for the First Time at the Division of Rheumatology
- 9:00AM-11:00AM
-
Abstract Number: 2445
Dermatomyositis and Pregnancy: Assessment of Disease Activity and Pregnancy Outcomes Complicated By Maternal Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 2690
Detection of Dorsal Root Ganglionitis with Magnetic Resonance Neurography in Sensory Ataxic Neuropathy Associated with SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2680
Determinants of Fatigue in Patients with Primary SjöGren’s Syndrome and Impact of Fatigue on Patients’ Treatments: A Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2397
Developing a Role for 18f-Flurodeoxyglucose PET/MRI in Pediatric Takayasu Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2089
Deviation of T and B Cell Subset and Its Association with Single Nucleotide Polymorphisms in Patients with Antiphospholipid Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2684
Diagnosis of Systemic Diseases in Patients Presenting with Sicca Syndrome Using a Minimally-Invasive Minor Salivary Gland Biopsy: Analysis of 901 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2127
Dicam Promotes Proliferation and Hypertrophic Differentiation of Chondrocyte through Indian Hedgehog Signaling of Primary Cilia
- 9:00AM-11:00AM
-
Abstract Number: 2828
Difference of d-Dimer Between Two Time Points Predicts Prognosis of Admitted Patients with SLE Flare up
- 9:00AM-11:00AM
-
Abstract Number: 2284
Differential Effect of MSU-Crystal Induced Inflammation on Macrophage Polarization
- 9:00AM-11:00AM
-
Abstract Number: 2423
Differential Interferon Score Expression in the Peripheral Blood in Mendelian Inflammatory Interferonopathies Versus Juvenile Dermatomyositis (JDM) Subtyped By Myositis Autoantibodies and Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2713
Differentially Expressed Microrna As Candidate Biomarker for Disease Activity in Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2952
Differentiation Between Neurosarcoidosis and Primary CNS Vasculitis Based on Clinical and Cerebrospinal Fluid Parameters
- 9:00AM-11:00AM
-
Abstract Number: 2922
Disability, Fatigue, and Their Associates in Early Diffuse Cutaneous Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2728
Discontinuation of Biologic Therapy in Patients with Ankylosing Spondylitis—Data from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 2465
Discordance Between Tender and Swollen Joint Count and Patient’s and Evaluator’s Global Assessment May Reduce Likelihood of Remission in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2120
Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Treatment for Degenerative Disc Disease
- 9:00AM-11:00AM
-
Abstract Number: 2704
Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 2719
Discriminating Value of Calprotectin in Disease Activity and Progression of Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2976
Disease Flares and Persistent Low-Level of Disease: Long-Term Outcome in a Cohort of Patients with BehçEt’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2112
Disease-Activity Associated Autoantibodies to Malondialdehyde-Modified Proteins Can be Isolated from Synovial B Cells in RA
- 9:00AM-11:00AM
-
Abstract Number: 2558
Dissociation of the Inhibitory Apoptosis Stimulating Protein of p53 (iASPP) Binding with Transcription Factor p73 Induces Synovial Fibroblast Apoptosis in the Rheumatoid Joint
- 9:00AM-11:00AM
-
Abstract Number: 2880
Distinct Metabolic Pathways Regulate Lipid Antigen Presentation By Monocytes and B Cells: Implications for SLE Patients with Pre-Clinical Atherosclerotic Plaque
- 9:00AM-11:00AM
-
Abstract Number: 2571
Distinct Oral and Fecal Community Profiles Enriched in Opportunistic Pathogens in RA Patients and First Degree Relatives Are Influenced By Environmental Risk Factors, Including Smoking, Dental History and Lung Infection
- 9:00AM-11:00AM
-
Abstract Number: 2204
Distinctive Personality Profiles of Fibromyalgia and Chronic Fatigue Syndrome Patients
- 9:00AM-11:00AM
-
Abstract Number: 2496
DMARD, Biologic and Small Molecule Drug Use Among ACPA Positive and ACPA Negative RA Patients in a Tertiary Referral Center
- 9:00AM-11:00AM
-
Abstract Number: 2108
DNA Hypomethylation in Promoter Region of Zbtb38 Gene Ultimately Leads to Downregulated Expression of Anti-Inflammatory IL1r2 in Experiential Model of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2450
Do Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Have Reduced Fertility and Parity? a Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 2218
Do Some Patients with Distal Upper Limb Pain Benefit More Than Others from Advice to Remain Active?
- 9:00AM-11:00AM
-
Abstract Number: 2743
Do Specific Entheseal Points in Spa Patients Impact Patient Reported Outcomes? Implications for Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 2660
Do Ultrasonographic Lesions of Salivary Glands Evolve in SjöGren Patients during Follow-up ?
- 9:00AM-11:00AM
-
Abstract Number: 2736
Do Validated Tools of Disease Activity in Ankylosing Spondylitis Measure Fibromyalgia Pain?
- 9:00AM-11:00AM
-
Abstract Number: 2447
Does a History of Abnormal Pap Smear or Preceeding HPV Infection Affect Humoral Immune Response to Quadrivalent Human Papilloma Virus (qHPV) Vaccine in Women with Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 2348
Does Arthritis in Other Joints and Spine Influence the 1-Year Outcome of Total Hip Replacement? a Prospective European Multicenter Cohort Study Measuring the Influence of Musculoskeletal Morbidity
- 9:00AM-11:00AM
-
Abstract Number: 2514
Does Combination of Conventional Synthetic Disease Modifying Antirheumatic Drug with Anti-TNF Influence the Long Term Retention Compared to Anti-TNF Monotherapy in Psoriatic Arthritis? an Analysis from Rhumadata® over 12 Years
- 9:00AM-11:00AM
-
Abstract Number: 2769
Does Gender Make a Difference in “Composite Psoriatic Disease Activity Index (CPDAI)” in Patients with Psoriatic Arthritis?
- 9:00AM-11:00AM
-
Abstract Number: 2339
Does Physical Activity Change after Total Hip or Knee Arthroplasty: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2716
Does Secretory Immunoglobulin a Influence Disease Activity in Patients with Reactive Arthritis and Undifferentiated Spondylarthritis?
- 9:00AM-11:00AM
-
Abstract Number: 2359
Dose-Related Risks of Cardiovascular, Gastrointestinal, and Renal Adverse Events Associated with Meloxicam Among Patients with Osteoarthritis: An Observational Study Using US Claims Data
- 9:00AM-11:00AM
-
Abstract Number: 2480
Dose-Related Short Term Clinical Response to Initial Treatment with Methotrexate in Mono- and Combination Therapy in Early Rheumatoid Arthritis Patients – a Meta-Regression Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2527
Drug Retention of Biologics in Rheumatoid Arthritis Patients: The Role of Baseline Characteristics and Impact of Time-Varying Factors
- 9:00AM-11:00AM
-
Abstract Number: 2647
Drug Trough Serum Levels Rather Than Antidrug Antibodies Explain Disease Flares in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with TNF Inhibitors in Clinical Remission/Low Disease Activity: A One Year Prospective, Multicenter Study (INMUNOREMAR)
- 9:00AM-11:00AM
-
Abstract Number: 2321
Early Damage and Mortality in a Cohort of Patients with Myositis Followed up to 20 Years
- 9:00AM-11:00AM
-
Abstract Number: 2472
Early DAS28 Drop Is a Predictor for Clinical Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis: An Observational Study of a Real Life Inception Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2630
EBV Load Quantification in Peripheral Blood Mononuclear Cells of Patients with Rheumatoid Arthritis Treated By Abatacept and Tocilizumab
- 9:00AM-11:00AM
-
Abstract Number: 2617
Economic Burden of Non-Responders to Biologic DMARD Treatments in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2229
Economic Burden of Rheumatoid Arthritis Is Higher for ACPA-Positive Patients
- 9:00AM-11:00AM
-
Abstract Number: 2234
Economic Impact of Above-Label Dosing with Biologics in Patients with Moderate-to-Severe Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2486
Effect of a Dynamic Exercise Program in Combination with a Mediterranean Diet in Strength, Joint Mobility and Disease Activity in Women with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2174
Effect of Anti-Rheumatic Treatment on Selenium Levels in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2379
Effect of Canakinumab Treatment on Health-Related Quality of Life in Patients with Periodic Fever Syndromes
- 9:00AM-11:00AM
-
Abstract Number: 2795
Effect of Complete or Partial Proteinuria Recovery Compared to No Recovery at 2 Years after the Diagnosis of Lupus Nephritis on Long Term Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 2633
Effect of Different Biologic Agents on Lipid Profile in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2371
Effect of Etanercept on Several Soluble Biomarkers in a Randomized Controlled Trial of Patients with Erosive Hand Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2606
Effect of Glucocorticoids on Clinical and Radiographic Efficacy Outcomes in Methotrexate-Naive Patients with RA Receiving Tofacitinib or Methotrexate Monotherapy: Analysis of Data from a Phase 3 Trial
- 9:00AM-11:00AM
-
Abstract Number: 2549
Effect of Interleukin-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type 9 Serum Levels in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2535
Effect of Methotrexate in the Presence of Drug and the Appearance of Antibodies Against Tumour Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2372
Effect of Oxytocin on Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2439
Effect of Pregnancy Counseling on the Outcome of Pregnancies in Women with Systemic Lupus Erythematosus: A Prospective Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 2615
Effect of Sarilumab on Circulating Biomarkers of Bone and Joint Destruction in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors
- 9:00AM-11:00AM
-
Abstract Number: 2662
Effect of Tobacco Smoking on the Clinical, Histopathological, and Serological Manifestations of SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2324
Effects of 12 Weeks Low-Intensity Blood-Flow Restricted Resistance Training on Knee Extensor Strength in Patients with Sporadic Inclusion Body Myositis
- 9:00AM-11:00AM
-
Abstract Number: 2632
Effects of Baseline Patient Characteristics on Baricitinib Efficacy in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2444
Effects of Disease Activity and Drug Exposure on Pregnancy Outcomes with Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2236
Effects of Repository Corticotropin Injection on Medication Use in Patients with Rheumatologic Conditions: A Claims Data Study
- 9:00AM-11:00AM
-
Abstract Number: 12L
Efficacy and Safety of Atacicept in Patients with Systemic Lupus Erythematosus: Results of a 24-Week Randomized, Placebo-Controlled, Phase IIb Study
- 9:00AM-11:00AM
-
Abstract Number: 2380
Efficacy and Safety of Canakinumab in Patients Aged One to Six Years with Cryopyrin-Associated Periodic Syndromes: Results of an Open-Label, Phase III Extension Study
- 9:00AM-11:00AM
-
Abstract Number: 9L
Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant Familial Mediterranean Fever, Hyper-Immunoglobulin D Syndrome/Mevalonate Kinase Deficiency and TNF Receptor-Associated Periodic Syndrome: 40 Week Results from the Pivotal Phase 3 Umbrella Cluster Trial
- 9:00AM-11:00AM
-
Abstract Number: 2374
Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Follow-up Study
- 9:00AM-11:00AM
-
Abstract Number: 2555
Efficacy and Safety of Conventional and Targeted Synthetic Disease-Modifying Antirheumatic Drugs As Well As Glucocorticoids: A Systematic Literature Review Informing the 2016 Update of the Eular Recommendations for the Management of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 10L
Efficacy and Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitors: OPAL Beyond, a Randomized, Double Blind, Placebo-Controlled, Phase 3 Trial
- 9:00AM-11:00AM
-
Abstract Number: 2968
Efficacy of Anti-TNF Alpha in Severe and Refractory Cardiovascular Involvement of Behcet’s Disease: A Multicenter Observational Study of 18 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2894
Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 2672
Elderly Patients Risk a False Positive Diagnosis of Primary Sjogren’s Syndrome If a Positive Labial Gland Biopsy Is Solely Based on Focus Score
- 9:00AM-11:00AM
-
Abstract Number: 2725
Elevated Disease Activity in Disease-Related Spondyloarthritis Despite Use of Tumor Necrosis Factor Inhibitor Therapies
- 9:00AM-11:00AM
-
Abstract Number: 2706
Elevated Levels of Serum Myeloid Related Protein 8/14 in Ankylosing Spondylitis: Associated with Peripheral Arthritis and Active Disease
- 9:00AM-11:00AM
-
Abstract Number: 2577
Elevated Matrix Metalloproteinases Levels in Oral Fluids of Most Rheumatoid Arthritis Patients, Even without Frank Periodontitis
- 9:00AM-11:00AM
-
Abstract Number: 2931
Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells
- 9:00AM-11:00AM
-
Abstract Number: 2459
Epidemiologic Profile of Erectile Dysfunction in SLE: A Multi-Center Study in Latin American Patients
- 9:00AM-11:00AM
-
Abstract Number: 2665
Epratuzumab Treatment of Patients with Systemic Lupus Erythematosus and Secondary Sjogren’s Syndrome: An Exploratory Analysis of Phase 3 Studies
- 9:00AM-11:00AM
-
Abstract Number: 2458
Erectile Dysfunction in Men with Rheumatic Diseases: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 2675
Essdai, Clinessdai and DAS Scoring at Diagnosis of Primary Sjogren Syndrome: Association with the Development of Hematologic and Solid Neoplasias in 1301 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2392
Establishing Quality of Life Content Domains in Pediatric Localized Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 2252
Estimated Cost of SLE Hospitalizations
- 9:00AM-11:00AM
-
Abstract Number: 2579
Etanercept Treatment Does Not Adversely Affect Traditional Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2678
EULAR Primary SjöGren’s Syndrome Disease Activity Index (ESSDAI), Results from the National Registry of the Spanish Society of Rheumatology (SJÖGRENSER)
- 9:00AM-11:00AM
-
Abstract Number: 2727
Evaluating Psoriatic Arthritis and Psoriasis Skin Lesions: Ultrasound As a Complementary Measure
- 9:00AM-11:00AM
-
Abstract Number: 2323
Evaluation of Case-Finding Algorithms for Identification of Patients with Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 2382
Evaluation of Intestinal Inflammation in Children with FMF
- 9:00AM-11:00AM
-
Abstract Number: 2451
Evaluation of Ovarian Reserve and Function in Adolescent Females with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2664
Evaluation of Thyroid Autoimmune Disease in Primary SjöGren’s Syndrome and Its Association with Disease Phenotype
- 9:00AM-11:00AM
-
Abstract Number: 2184
Evidence Based Physical Activity Threshold to Predict Improved/High Function in Older Adults with Lower Extremity Conditions: The Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 2274
Evidence of Phospho-Degron Regulating Expression of Urate Secretory Transporter ABCG2
- 9:00AM-11:00AM
-
Abstract Number: 2693
Evolution of Disease Activity over a 5-Year Period in the 395 Patients with Primary SjöGren’s Syndrome of the Assess Prospective Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2722
Evolution over Thirty Years of the Profile of Inpatients with Reactive Arthritis in a Tertiary Rheumatology Unit
- 9:00AM-11:00AM
-
Abstract Number: 2860
Exercise Significantly Improves Cardiorespiratory Fitness and Reduces Disease-Related Fatigue without Adverse Effects on Disease Activity in Systemic Lupus Erythematosus: a Systematic Review with Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2277
Exon Sequencing Reveals a Significant Burden of Non-Synonymous Variants in Both SLC22A11 (OAT4) and SLC22A12 (URAT1) in European Hyperuricemic Individuals
- 9:00AM-11:00AM
-
Abstract Number: 2114
Exposure to Carbamylated Self- and Non-Self-Proteins Can Lead to a Break-of -Tolerance and the Induction of Autoimmunity
- 9:00AM-11:00AM
-
Abstract Number: 2885
Expression Levels and Function of the Inhibitory Molecule, Immunoglobulin like Transcript 7 (ILT7), Are Decreased on Circulating Plasmacytoid Dendritic Cells in SLE Patients with High ANA Titers
- 9:00AM-11:00AM
-
Abstract Number: 2962
Expression Profile of Chemokines Is Skewed to Th17/Th22 Recruitment in Circulation of Patients with Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2129
Extracellular Adenosine Deficiency Plays a Role in the Pathogenesis of Osteoarthritis (OA) and Adenosine Replacement Prevents Post-Traumatic Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2370
Factors Affecting Interval Changes in Perceived Fatigue over Five Years in Patients with Rheumatoid Arthritis Compared with Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2733
Fatigue, Pain and Patient Global Assessment Fluctuate Substantially in Spondyloarthropathy Patients with Stable Disease According to Basdai
- 9:00AM-11:00AM
-
Abstract Number: 2607
Favorable Changes in Lipid Profile with Additive DMARD Therapy in Rheumatoid Arthritis Patients Failing Methotrexate Monotherapy
- 9:00AM-11:00AM
-
Abstract Number: 2890
Feasibility of Same Day Adipose Tissue Harvest, Cell Processing and Subcutaneous Delivery of Adipose Derived Regenerative Cells into Fingers of Scleroderma Patients within a Randomized Double Blind Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 2948
Fecal Calprotectin Level Is Useful in Identifying Active Disease in Behçet’s Syndrome Patients with Gastrointestinal Involvement: A Controlled Study
- 9:00AM-11:00AM
-
Abstract Number: 2282
Ferritin Levels Are Associated with Urate and Gout – a Role for Iron Metabolism in Gout ?
- 9:00AM-11:00AM
-
Abstract Number: 2440
First Results from the Prospective German Pregnancy Register
- 9:00AM-11:00AM
-
Abstract Number: 2309
Focal Myositis: New Insights on Diagnosis and Pathology
- 9:00AM-11:00AM
-
Abstract Number: 2123
Follistatin-like Protein 1 Is a Potent Regulator of Articular Chondrocytes in Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2913
Four Year Effects of Combined Bosentan and Iloprost Treatment on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion and Clinical Status, in Systemic Sclerosis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2151
Fractalkine (CX3CL1) Is Expressed By Arterial Endothelium and Vascular Smooth Muscle Cells (VSMC) in GCA
- 9:00AM-11:00AM
-
Abstract Number: 2774
Framingham Risk Score Discriminates Coronary Atherosclerosis in Psoriatic Arthritis Patient Better Than Other Cardiovascular Scores Do
- 9:00AM-11:00AM
-
Abstract Number: 2162
Frequent Discussion of Insomnia and Weight Gain with Glucocorticoid Therapy: An Analysis of Twitter Posts
- 9:00AM-11:00AM
-
Abstract Number: 2268
Fructose Amplifies Inflammatory Potential in Human Monocytic Cells Via Reduction of AMP-Activated Protein Kinase Activity
- 9:00AM-11:00AM
-
Abstract Number: 2144
Functional Analysis of Macrophages in BehçEt’s Disease: C-C Chemokine Receptor Type 1 (CCR1) and IL-10 Are Implicated in Pathogenesis of the Disease
- 9:00AM-11:00AM
-
Abstract Number: 2573
Galectin 1 As Potential Prognostic Biomarker in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2751
Gender and Disease Duration Are Associated with Extra-Articular Manifestations in Axial Spondyloarthropathy
- 9:00AM-11:00AM
-
Abstract Number: 2756
Gender Differences in Body Composition with Dual-Energy X-Ray Absorptiometry in TNF-α Blocker Naive Ankylosing Spondylitis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2111
Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B-Cell Clones
- 9:00AM-11:00AM
-
Abstract Number: 2410
Genetic Architecture of Systemic Juvenile Idiopathic Arthritis Distinguishes It from Oligoarticular and Polyarticular Forms of Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2695
Genetic Association of Ankylosing Spondylitis with TBX21 Influences T-Bet and Pro-Inflammatory Cytokine Expression in Humans and SKG Mice As a Model of Spondyloarthritis and Alters Host Microbiome and Response to Microbial Stimuli
- 9:00AM-11:00AM
-
Abstract Number: 2409
Genetic Insights into Juvenile Idiopathic Arthritis Derived from Deep Whole Genome Sequencing
- 9:00AM-11:00AM
-
Abstract Number: 2715
Genetic Variants in TNF, TNFRSF1A, and IL23R Are Associated with Risk of Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2720
Genome-Wide Association Study of Clinical Phenotypes in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2275
Genome-Wide Association Study of Gout in New Zealand Polynesian People
- 9:00AM-11:00AM
-
Abstract Number: 2879
Genome-Wide Pathway Analysis Reveals That VEGF Genetic Pathway Is Associated with Oral Ulcers in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2673
Glandular Ultrasonography in Primary SjöGren Syndrome: Clinical and Laboratory Correlation
- 9:00AM-11:00AM
-
Abstract Number: 2544
Glucocorticoid Treatment for 12 Weeks in Early Rheumatoid Arthritis Is Related to an Increase in BMI
- 9:00AM-11:00AM
-
Abstract Number: 2541
Glucocorticoid Use and Low Thoracic Bone Mineral Density Are Predictors for Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of the Tomorrow Study
- 9:00AM-11:00AM
-
Abstract Number: 2246
Glucocorticoids in Early Rheumatoid Arthritis Management, Friend or Foe?
- 9:00AM-11:00AM
-
Abstract Number: 2301
Gout and Subsequent Risk of Incident Erectile Dysfunction: A Population-Based Cohort Study from the United Kingdom
- 9:00AM-11:00AM
-
Abstract Number: 2241
Health Economics of Uncontrolled Gout in the United States: A Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 2859
Health-Related Interference of Social Activities and Suicidal Ideation in Systemic Lupus Erythematosus: Georgians Organized Against Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2086
Hexagonal Phase Phospholipid Neutralization Assay Is the Most Sensitive but Least Specific Among Nine Tests for Detecting APS in SLE or Non-SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 2566
Hexokinase 2 As a Novel Metabolic Target for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2181
High Dietary Fiber Intake Is Associated with Lower Likelihood of Severe Knee Pain Trajectory
- 9:00AM-11:00AM
-
Abstract Number: 2417
High Dimensional Interrogation of the T Cell Immunome in Polyarticular Juvenile Idiopathic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2139
High Fat Diet Induced Longitudinal Metabolic Changes Contribute to Acceleration of Osteoarthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2863
High Frequency of Terminally Differentiated CD8+ T Cells Characterize Systemic Lupus Erythematosus Patients with Renal Involvement
- 9:00AM-11:00AM
-
Abstract Number: 2319
High Prevalence of Asymptomatic Vertebral Fractures in Inflammatory Myositis
- 9:00AM-11:00AM
-
Abstract Number: 2537
High Retention Rates and Clinical Efficacy of Tocilizumab As First-Line Biologic Treatment in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2818
High Sensitivity Multiplex ELISA Reveals Cytokine Expression Heterogeneity in Active SLE
- 9:00AM-11:00AM
-
Abstract Number: 2358
High-Fat Diet Is Associated with a Higher Incidence of Radiographic Knee OA and Progression of Knee Joint Space Narrowing: Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 2771
Higher Incident Rates of Comorbidities in Patients with Psoriatic Arthritis (PsA) Compared to Controls
- 9:00AM-11:00AM
-
Abstract Number: 2462
Higher Number of Tender Than Swollen Joint Count Is Associated to Higher Patient Reported Outcomes and Composite Scores As Well As Reduced Probability of Obtaining Remission: Results from a One-Year Follow-up Study of Established RA Patients Starting Bdmards
- 9:00AM-11:00AM
-
Abstract Number: 2355
Histology of Bone Marrow Lesions in Osteoarthritis: A Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 2838
Histopatholgic Predictors of Poor Renal Outcomes in a Multi-Ethnic Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2256
Histopathologic Features and Tissue Interferon-Response Gene Scoring of Lesional Skin Samples for Diagnosis in Autoinflammatory Disorders
- 9:00AM-11:00AM
-
Abstract Number: 2932
HLA-DR3 Restricted Response to Lupus-Related Auto-Antigen Smd: Autoreactive T Cells Are Inherent in Normal Immune Repertoires
- 9:00AM-11:00AM
-
Abstract Number: 2933
HLA-DR3 Restricted T Cell Response to Smd and Ro60 Reveals Multiple Cross-Reactive Intra- and Inter-Molecular T Cell Epitopes: Unique Antigenic Structures of Lupus-Related Auto-Antigens and the Basis for B Cell Epitope Spreading
- 9:00AM-11:00AM
-
Abstract Number: 2742
How Are Enthesitis, Dactylitis and Nail Involvement Measured and Reported in Recent Clinical Trials of Psoriatic Arthritis (PsA)? a Systematic Literature Review
- 9:00AM-11:00AM
-
Abstract Number: 2682
How Does Primary Sjogren Syndrome Present in Biopsy-Proven Patients without Circulating Ro/La Autoantibodies? Characteristics at Diagnosis of 2073 Patients from the SjöGren Big Data Project
- 9:00AM-11:00AM
-
Abstract Number: 2469
How Rheumatoid Arthritis Patients and Rheumatologists Communicate during Clinic Visits When a New DMARD Is Prescribed
- 9:00AM-11:00AM
-
Abstract Number: 2412
Human Gut Microbial Species Correlate with Arthritis in the K/BxN Mouse Model
- 9:00AM-11:00AM
-
Abstract Number: 2783
Human Mesenchymal Stem Cells from Different Tissues Exert Distinct Therapeutic Effect on Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2562
Human Seroreactivity to Gut Microbiota Antigens in Rheumatoid Arthritis and Controls-Lack of Association with Rheumatoid Arthritis Autoantibodies
- 9:00AM-11:00AM
-
Abstract Number: 2792
Hyperhomocysteinemia in SLE
- 9:00AM-11:00AM
-
Abstract Number: 2958
Hypocomplementemic Urticarial Vasculitis (HUV) Syndrome in Two Geographically Defined Populations of Sweden
- 9:00AM-11:00AM
-
Abstract Number: 2928
Hypomethylation of an Intragenic Alternative Promoter Contributes to Impaired Treg Function in Rheumatoid Arthritis By Transcriptional Interference with Expression of the Treg-Specific Protein, Glycoprotein a Repetitions Predominant (GARP)
- 9:00AM-11:00AM
-
Abstract Number: 2563
Hypoxia Induce Slug Expression Via JAK/STAT3 Pathway in Rheumatoid Arthritis Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 2696
Identification of a Potential Commensal Immunologic Target in Enthesitis-Related Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2427
Identification of Biomarkers Using Tear Proteomics in Children with Chronic Anterior Uveitis
- 9:00AM-11:00AM
-
Abstract Number: 2121
Identification of microRNA-181a-5p and microRNA-4454 As Mediators of Facet Cartilage Degeneration
- 9:00AM-11:00AM
-
Abstract Number: 2142
Identification of Novel Molecules Targeting Cartilage Aging As Osteoarthritis Therapeutics
- 9:00AM-11:00AM
-
Abstract Number: 2817
Identification of Subsets of Systemic Lupus Erythematosus Patients By Principal Component Analysis and Urine Biomarkers
- 9:00AM-11:00AM
-
Abstract Number: 2967
Identifying Core Domains for BehçEt’s Syndrome Trials: An International Physician and Patient Delphi Exercise
- 9:00AM-11:00AM
-
Abstract Number: 2864
Identifying Dysregulated and Co-Dysregulated Markers in Systemic Lupus Erythematosus Using Multi-Modal Biomarker Data from a Large Pre-Clinical Study
- 9:00AM-11:00AM
-
Abstract Number: 2461
Identifying Flare in Rheumatoid Arthritis: What Is the Threshold?
- 9:00AM-11:00AM
-
Abstract Number: 2475
Identifying Key Variables for Inclusion in a Smartphone App to Support Clinical Care and Research in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2574
IL-22 As a Biomarker for Erosive Disease in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2156
IL-6 and TNF-α Modulate Expressions of Cell Cycle Regulators of Rheumatoid Arthritis Fibroblast-like Synoviocytes
- 9:00AM-11:00AM
-
Abstract Number: 2731
Illness Perceptions and Health-Related Quality of Life in Patients with Axial Spondyloarthritis and Other Forms of Chronic Back Pain in the Spondyloarthritis Caught Early (SPACE)-Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2432
Immune Abnormalities Leading to Exaggerated Production of IFN-Gamma (IFNγ) and the Therapeutic Response to an Anti-IFNγ Antibody in a Patient with NRLC4 Mediated Disease
- 9:00AM-11:00AM
-
Abstract Number: 2781
Immunization with ApoB100 Peptide Vaccine Reduces Atherosclerosis Development in a Mouse Model of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2814
Immunofluorescence Pattern and Titer of the Antinuclear Antibody Test Correlate with Disease Activity in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2610
Immunogenicity Assessment of Biologics in Clinical Studies in Chronic Inflammatory Disease: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 2844
Immunoglobulins Level and Risk of Infection in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2109
Immunoprofiling of Bruton’s Tyrosine Kinase (Btk)/Tec Family Kinase Inhibitors Indicate Activities Beyond Btk in Immunocyte Function
- 9:00AM-11:00AM
-
Abstract Number: 2172
Impact of Biologic and Non-Biologic Treatment on the Incidence of Traditional Cardiovascular Risk Factors Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 2543
Impact of Concomitant Methotrexate Administration on the Risk of Infections Among Rheumatoid Arthritis Patients Treated with Anti-TNF in Real-World
- 9:00AM-11:00AM
-
Abstract Number: 2730
Impact of Disease Flare Perception on Work Productivity and Treatment Satisfaction in Patients with Psoriatic Arthritis in Real World Setting
- 9:00AM-11:00AM
-
Abstract Number: 2220
Impact of Fibromyalgia on DAS28 in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2551
Impact of Multmorbidity on Disability and Disease Activity over Time in Patients with RA Taking Biologics: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2721
Impact of Nail Psoriasis on Clinical Presentation of Psoriatic Arthritis—Descriptive Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
- 9:00AM-11:00AM
-
Abstract Number: 2490
Impact of Obesity Activity Indices and Therapeutic Dosage in Patients with Rheumatoid Arthritis in Dominican Republic
- 9:00AM-11:00AM
-
Abstract Number: 2531
Impact of Participation in the Adalimumab (Humira) Patient Support Program on Functional and Clinical Outcomes Among Patients with Rheumatoid Arthritis: Passion Study
- 9:00AM-11:00AM
-
Abstract Number: 2291
Impact of Plasma Urate and Tophaceous Burden on Inflammatory Biomarkers of Cardiovascular Disease
- 9:00AM-11:00AM
-
Abstract Number: 2478
Impact of Poor Prognostic Factors on Treatment Decisions in Clinical Practice in Patients with Rheumatoid Arthritis: Findings from a US Observational Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2899
Impact of the Clinical Characteristics of Systemic Sclerosis in Patients Quality of Life
- 9:00AM-11:00AM
-
Abstract Number: 2671
Impaired Bone Health in Patients with Primary Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2504
Impaired Vasodilator Function in Rheumatoid Arthritis Patients Who Flared Due to Stopping Adalimumab or Etanercept
- 9:00AM-11:00AM
-
Abstract Number: 2509
Implementation of the Treat to Target Concept in Evaluation of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2837
Importance of Mixed Speckled/ Homogeneous DFS70 ANA Patterns
- 9:00AM-11:00AM
-
Abstract Number: 2306
Improving Predictive Value of Gout Case Definitions in Electric Medical Records Utilizing Natural Language Processing: a Novel Informatics Approach
- 9:00AM-11:00AM
-
Abstract Number: 2487
In Patients with Rheumatoid Arthritis in Clinical Remission Undergoing Treatment Tapering Tenosynovitis and Synovitis Detected By Ultrasonography Predict Disease Flare
- 9:00AM-11:00AM
-
Abstract Number: 2638
In Vitro Expansion of Treg By Adaimumab Predicts Clinical Response to Therapy in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2970
Incidence and Characteristics of Vasculitis Associated with Monoclonal Antibodies and Peptide Fusion Proteins: A Survey from the French National Pharmacovigilance Database
- 9:00AM-11:00AM
-
Abstract Number: 2298
Incident Risk of Acute Gout Among Active Smokers: Data from Nationwide Inpatient Sample
- 9:00AM-11:00AM
-
Abstract Number: 2975
Increase of Sacroiliitis By Follow-up and Routine CT in Patients with Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2701
Increased Frequency of Regulatory CD19+CD24high Cd38high B Cells in Patients with Ankylosing Spondylitis (AS)
- 9:00AM-11:00AM
-
Abstract Number: 2960
Increased Post-Thrombotic Syndrome Is Unassociated with Anticoagulant Use in Vascular Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2171
Increased Rates of Hypertension in Patients with Psoriatic Arthritis Compared to Psoriasis Alone: Results from the UK Biobank
- 9:00AM-11:00AM
-
Abstract Number: 2438
Increased Risk of Postpartum Depression in SLE Pregnancies
- 9:00AM-11:00AM
-
Abstract Number: 2621
Incremental Benefit of Radiographic Inhibition on Long-Term Outcomes in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2226
Independent and Combined Association of Overall Physical Fitness and Subjective Well-Being Components with Fatigue in Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2446
Infantile Hemangiomas in Infants Born to Women with Autoimmune Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2449
Infertility in Women with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2270
Inflammasome/IL-1β Activation Induced By Calcium Pyrophosphate Dihydrate Crystals Is Mainly Driven By a P2X7 Receptor-Independent Potassium Efflux
- 9:00AM-11:00AM
-
Abstract Number: 2344
Inflammation and Glucose Homeostasis Are Associated with Specific Structural Features Among Adults without Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2980
Inflammation As an Under-Recognized Cause of Ascending Aortic Aneurysms: A Single-Center Clinical and Pathological Study of 53 Cases over 6 Years
- 9:00AM-11:00AM
-
Abstract Number: 2413
Inflammation Regulating microRNAs, Mir-146b, Mir-155 and Mir-192-5p Are Altered in Plasma and Synovial Fluid of Oligoarticular Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2166
Inflammatory Arthropathy and Hashimoto’s Thyroiditis: Prevalence and Associated Factors
- 9:00AM-11:00AM
-
Abstract Number: 2288
Inflammatory Status and Serum Uric Acid Determine High-Density Lipoprotein Cholesterol Levels in a Non-Rheumatic Population
- 9:00AM-11:00AM
-
Abstract Number: 2481
Infliximab Low Levels at Early Stages Predict the Loss of Drug Levels and the Clinical Response at One Year of Treatment in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2224
Influence of Caffeine on Opioid Analgesics in Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2307
Influence of Season and Residential Environment on Development of Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis with Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 2311
Initial Predictors of Short-Term Poor Survival Rates in Patients with Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 2396
Initiation of Dialysis in Pediatric ANCA-Associated Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 2245
Injectable Corticosteroid Use in Musculoskeletal Care Specialties
- 9:00AM-11:00AM
-
Abstract Number: 2377
Innovative Use of PK and PD to Guide Dose Selection for a Monoclonal Antibody Aimed at Neutralizing the High IFNγ Activity Present in Patients with Macrophage Activation Syndrome (MAS)
- 9:00AM-11:00AM
-
Abstract Number: 2518
Intensive Treatment for Rheumatoid Arthritis Reduces Disease Activity over Time
- 9:00AM-11:00AM
-
Abstract Number: 2326
Intravenous Cyclophosphamide Followed By Oral Immunosuppressive Treatment Versus Rituximab in Inflammatory Myopathy-Related Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 2329
Intravenous Immunoglobulins in the Treatment of Idiophatic Inflammatory Myopathies: Where Do We Stand?
- 9:00AM-11:00AM
-
Abstract Number: 2623
Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase 1, Proof-of-Concept Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 2712
Inverse Correlation Between IL-10-Producing Bregs and IFN-Gamma-Producing NK Cells in Psoriatic Arthritis and Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 2420
Investigating Genome-Wide Inbreeding Coefficients and Age of Diagnosis in a Multi-Ethnic Population of Childhood-Onset Systemic Lupus Erythematosus (cSLE)
- 9:00AM-11:00AM
-
Abstract Number: 2090
Investigating the Genetic Variations of Antiphospholipid Syndrome By High-Throughput Exome Sequencing
- 9:00AM-11:00AM
-
Abstract Number: 2734
Is Disease Activity Associated with Negative Illness Perceptions in Early Axial Spondyloarthritis Patients in the Spondyloarthritis Caught Early (SPACE)-Cohort?
- 9:00AM-11:00AM
-
Abstract Number: 2821
Is Hyperuricemia an Independent Risk Factor for Arterial Thrombosis in Systemic Lupus Erythematosus?
- 9:00AM-11:00AM
-
Abstract Number: 2491
Is It Possible to Predict Which Patients Treated with Biologic Agents for Rheumatic Diseases Will Develop Anti-Drug Antibodies ?
- 9:00AM-11:00AM
-
Abstract Number: 2198
Is Joint Hypermobility Related to Foot Osteoarthritis and Symptoms?
- 9:00AM-11:00AM
-
Abstract Number: 2777
Is There a Difference in Clinical Features and Burden of Disease in Patients with Axial Spondyloarthritis with and without Extra-Articular Manifestations?
- 9:00AM-11:00AM
-
Abstract Number: 2389
Is There a Difference in the Presentation of Diffuse and Limited Subtype in Childhood? Results from the Juvenile Scleroderma Inception Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2778
Is There Any Gender Specific Difference in Discriminative Value of Inflammatory Back Pain Criteria?
- 9:00AM-11:00AM
-
Abstract Number: 2683
Isolated Anti-La/SS-B Positivity in Patients Diagnosed with Primary Sjogren Syndrome: Analysis of 222 Patients from the Sjogren Big Data Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2489
Joint Damage Appears As Severe As Inflammation According to Physician Visual Analog Scales in Patients with Rheumatoid Arthritis Regardless of Disease Severity at 2 Sites, Which May Limit Results of a Treat-to-Target Strategy
- 9:00AM-11:00AM
-
Abstract Number: 2122
KiSS1 Is a Regulator of ADAMTS4 and ADAMTS5 Expression and Is Post-Transcriptionally Regulated By Micro-RNA N105 in Human OA Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 2135
Knee Osteoarthritis Pain Is Differentially Associated with Tissue Degradation and Joint Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 2854
Laboratory and Demographic Longitudinal Profile of a Large Cohort of Individuals Presenting with the ANA Nuclear Dense Fine Speckled Immunofluorescence Pattern
- 9:00AM-11:00AM
-
Abstract Number: 2634
Lack of Autoantibodies to Peptidyl Arginine Deiminase 4 Predict Increased Efficacy of Mavrilimumab in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2264
Lack of Obesity-Related Changes in Adipocytes and Inflammatory Cells in the Infrapatellar Fat Pad (IFP): A Different Type of Fat?
- 9:00AM-11:00AM
-
Abstract Number: 2824
Lack of Partial Renal Response By 12 Weeks after Induction Therapy Is an Indicator to Switch the Treatment in Lupus Nephritis Class III or IV for Reducing Future Damage Accrual
- 9:00AM-11:00AM
-
Abstract Number: 2147
Lack of Pro-Inflammatory Cyto/Chemokines in ANA+ Individuals with Insufficient Criteria for a Diagnosis of Systemic Autoimmune Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 2946
Large Scale Genetic Analysis in BehçEt Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci
- 9:00AM-11:00AM
-
Abstract Number: 2965
Late-Onset Relapse in Patients with Systemic Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 2182
Levels of Severity of Hip and Knee OA – Validation of Lay Descriptions
- 9:00AM-11:00AM
-
Abstract Number: 2550
Long Persistence of Anti-Drug Antibodies in Adalimumab Treated RA Patients
- 9:00AM-11:00AM
-
Abstract Number: 2482
Long Term Drug Survival of Adalimumab and Etanercept Treatment for Rheumatoid Arthritis with and without Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 2852
Long Term Prognosis of Lupus Nephritis in the Afro-Caribbean Population of Martinique with Free Access to Healthcare
- 9:00AM-11:00AM
-
Abstract Number: 2517
Long-Term Stability of the 5-Item Compliance Questionnaire Rheumatology As a Measure of Adherence in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2835
Longitudinal Analysis of Th1 and Th2 Cytokines in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2349
Longitudinal Construct Validity for Four Patient-Reported Outcomes Measurement Information System (PROMIS) Short Forms: Physical Function, Pain Interference, Depression, and Anxiety Among Adults with Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2511
Longitudinal Observation of Disease Activity and Treatment of Rheumatoid Arthritis Who Developed Methotrexate-Associated Lymphoproliferative Disorders
- 9:00AM-11:00AM
-
Abstract Number: 2833
Low Plasma Concentrations of Apolipoprotein M Correlate to Disease Activity and Endothelial Dysfunction in SLE
- 9:00AM-11:00AM
-
Abstract Number: 2796
Low Versus High Dose Glucocorticosteroid Used in Lupus Nephritis: Is There a Difference
- 9:00AM-11:00AM
-
Abstract Number: 13L
Low-Dose IL-2 Therapy in Refractory SLE: Results from Single Center Phase I/IIa Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 2521
Lower Baseline 14-3-3η Levels Are Associated with Better Patient Reported Outcomes in Tocilizumab Treated Patients
- 9:00AM-11:00AM
-
Abstract Number: 2866
Lupus HDL Induces Pro-Inflammatory Responses in Macrophages By Binding LOX1Rand Failing to Promote ATF3 Activity
- 9:00AM-11:00AM
-
Abstract Number: 2513
Maintained Remission in Rheumatoid Arthritis over 7 Years in «Real Life Conditions» : A Monocentric Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 2124
Maintenance of Chondrocyte Phenotypic Stability By TRPC6 Calcium Channel Activity
- 9:00AM-11:00AM
-
Abstract Number: 2878
Major Lymphocyte Populations Share a Common Interferon Signature but Express Cell Type-Specific Interferon Pathway Genes in SLE
- 9:00AM-11:00AM
-
Abstract Number: 2503
Making Room for RA Patient Symptoms into Treatment Decision: A Physician Perspective Study
- 9:00AM-11:00AM
-
Abstract Number: 2305
Mapping the Topography of Gout Flares: Solutions for Flare Reporting in Gout Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 2732
Meaningful Involvement of Patients in the Development of a Core Outcome Set for Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2429
Mechanisms for the Development of Lung Fibrosis in Sting-Associated Vasculopathy with Onset in Infancy (SAVI)
- 9:00AM-11:00AM
-
Abstract Number: 2927
Mechanisms Regulating the Loss of Tregs in CD11c-Flip-KO Mice That Contribute to the Spontaneous Development of Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2208
Mediators of the Relationship Between Pain and Disability in the Distal Upper Limb
- 9:00AM-11:00AM
-
Abstract Number: 2393
Medication Use in the Juvenile Systemic Sclerosis Inception Cohort. ARE There Differences in the Diffuse and Limited Subset Patients?
- 9:00AM-11:00AM
-
Abstract Number: 2406
Mental Health Care for Adolescents with Rheumatologic Conditions: Perspectives from Pediatric Behavioral Health Providers in North America
- 9:00AM-11:00AM
-
Abstract Number: 2784
Mesenchymal Stem Cells Ameliorate Lupus By Promoting T Cell Apoptosis Via Bcl-2/Bim Independent Pathway in MRL/Lpr Mice
- 9:00AM-11:00AM
-
Abstract Number: 2168
Metabolic Syndrome, All Cause Mortality and Atherosclerotic Cardiovascular Disease in Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2532
Methotrexate Adherence in an Online Network of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2261
Methotrexate Inhibits Intracellular Redox Signaling Induced By the Reactive Oxygen Species; Malondialdehyde and Acetaldehyde
- 9:00AM-11:00AM
-
Abstract Number: 2836
Microparticles of Endothelial Origin in Women with Systemic LUPUS Erythematosus UNDER Treatment
- 9:00AM-11:00AM
-
Abstract Number: 2414
Microrna Associated with Active Systemic Juvenile Idiopathic Arthritis Regulate CD163 Expression in Polarized Macrophages through Two Distinct Mechanisms
- 9:00AM-11:00AM
-
Abstract Number: 2099
Micrornas As Potential Modulators of Atherothrombosis in Antiphospholipid Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2897
Microvascular Function in Systemic Sclerosis Patients with End-Stage Vascular Manifestations of the Disease
- 9:00AM-11:00AM
-
Abstract Number: 2332
Midterm Outcome of Modular Metal-on-Metal Total Hip Arthroplasty
- 9:00AM-11:00AM
-
Abstract Number: 2767
Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Evaluation of Modified Minimal Disease Activity upon Elimination of Each Component
- 9:00AM-11:00AM
-
Abstract Number: 2758
Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Which Unmet Criteria Are More Prevalent Among Responders?
- 9:00AM-11:00AM
-
Abstract Number: 2492
Mode of Administration in Rheumatoid Arthritis Treatments: An Exploration of Patient Preference for an ‘Ideal Treatment’
- 9:00AM-11:00AM
-
Abstract Number: 2230
Models Using Claims-Based Administrative Data Are Poor Predictors of Rheumatoid Arthritis Disease Activity in VA Rheumatoid Arthritis (VARA) Patients
- 9:00AM-11:00AM
-
Abstract Number: 2697
Modulator Role of Inducible Costimulator (ICOS) in Spondyloarthritis Animal Model
- 9:00AM-11:00AM
-
Abstract Number: 2280
Monosodium Urate Crystal-Induced Inflammation Promotes Osteocyte Expression of Pro-Resorptive and Inflammatory Mediators: Implications for Erosive Gout
- 9:00AM-11:00AM
-
Abstract Number: 2281
Monosodium Urate Monohydrate (MSU) Crystals Induces Cartilage Degeneration By Accelerating Hypertrophy and Mineralization.
- 9:00AM-11:00AM
-
Abstract Number: 2401
Mucocutaneous Lesions and Recurrent Fevers in Patients with Trisomy 8 Mosaicism and Chromosome 8 Duplication
- 9:00AM-11:00AM
-
Abstract Number: 2520
Multi-Biomarker Disease Activity (MBDA) Score and Prediction of Radiographic Progression in a Randomized Study of Patients with Early RA Treated with Methotrexate Alone or with Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 2798
Multi-Center Validation of Platelet Bound C4d, a Biomarker for Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2411
Multiple Genetic Susceptibility Loci in Juvenile Idiopathic Arthritis Are Bound By a Set of Transcription Factors
- 9:00AM-11:00AM
-
Abstract Number: 2405
Musculoskeletal Manifestations As Presenting Symptoms of Inflammatory Bowel Disease in Children and Adolescents
- 9:00AM-11:00AM
-
Abstract Number: 2271
Mutation in Osteoprotegerin Gene: Early-Onset Osteoarthritis and Chondrocalcinosis in a US Family of Italian/German Ancestry
- 9:00AM-11:00AM
-
Abstract Number: 2430
Mutations in the Tyrosine-Protein Kinase Lyn Cause an Early-Onset Neutrophilic Vasculitis Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2582
N-Acetylcysteine Regulates Osteoclastogenesis and Th17 Cell Differentiation in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2917
Nailfold Capillaroscopy and Mortality in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2165
Natural Language Processing to Rapidly Identify Potential Signals for Adverse Events Using Electronic Medical Record Data: Example of Arthralgias and Vedolizumab
- 9:00AM-11:00AM
-
Abstract Number: 2848
Near Patient Anti-Nuclear Antibody Multiplex Testing Using Whole Blood for the Diagnosis of Connective Tissue Diseases in a Tertiary Care Center
- 9:00AM-11:00AM
-
Abstract Number: 2265
NET-Inducing Capacity Is a Biomarker in ANCA-Associated Vasculitis Independent of ANCA Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 2853
Neutrophilia in Systemic Lupus Erythematosus As a Potential Indicator of Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2763
New Treatment Option for SAPHO?
- 9:00AM-11:00AM
-
Abstract Number: 2415
Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (secHLH)
- 9:00AM-11:00AM
-
Abstract Number: 2868
NK Cell Characterization in Patients with Systemic Lupus Erythematosus: Increased Frequency of Ki67+ NK Cells Associated with Disease Activity and Type I Interferon Signature
- 9:00AM-11:00AM
-
Abstract Number: 2636
No Strong Evidence Supporting Predictors for Successful Dose Reduction or Discontinuation of a Biologic in Rheumatoid Arthritis: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 2098
Non-Criteria Anti-Phospholipid Antibodies in SLE Patients
- 9:00AM-11:00AM
-
Abstract Number: 2830
Non-Calcified Coronary Artery Plaque Associates with Adverse Lipoprotein Profiles in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2877
Notch Ligand Delta-like Ligand 4 (DLL4) Expression on Dendritic Cells Is Increased in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2424
Novel Autoantigens for Anti- Endothelial Cell Antibodies in Pediatric Rheumatic Diseases Identified By Proteomics
- 9:00AM-11:00AM
-
Abstract Number: 2832
Novel Gene Variants Associated with Cardiovascular Disease in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2789
Novel Glucocorticoid Prodrug Effectively Attenuates Late Stage Lupus Nephritis with Improved Safety Profile
- 9:00AM-11:00AM
-
Abstract Number: 2154
Novel Pathogenic Functions of IL-11 on RA Joint Fibroblasts and Endothelial Cells
- 9:00AM-11:00AM
-
Abstract Number: 2289
Obesity and Echocardiographic Changes in the Different Stages of Gout
- 9:00AM-11:00AM
-
Abstract Number: 2369
Obesity and Severity of Joint Space Narrowing Are Associated with Viscosupplementation Failure in Patients with Knee Osteoarthritis. Post-Hoc Analysis of a Double-Blind, Controlled, Multicentre, Randomized Trial
- 9:00AM-11:00AM
-
Abstract Number: 2352
Obesity-Related Systemic Inflammation and Knee Synovitis
- 9:00AM-11:00AM
-
Abstract Number: 2686
Objective Improvement in Fatigue Scores for Primary Sjögren’s Patients Receiving a Tailored Multidisciplinary Fatigue Intervention in a Generic Fatigue Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2941
Optimization of Adalimumab on Refractory Uveitis of Behcet’s Syndrome. Multicenter Study of 23 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2956
Optimization of Thiopurines with a Xanthine Oxidase Inhibitor in Patients with Autoimmune Systemic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2320
Oropharyngeal Dysphagia in Autoimmune Myositis
- 9:00AM-11:00AM
-
Abstract Number: 2799
Outcomes in Patients with Early and Delayed Onset Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2805
Outcomes of Lupus Nephritis Patients Following Discontinuation of Treatment
- 9:00AM-11:00AM
-
Abstract Number: 7L
Overall Reduction in Acute Flares during Treatment with Febuxostat Compared with Placebo over 2 Years in Patients with Early Gout
- 9:00AM-11:00AM
-
Abstract Number: 2870
Overexpression of EZH2 at the microRNA-142 Regulatory Region Contributes to Down-Regulation of microRNA-142-3p/5p in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2254
Patient Adherence with Biologic Therapy in Rheumatoid Arthritis: A Real-World Review of Compliance
- 9:00AM-11:00AM
-
Abstract Number: 2394
Patient and Parent Global Assessments of Disease Impact in Pediatric Localized Scleroderma: Correlates of Patient Reported Health-Related Quality of Life and Parent Reported Family Impact Domains
- 9:00AM-11:00AM
-
Abstract Number: 2493
Patient Characteristics and Medication Utilization Patterns of Infliximab-Treated Rheumatoid Arthritis Patients Subsequently Transitioned to Intravenous Golimumab
- 9:00AM-11:00AM
-
Abstract Number: 2525
Patient Characteristics Predicting Remission Using Intensive Treatment Strategies in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2951
Patient Outcomes in Primary Angiitis of the Central Nervous System
- 9:00AM-11:00AM
-
Abstract Number: 2921
Patient Participation in Patient Reported Outcome Instrument Development in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2373
Patient Preference for Display of Electronic Patient-Reported Outcomes in Osteoarthritis Clinical Trials: Wording Emphasis, Question Format, and Navigation Button Placement
- 9:00AM-11:00AM
-
Abstract Number: 2649
Patient Preferences Regarding Rheumatoid Arthritis Therapies in Lebanon: Results from a National, Multicenter, Cross-Sectional Survey
- 9:00AM-11:00AM
-
Abstract Number: 2173
Patient Reported Disease Activity and Efficacy of Biologic Therapy in Patients with Psoriatic Arthritis. an Observational Study of 107 Patients of the Estonian Society for Rheumatology Biologic Therapy Register during 2008-2014
- 9:00AM-11:00AM
-
Abstract Number: 2644
Patient Survey Regarding Generic and Bio-Similar Drugs
- 9:00AM-11:00AM
-
Abstract Number: 2530
Patient´s Motivations for Non-Persistence with Medication Impact How They Score Compliance
- 9:00AM-11:00AM
-
Abstract Number: 2515
Patient-Reported Outcomes in Two Randomized, Controlled Trials (RCTs) in Patients with Rheumatoid Arthritis (RA) Treated with Tocilizumab (TCZ) Monotherapy Compared with Methotrexate (MTX) or Adalimumab (ADA)
- 9:00AM-11:00AM
-
Abstract Number: 2474
Patients’ Experiences of Using a Smartphone App for Remote Monitoring of Rheumatoid Arthritis, Integrated into the Electronic Medical Record, and Its Impact on Consultations
- 9:00AM-11:00AM
-
Abstract Number: 2239
Patterns of Abatacept Utilization in Patients with Rheumatoid Arthritis. Have the Baseline Characteristics of These Patients Changed over Time?
- 9:00AM-11:00AM
-
Abstract Number: 2476
Performance of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) Appears to be Better Than Gold Standard Disease Assessment Score (DAS-28 CRP)
- 9:00AM-11:00AM
-
Abstract Number: 2912
Performance of the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 in Systemic Sclerosis -Associated Interstitial Lung Disease (SSc-ILD)
- 9:00AM-11:00AM
-
Abstract Number: 2661
Performance of the Proposed ACR-EULAR Criteria for Sjogren’s Syndrome in a Prospective Multidisciplinary Diagnostic Cohort from Daily Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 2199
Peri-Aortic Adipose Tissue Volume Is Directly Associated with Fat Accumulation in Adjacent Trunk Muscles Independent of Other Fat Depots: The Framingham Study
- 9:00AM-11:00AM
-
Abstract Number: 2103
Peripheral Blood B Cells Are Expanded and Their Cytokine Expression Is Dysregulated in Juvenile Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 2100
Pharmaceutical Disruption of B2GPI CXCL4 Complex Using Computationally Designed Oligopeptides
- 9:00AM-11:00AM
-
Abstract Number: 2354
Pharmaceutical Grade Chondroitin Sulfate Improves Knee Osteoarthritis Symptoms More Than Placebo and As Much As Celecoxib: Results of the Chondroitin Vs Celecoxib Vs Placebo Trial (CONCEPT)
- 9:00AM-11:00AM
-
Abstract Number: 2378
Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial
- 9:00AM-11:00AM
-
Abstract Number: 2522
Pharmacomicrobiomics of Methotrexate: Baseline Intestinal Microbiota Correlates with Therapeutic Response
- 9:00AM-11:00AM
-
Abstract Number: 2140
Phenotypic and Functional Characteristics of Exosomes Isolated from Human Osteoarthritis (OA) Synovial Fluid
- 9:00AM-11:00AM
-
Abstract Number: 2594
Physician/Site Staff Assessments Contribute to High Placebo Response in Rheumatoid Arthritis Clinical Trials
- 9:00AM-11:00AM
-
Abstract Number: 2545
Physicians, but Not Patients, Agree That EULAR Good Response Indicates Remission after 12 Weeks Treatment of Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2578
Plasma Levels of Bone Morphogenetic Protein (BMP) Subgroups and Their Inhibitors (noggin, sclerostin) in Rheumatoid Arthritis Patients and Correlation with Disease Activity, Clinical and Radiographic Progression
- 9:00AM-11:00AM
-
Abstract Number: 2718
Plasma Levels of the M2 Macrophage Markers, CD163 and CD206, Changes Reversely and Soluble CD163 Is Associated with Disease Activity in Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2092
Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Is Elevated in Patients with Thrombotic Primary Antiphospholipid Syndrome.
- 9:00AM-11:00AM
-
Abstract Number: 2276
Pleiotropic Effect of ABCG2 in Gout
- 9:00AM-11:00AM
-
Abstract Number: 2737
Posttraumatic Stress Disorder and Correlates of Disease Activity Among Veterans with Ankylosing Spondylitis
- 9:00AM-11:00AM
-
Abstract Number: 2765
Practicing What We Preach? Do Psoriatic Arthritis Patients Treated at an Academic Medical Center Meet Caspar Criteria?
- 9:00AM-11:00AM
-
Abstract Number: 2278
Precision of Gout Definitions for Population-Based Genetic Studies: Analysis of the UK Biobank
- 9:00AM-11:00AM
-
Abstract Number: 2639
Predicting Flare and Sustained Clinical Remission after Adalimumab Withdrawal Using the Multi-Biomarker Disease Activity (MBDA) Score
- 9:00AM-11:00AM
-
Abstract Number: 2650
Prediction of Inhibition of Radiographic Progression By Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of a Global, Phase 3 Trial
- 9:00AM-11:00AM
-
Abstract Number: 2341
Prediction of Triaxial Accelerometer Counts from Unaxial Acceleromenter Counts Among Adults with or at Risk for Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 2460
Predictive Factors of Good Response to Conventional Dmards in Patients with Early Seronegative Rheumatoid Arthritis: Data from the Espoir Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2648
Predictive Role of Biomarkers for the Response to Biologic Therapy in Rheumatoid Arthritis. Old, New and How Future Looks like?
- 9:00AM-11:00AM
-
Abstract Number: 2552
Predictive Value of Chest HRCT Patterns for Respiratory Adverse Event Among RA Patients Treated with Biological Therapy: Long-Term Results from an Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 2402
Predictive Value of the History and Labs in Distinguishing Inflammatory from Non-Inflammatory and Mechanical Joint Pain
- 9:00AM-11:00AM
-
Abstract Number: 2233
Predictors of Adherence and Costs in First and Second Years after Biologic Initiation in Patients with Rheumatoid Arthritis (RA)
- 9:00AM-11:00AM
-
Abstract Number: 2519
Predictors of Flare in Rheumatoid Arthritis Patients Treated Preventively with Rituximab: A Prospective Study Using Ultrasound and Patient Reported Outcomes
- 9:00AM-11:00AM
-
Abstract Number: 2842
Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2651
Predictors of Inadequate Response and Rapid Radiographic Progression in Patients with Early Rheumatoid Arthritis Receiving Methotrexate: a Post Hoc Analysis of 2 Randomized, Controlled Trials of Adalimumab
- 9:00AM-11:00AM
-
Abstract Number: 2801
Predictors of Incident Episodes of Proteinuria Among Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2528
Predictors of Long Term Survival of Low-Dose Etanercept: An Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 2299
Predictors of Mortality in People with Recent Onset of Gout: A Prospective Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 2811
Predictors of Persistent Disease Activity and Persistent Remission in Systemic Lupus Erythematosus – Results from the Hopkins Lupus Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2905
Predictors of Poor Hand Function in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2804
Predictors of Survival in Renal Transplantation for Lupus Nephritis – 40 Patients in 40 Years
- 9:00AM-11:00AM
-
Abstract Number: 2443
Pregnancy Comorbidities and Outcomes in Psoriasis and Psoriatic Arthritis: A Prospective Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2553
Pregnancy Outcomes in Patients with Rheumatoid Arthritis Treated with Abatacept – Review of a Safety Database
- 9:00AM-11:00AM
-
Abstract Number: 2902
Preliminary Evaluation of Gastroesophageal Reflex Disease Outcome Measures in Scleroderma– Scleroderma Clinical Trials Consortium Gastrointestinal Working Group
- 9:00AM-11:00AM
-
Abstract Number: 2317
Preliminary Validation of a Magnetic Resonance Imaging-Based Inflammatory Scoring System in Adult Myositis
- 9:00AM-11:00AM
-
Abstract Number: 2169
Presence of Cardiovascular Risk Factors Across Different Inflammatory Joint Disease Entities: Results from a Norwegian, Multi-Centre Project
- 9:00AM-11:00AM
-
Abstract Number: 2655
Prevalence and Risk Factors of Reactivation of Resolved Hepatitis B Virus in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 2185
Prevalence and Trends in Prescribed Opioid Use Among US Adults with Arthritis, 2008-2013, Medical Expenditure Panel Survey
- 9:00AM-11:00AM
-
Abstract Number: 2687
Prevalence of Abortions and Fetal Atrioventricular Block in Patients with Positive ANTI-RO and ANTI-La Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 2584
Prevalence of Anemia Among Rheumatoid Arthritis Patients Treated with Conventional Disease-Modifying Antirheumatic Drugs
- 9:00AM-11:00AM
-
Abstract Number: 2843
Prevalence of Anti-DFS70 Antibodies in Patients with and without Systemic Autoimmune Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2919
Prevalence of Antiphospholipid Antibodies and Their Clinical Associations in Systemic Sclerosis: Data from a French Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2759
Prevalence of Comorbidities and Risk Factors of Spondyloarthritis in Latin America: A Comparative Study with the General Population: Data from the Multinational ASAS-Comospa Study
- 9:00AM-11:00AM
-
Abstract Number: 2748
Prevalence of Comorbidities in Patients with Axial Spondyloarthritis and Its Association with Aspects of the Disease
- 9:00AM-11:00AM
-
Abstract Number: 2726
Prevalence of HLA-B27 in the Normal Population and Patients with Axial Spondyloarthritis in Saudi Arabia
- 9:00AM-11:00AM
-
Abstract Number: 2768
Prevalence of Obesity in Patients with Psoriatic Arthritis and Its Impact on the Severity of the Disease
- 9:00AM-11:00AM
-
Abstract Number: 2190
Prevalence of Severe Joint Pain Among Adults with Doctor-Diagnosed Arthritis— United States, 2002–2014
- 9:00AM-11:00AM
-
Abstract Number: 2404
Prevalence of Subclinical Entheseal Involvement in Children and Adolescents with Type 1 Diabetes: A Case Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2500
Prevalence of Sustained Remission in Patients with Rheumatoid Arthritis in Sweden. Impact of Criteria Sets and Early Treatment, a Nationwide Register Study in Sweden
- 9:00AM-11:00AM
-
Abstract Number: 2957
Primary Central Nervous System Vasculitis Associated with Lymphomas
- 9:00AM-11:00AM
-
Abstract Number: 18L
Primary CNS Vaculitis Vs Neurosarcoidosis: Can We Predict the Diagnosis with MRI?
- 9:00AM-11:00AM
-
Abstract Number: 2674
Primary Sjögren’s Syndrome: Extraglandular Manifestations and Hydroxychloroquine Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2313
Profile of Cardiovascular Burden in Myositis: A Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2891
Prognostic Significance of Autoantibody Positivity in Interstitial Lung Disease: A Retrospective Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2827
Prognostic Significance of Repeat Biopsy in Lupus Nephritis: Histopathologic Worsening Is an Independent Risk Factor for End Stage Renal Disease and Death
- 9:00AM-11:00AM
-
Abstract Number: 2925
Programmed Cell Death (PD)-1 May Play a Significant Role in the Pathogenesis of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2362
Progression of Pain and Ultrasound Detected Synovitis in Patients with Erosive Hand Osteoarthritis over One Year
- 9:00AM-11:00AM
-
Abstract Number: 2861
Proportions of Circulating Follicular Helper T Cells and Complement Levels, White Blood Cell Counts, and Skin Manifestations in Patients with Active Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2390
Proposal of Assessment of the Activity of Juvenile Localised Scleroderma. Results of the Consensus Meeting in Hamburg, Germany December 2015
- 9:00AM-11:00AM
-
Abstract Number: 2981
Prospective Cohort of Surgically-Diagnosed Aortitis at the Ottawa Hospital
- 9:00AM-11:00AM
-
Abstract Number: 2797
Prospective Validation of a Panel of Autoantibodies in Combination with C4d-Bound Complement Activation Products for the Differential Diagnosis of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2269
Proteinaceous Amorphous Calcium Carbonates As a Novel Family of Crystals in Synovial Fluid from Symptomatic Joints
- 9:00AM-11:00AM
-
Abstract Number: 2770
Psoriatic Arthritis Limits Patients’ Abilities to Undertake Activities Crucial for Normal Daily Life and Impacts Happiness, Results from a Multinational Real-World Sample
- 9:00AM-11:00AM
-
Abstract Number: 2978
Psychiatric Involvement and Behcet’S Syndrome: Does Bipolar Disorder Represent a Clinical Feature of the Disease?
- 9:00AM-11:00AM
-
Abstract Number: 2692
Pulmonary Involvement, As Part of the Essdai, in Primary Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2570
Pyruvate Regulates Reactive Oxygen Species (ROS) Production, Dysfunction and Aberrant Metabolism of Mitochondria in Fibroblast-like Synoviocytes of Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2547
Quantification of Adverse Glucocorticoid Effects on Skin in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2238
RA Medication Preferences Among U.S. Patients in an Online Rheumatoid Arthritis Community
- 9:00AM-11:00AM
-
Abstract Number: 2351
Racial Differences in Magnetic Resonance Image-Based Three-Dimensional Bone Shape of the Knee: Data from the Osteoarthritis Initiative (OAI)
- 9:00AM-11:00AM
-
Abstract Number: 2501
Radiographic Damage in Patients with RA Increases By 8.3% per Year Disease Duration, in the Era of Biologic Dmards. Results from the Scqm Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2350
Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
- 9:00AM-11:00AM
-
Abstract Number: 2534
Radiographic Remission in Patients with Seropositive RA at Ten Years after Diagnosis, Treated in a Real Life Setting
- 9:00AM-11:00AM
-
Abstract Number: 2353
Radiographic Variations in Hip Morphology Are Associated with Hip Symptoms: A Cross-Sectional Analysis of a Large Community-Based Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2398
Reaching the Masses: A Novel Approach to Pediatric Rheumatology Education Via Tele-Learning
- 9:00AM-11:00AM
-
Abstract Number: 2668
Real Time Sonoelastography in Primary Sjögren’s Syndrome Correlates with Morphological Ultrasonographic Features and Glandular Activity but Not with Glandular Fibrosis
- 9:00AM-11:00AM
-
Abstract Number: 2603
Real World Practice Based Clinical Study of Delayed-Release Prednisone Produces Comparable Results to a Controlled Clinical Trial: Morning Stiffness and Disease Measures in Moderate-Severe RA Patients Switched from Immediate-Release to Delayed Release-Prednisone
- 9:00AM-11:00AM
-
Abstract Number: 2595
Real World Results from a Post-Approval Safety Surveillance of Tofacitinib (Xeljanz): Over 3 Year Results from an Ongoing US-Based Rheumatoid Arthritis Registry
- 9:00AM-11:00AM
-
Abstract Number: 2484
Real World Treat to Target Strategy in Rheumatoid Arthritis: Radiograph and MRI Outcomes in Three Cohorts with 18 Month Follow up
- 9:00AM-11:00AM
-
Abstract Number: 2318
Real World Use of the Myositis Autoantibody Panel
- 9:00AM-11:00AM
-
Abstract Number: 2247
REAL-Life Cost of UK Healthcare Resource for Patients with Rheumatoid Arthritis, Comparing High and Low/Remission Disease States
- 9:00AM-11:00AM
-
Abstract Number: 2228
Real-World Cost of Treating Inadequate Responders to Anti-Tumor Necrosis Factor Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2523
Reasons for Provider Non-Adherence to a Treat to Target Strategy in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2335
Recent Changes of Radiological Findings and Patients’ Background of Rheumatoid Hip and Knee
- 9:00AM-11:00AM
-
Abstract Number: 2221
Recognition of Secondary Fibromyalgia Using an Index of 3 Components of the Multi-Dimensional Health Assessment Questionnaire: 90% Agreement with ACR Criteria for Fibromyalgia
- 9:00AM-11:00AM
-
Abstract Number: 2510
Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2148
Recruitment of Circulating Monocytes By TNF/IL-6-Induced Expression of Vascular Cell Adhesion Molecule 1 (VCAM-1) Drives Valvular Inflammation in K/B/g7 Mice
- 9:00AM-11:00AM
-
Abstract Number: 2881
Reduced Hippocampal-Thalamic Fiber Tracts in Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2452
Reduced Ovarian Reserve in Young Juvenile Idiopathic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2542
Reducing the Dosage of Glucocorticoid to Zero Might Decrease Risk of Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of the Tomorrow Study
- 9:00AM-11:00AM
-
Abstract Number: 2735
Regional Variability of Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: An Analysis from a Prospective, Observational Registry
- 9:00AM-11:00AM
-
Abstract Number: 2937
Regulation of Follicular Helper T (TFH) Cells By ROCK2 (Rho-associated coiled-coil containing protein kinase 2)
- 9:00AM-11:00AM
-
Abstract Number: 2698
Regulation of Inflammation By Interleukin-27 in a Rat Model of Spondyloarthritis (SpA)
- 9:00AM-11:00AM
-
Abstract Number: 2106
Regulation of Marginal Zone B Cell Differentiation By microRNA-146a
- 9:00AM-11:00AM
-
Abstract Number: 2257
Regulation of Mitochondrial Proton Gradient Is Critical for NLRP3 Inflammasome Activation
- 9:00AM-11:00AM
-
Abstract Number: 2340
Relation Between Range of Motion and Physical Activity While Recovering after Total Knee Replacement
- 9:00AM-11:00AM
-
Abstract Number: 2345
Relation of Varus Knee Thrust during Walking to Two-Year Incidence of Frequent Ankle, Hip, and Lower Back Pain
- 9:00AM-11:00AM
-
Abstract Number: 2943
Relationship Between Menstruation and Symptoms of Behcet’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2741
Reliability and Construct Validity of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire – Independent Validation Study in a UK Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2466
Remission According to RAPID3 (routine assessment of patient index data 3) in Patients with Rheumatoid Arthritis: A Cross-Sectional 3 Center Study from Routine Care
- 9:00AM-11:00AM
-
Abstract Number: 2659
Respiratory Symptoms in Patients with Primary SjöGren’s Syndrome – a Case-Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2387
Response to Pamidronate Treatment Assessed By Whole Body Magnetic Resonance Imaging in Pediatric Chronic Non-Bacterial Osteomyelitis
- 9:00AM-11:00AM
-
Abstract Number: 2569
Restoration of Decreased Lymphocyte Counts and the Shift to Th1 and Effector Memory CD8+T Cell Subsets Associate with Spontaneous Regression of Lympho-Proliferative Disorders Developed in RA Patients Treated with Methotrexate
- 9:00AM-11:00AM
-
Abstract Number: 2857
Results from a Phase 0 Longitudinal Clinical Trial in Cutaneous Lupus Erythematosus: Analysis of the Type I IFN Signature in the Skin and Blood and Its Relationship with Disease Activity Scores and Autoantibody Profiles
- 9:00AM-11:00AM
-
Abstract Number: 2653
Results of a Comprehensive Review of Pulmonary Function and Safety Data in a Phase IIb Clinical Program Testing Anti-GM-CSF Receptor Antagonist Mavrilimumab for Treatment of RA
- 9:00AM-11:00AM
-
Abstract Number: 2483
Results of a Pilot Study of a Tailored Symptom Assessment Tool to Enhance Patient-Centered Care in Rheumatoid Arthritis: Choice RA
- 9:00AM-11:00AM
-
Abstract Number: 2656
Resume of Biologic Therapy after Tuberculosis Infection in Patients with Inflammatory Arthropathies. Daily Clinical Practice Data from an Endemic Country
- 9:00AM-11:00AM
-
Abstract Number: 2628
Retention of Use and Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: A Patient Record Assessment in a Compassionate Use Programme in South Africa, a Tuberculosis Endemic Country
- 9:00AM-11:00AM
-
Abstract Number: 2620
Retrospective Analysis for Determining the Signs and Symptoms of Infections before They Become Serious in Tocilizumab-Treated RA Patients Using a Postmarketing Adverse Events Reporting Database
- 9:00AM-11:00AM
-
Abstract Number: 2652
Rheumatoid Arthritis and Excess Mortality Associated with Treatments: a Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2441
Rheumatoid Arthritis Flares and Pregnancy Outcomes Among Women in a Longitudinal Registry
- 9:00AM-11:00AM
-
Abstract Number: 2115
Rheumatoid Factors May Potentiate Immune Complex Formation of Anti-Citrullinated Protein Antibodies
- 9:00AM-11:00AM
-
Abstract Number: 2456
Risk Factors for Adverse Pregnancy Outcome in Antiphospholipid Antibodies Carriers: Results from a Multicenter Italian Cohort over 20 Years of Experience
- 9:00AM-11:00AM
-
Abstract Number: 2643
Risk Factors of Pneumocystis Jiroveci Pneumonia (PJP) in Patients with RA and Sulfasalazine As a Possible Protective Agent
- 9:00AM-11:00AM
-
Abstract Number: 2618
Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in the French Registry Regate (REGISTRY –ROACTEMRA)
- 9:00AM-11:00AM
-
Abstract Number: 2646
Risk of Hepatitis B Reactivation in Inflammatory Arthritis Patients Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs): A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2813
Risk of Renal Failure within 10 or 20 Years of SLE Diagnosis, By Patient Characteristics
- 9:00AM-11:00AM
-
Abstract Number: 2939
Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2904
Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2118
Rituximab Treated Non Responder Rheumatoid Arthritis Patients Are Generating a New Autoantibody Repertoire
- 9:00AM-11:00AM
-
Abstract Number: 2088
Rituximab Use in Pediatric Lupus Anticoagulant Hypoprothrombinemia Syndrome – Report of Three Cases and Review of the Literature
- 9:00AM-11:00AM
-
Abstract Number: 2418
Rnaseq Reveals Treatment-Associated Gene Expression Dynamics in Juvenile Idiopathic Arthritis CD4+ T Cells
- 9:00AM-11:00AM
-
Abstract Number: 2457
Role of Hydroxychloroquine in Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies without Other Underlying Connective Tissue Disease
- 9:00AM-11:00AM
-
Abstract Number: 2258
Role of NLRP12 on Disease Severity in Autoimmune Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2386
Role of Pentraxin 3 in Patients with Juvenile Scleroderma
- 9:00AM-11:00AM
-
Abstract Number: 2808
Role of Serum Autoantibodies in Blood Brain Barrier Damages in Neuropsychiatric Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2926
Rorc Positive Th17, Th17/Th1, and Th17.1 Cells from the Blood of Treatment NaïVe RA Patients Differ in IL-17A but Are All Pathogenic When Co-Cultured with RA Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 2152
S100A11 Protein Is Increased in Rheumatoid Arthritis and Is Associated with Disease Activity and Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 2896
Safety and Effectiveness of Hyperbaric Oxygen Therapy for Systemic Sclerosis Ulcers
- 9:00AM-11:00AM
-
Abstract Number: 2625
Safety of Multiple Retreatments with Rituximab in Real Life: Long Term Registry Data from 1984 Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2641
Safety of Synthetic and Biological Dmards: Slr Informing the Update of the EULAR Recommendations for the Management of RA
- 9:00AM-11:00AM
-
Abstract Number: 2622
Safety, Pharmacokinetics, and Biomarker Profile from Phase 1 Clinical Trials of Healthy Volunteers Treated with GDC-0853, a Highly Selective Reversible Oral Bruton’s Tyrosine Kinase (BTK) Inhibitor
- 9:00AM-11:00AM
-
Abstract Number: 2717
Sclerostin and Dickkopf-1 but Not Periostin May Have a Role in Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2757
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 104 Weeks Results from a Phase 3 Trial
- 9:00AM-11:00AM
-
Abstract Number: 2251
Secukinumab Vs Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis at 52 Weeks from the US Perspective
- 9:00AM-11:00AM
-
Abstract Number: 2512
Secular Trends of Sustained Remission in Rheumatoid Arthritis, a Nationwide Register Study in Sweden
- 9:00AM-11:00AM
-
Abstract Number: 2790
Selective Disruption of Estrogen Receptor Alpha Expression in Dendritic Cells of Lupus-Prone Mice Results in Increased Female-Specific Death
- 9:00AM-11:00AM
-
Abstract Number: 15L
Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis vulgaris and Normalizes Skin Pathology Via Concurrent Regulation of IL-17 and IL-10 Levels
- 9:00AM-11:00AM
-
Abstract Number: 2201
Self-Reported Breathlessness on Exertion Is Associated with Poor Outcomes Among Women with Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 2203
Self-Reported Childhood Maltreatment and Traumatic Events Among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2754
Self-Reported Physical Activity Questionnaire in Axial Spondyloarthritis: Modification of the Squash
- 9:00AM-11:00AM
-
Abstract Number: 2942
Sequencing of 16S rRNA Reveals a Distinct Salivary Microbiome Signature in Behcet’s Disease
- 9:00AM-11:00AM
-
Abstract Number: 2629
Serious Adverse Events in Patients with RA Taking Abatacept Compared with Other Dmards. Results from a US-Wide Safety Registry
- 9:00AM-11:00AM
-
Abstract Number: 2612
Sero-Positivity for Rheumatoid Factor Is an Independent Predictor for Achievement of Good EULAR Response at 24 Weeks in ACPA Positive Rheumatoid Arthritis Patients Treated with Abatacept: Results from Japanese Multicenter Registry
- 9:00AM-11:00AM
-
Abstract Number: 2613
Seropositivity for RF or ACPA Predicts Long Term Drug Retention with Rituximab, but Not with Abatacept and Tocilizumab : Long-Term Registry Data in 4498 Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2506
Seropositivity Predicts Bone Biomarker Change in an Inception Cohort of Rheumatoid Arthritis Patients Treated-to-Target with Combination Conventional DMARD Therapy
- 9:00AM-11:00AM
-
Abstract Number: 2822
Serum 25-Hydroxyvitamin D3 Levels and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2856
Serum C5a Is Elevated in Lupus Nephritis and in Neuropsychiatric Systemic Lupus Erythematosus through Different Mechanisms
- 9:00AM-11:00AM
-
Abstract Number: 2328
Serum Ferritin Levels, Distribution of Ground Glass Opacities and New Development of Lung Infiltration during Therapy Predict Prognosis of Interstitial Lung Disease in Anti-MDA5 Ab Positive Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 2907
Serum KL-6 Levels in Interstitial Lung Diseases (ILDs) Associated to Connective Tissue Diseases (CTDs)
- 9:00AM-11:00AM
-
Abstract Number: 2892
Serum Level of KL-6, a Biomarker of Interstitial Lung Disease (ILD), Is Higher in Diffuse SSc Than in Limited SSc and RA Even When the Activity of ILD Is Low
- 9:00AM-11:00AM
-
Abstract Number: 2347
Serum Levels of Resistin Are Associated with Synovial Inflammation and Knee Structural Changes in Patients with Symptomatic Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2585
Serum MMP-3 and OPG As Predictors of Response to Traditional Dmards in a Treatment NaïVe Early Rheumatoid Arthritis Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2287
Serum Urate and Its Association with Endothelial Dysfunction in Young Adults
- 9:00AM-11:00AM
-
Abstract Number: 2297
Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 2158
Serum Uric Acid Is Positively Associated with Pulmonary Function in Korean Health Screening Examinees: A Cross-Sectional Study
- 9:00AM-11:00AM
-
Abstract Number: 2408
Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88
- 9:00AM-11:00AM
-
Abstract Number: 2157
Share the Fate: Fibroblast-like Synoviocyte Cell-to-Cell Organelle Transfer Is Directed By the Inflammatory Microenvironment
- 9:00AM-11:00AM
-
Abstract Number: 2477
Short Term Clinical Response to Initial Treatment with High Versus Low Dose Methotrexate in Mono- and Combination Therapy in Early Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2508
Significant Improvement of Rheumatoid Arthritis (RA) Outcome with Repeat Application of Disease Management (SSDM) Mobiles Tools: A Cohort Study of RA Patients in China
- 9:00AM-11:00AM
-
Abstract Number: 2614
Similar Rates of Death, Serious Infections, Cancers, Major Cardiovascular Events in Patients Treated with Abatacept, Rituximab and Tocilizumab: Long-Term Registry Data in 4498 Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2133
Simulation of Cartilage Damage in Osteoarthritis Using Patient-Derived Induced Pluripotent Stem Cells
- 9:00AM-11:00AM
-
Abstract Number: 2548
Single 1g Infusion Vs Double 1g Infusion of Rituximab in Rheumatoid Arthritis in a Large Teaching Hospital: Potential Clinical Benefits and Financial Savings
- 9:00AM-11:00AM
-
Abstract Number: 2419
Single-Cell Analysis of CD163 mRNA and Protein Expression By Primeflow™ in Polarized Monocyte and Macrophage Populations
- 9:00AM-11:00AM
-
Abstract Number: 2807
Skin and Muscle Sodium Concentrations in Patients with Systemic Lupus Erythematosus: A Proof of Concept Study
- 9:00AM-11:00AM
-
Abstract Number: 2876
SLE Serum Impairs NO Production in Huvecs through Induction of eNOS Uncoupling
- 9:00AM-11:00AM
-
Abstract Number: 2872
SLE Subjects Express High Levels of Intracellular Interferon-β That Acts in an Autocrine Fashion to Promote Survival of Transitional Stage B Cells
- 9:00AM-11:00AM
-
Abstract Number: 2403
Sleep Disruption in Children with Chronic Pain
- 9:00AM-11:00AM
-
Abstract Number: 2761
Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors
- 9:00AM-11:00AM
-
Abstract Number: 2337
Sleep Quality, Disturbances and Physical Activity: A Nationwide Survey Among Health Professionals on Their Engagement with Irish People Who Have Rheumatic Disease
- 9:00AM-11:00AM
-
Abstract Number: 2762
Smoking and Severity of Psoriatic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 17L
Sofosbuvir Plus Daclatasvir for Hepatitis C Virus Associated Cryoglobulinemia Vasculitis
- 9:00AM-11:00AM
-
Abstract Number: 2626
Soluble CD206 Plasma Levels Decreases with Treatment and Reflects Anti-Tnfa Discontinuation in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2279
Soluble Urate: A Direct Mediator of Bone Turnover?
- 9:00AM-11:00AM
-
Abstract Number: 2699
Spa-Associated HLA-B*27 Subtypes Accumulate More in Endoplasmic Reticulum (ER) Compartment and in Association with β2-Microglobulin (β2m) Than Non-Associated HLA-B Alleles
- 9:00AM-11:00AM
-
Abstract Number: 2930
Specific Metabolic and Functional Changes in Peripheral CD8+ T Cells Specifically Distinguish RA from PSA and SPA
- 9:00AM-11:00AM
-
Abstract Number: 2177
Specificity of Spinal Pain Features in Assessment and Classification of Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2336
Splinting for Trigger Finger. Short Term Effects
- 9:00AM-11:00AM
-
Abstract Number: 2560
Sputum Antibody to Malondialdehyde-Acetaldehyde Adduct in Subjects with Established Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2901
SSc and the Significance of Blood Group Antigens
- 9:00AM-11:00AM
-
Abstract Number: 2178
Statin Use and Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study with Propensity Score-Matching
- 9:00AM-11:00AM
-
Abstract Number: 2572
Study of Two Biomarkers of Biological Age in the Blood of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2137
Subchondral Bone Structure and Pain Behaviors in Collagenase Induced Noninflammatory Monoarthritis in Mice
- 9:00AM-11:00AM
-
Abstract Number: 2739
Subclinical Ungueal Distrophy in Patients with Psoriasis without Joint Involvement: Is There Any Role for Nail Ultrasound?
- 9:00AM-11:00AM
-
Abstract Number: 2559
Subgingival Microbiome Signatures in Patients with Established Rheumatoid Arthritis and Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2316
Successful Treatment of Statin-Induced Autoimmune Myopathy without Corticosteroids
- 9:00AM-11:00AM
-
Abstract Number: 2788
Suppression of IL-1 Signaling Ameliorates Dermatitis in a Murine Model of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2283
Suppression of Monosodium Urate (MSU) Crystals-Induced Inflammatory Response By Inhibiting TGF-β Activated Kinase 1 (TAK1)
- 9:00AM-11:00AM
-
Abstract Number: 2259
Suppression of Monosodium Urate Crystal-Induced Cytokine Production Via Inhibition of Histone Deacetylases 1/2
- 9:00AM-11:00AM
-
Abstract Number: 2949
Surgical Method for Aortic Root Involvement of Behcet Disease
- 9:00AM-11:00AM
-
Abstract Number: 2794
Sustained Complete Remission in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2227
Sustained Remission and Relapse Rate after Non-Conventional DMARD Withdrawal in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2619
Sustained Suppression of Peripheral Biomarkers By Mavrilimumab but Not Golimumab in Anti-Tumor Necrosis Factor-Inadequate Responders: An Exploratory Analysis in the Phase IIb Earth Explorer 2 Clinical Trial
- 9:00AM-11:00AM
-
Abstract Number: 2364
Swimming May Associate with Less Osteoarthritis: Data from the Osteoarthritis Initiative
- 9:00AM-11:00AM
-
Abstract Number: 2153
Syndecans Mediate Rantes/CCL5 Induced MMP-1 and MMP-13 Expression in Rheumatoid Arthritis Synovial Fibroblasts
- 9:00AM-11:00AM
-
Abstract Number: 2363
Synovial Changes Detected By Ultrasound and Its Association with Knee Pain: A Population-Based Case Control Study
- 9:00AM-11:00AM
-
Abstract Number: 2110
Synovial Fibroblasts Regulate B Cell Survival Via B Cell Activating Factor of the TNF Family (BAFF)
- 9:00AM-11:00AM
-
Abstract Number: 2945
Systematic Review: “Efficacy and Safety of Biological Versus Immunosuppressive Therapy Compared to Placebo in the Treatment of Uveitis Associated with BehçEt’s Disease.”
- 9:00AM-11:00AM
-
Abstract Number: 2849
Systemic Lupus Erythematosus Patients with Antibodies Against U1-Ribonucleoprotein Exhibit a Specific Pattern of Disease Manifestations
- 9:00AM-11:00AM
-
Abstract Number: 2923
T-Cell Receptor Signaling Inhibition By CC-90005, a Selective Protein Kinase C Theta Antagonist, Reduces Antigen Mediated T-Cell Activation and Arthritis Pathology in the Mouse CIA Model
- 9:00AM-11:00AM
-
Abstract Number: 2222
Tai Chi Is More Effective Than Aerobic Exercise in Treating Fibromyalgia: A Randomized Controlled Trial
- 9:00AM-11:00AM
-
Abstract Number: 2702
Taking Fly for Understanding the Molecular Role of HLA-B27/hB2m in Spondyloarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2791
Targeting Micro-RNAs Derived from Extracellular Vesicles to Inhibit of TLR7 and TLR8 Signaling Suppresses Inflammation in a Novel Human-Mouse Chimeric Model of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2107
Targeting Mir-155 in Rheumatoid Arthritis B Cells Reduces Antibody Production
- 9:00AM-11:00AM
-
Abstract Number: 2599
TCZ Improves the Pro-Atherothrombotic Profile of Rheumatoid Arthritis Patients Modulating Endothelial Dysfunction, Netosis and Inflammation
- 9:00AM-11:00AM
-
Abstract Number: 2498
Tender Joints Is a Consistent Negative Predictor of Sustained Remission in Aggressively Treated Patients with Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2141
Terminal Uridylyl Transferase ZCCHC6-Dependent Generation of miRNA Diversity in Primary Human Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 2924
Terminally Differentiated CD8 T Cell Subset Has Distinct Signiture in RA
- 9:00AM-11:00AM
-
Abstract Number: 2248
The “Financial Toxicity” of Therapy in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2101
the Association Between ABO Blood Types and Venous Thromboembolism in Individuals with a Positive Antiphospholipid Antibody Profile Is Varied By Sex
- 9:00AM-11:00AM
-
Abstract Number: 2194
The Association Between Arthritis and Carpal Tunnel Syndrome: National Health Interview Survey, 2010
- 9:00AM-11:00AM
-
Abstract Number: 2189
The Association of Arthritis and Lung Diseases: A Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2360
The Association of Superolateral Hoffa’s Fat Pad Edema and Synovitis with Structural Changes in the Patellofemoral and Tibiofemoral Joints: The Multicenter Osteoarthritis Study
- 9:00AM-11:00AM
-
Abstract Number: 2929
The Baseline Th17 Lymphocytes Level Is a Predictive Marker of Good Response to Biologics in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2883
The CD4+CD52low T Cell Contributes to the Development of Systemic Lupus Erythematosus through the CCR8/TARC Pathway
- 9:00AM-11:00AM
-
Abstract Number: 2918
The Clinical Relevance of Common ANA Patterns in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2322
The Clinical Significance of Curvilinear Bodies on Ultrastructural Examination of Muscle
- 9:00AM-11:00AM
-
Abstract Number: 2366
The Clinical Utility of the Bulge Sign in Evaluating Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2723
The Co-Occurrence of Axial Spondyloarthritis and Fibromyalgia: A National Register-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2365
The Cross-Sectional and Longitudinal Associations Between Metabolic Syndrome and Hand Osteoarthritis – Data from the Framingham Study
- 9:00AM-11:00AM
-
Abstract Number: 2407
The Descriptive Epidemiology of Acute Rheumatic Fever and Post-Streptococcal Reactive Arthritis in Japan
- 9:00AM-11:00AM
-
Abstract Number: 2376
The Disease Burden of Systemic Juvenile Idiopathic Arthritis for Patients and Caregivers: An International Health Related Quality of Life Survey and Retrospective Chart Review
- 9:00AM-11:00AM
-
Abstract Number: 2494
The Effect of Body Mass on DAS28 Response in Patients with Rheumatoid Arthritis Treated with Abatacept
- 9:00AM-11:00AM
-
Abstract Number: 2567
The Effect of Fibroblast Growth Factor 4 on the Proliferation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2627
The Effect of Fostamatinib with Methotrexate on Circulating Biomarkers of Synovium, Cartilage and Bone Metabolism: Potential Utility for Clinical Development Decision Making in Rheumatoid Arthriti
- 9:00AM-11:00AM
-
Abstract Number: 2738
The Effect of Pregnancy on Disease Activity Outcomes in Psoriatic Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2920
The Effect of Rituximab on B Cells in Skin and Peripheral Blood in Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2593
The Effect of Tofacitinib on Bone Mineral Density in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2315
The Effectiveness of Social Media in Recruiting for Rare Rheumatic Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2609
The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated up to 19 Months with Tofacitinib
- 9:00AM-11:00AM
-
Abstract Number: 2590
The Efficacy of Additional Immunoadsorption on the Modulation of Disease Activity in Patients with Severe Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2183
The Electronic Osteoarthritis Knee and Hip Quality of Life (OAKHQOL) Questionnaire: A Useful and Valid Alternative to Measure Health-Related Quality of Life in Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2213
The Four Stages of Fibromyalgia: Potential for More Precise Treatment Approaches
- 9:00AM-11:00AM
-
Abstract Number: 2193
The Frequency of and Patient Characteristics Associated with Fear of Movement in Adults with Symptomatic Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2592
The Impact of Biologic Therapy Introduction on Hip and Knee Replacement Among Rheumatoid Arthritis Patients: An Interrupted Time Series Analysis Using the Clinical Practice Research Datalink
- 9:00AM-11:00AM
-
Abstract Number: 2346
The Improving Motivation for Physical Activity in Arthritis Clinical Trial for Adults with Knee Osteoarthritis and Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2900
The Incidence and Prevalence of Systemic Sclerosis in Northwestern Part of Turkey
- 9:00AM-11:00AM
-
Abstract Number: 2296
The Influence of Androgen Deprivation Therapy on Serum Uric Acid Level
- 9:00AM-11:00AM
-
Abstract Number: 2272
The Influence of Genetic Variants on Renal Uric Acid Excretion in Response to Frusemide
- 9:00AM-11:00AM
-
Abstract Number: 2616
The JAK1-Selective Inhibitor Filgotinib Displays an Anti-Inflammatory Biomarker Signature in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2786
The Janus Kinase Inhibitor Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
- 9:00AM-11:00AM
-
Abstract Number: 2855
The Long-Term Clinical Outcomes of Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2540
The Longitudinal Impact of Biologic Use on Disability within a RA Registry
- 9:00AM-11:00AM
-
Abstract Number: 2700
The Lymphatic System: A Gatekeeper for Migration of Pathogenic T-Cells Towards Synovial Joints and Entheses in Psoriasis
- 9:00AM-11:00AM
-
Abstract Number: 2145
The Modulation of Macrophage Polarization By SIRT1 Maybe New Target Therapy in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2916
The Number of Micro-Haemorrhages and Micro-Thrombosis Detected By Nailfold Videocapillaroscopy Is a Good Predictor of Disease Activity in Systemic Sclerosis: The Validation Study of NEMO Score
- 9:00AM-11:00AM
-
Abstract Number: 2243
The Paucity of the Evidence Base for American College of Rheumatology Practice Guidelines
- 9:00AM-11:00AM
-
Abstract Number: 2536
The Performance of a Single Centre Interventional Clinic in Early Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2395
The Performance of the Kobayashi and Egami Scores in Detecting IVIG Resistance in Kawasaki Disease in a Single Centre Canadian Cohort Treated with IVIG and Low Dose Aspirin
- 9:00AM-11:00AM
-
Abstract Number: 2310
The Predictive Risk Factors for Complication of Infection during the Treatment for Inflammatory Myopathies Complicated with Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 2766
The Predictive Value of Patient’s and Evaluator’s Global Assessment and Tender and Swollen Joint Count Differences on Treatment Efficacy in Psoriatic Arthritis: Data from a Longitudinal Multicenter Study
- 9:00AM-11:00AM
-
Abstract Number: 2793
The Predictors of Sustained Complete Remission in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2575
The Presence of Staphylococcal Toxins in the Urine of Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2102
the Prevalence and Associations of IgG/a/M ANTI-β2GPI and ANTI-Domain I Antibodies in an Antiphospholipid Syndrome (APS) Cohort of Patients from Turkey
- 9:00AM-11:00AM
-
Abstract Number: 2495
The Prevalence of Loss of Response to Treatment with a Tumor Necrosis Factor Inhibitor and/or Methotrexate in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2453
The Prevention, Screening, and Treatment of Congenital Heart Block from Neonatal Lupus: A Survey of Provider Practices
- 9:00AM-11:00AM
-
Abstract Number: 2588
The Real World Comparative Safety of Certolizumab Pegol (CZP) As Compared to Other TNFi in a National US Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2338
The Relationship Between Anxiety and Physical Activity Participation in Adults with Persistent Knee Pain and the Moderating Effect of Neighborhood Social Cohesion
- 9:00AM-11:00AM
-
Abstract Number: 2587
The Serum Level of Reactive Oxygen Metabolities (ROM) at 12 Weeks during Treatment with Biologic Agents for Rheumatoid Arthritis Is a Predictor for the 52-Week Remission
- 9:00AM-11:00AM
-
Abstract Number: 2906
The Survival and Prognostic Factors of Patients with Systemic Sclerosis Turkish Experience
- 9:00AM-11:00AM
-
Abstract Number: 2425
The Vasculopathy of Juvenile Dermatomyositis (JDM); Evidence of Persistent Endothelial Injury, Hypercoagulability, Subclinical Inflammation and Increased Arterial Stiffness
- 9:00AM-11:00AM
-
Abstract Number: 2666
Therapeutic Efficacy of Iguratimod in Patients with Primary Sjogren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2889
Therapeutic Plasma Exchange for the Treatment of Raynaud’s and Digital Ulcers in Systemic Sclerosis: A Systematic Review
- 9:00AM-11:00AM
-
Abstract Number: 2605
Therapy with Biologic Agents after Diagnosis of Solid Malignancies; Results from the Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 2308
Thigh Muscle MRI Reveals Extensive Muscle Edema and Early Fatty Replacement in Patients with Immune-Mediated Necrotizing Myopathy
- 9:00AM-11:00AM
-
Abstract Number: 2505
Thresholds of Benefit-Risk Trade-Offs from the Patient Perspective for Treatment Decisions in Moderate-to-Severe Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2964
Thromboangiitis Obliterans (Buerger’s disease) : An Observational Study of 174 Patients
- 9:00AM-11:00AM
-
Abstract Number: 2597
Time to Initiation of Biologic Agents Is Associated with Glucocorticoid Use: Results from the Corrona Registry
- 9:00AM-11:00AM
-
Abstract Number: 2711
Tissue-Resident IL-23 Responsive Innate T Cells in Mice Comprise Tcrαβ+ and TCRγδ+ Subsets with Overlapping Function
- 9:00AM-11:00AM
-
Abstract Number: 2526
TNF Blocker Concentrations or Detection of Antibodies Against Anti-TNF before a Tapering Process Are Not Predictive to Relapse
- 9:00AM-11:00AM
-
Abstract Number: 2499
Tocilizumab Achieves Rapid Reduction of Disease Activity and Has Beneficial Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2502
Tocilizumab Therapy Reduces Corrected QT Interval in Patients with Rheumatoid Arthritis without Cardiac Symptoms
- 9:00AM-11:00AM
-
Abstract Number: 2580
Tofacitinib Do Not Get Worse Subclinical Atherosclerosis Despite up-Regulating Serum Cholesterol in Methotrexate-Resistant Active Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2600
Tofacitinib Is Associated with an Impaired Function of NK Cells and a Defective Immunosurveillance Against B-Cell Lymphomas
- 9:00AM-11:00AM
-
Abstract Number: 2300
Tophaceous Gout and the Risk of Mortality: A General Population-Based Study
- 9:00AM-11:00AM
-
Abstract Number: 2357
Topical Application of Aceclofenac Might NOT Produce a Significant Increase of Blood Pressure in Osteoarthritic Patients – a Continuous Automated Blood Pressure Monitor Study
- 9:00AM-11:00AM
-
Abstract Number: 2196
Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study
- 9:00AM-11:00AM
-
Abstract Number: 2273
Trans-Ancestral Meta-Analysis Identifies Nine New Loci Associated with Serum Uric Acid Concentrations
- 9:00AM-11:00AM
-
Abstract Number: 2138
Transcriptional Analysis of Synovial Tissue Reveals Sustained Inflammatory Chemokine Expression Despite Minimal Histopathologic Change in the Destabilization of Medial Meniscus Model of Murine Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2455
Transcriptome Profile of Cells Isolated from a CHB Heart Support an Exuberant Inflammatory ⁄Pro-Fibrotic Cascade
- 9:00AM-11:00AM
-
Abstract Number: 2426
Transcriptomic Analysis of Immune Subsets in Juvenile Dermatomyositis before and after Treatment Identifies Novel Pathways Involved in Pathogenesis
- 9:00AM-11:00AM
-
Abstract Number: 2131
Transient Receptor Potential Ankyrin 1 (TRPA1) Is Functionally Expressed in Primary Human Osteoarthritic Chondrocytes and Mediates Cartilage Destruction and Joint Pain in the Mia-Model of Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 2903
Transition of Nailfold Microangiopathy throughout Different Patterns of Microvascular Damage and Correlations with Organ Involvement in Systemic Sclerosis: A Twelve Year Follow-up
- 9:00AM-11:00AM
-
Abstract Number: 2785
Translatable in Vitro Immunocyte Functional Measures of CC-292 and CC-90008 Inhibitors of the Bruton’s Tyrosine Kinase (Btk)/Tec Family and the Pathology Observed in the MLR/Lpr Mouse Model of Systemic Lupus Erythematosus (SLE)
- 9:00AM-11:00AM
-
Abstract Number: 2470
Treat to Target: Theoretical Agreement Vs Daily Applicability
- 9:00AM-11:00AM
-
Abstract Number: 2977
Treatment of Cryoglobulinemic Vasculitis with Sofosbuvir in Four Combination Protocols
- 9:00AM-11:00AM
-
Abstract Number: 2694
Treatment of ZAP-70 Mutant SKG Mice with Anti-IL-23 Antibody Alters Fecal Microbiota Composition and Prevents Outgrowth of Bacteria Associated with Susceptibility to Spondyloarthritis and Ileitis
- 9:00AM-11:00AM
-
Abstract Number: 2225
Treatment Outcomes of Newly and Formerly Diagnosed Patients with Fibromyalgia after Fibromyalgia Treatment Program
- 9:00AM-11:00AM
-
Abstract Number: 2729
Treatment Patterns, Unmet Need, and Impact of Psoriatic Arthritis on Patient-Reported Outcomes in the United States
- 9:00AM-11:00AM
-
Abstract Number: 2253
Treatment Persistence with Subcutaneous TNF-Alpha Inhibitors in France
- 9:00AM-11:00AM
-
Abstract Number: 2104
Treatment with Tocilizumab Decreases CXCL13 Expression in Cultured Temporal Arteries from Patients with Giant Cell Arteritis
- 9:00AM-11:00AM
-
Abstract Number: 2645
Treatments for Early Rheumatoid Arthritis (RA): A Systematic Review of Randomized Controlled Trials
- 9:00AM-11:00AM
-
Abstract Number: 2433
Trends in Use of Hydroxychloroquine during Pregnancy in SLE Patients from 2001 to 2012
- 9:00AM-11:00AM
-
Abstract Number: 2631
Trends and Factors Associated with Use of Biologic Agents As Monotherapy Among US Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2303
Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011
- 9:00AM-11:00AM
-
Abstract Number: 2331
Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2581
Tripterygium Wilfordii Hook F Applied Topically in Patients with Active Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2557
Tumor Necrosis Factor (TNF) Sensitizes Rheumatoid Synovial Fibroblasts to TRPA1-Mediated Calcium Flux, Anti-Proliferation and Cell Death
- 9:00AM-11:00AM
-
Abstract Number: 2708
Type 17 Immunity in Spondyloarthritis Is Expanded Across Multiple Lymphocyte Subsets
- 9:00AM-11:00AM
-
Abstract Number: 2938
U4ATAC Mutation Is Associated with an Immune Dysregulation Syndrome Characterized By Primary Immunodeficiency, Short Stature and Polyglandular Endocrinopathy
- 9:00AM-11:00AM
-
Abstract Number: 2604
Ultrasound and Immunological Changes and Associations after One Year of IL-6/IL- 6R Blockade with Tocilizumab in Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2330
Ultrasound Imaging in Inclusion Body Myositis
- 9:00AM-11:00AM
-
Abstract Number: 2685
Ultrasound of the Major Salivary Glands Is a Reliable Imaging Technique for Diagnosing Patients Clinically Suspected with SjöGren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2334
Ultrasound-Guided Facet Joint Injections through a Longitudinal Approach
- 9:00AM-11:00AM
-
Abstract Number: 2871
Unaffected Lupus Relatives Are Distinguished from SLE Patients and Unaffected Individuals Not Related to SLE Patients By Lupus-Specific Connective Tissue Disease Questionnaire Scores, Autoantibodies, and Distinct Soluble Mediators
- 9:00AM-11:00AM
-
Abstract Number: 2342
Understanding Patient Barriers and Facilitators to Healthy Eating and Physical Activity before and after Knee Replacement
- 9:00AM-11:00AM
-
Abstract Number: 2764
Unhappiness Is Related to Worse Outcomes for Patients with Ankylosing Spondylitis and Increased Impairment in Daily Life Activities, Results from a Multinational Real-World Sample
- 9:00AM-11:00AM
-
Abstract Number: 2130
Unloading Results in Rapid Loss of TGFβ Signaling in Cartilage: Role of Loading-Induced TGF-Β Signaling in Maintenance of Articular Chondrocyte Phenotype?
- 9:00AM-11:00AM
-
Abstract Number: 2576
uPAR Promotes Tumor-like Biologic Role of Fibroblast-like Synoviocytes through PI3K/Akt Signaling Pathway in Patients with Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2391
Update on the Juvenile Systemic Sclerosis Inception Cohort Project. Characteristics of the First 80 Patients at First Assessment
- 9:00AM-11:00AM
-
Abstract Number: 2294
Uric Acid Production and Blood Pressure: The Role of Uric Acid Concentration As Well As Uric Acid Production
- 9:00AM-11:00AM
-
Abstract Number: 2823
Urinary Angiostatin, CXCL4 and VCAM-1 As Biomarkers for Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2825
Urinary BAFF and APRIL Levels: Potential Biomarkers of Active Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 2858
Urinary PF4 and E-Selectin As Novel Biomarkers for Disease Activity and Renal Damage in Lupus Nephritis
- 9:00AM-11:00AM
-
Abstract Number: 14L
Use of Intravenous Epoprostenol As a Treatment for the Digital Vasculopathy Associated with the Scleroderma Spectrum of Diseases
- 9:00AM-11:00AM
-
Abstract Number: 2944
Use of Muscle Biopsies for the Diagnosis of Systemic Vasculitis in a Rheumatology Service
- 9:00AM-11:00AM
-
Abstract Number: 2442
Use of Nonsteroidal Anti-Inflammatory Drugs in Pregnant Women with Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2888
Usefulness of Bosentan in the Prevention of Pulmonary Hypertension in Patients with Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2893
Usefulness of the Eustar Preliminary Criteria for Vey Early Systemic Sclerosis and Le Roy Criteria for Early-Systemic Sclerosis in Identifying Patients at Risk of Development of Systemic Sclerosis
- 9:00AM-11:00AM
-
Abstract Number: 2635
Using Patient Reported Outcomes to Inform a Treat to Target Treatment Approach in RA
- 9:00AM-11:00AM
-
Abstract Number: 2834
Utility of the Brain Perfusion Single Photon Emission Computed Tomography in Neuropsychiatric Manifestations of Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 2235
Utilization of Ambulatory Physician Encounters, Emergency Room Visits and Hospitalizations By RA Patients: A 13 Year Population Health Study
- 9:00AM-11:00AM
-
Abstract Number: 2546
Utilization of Biologic Therapy in Patients with Rheumatoid Arthritis and Cancer
- 9:00AM-11:00AM
-
Abstract Number: 2744
Utilization of the Psoriasis Epidemiology Screening Tool (PEST) Questionnaire to Detect Psoriatic Arthritis in Clinical Practice: Data from the Validation of Psoriatic Arthritis Screening Tool for Korean Psoriasis Patients (VALOR) Study
- 9:00AM-11:00AM
-
Abstract Number: 2244
Utilization Patterns of Subcutaneously Administered Biologic Medications within a Sample of Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 2972
Vaccination and Risk of Childhood IgA Vasculitis (Henoch–Schönlein): A Case-Crossover Analysis
- 9:00AM-11:00AM
-
Abstract Number: 2385
Validation of Diary Score for the Assessment of Disease Activity in Candle (Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature) and SAVI (STING associated vasculopathy with onset in Infancy) Patients
- 9:00AM-11:00AM
-
Abstract Number: 2167
Validation of the Earp Questionnaire: Detection of Psoriatic Arthritis in the Spanish Population
- 9:00AM-11:00AM
-
Abstract Number: 2467
Validation of the FLARE Questionnaire for the Detection of a Disease Flare in Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 2384
Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA 2 Deficiency
- 9:00AM-11:00AM
-
Abstract Number: 2096
Venous Antiphospholipid Syndrome: Is the Unprovoked Nature of the 1st Thrombosis Associated with Clinical or Biological Features?
- 9:00AM-11:00AM
-
Abstract Number: 2187
Vitamin D Levels and Fragility Fractures in Postmenopausal Portuguese Women- Results from Epireumapt
- 9:00AM-11:00AM
-
Abstract Number: 2399
Waning Hepatitis B Immunity Status in a Significant Proportion of Immunocompromised Pediatric Rheumatology and Gastroenterology Patients
- 9:00AM-11:00AM
-
Abstract Number: 2471
What Are the Reasons of Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity and What Is the Impact of This Discordance on Remission, Function and Structure at 1 Year?
- 9:00AM-11:00AM
-
Abstract Number: 2179
What Are the Risk Factors for Knee Pain, Radiographic Knee Osteoarthritis and Total Knee Replacement in Professional Footballers?
- 9:00AM-11:00AM
-
Abstract Number: 2709
Which Cells Correspond to the Typical Signals for Fatty and Inflammatory Lesions Seen in Magnetic Resonance Imaging in Ankylosing Spondylitis ? -a Prospective Study Using Biopsy Material Obtained during Spinal Surgery-
- 9:00AM-11:00AM
-
Abstract Number: 2862
Whole Blood Phenotyping and Innate and Adaptive Stimulation Reveal Unique Differences in Granulocytes and Innate Pathways of African American SLE Patients with Variable Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2667
Whole Frequency Audiometrical Correlation with Disease Activity in Primary SjöGren’s Syndrome in Hispanic Population
- 9:00AM-11:00AM
-
Abstract Number: 2657
Withdrawal of Nonsteroidal Anti-Inflammatory Drugs in Rheumatoid Arthritis Patients with Low Disease Activity
- 9:00AM-11:00AM
-
Abstract Number: 2119
Wogonin, a Plant-Derived Flavonoid, Exert Anti-Inflammatory and Chondroprotective Effects through the Activation Nrf2/HO-1 Signaling in Human OA Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 2670
Work Disability in Newly Diagnosed Patients with Primary SjöGren’s Syndrome – a Population-Based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2479
Work Productivity in Early Rheumatoid Arthritis Patients Treated before and after Implementation of a Treat-to-Target Strategy
- 9:00AM-11:00AM
-
Abstract Number: 2910
Work Productivity in Systemic Sclerosis and Association with Health Related Quality of Life
- 11:00AM-12:30PM
-
Abstract Number: 2987
Comparison of Certolizumab Pegol Versus Adalimumab: 2 Year Efficacy and Safety Results from a Superiority, Investigator-Blind, Head-to-Head Study
- 11:00AM-12:30PM
-
Abstract Number: 2983
Efficacy and Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, or Adalimumab in Patients with Active Psoriatic Arthritis and an Inadequate Response to Conventional Synthetic Dmards: A Randomized, Placebo‑Controlled, Phase 3 Trial
- 11:00AM-12:30PM
-
Abstract Number: 2984
Novel Anti-Malarial Drug Derivative Inhibited Type I Interferon Production and Autoimmune Inflammation through Inhibition of CGAS-Sting Pathway in Trex1-/- Mouse
- 11:00AM-12:30PM
-
Abstract Number: 2985
Practice-Level Variation in Quality of Care in the Acr’s Rheumatology Informatics System for Effectiveness (RISE) Registry
- 11:00AM-12:30PM
-
Abstract Number: 2986
Trends and Determinants of Osteoporosis Prevention and Management in Patients with Rheumatoid Arthritis Compared to Osteoarthritis
- 11:00AM-12:30PM
-
Abstract Number: 2982
Tumor Necrosis Factor Inhibitors and the Risk of Malignancy in the Treatment of Juvenile Idiopathic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2991
A Molecular Signature Based on IFN Gene Signature and Serology Defines Two Populations of Patients with Different Baseline Disease Activity in a Large Multinational Phase 3 SLE Trial Population
- 2:30PM-4:00PM
-
Abstract Number: 3034
A Selective JAK1 Inhibitor, Filgotinib Suppresses Lymphocytic Infiltration in Salivary Gland of Non Obese Diabetic Mice Via Suppression of BAFF and Chemokine Production of Salivary Gland Epithelial Cells
- 2:30PM-4:00PM
-
Abstract Number: 3028
A Single Infusion of Rituximab Delays the Onset of Arthritis in Subjects at High Risk of Developing RA
- 2:30PM-4:00PM
-
Abstract Number: 3032
Abnormalities in the Biological or Haematological Domain of the Essdai Predict an Increase in Systemic Disease Activity the Year after: 5-Year Data from the Prospective Multicenter Assess Cohort
- 2:30PM-4:00PM
-
Abstract Number: 3041
Age-Related Defects in the Immune System of Patients with GCA
- 2:30PM-4:00PM
-
Abstract Number: 3039
Anti-IL-17A, but Not Anti-TNF, Can Halt Pathological New Bone Formation in Experimental Spondyloarthritis
- 2:30PM-4:00PM
-
Abstract Number: 3022
Autoantibodies to Peptidylarginine Deiminase 2 Protect Against Radiographic Progression in Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2999
Autologous Osteoblastic Cells Versus Concentrated Bone Marrow Implantation in Osteonecrosis of the Femoral Head: A Randomized Controlled Single Blind Study
- 2:30PM-4:00PM
-
Abstract Number: 2994
Binding of Periostin to Discoidin Domain Receptor-1 (DDR1) Promotes Cartilage Degeneration By Inducing MMP-13 Expression
- 2:30PM-4:00PM
-
Abstract Number: 3037
Calprotectin Is Highly Upregulated in Inflamed Axial Entheses in SKG Mice
- 2:30PM-4:00PM
-
Abstract Number: 2990
Cancer in Systemic Lupus Erythematosus: Results from the Systemic Lupus International Collaborating Clinics Inception Cohort
- 2:30PM-4:00PM
-
Abstract Number: 3052
Causes of Death for Patients with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3035
Characterization of DC-STAMP+ T Cells, a CD3+CD4+ T Cell Subset Uniquely Present in Patients with Psoriatic Disease
- 2:30PM-4:00PM
-
Abstract Number: 2988
Cigarette Smoking Increases the Risk of Anti-Double-Stranded DNA Positive SLE Among Women in the Nurses’ Health Studies
- 2:30PM-4:00PM
-
Abstract Number: 3020
Citrullination of Inhibitor of DNA Binding-1 at Specific Locations Leads to Autoantigenicity in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3008
Clinical Factors Associated with Non-Response to Methotrexate in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Response to Treatment Consortium
- 2:30PM-4:00PM
-
Abstract Number: 3012
Clinical Predictors of TNF-Inhibitor Free Disease Control in Patients with Rheumatoid Arthritis after Stopping TNFi Treatment: Results from a Dutch Multicentre Pragmatic Open-Label Randomized Controlled Trial.
- 2:30PM-4:00PM
-
Abstract Number: 3043
Dense Genotyping of Immune Related Loci in a Multi-Ethnic Behçet’s Disease Cohort Identifies Genetic Associations in a Long Noncoding RNA Near QSOX2, RASIP1/FUT2, and IL12A-AS1
- 2:30PM-4:00PM
-
Abstract Number: 3005
Development and Initial Validation of the “MH Score”, a New Diagnostic Tool That Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 3047
Diabetes and BMI Modify the Association Between Painful Hip OA and All-Cause Mortality
- 2:30PM-4:00PM
-
Abstract Number: 3002
Does Morbid Obesity Negatively Affect Patient Reported Outcomes Following Total Knee Arthroplasty?
- 2:30PM-4:00PM
-
Abstract Number: 3013
Dose Reduction or Discontinuation of Biological Therapy in Patients with Rheumatoid Arthritis in Remission – 1-Year Results of a Guideline-Directed Longitudinal Cohort Study
- 2:30PM-4:00PM
-
Abstract Number: 3017
Elevated Neutrophil Extracellular Trap Levels Correlate with Anti-CCP3-IgG and Anti-CCP3-IgA Levels in the Sputum of Individuals at-Risk for Future Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3044
Endothelin 1 Induces a Myofibroblastic Phenotype in Vascular Smooth Muscle Cells. A Mechanism Potentially Contributing to Vascular Remodeling and Intimal Hyperplasia in Giant Cell Arteritis
- 2:30PM-4:00PM
-
Abstract Number: 3038
Enumeration and Preliminary Characterisation of Peri-Entheseal Bone Type 3 Innate Lymphoid Cells
- 2:30PM-4:00PM
-
Abstract Number: 3030
Evidence of Inflammasome Activation in the Peripheral Blood and Salivary Gland Tissues of Primary Sjögren’s Syndrome Patients: Correlation with Clinical Indices of Severe Disease and Lymphoma Development
- 2:30PM-4:00PM
-
Abstract Number: 3021
Frequency of Arthralgia, Seropositivity, and Seropositive Arthralgia and Their Association with Development of Rheumatoid Arthritis in a Cohort of Indigenous North Americans with or without a First Degree Relative with Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2998
Gut Microbiota Induce IGF-1 and Promote Bone Formation and Growth
- 2:30PM-4:00PM
-
Abstract Number: 3027
Herpes Zoster in Patients with Moderate to Severe Rheumatoid Arthritis Treated with Baricitinib
- 2:30PM-4:00PM
-
Abstract Number: 2996
High Fat Diet-Induced Osteoarthritis Progression Is Dependent on Toll-like Receptor 4
- 2:30PM-4:00PM
-
Abstract Number: 3006
IFN-Gamma (IFNγ), IFNγ-Induced Chemokines and Other Biomarkers in Macrophage Activation Syndrome (MAS)
- 2:30PM-4:00PM
-
Abstract Number: 3036
IL-22 Is Dysregulated in Psoriatic Arthritis and Acts to Limit IFN-γ Driven Inflammatory Chemokine Production
- 2:30PM-4:00PM
-
Abstract Number: 3045
Immunometabolism in ANCA-Associated Glomerulonephritis
- 2:30PM-4:00PM
-
Abstract Number: 3003
Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes
- 2:30PM-4:00PM
-
Abstract Number: 3010
Improvement of Spinal Inflammation Induced By Etanercept in Enthesitis Related Arthritis JIA-Patients. Data of the Reminder-Study
- 2:30PM-4:00PM
-
Abstract Number: 2992
In Systemic Lupus Erythematosus with Antiphospholipid Antibodies, Hypocomplementemia Associates with Thrombosis
- 2:30PM-4:00PM
-
Abstract Number: 3046
Inflammatory Pathways As Shared Molecular Targets Across ANCA-Associated Vasculitis and Nephrotic Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 3051
Is Frailty a Relevant Concept in Systemic Lupus Erythematosus (SLE)?
- 2:30PM-4:00PM
-
Abstract Number: 3023
Lipid Profile and Effect of Statin Treatment in Pooled Phase 2 and Phase 3 Baricitinib Studies
- 2:30PM-4:00PM
-
Abstract Number: 3007
Long-Term Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results from a PHASE III Extension Study
- 2:30PM-4:00PM
-
Abstract Number: 3011
Long-Term Outcomes after Disease Activity Guided Tapering of Tumor Necrosis Factor Inhibition in Rheumatoid Arthritis: 3 Year Data of a Randomised Controlled Pragmatic Non Inferiority Strategy Study
- 2:30PM-4:00PM
-
Abstract Number: 3001
Lumbar CT-Guided Steroid Infiltration on the Refractory Low Back Pain. Study of 258 Procedures in the Same Center
- 2:30PM-4:00PM
-
Abstract Number: 3024
Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib
- 2:30PM-4:00PM
-
Abstract Number: 2993
Membrane-Type 1 Matrix Metalloproteinase Controls Osteo- and Chondrogenesis By a Proteolysis-Independent Mechanism Mediated By Its Cytoplasmic Tail
- 2:30PM-4:00PM
-
Abstract Number: 2997
Microrna-29a Curtails Synovitis in the Development of Knee Osteoarthritis By Disrupting VEGF
- 2:30PM-4:00PM
-
Abstract Number: 3048
Pain Severity As a Mediator of the Effect of Depressive Symptoms on Physical Performance in Knee Osteoarthritis
- 2:30PM-4:00PM
-
Abstract Number: 3042
PD-1–Expressing T Cells in GCA Fail to Promote Immune Tolerance Functions
- 2:30PM-4:00PM
-
Abstract Number: 3050
Post-Partum Complications and Depression in New Mothers with Juvenile Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3049
Prevalence of Doctor-Diagnosed Arthritis Among Adults with Clinically Measured Pre-Diabetes— United States, 2009–2014
- 2:30PM-4:00PM
-
Abstract Number: 3031
Rethinking Primary Sjögren’s Syndrome: Stratification By Clinical Phenotypes to Improve Understanding of Disease Pathogenesis, Trial Design, Clinical Management and Prospective Health Gains?
- 2:30PM-4:00PM
-
Abstract Number: 2989
Risk of Cardiovascular Disease Events Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort
- 2:30PM-4:00PM
-
Abstract Number: 3009
Safety and Effectiveness of Adalimumab±Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3033
Safety and Efficacy of Single Dose VAY736 (anti-BAFF-R mAb) in Patients with Primary Sjögren’s Syndrome (pSS)
- 2:30PM-4:00PM
-
Abstract Number: 3000
Safety of the Knee Needle Arthroscopy: A Review of 1136 Procedures in 919 Patients
- 2:30PM-4:00PM
-
Abstract Number: 3019
Sputum Antibodies to Individual Citrullinated Protein/Peptide Antigens Are Elevated in Subjects at-Risk of Future RA and Subjects with Established Disease
- 2:30PM-4:00PM
-
Abstract Number: 3014
Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 3040
Th17 Migration into the Synovial Fluid of Patients with Active Psoriatic Arthritis Is Enhanced By Regulatory T Cells
- 2:30PM-4:00PM
-
Abstract Number: 3018
The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice
- 2:30PM-4:00PM
-
Abstract Number: 3004
The Choosing Wisely Initiative: Is It Complete?
- 2:30PM-4:00PM
-
Abstract Number: 3025
The Effect of Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor on Patient-Reported Outcomes: Results from Two 24-Week Phase 2B Dose Ranging Studies
- 2:30PM-4:00PM
-
Abstract Number: 3026
The Efficacy and Safety of Low Dose IL-2 Therapy in over-Treated Patients with Rheumatoid Arthritis: A Preliminary Study
- 2:30PM-4:00PM
-
Abstract Number: 3015
The Good, the Bad and the Ugly – Refractory Rheumatoid Arthritis in 2016
- 2:30PM-4:00PM
-
Abstract Number: 3029
Ultrasonography of Major Salivary Glands in Patients Suspected with Primary Sjögren’s Syndrome: Comparison with Salivary Gland Biopsy and Classification Criteria
- 2:30PM-4:00PM
-
Abstract Number: 3016
Validity of a 2-Component Disease Activity Score for Accurate Assessment of Synovitis in Rheumatoid Arthritis
- 2:30PM-4:00PM
-
Abstract Number: 2995
WISP1/CCN4 Aggravates Experimental Osteoarthritis and Is Associated with Disease Progression in Early Osteoarthritis Patients
- 4:30PM-6:00PM
-
Abstract Number: 3106
A Simple Test for Assessing and Monitoring SLE Disease Activity Status
- 4:30PM-6:00PM
-
Abstract Number: 3103
Apolipoprotein L1 Risk Variants Associate with Prevalent Cardiovascular Disease in African American Systemic Lupus Erythematous Patients
- 4:30PM-6:00PM
-
Abstract Number: 3096
Association Between Smoking and Psoriatic Arthritis Among Psoriasis Patients and the General Population: Data from National Inpatient Sample
- 4:30PM-6:00PM
-
Abstract Number: 3087
Association of Weight Loss with Improved Disease Activity in Patients with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3100
Can Achieving Sustained Minimal Disease Activity (MDA) Prevent Progression of Subclinical Atherosclerosis? a Prospective Cohort Study in Psoriatic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3053
Cartilage Loss Primarily Occurs in the Most Affected Tibiofemoral Compartment with No Evidence of a Ceiling Effect Among Advanced-Stage Disease: A Two-Year Longitudinal Study of Data from the Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 3086
Changing Patterns over Time in Opiate Use in U.S. Rheumatoid Arthritis Patients
- 4:30PM-6:00PM
-
Abstract Number: 3108
Citrullinated Aggrecan Peptides Are Targets of Auto-Reactive CD4+ T-Cells in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3L
Comparative Cardiovascular Safety of Tocilizumab Vs Etanercept in Rheumatoid Arthritis: Results of a Randomized, Parallel-Group, Multicenter, Noninferiority, Phase 4 Clinical Trial
- 4:30PM-6:00PM
-
Abstract Number: 3093
Comparison of Changes in Cardiovascular Risk-Associated Biomarkers in RA Patients Treated with Anti-TNF or Other Biological Agents: A Metabolic Study from a Randomized Trial
- 4:30PM-6:00PM
-
Abstract Number: 3060
Development and Implementation of a Question-Based Tool Promoting Learning of Relevant Epidemiology and Biostatistics in Rheumatology: The Critical Literature Assessment Skills Support – Rheumatology (CLASS-Rheum) Pilot
- 4:30PM-6:00PM
-
Abstract Number: 3076
Development of a Matrix-Binding Interlukin-1 Receptor Antagonist Fusion Protein for Extended Retention in the Joint Tissues
- 4:30PM-6:00PM
-
Abstract Number: 3078
Diffuse Idiopathic Skeletal Hyperostosis and Diabetes- Using Genetic Risk Scores to Explore the Association
- 4:30PM-6:00PM
-
Abstract Number: 3085
Do Depression and Anxiety Reduce the Chance of Remission in Rheumatoid Arthritis and Psoriatic Arthritis?
- 4:30PM-6:00PM
-
Abstract Number: 3112
DOCK8 Associates with STAT5 and Promotes Regulatory T Cell Function
- 4:30PM-6:00PM
-
Abstract Number: 3104
Early Proteinuria Response in Real Life Situation Predicts Long-Term Lupus Renal Outcome in Ethnically Diverse Group with Biopsy-Proven Nephritis
- 4:30PM-6:00PM
-
Abstract Number: 2L
Effect of Denosumab Compared with Risedronate in Glucocorticoid-Treated Individuals: Results from the 12-Month Primary Analysis of a Randomized, Double-Blind, Active-Controlled Study
- 4:30PM-6:00PM
-
Abstract Number: 3070
Effect of Sarcopenia, Subcutaneous Adipose Tissue and Abdominal Visceral Fat on Mortality Risk of Community-Dwelling Older Adults: A Population-Based Prospective Cohort Study
- 4:30PM-6:00PM
-
Abstract Number: 3091
Effect of Sarilumab on Circulating Biomarkers of Bone and Joint Destruction in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate
- 4:30PM-6:00PM
-
Abstract Number: 4L
Efficacy and Safety Results of Guselkumab, an Anti-IL23 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis over 24 Weeks: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
- 4:30PM-6:00PM
-
Abstract Number: 3056
Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Randomized Controlled Trial
- 4:30PM-6:00PM
-
Abstract Number: 3094
Factors Associated with Initial or Subsequent Choice of Biologic Disease Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3064
From Art to Science: A Mobile App for Point-of-Care Relevance Determination for the Musculoskeletal Exam
- 4:30PM-6:00PM
-
Abstract Number: 3061
Future Challenges in Pediatric Rheumatology: The Role of Graduate Medical Education (GME)
- 4:30PM-6:00PM
-
Abstract Number: 3099
Higher Prevalence and Severity of Coronary Atherosclerosis in Psa Patients
- 4:30PM-6:00PM
-
Abstract Number: 3059
Impact of a Musculoskeletal Training Program on Residents’ Evaluation, Diagnosis, and Treatment of Osteoporosis
- 4:30PM-6:00PM
-
Abstract Number: 3072
Increased Platelet Reactivity in Gout: Relationship to Tophus Burden and Colchicine Use
- 4:30PM-6:00PM
-
Abstract Number: 3090
Inflammation Detected with Modern Sensitive MRI Analysis Demonstrates That Therapeutic Response As Early As One Month Predicts 12-Month Radiographic Progression: Data from a Study Using Tofacitinib and Methotrexate in Early RA
- 4:30PM-6:00PM
-
Abstract Number: 3063
Learning Rheumatology through Fellow-Generated Questions: The Rheumatology Image of the Week Project
- 4:30PM-6:00PM
-
Abstract Number: 3101
Lipoprotein Profile and Serum Glycoprotein Acetylation As Markers of Cardiovascular Risk in Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 3082
Macrophage Activation Syndrome Is Identified By Coagulopathy, Hyperferritinemia, Fever, and Cytopenia in Hospitalized Patients, Resulting in Poor Outcome
- 4:30PM-6:00PM
-
Abstract Number: 3075
Mitochondrial Genetic Variation, Copy Number and Susceptibility to Gout in the New Zealand Polynesian Population
- 4:30PM-6:00PM
-
Abstract Number: 3065
Mortality in Patients with Rheumatoid Arthritis and Interstitial Lung Disease Treated with First Line TNFi or Rituximab Therapies
- 4:30PM-6:00PM
-
Abstract Number: 6L
Myeloablative Autologous Transplantation of CD34+ -Selected Hematopoietic Stem Cells (HSCT) Vs Monthly Intravenous Cyclophosphamide (CYC) for Severe Scleroderma with Internal Organ Involvement: Outcomes of a Randomized North American Clinical Trial
- 4:30PM-6:00PM
-
Abstract Number: 3102
Neutrophil Subsets, Arterial Inflammation, and Vascular Stiffness in Patients with Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 3073
Non-Additive Interaction of the Glucokinase Regulatory Protein and APOBEC1 Complementation Factor Loci with Alcohol Consumption to Influence the Risk of Gout
- 4:30PM-6:00PM
-
Abstract Number: 3057
Objectively Measured Physical Activity and Risk of Knee Osteoarthritis: The Osteoarthritis Initiative
- 4:30PM-6:00PM
-
Abstract Number: 3097
Osteoclast Precursor Frequency and Imaging Findings Associated with Arthritis Onset in a Psoriasis Longitudinal Cohort
- 4:30PM-6:00PM
-
Abstract Number: 3111
Pathogenic T Cell Responses in Systemic Sclerosis Is Shaped By Novel Cytokine Axis in the Microenvironment: A Multidimensional, High Throughput Analysis
- 4:30PM-6:00PM
-
Abstract Number: 3074
Population-Specific Association Between ABCG2 Variants and Tophaceous Disease in People with Gout
- 4:30PM-6:00PM
-
Abstract Number: 3089
Predicting the Response to TNF Inhibition or B Cell Depletion Therapy from Peripheral Whole Blood Gene Expression Profiles in Patients with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3092
Predictive Factors for Better Outcome of Switching of Biologics for Patients with Rheumatoid Arthritis in Daily Clinical Practice
- 4:30PM-6:00PM
-
Abstract Number: 3088
Predictors of Non-Adherence with Anti-Rheumatic Medication in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort
- 4:30PM-6:00PM
-
Abstract Number: 3081
Prognostic Factors of Death in a Cohort of 116 Adults with Hemophagocytic Syndrome: Impact of Underlying Disease and Laboratory Parameters
- 4:30PM-6:00PM
-
Abstract Number: 3077
Quiescence in Active and Inactive Non-Infectious, Intermediate, Posterior, or Panuveitis in Patients Treated with Adalimumab
- 4:30PM-6:00PM
-
Abstract Number: 3110
Rab4A Is Required for Development of Tregs, Restricts Antiphospholipid Antibody Production and Pro-Inflammatory Expansion of Macrophages and Neutrophils, and Blocks Pristane-Induced Intra-Alveolar Hemorrhage in a Mouse Model of SLE
- 4:30PM-6:00PM
-
Abstract Number: 3071
Recombinant Human Proteoglycan-4 (rhPRG4) Inhibits Monosodium Urate (MSU) Crystal Phagocytosis By Human Macrophages and Resultant Inflammatory Response
- 4:30PM-6:00PM
-
Abstract Number: 3109
Regulatory T Cells Deficient in Protein Phosphatase 2A Lose Suppressive Function and Convert to an Effector Phenotype
- 4:30PM-6:00PM
-
Abstract Number: 3105
Relationships Between a Serum Biomarker of B Cell Differentiation and B Cell Activating Factor Suggest Possible Distinct Pathways of Response to Rituximab in Patients with Systemic Lupus Erythematosus
- 4:30PM-6:00PM
-
Abstract Number: 3080
Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg
- 4:30PM-6:00PM
-
Abstract Number: 3066
Risk of Incident Cancer with Biologic and Tofacitinib Therapy in Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3068
Smoking and Excess Weight Attenuate Rate of Improvement over First 3 Years in Early RA
- 4:30PM-6:00PM
-
Abstract Number: 5L
Speed of Remission with the Use of Voclosporin, MMF and Low Dose Steroids: Results of a Global Lupus Nephritis Study
- 4:30PM-6:00PM
-
Abstract Number: 3107
Switching from Anabolic to Catabolic Metabolism – a Novel Immunomodulatory Therapy in RA
- 4:30PM-6:00PM
-
Abstract Number: 1L
The Cardiovascular Safety of Celecoxib Versus Ibuprofen or Naproxen in 24,081 Patients with Osteoarthritis or Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 3079
The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)
- 4:30PM-6:00PM
-
Abstract Number: 3084
The Impact of Mental Health on Indicators of Disease Severity Among Patients with Inflammatory Arthritis: A Cross-Sectional and Longitudinal Investigation
- 4:30PM-6:00PM
-
Abstract Number: 3054
The Impact of Obesity on Knee Osteoarthritis Symptoms and Related Biomarker Profiles in a Bariatric Surgery Cohort
- 4:30PM-6:00PM
-
Abstract Number: 3098
The Occurrence of Peripheral Arthritis Mutilans in Psoriatic Arthritis Is Associated with Certain Major Histocompatibility Class I Alleles
- 4:30PM-6:00PM
-
Abstract Number: 3067
Treatment Decisions Following Diagnosis of Cancer during TNFi Inhibitor Treatment in Patients with Rheumatoid Arthritis: Results from the BSRBR-RA
- 4:30PM-6:00PM
-
Abstract Number: 3055
Ultrasound Features of the First Metatarsophalangeal Joint in Gout and Asymptomatic Hyperuricaemia: Comparison with Normouricaemic Individuals
- 4:30PM-6:00PM
-
Abstract Number: 3062
Use of Script Concordance Testing to Evaluate the Efficacy of a Web-Based Module on Gout: Three Years of Experience
- 4:30PM-6:00PM
-
Abstract Number: 3083
Utility of Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Short Form for Understanding Interplay Between Patient-Reported Outcome Measures and Physician Driven Disease Activity Measures
- 4:30PM-6:00PM
-
Abstract Number: 3058
Varus Thrust and Incident and Progressive Knee Osteoarthritis
- 4:30PM-6:00PM
-
Abstract Number: 3069
Weight Loss in the Early Rheumatoid Arthritis Period Is Associated with Subsequent Increased Mortality in RA Patients and Matched Comparators: Evidence Against an RA-Specific Obesity Paradox
- 4:30PM-6:00PM
-
Abstract Number: 3095
What Should be the Primary Target of ‘Treat to Target’ in Psa?
- 9:00AM-10:30AM
-
Abstract Number: 3149
“Early Use of Subcutaneous MTX Monotherapy Vs. MTX Oral or Combination Therapy Significantly Delays Time to Initiating Biologics in Early RA
- 9:00AM-10:30AM
-
Abstract Number: 3128
A Longitudinal Dual Energy Computed Tomography Study on the Effect of Urate Lowering Therapies on the Reduction of Tophus Burden in Patients with Chronic Gout
- 9:00AM-10:30AM
-
Abstract Number: 3156
Adding MRI of the Spine to the ASAS Classification Criteria for Axial Spondyloarthritis, Redundant or Beneficial? Results from the Spondyloarthritis Caught Early (SPACE)-Cohort
- 9:00AM-10:30AM
-
Abstract Number: 3184
Antiphospoholipid Antibodies in Giant Cell Arteritis. What Can They Tell Us?
- 9:00AM-10:30AM
-
Abstract Number: 3174
Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis
- 9:00AM-10:30AM
-
Abstract Number: 3154
Assessing Bone Erosions in the Metatarsophalangeal Joints of Patients with Early Rheumatoid Arthritis: a Comparison Between MRI and Ultrasound
- 9:00AM-10:30AM
-
Abstract Number: 3137
Assessing System-Level Performance Measures for Early Rheumatoid Arthritis in a Large Multicenter Cross-Country Prospective 8-Year Observational Cohort Study
- 9:00AM-10:30AM
-
Abstract Number: 3140
Assessment of American College of Rheumatology Gout Quality Measures at a University Practice Plan
- 9:00AM-10:30AM
-
Abstract Number: 3170
Association Between Insulin Resistance, Subclinical Artheriosclerosis and Activity/Damage Status in Systemic Lupus Erythematosus Patients
- 9:00AM-10:30AM
-
Abstract Number: 3133
Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal Intensity Alteration and Knee Structural and Symptomatic Abnormalities in Patients with Symptomatic Knee Osteoarthritis
- 9:00AM-10:30AM
-
Abstract Number: 3182
Attenuation of Fluorine-18-Fluorodeoxyglucose Uptake in Large Vessel Giant Cell Arteritis after Short-Term High-Dose Steroid Treatment – a Diagnostic Window of Opportunity
- 9:00AM-10:30AM
-
Abstract Number: 3153
Automated Cell Phone Monitoring of Disease Activity and Medication Adherence in Early Rheumatoid Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3139
Breaking the Cycle: Analyzing Preventable Hospital Admissions Due to Gout
- 9:00AM-10:30AM
-
Abstract Number: 3114
Cardiorespiratory Fitness in Children with Juvenile Idiopathic Arthritis Treated in the Biological Era Is Comparable with Controls- a Cross-Sectional Study
- 9:00AM-10:30AM
-
Abstract Number: 3119
Complete Whole Genome Transcriptome, DNA Methylation, and Histone Mark Analysis of Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS) Reveals a Distinctive Epigenetic Landscape and Critical Pathogenic Pathways
- 9:00AM-10:30AM
-
Abstract Number: 3126
Computational Polarizing Microscopy: A Novel Method to Detect Birefringent Crystals Using Lens-Free on-Chip Microscopy
- 9:00AM-10:30AM
-
Abstract Number: 3130
Development and Pilot Testing of an Online Educational Tool for Gout Patients — Mygoutcare®
- 9:00AM-10:30AM
-
Abstract Number: 3141
Development of a Glucocorticoid Toxicity Index Using Multi-Criteria Decision Analysis
- 9:00AM-10:30AM
-
Abstract Number: 3117
Development of Autoimmune Diseases and Genetic Predisposition in Children with Neonatal Lupus and Their Unaffected Siblings
- 9:00AM-10:30AM
-
Abstract Number: 3118
Differences in Disease Phenotype, Management and Outcomes of Children with Juvenile Idiopathic Arthritis throughout the World – Analysis of 8,325 Patients Enrolled in the Epoca Study
- 9:00AM-10:30AM
-
Abstract Number: 3168
Economic Evaluation of Damage Accrual in an International SLE Inception Cohort
- 9:00AM-10:30AM
-
Abstract Number: 3113
Evaluation of a Clinical Transition Pathway for Adolescents with Autoimmune Diseases
- 9:00AM-10:30AM
-
Abstract Number: 3122
Genome-Wide DNA Methylation Association Study of Hand Osteoarthritis
- 9:00AM-10:30AM
-
Abstract Number: 3178
Heart Dysfunction in Systemic Sclerosis: Involvement of a Novel Fibrogenic Stromal Cell Subset
- 9:00AM-10:30AM
-
Abstract Number: 3166
HLA-B27 and Ankylosing Spondylitis Have Shared Effects on the Gut Microbiome
- 9:00AM-10:30AM
-
Abstract Number: 3165
HLA-B27 Expression Is Accompanied By a Profoundly Altered IgA Response to the Intestinal Microbiota and Microbial Translocation to the Joint
- 9:00AM-10:30AM
-
Abstract Number: 3124
Huntingtin Interacting Protein 1 (Hip1) Is a New Arthritis Severity Gene
- 9:00AM-10:30AM
-
Abstract Number: 3134
Hydroxychloroquine Is Not Effective in Reducing Symptoms of Hand Osteoarthritis: Results from a Placebo-Controlled Randomised Trial
- 9:00AM-10:30AM
-
Abstract Number: 3136
Impact of Novel Smartphone Application on Pain and Mobility in Osteoarthritis Patients Treated with Hylan G-F 20
- 9:00AM-10:30AM
-
Abstract Number: 3142
Improving Counseling, Documentation and Adherence to Highly Effective Birth Control in Women on Teratogenic Medications at a Rural Medical Center: A Quality Improvement Initiative
- 9:00AM-10:30AM
-
Abstract Number: 3135
Influence of Baseline Magnetic Resonance Imaging Features on Outcomes of Operative and Non-Operative Treatment of Meniscal Tear in Patients ≥ 45
- 9:00AM-10:30AM
-
Abstract Number: 3175
Longitudinal Analysis of MMF Clinical, Molecular, and Immunohistochemistry (IHC) Responses Shows SSc Patients Lose Their Inflammatory Signature and Rebound upon Treatment Cessation
- 9:00AM-10:30AM
-
Abstract Number: 3176
Meta-Analysis of SSc Clinical Trials with Molecular Gene Expression Data Suggests Potential Combination Therapies
- 9:00AM-10:30AM
-
Abstract Number: 3169
Mortality Trends in Systemic Lupus Erythematosus: A General Population-Based Cohort Study
- 9:00AM-10:30AM
-
Abstract Number: 3173
Pan-PPAR Agonist IVA337 Is Effective in the Prevention of Experimental Lung Fibrosis and Related Pulmonary Hypertension
- 9:00AM-10:30AM
-
Abstract Number: 3148
Peptidylarginine Deiminase 2 Is Required for Tumor Necrosis Factor Alpha Induced Citrullination and Arthritis, but Not Neutrophil Extracellular Trap Formation
- 9:00AM-10:30AM
-
Abstract Number: 3131
Pregabalin Is More Effective in Treating Hand Osteoarthritis Pain Than Duloxetine or Placebo: A Double-Blind Randomized Controlled Trial
- 9:00AM-10:30AM
-
Abstract Number: 3132
Protective Effects of Replacing Sedentary Time with Light and Moderate to Vigorous Physical Activity on Functional Limitation in Knee OA
- 9:00AM-10:30AM
-
Abstract Number: 3120
RA Net: A Systems Biology Approach to Identify Genes Regulating Pathogenic Pathways in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS)
- 9:00AM-10:30AM
-
Abstract Number: 3123
Rare Mediterranean Fever (MEFV) Gene Polymorphisms Are Associated with Ankylosing Spondylitis in Turkish and Iranian Population
- 9:00AM-10:30AM
-
Abstract Number: 3115
Reconsidering the Juvenile Idiopathic Arthritis Core Set: How Patients and Caregivers Define Disease Activity
- 9:00AM-10:30AM
-
Abstract Number: 3147
Remote Inflammation Triggers Autoimmune Arthritis through Th17 Distribution
- 9:00AM-10:30AM
-
Abstract Number: 3152
Rheumatoid Arthritis (RA): Premature Use of Biologics Accelerating in United States (US)
- 9:00AM-10:30AM
-
Abstract Number: 3116
Risk of Infections in Juvenile Idiopathic Arthritis Patients Treated with Biologic Agentsand/or Methotrexate: Results from Pharmachild Registry
- 9:00AM-10:30AM
-
Abstract Number: 3144
Role of the Gut Microbiome in Modulating Arthritis Progression in Mice
- 9:00AM-10:30AM
-
Abstract Number: 3179
Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- 9:00AM-10:30AM
-
Abstract Number: 3160
Scoring Syndesmophytes on CT Spine Images of Patients with Radiographic Axial Spondyloarthritis from the Sensitive Imaging of Axial Spondyloarthritis (SIAS) Cohort
- 9:00AM-10:30AM
-
Abstract Number: 3163
SEC16A and Intracellular Trafficking Abnormalities in Axial Spondyloarthritis
- 9:00AM-10:30AM
-
Abstract Number: 3125
Secular Trend of Premature Mortality in Gout: A Contrast from Rheumatoid Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3146
Selective Deletion of a Pathogenic Subset Synovial Fibroblasts Attenuates Synovial Inflammation
- 9:00AM-10:30AM
-
Abstract Number: 3121
Specific Antibody Subphenotypes in Rheumatoid Arthritis Are Associated with Unique HLA-DRB1 Residues at Position 11
- 9:00AM-10:30AM
-
Abstract Number: 3164
Spondyloarthritis Pathogenesis Involves Interplay Between Gut Microbiota and Genetic Background
- 9:00AM-10:30AM
-
Abstract Number: 3138
Sustained Improvement in Follow-up of Hypertension in Rheumatology Patients: Results of an Intervention Sustainability Assessment
- 9:00AM-10:30AM
-
Abstract Number: 3162
Symmetric and Asymmetric Sacroiliitis Are Associated with Different Major Histocompatibility Class I Alleles in Psoriatic Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3177
Targeted Nuclear Imaging for the Early Detection of Lung Involvement in Systemic Sclerosis
- 9:00AM-10:30AM
-
Abstract Number: 3172
Temporal Trends in SLE Mortality According to Sex, Race, Ethnicity, and Geographic Region in the United States over the Past Five Decades
- 9:00AM-10:30AM
-
Abstract Number: 3161
The Association Between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3157
The Association Between Sonographic Enthesitis and Radiographic Damage in Psoriatic Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 3143
The Caspase 8/RIPK3 Signaling Axis in Dendritic Cells Controls Joint Homeostasis Under Steady-State and Arthritic Conditions
- 9:00AM-10:30AM
-
Abstract Number: 3151
The Diagnostic and Predictive Value of Anti-Acetylated Peptide Antibodies in RA Patients Starting Methotrexate Treatment
- 9:00AM-10:30AM
-
Abstract Number: 3171
The Impact of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases
- 9:00AM-10:30AM
-
Abstract Number: 3150
The Initial Dose of Methotrexate per Weight Is Determinant of Disease Activity and Early DAS28 Remission in DMARD-Naive Early Rheumatoid Arthritis Patients Receiving Usual Care
- 9:00AM-10:30AM
-
Abstract Number: 3129
The Pharmacokinetics of Oxypurinol in Patients Treated with Hemodialysis and Allopurinol
- 9:00AM-10:30AM
-
Abstract Number: 3181
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis
- 9:00AM-10:30AM
-
Abstract Number: 3183
Tocilizumab for the Treatment of Giant Cell Arteritis – MR-Angiography Results from the First Randomized Placebo-Controlled Trial
- 9:00AM-10:30AM
-
Abstract Number: 3167
Total and Glucocorticoid-Related Damage Accrual in the Systemic Lupus International Collaborating Clinics Inception Cohort
- 9:00AM-10:30AM
-
Abstract Number: 3127
Ultrasound Evaluation of the Achilles Tendon in Tophaceous Gout: A Case-Control Study
- 9:00AM-10:30AM
-
Abstract Number: 3180
Utility of Measurements of Urinary Soluble CD163 & MCP-1 in the Identification of Subtle Renal Flares in ANCA-Associated Vasculitis
- 9:00AM-10:30AM
-
Abstract Number: 3159
Validation of MRI Structural Lesions Using Computed Tomography in Patients with Axial Spondyloarthritis
- 9:00AM-10:30AM
-
Abstract Number: 3158
What Predicts Absence of Spinal Damage in Patients with Spondyloarthritis after Prolonged Follow up?
- 9:00AM-10:30AM
-
Abstract Number: 3155
Zygapophyseal Joint Fusion in Ankylosing Spondylitis Assessed Using Computed Tomography: Associations with Syndesmophytes and Spinal Motion
- 11:00AM-12:30PM
-
Abstract Number: 3210
10+ Years’ Follow-up of a Danish 2-Year Treat-to-Target RCT in Patients with Early Rheumatoid Arthritis: Baseline Predictors of Functional and Radiographic Outcomes
- 11:00AM-12:30PM
-
Abstract Number: 3196
A Natural Language Processing System Can Capture Rheumatoid Arthritis Disease Activity Measures in US Veterans Across Multiple Sites
- 11:00AM-12:30PM
-
Abstract Number: 3255
A Randomized Trial of Automated Telephone-Linked Communication to Improve Exercise Adherence for a Progressive Resistance Training Program in People with Knee Osteoarthritis
- 11:00AM-12:30PM
-
Abstract Number: 3219
Altered microRNA Expression Pattern in Synovial and Blood Neutrophils in Rheumatoid Arthritis Reveals the Pathogenic Profile of These Cells. Effect of Biological Therapies
- 11:00AM-12:30PM
-
Abstract Number: 3203
Analysis of Efficacy and Safety of Cyclophosphamide in Juvenile Dermatomyositis Using a Large National UK Cohort
- 11:00AM-12:30PM
-
Abstract Number: 3215
ASK1 Is Regulated By IL-1β and TNF and Modulates Key Rheumatoid Arthritis (RA) Fibroblast-like Synoviocyte Functions (FLS)
- 11:00AM-12:30PM
-
Abstract Number: 3213
Assessment of Two Different DAS Treatment Targets in Early Active Rheumatoid Arthritis Patients
- 11:00AM-12:30PM
-
Abstract Number: 3188
Association of Gout with Risk of Advanced Chronic Kidney Disease
- 11:00AM-12:30PM
-
Abstract Number: 3204
Body Composition and Adipose Tissue Distribution in Juvenile Dermatomyositis and Associations with Cardiac Function
- 11:00AM-12:30PM
-
Abstract Number: 3229
Bone Morphogenetic Protein 6 Receptor Inhibition Restores Salivary Gland Function in a Mouse Model of Primary Sjögren’s Syndrome
- 11:00AM-12:30PM
-
Abstract Number: 3217
Broad-Based Interrogation of the Serum Proteome Suggests That RA Onset Is Associated with Activation of the Intrinsic Coagulation Cascade
- 11:00AM-12:30PM
-
Abstract Number: 3209
Clinical and Radiological Outcomes of 5 Years Remission Steered Treatment in Early Rheumatoid and Undifferentiated Arthritis Patients
- 11:00AM-12:30PM
-
Abstract Number: 3202
Clinical and Ultrasonographic Evaluation of Joint Involvement in Patients with Systemic Sclerosis
- 11:00AM-12:30PM
-
Abstract Number: 3252
Content Analysis of Ergonomic Recommendations Using the Ergonomic Assessment Tool for Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3191
Coronary Revascularization Procedure Rates and Risks Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort
- 11:00AM-12:30PM
-
Abstract Number: 3232
Decreased Expression of Micro-RNA 130a and Micro-RNA 708 in Type-1 Classical Dendritic Cells of Patients with Primary SS Indicates Their Dysregulation
- 11:00AM-12:30PM
-
Abstract Number: 3238
Depression Symptoms throughout the Lifespan in a Low-Income, Minority Cohort of Lupus Patients: Who Is at Risk?
- 11:00AM-12:30PM
-
Abstract Number: 3233
Determinants of Pain, Fatigue, Physical Function and Social Participation in SLE Patients, Measured with Patient Reported Outcomes Measurement Information System (PROMIS®) Computerized Adaptive Tests
- 11:00AM-12:30PM
-
Abstract Number: 3186
Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis and Levels of Discordance According to Disease Activity: A Multicenter European Study
- 11:00AM-12:30PM
-
Abstract Number: 3201
Diagnostic Value of Quantitative Sialoscintigraphy Compared to Labial Salivary Gland Biopsy in Patients with Suspected SjöGren’ Syndrome
- 11:00AM-12:30PM
-
Abstract Number: 3220
Distinct Single Cell Gene Expression Signatures of Monocyte Subsets Differentiate Between TNF-Alpha Inhibitor Treatment Response Groups in Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3225
Dual Cytokine Inhibition with ABT-122, a Tnf– and IL-17–Targeted Dual Variable Domain Immunoglobulin (DVD-Ig™): Results from a 24-Week Open-Label Extension Study in Patients with Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3211
Early Radiological Progression in Rheumatoid Arthritis Leads to More Long-Term Joint Damage in Daily Clinical Practice; Six Year Radiological Outcomes of a Strict Treat-to-Target Cohort in the Netherlands
- 11:00AM-12:30PM
-
Abstract Number: 3206
Effectiveness of Childhood Vaccinations in CAPS Patients Treated with Canakinumab: Results from an Open-Label Phase III Extension Study
- 11:00AM-12:30PM
-
Abstract Number: 3205
Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD AND TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
- 11:00AM-12:30PM
-
Abstract Number: 3222
Efficacy and Safety of Monotherapy with Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, Compared with Adalimumab Monotherapy in Biologic-Naive Patients with Active Rheumatoid Arthritis: Results of a Global, Randomized, Double-Blind, Parallel-Group, Phase 3 Study
- 11:00AM-12:30PM
-
Abstract Number: 3221
Efficacy and Safety of Sarilumab Versus Adalimumab in a Phase 3, Randomized, Double-Blind, Monotherapy Study in Patients with Active Rheumatoid Arthritis with Intolerance or Inadequate Response to Methotrexate
- 11:00AM-12:30PM
-
Abstract Number: 3223
Efficacy and Safety of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study
- 11:00AM-12:30PM
-
Abstract Number: 3248
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post-Hoc Analyses from the Scleroderma Lung Study I and II
- 11:00AM-12:30PM
-
Abstract Number: 3224
Efficacy of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, Based upon Prior Use of Non-Anti-TNF Biologics in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Global Phase 3 Study
- 11:00AM-12:30PM
-
Abstract Number: 3190
Epidemiology of Polymyalgia Rheumatica 2000-2014: A Population Based Study
- 11:00AM-12:30PM
-
Abstract Number: 3239
Expression of IFN-Regulated Genes in Autoantibody Exposed Babies in Utero
- 11:00AM-12:30PM
-
Abstract Number: 3194
Factors Related to Physicians’ Prescriptions for Rheumatoid Arthritis Drugs Never Filled or Subsequently Discontinued By Patients
- 11:00AM-12:30PM
-
Abstract Number: 3256
Functional Ability ‘to Rise’ and Autonomy Support for Physical Activity: Implications for Light Physical Activity Engagement and Psychological Wellbeing in People Living with Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3241
Genetic Variation and Tobacco Smoke Exposure in Systemic Lupus Erythematosus: A Case Control Study Among African Americans
- 11:00AM-12:30PM
-
Abstract Number: 3230
Genome-Wide Association Study Identifies Novel Sjögren’s Syndrome Risk Loci in the Regions of NAB1, TYK2, and PTTG1-mir146a
- 11:00AM-12:30PM
-
Abstract Number: 3242
Identification and Functional Characterization of TNIP1 Causal Variants Associated with Systemic Lupus Erythematosus
- 11:00AM-12:30PM
-
Abstract Number: 3200
Immunoscintigraphic Detection Of Tumor Necrosis Factor By Radiolabeled Certolizumab Pegol in Patients with Erosive Hand Osteoarthritis in Relation to Disease Activity: A Proof of Concept Study
- 11:00AM-12:30PM
-
Abstract Number: 3214
Implementation of Treat to Target in Rheumatoid Arthritis through a Learning Collaborative
- 11:00AM-12:30PM
-
Abstract Number: 3249
Improvement in Cough and Cough-Related Quality of Life in Participants Undergoing Treatment for Systemic Sclerosis-Related Interstitial Lung Disease
- 11:00AM-12:30PM
-
Abstract Number: 3192
Influence of Temperature and Humidity on Disease Activity in Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3216
Integrated High-Dimensional Analyses Reveal a Pathologically Expanded ‘Peripheral’ B Cell-Helper T Cell Population in Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3198
Inter-Reader and Intra-Reader Reliability of the New Omeract Ultrasonographic Criteria for the Diagnosis of Calcium Pyrophosphate Deposition Disease
- 11:00AM-12:30PM
-
Abstract Number: 3240
Interferon Kappa Is a Novel Type I IFN That Drives Cutaneous Inflammation in Systemic Lupus
- 11:00AM-12:30PM
-
Abstract Number: 3243
Intestinal Microbial Dysbiosis in SLE Is Linked to Elevated IgA and Induction of Autoimmunity
- 11:00AM-12:30PM
-
Abstract Number: 3193
Is an Intensive Diet and Exercise Regimen Cost-Effective for Obese and Overweight Patients with Symptomatic Knee OA?
- 11:00AM-12:30PM
-
Abstract Number: 3235
Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus: Up to 7 Years of Treatment Exposure
- 11:00AM-12:30PM
-
Abstract Number: 3226
Maintenance of Clinical Remission and Radiographic Non-Progression with MTX after Completion of 1 Year Initial Treatment with Certolizumab Pegol in Japanese Patients with Early Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3253
Minimum Physical Function Needed to Walk 6000 Steps/Day in People with Knee Osteoarthritis
- 11:00AM-12:30PM
-
Abstract Number: 3231
miR200b-5p Expression in Minor Salivary Glands (MSG): A Possible Predictor of Lymphoma Development in Sjögren’s Syndrome (SS)?
- 11:00AM-12:30PM
-
Abstract Number: 3227
Modelling Primary Sjögren’s Syndrome Using Salivary Gland Stem Cells
- 11:00AM-12:30PM
-
Abstract Number: 3244
Observations of Early and Late B Cell Alterations during Belimumab Treatment in Patients with Systemic Lupus Erythematosus Using Mass Cytometry (CyTOF)
- 11:00AM-12:30PM
-
Abstract Number: 3189
Patient Perceptions of Glucocorticoid Side Effects: A Survey of Users in an Online Health Community
- 11:00AM-12:30PM
-
Abstract Number: 3195
Patterns and Predictors of Hydroxychloroquine Nonadherence in a Nationwide Cohort of Medicaid Beneficiaries with Systemic Lupus Erythematosus
- 11:00AM-12:30PM
-
Abstract Number: 3246
Predictors of Long-Term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
- 11:00AM-12:30PM
-
Abstract Number: 3208
Preliminary Response to JAK1/2 Inhibition with Baricitinib in “Candle”,“Savi” and “Candle-like” Diseases. a New Therapeutic Approach for Type I IFN Mediated Autoinflammatory Diseases
- 11:00AM-12:30PM
-
Abstract Number: 3234
Prevalence and Metric of Depression and Anxiety in Lupus: A Systematic Review and Meta-Analys
- 11:00AM-12:30PM
-
Abstract Number: 3237
Responsiveness and Its Magnitude in the 36-Item Short Form Health Survey and the Lupus Quality of Life Questionnaire in Patients with Active Disease
- 11:00AM-12:30PM
-
Abstract Number: 3247
Safety and Efficacy of Belimumab with Background Mycophenolate for Early Diffuse Cutaneous Systemic Sclerosis: A Randomized, Placebo Controlled, Pilot Trial
- 11:00AM-12:30PM
-
Abstract Number: 3185
Sensitivity Analysis for the Smoking Paradox in the Development of Psoriatic Arthritis Among Psoriasis Patients
- 11:00AM-12:30PM
-
Abstract Number: 3250
Serum MCP-1 Levels Predict Long-Term Progression of Interstitial Lung Disease in Systemic Sclerosis
- 11:00AM-12:30PM
-
Abstract Number: 3251
Sleep and Physical Activity: A Nationwide Survey Among People with Rheumatic Disease in Ireland
- 11:00AM-12:30PM
-
Abstract Number: 3187
Societal Costs and Patients’ Experience of Health Inequities from Psoriatic Arthritis: A Danish Cohort Study
- 11:00AM-12:30PM
-
Abstract Number: 3236
Socio-Demographic and Clinical Factors Influencing Generic and Disease-Specific Quality of Life in Patients with Systemic Lupus Erythematosus: Results of a Prospective Multicenter Study
- 11:00AM-12:30PM
-
Abstract Number: 3228
Specific T Cell and B Cell Distributions Characterize Subgroups of Patients with Primary Sjögren’s Syndrome and Are Associated with Disease Activity and Pro-Inflammatory Cytokine Expression
- 11:00AM-12:30PM
-
Abstract Number: 3245
Surfactant Protein D and Krebs Von Den Lungen-6 Predict Severity of Systemic Sclerosis-Related Interstitial Lung Disease in Two Independent Cohorts
- 11:00AM-12:30PM
-
Abstract Number: 3218
Synovial Mast Cells Associate with High Disease Activity and Predict Radiographic Progression at 12 Months in Patients with Early Rheumatoid Arthritis
- 11:00AM-12:30PM
-
Abstract Number: 3207
The Deficiency of Adenosine Deaminase Type 2 (DADA2)—Results of Anti-TNF Treatment in a Cohort of Patients with a History of Stroke
- 11:00AM-12:30PM
-
Abstract Number: 3212
Treat-to-Target in RA: Does Early Simplified Disease Activity Index (SDAI) Remission Lead to Better 5-Year Functional Outcomes Than SDAI Low Disease Activity?
- 11:00AM-12:30PM
-
Abstract Number: 3197
Ultrasound Definitions for Cranial and Large Vessel Giant Cell Arteritis: Results of a Reliability Exercise on Images and Videos of the Omeract Ultrasound Large Vessel Vasculitis Task Force
- 11:00AM-12:30PM
-
Abstract Number: 3199
Urate Crystal Deposition and Bone Erosion in Gout: Inside-out or Outside-in? a Dual Energy Computed Tomography Study
- 11:00AM-12:30PM
-
Abstract Number: 3254
Use of the Short Valued Life Activities Scale in People with Systemic Sclerosis